BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= psy17882
(181 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|3CJW|A Chain A, Crystal Structure Of The Human Coup-Tfii Ligand Binding
Domain
Length = 244
Score = 122 bits (305), Expect = 2e-28, Method: Compositional matrix adjust.
Identities = 63/177 (35%), Positives = 99/177 (55%)
Query: 2 AVKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPN 61
AV+WA+N+P F L DQV NA Q S+PL + L A H + +
Sbjct: 53 AVEWARNIPFFPDLQITDQVALLRLTWSELFVLNAAQCSMPLHVAPLLAAAGLHASPMSA 112
Query: 62 GKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQAQ 121
+ +R+ +++ + + VD AE++CLKA+VLF S+ GL D VE+LQ+++Q
Sbjct: 113 DRVVAFMDHIRIFQEQVEKLKALHVDSAEYSCLKAIVLFTSDACGLSDVAHVESLQEKSQ 172
Query: 122 VMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSMEKLLCDM 178
L ++VR+ +P QP RFG+LLL R + S+ ++ +FF + V T +E L+ DM
Sbjct: 173 CALEEYVRSQYPNQPTRFGKLLLRLPSLRTVSSSVIEQLFFVRLVGKTPIETLIRDM 229
>pdb|1Z5X|U Chain U, Hemipteran Ecdysone Receptor Ligand-Binding Domain
Complexed With Ponasterone A
Length = 262
Score = 97.1 bits (240), Expect = 5e-21, Method: Compositional matrix adjust.
Identities = 57/182 (31%), Positives = 90/182 (49%), Gaps = 7/182 (3%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPNG 62
++WAK++P F LP DQVI S+ + + L V
Sbjct: 81 IEWAKHIPHFTELPVEDQVILLKSGWNELLIAGFSHRSMSVKDGIMLATG----LVVHRN 136
Query: 63 KASQTAADV---RVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQ 119
A Q RVL ++ + R + +D E CL+++VLF E +GLK + QVENL+++
Sbjct: 137 CAHQAGVGAIFDRVLTELVAKMREMKMDKTELGCLRSIVLFNPEAKGLKSTQQVENLREK 196
Query: 120 AQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSMEKLLCDMY 179
+L ++ R +P Q RF +LLL R+I ++H+FF K V NTS++ L M
Sbjct: 197 VYAILEEYCRQTYPDQSGRFAKLLLRLPALRSIGLKCLEHLFFFKLVGNTSIDSFLLSML 256
Query: 180 KN 181
++
Sbjct: 257 ES 258
>pdb|2Q60|A Chain A, Crystal Structure Of The Ligand Binding Domain Of
Polyandrocarpa Misakiensis Rxr In Tetramer In Absence Of
Ligand
pdb|2Q60|B Chain B, Crystal Structure Of The Ligand Binding Domain Of
Polyandrocarpa Misakiensis Rxr In Tetramer In Absence Of
Ligand
pdb|2Q60|C Chain C, Crystal Structure Of The Ligand Binding Domain Of
Polyandrocarpa Misakiensis Rxr In Tetramer In Absence Of
Ligand
pdb|2Q60|D Chain D, Crystal Structure Of The Ligand Binding Domain Of
Polyandrocarpa Misakiensis Rxr In Tetramer In Absence Of
Ligand
Length = 258
Score = 95.9 bits (237), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 55/179 (30%), Positives = 92/179 (51%), Gaps = 1/179 (0%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPNG 62
V+WAK +P F++LP DQVI + S+ + + S L + HV
Sbjct: 75 VEWAKRIPHFSSLPLEDQVILLRAGWNELLIASFSHRSIDV-KDSILLASGLHVHRHSAH 133
Query: 63 KASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQAQV 122
+A RVL ++ + R + +D E CL+AVVLF + + DS +E+L+++
Sbjct: 134 QAGVGPIFDRVLTELVSKMRDMMMDKTELGCLRAVVLFNPDVKNPSDSAHIESLREKVYA 193
Query: 123 MLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSMEKLLCDMYKN 181
L + R+ +P QP RF +LLL R+I ++H+FF K + +T ++K L +M +
Sbjct: 194 SLEAYCRSKYPDQPGRFAKLLLRLPALRSIGLKCLEHLFFFKLIGDTPIDKFLMNMLET 252
>pdb|1DKF|A Chain A, Crystal Structure Of A Heterodimeric Complex Of Rar And
Rxr Ligand-Binding Domains
Length = 233
Score = 94.7 bits (234), Expect = 3e-20, Method: Compositional matrix adjust.
Identities = 54/178 (30%), Positives = 90/178 (50%), Gaps = 1/178 (0%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPNG 62
V+WAK +P F+ LP DQVI +A S+ + + L HV
Sbjct: 56 VEWAKRIPHFSELPLDDQVILLRAGWNELLIASASHRSIAV-KDGILLATGLHVHRNSAH 114
Query: 63 KASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQAQV 122
A A RVL ++ + R + +D E CL+A+VLF +++GL + +VE L+++
Sbjct: 115 SAGVGAIFDRVLTELVSKMRDMQMDKTELGCLRAIVLFNPDSKGLSNPAEVEALREKVYA 174
Query: 123 MLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSMEKLLCDMYK 180
L + + +P QP RF +LLL R+I ++H+FF K + +T ++ L +M +
Sbjct: 175 SLEAYCKHKYPEQPGRFAKLLLRLPALRSIGLKCLEHLFFFKLIGDTPIDTFLMEMLE 232
>pdb|3EYB|A Chain A, Structural And Functional Insights Into The Ligand Binding
Domain Of A Non-Duplicated Rxr From The Invertebrate
Chordate Amphioxus
pdb|3EYB|B Chain B, Structural And Functional Insights Into The Ligand Binding
Domain Of A Non-Duplicated Rxr From The Invertebrate
Chordate Amphioxus
pdb|3EYB|C Chain C, Structural And Functional Insights Into The Ligand Binding
Domain Of A Non-Duplicated Rxr From The Invertebrate
Chordate Amphioxus
pdb|3EYB|D Chain D, Structural And Functional Insights Into The Ligand Binding
Domain Of A Non-Duplicated Rxr From The Invertebrate
Chordate Amphioxus
Length = 219
Score = 92.8 bits (229), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 53/176 (30%), Positives = 88/176 (50%), Gaps = 1/176 (0%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPNG 62
V+WAK +P F+ LP DQVI S+ + + L + HV
Sbjct: 44 VEWAKRIPHFSDLPIDDQVILLRAGWNELLIAAFSHRSIDV-KDGILLASGLHVHRSSAH 102
Query: 63 KASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQAQV 122
+A RVL ++ + R + +D E CL+A+VLF + +GL D VE+L+++
Sbjct: 103 QAGVGTIFDRVLTELVAKMRDMKMDKTELGCLRAIVLFNPDAKGLTDPSLVESLREKVYA 162
Query: 123 MLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSMEKLLCDM 178
L ++ + +P QP RF +LLL R+I ++H+FF K + +T ++ L +M
Sbjct: 163 SLEEYCKQQYPEQPGRFAKLLLRLPALRSIGLKCLEHLFFFKLIGDTPIDTFLMEM 218
>pdb|3PCU|A Chain A, Crystal Structure Of Human Retinoic X Receptor Alpha
Ligand-Binding Domain Complexed With Lx0278 And Src1
Peptide
Length = 230
Score = 92.4 bits (228), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 53/178 (29%), Positives = 89/178 (50%), Gaps = 1/178 (0%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPNG 62
V+WAK +P F+ LP DQVI + S+ + + L HV
Sbjct: 52 VEWAKRIPHFSELPLDDQVILLRAGWNELLIASFSHRSIAV-KDGILLATGLHVHRNSAH 110
Query: 63 KASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQAQV 122
A A RVL ++ + R + +D E CL+A+VLF +++GL + +VE L+++
Sbjct: 111 SAGVGAIFDRVLTELVSKMRDMQMDKTELGCLRAIVLFNPDSKGLSNPAEVEALREKVYA 170
Query: 123 MLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSMEKLLCDMYK 180
L + + +P QP RF +LLL R+I ++H+FF K + +T ++ L +M +
Sbjct: 171 SLEAYCKHKYPEQPGRFAKLLLRLPALRSIGLKCLEHLFFFKLIGDTPIDTFLMEMLE 228
>pdb|3OAP|A Chain A, Crystal Structure Of Human Retinoid X Receptor
Alpha-Ligand Binding Domain Complex With 9-Cis Retinoic
Acid And The Coactivator Peptide Grip-1
Length = 231
Score = 92.4 bits (228), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 53/178 (29%), Positives = 89/178 (50%), Gaps = 1/178 (0%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPNG 62
V+WAK +P F+ LP DQVI + S+ + + L HV
Sbjct: 53 VEWAKRIPHFSELPLDDQVILLRAGWNELLIASFSHRSIAV-KDGILLATGLHVHRNSAH 111
Query: 63 KASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQAQV 122
A A RVL ++ + R + +D E CL+A+VLF +++GL + +VE L+++
Sbjct: 112 SAGVGAIFDRVLTELVSKMRDMQMDKTELGCLRAIVLFNPDSKGLSNPAEVEALREKVYA 171
Query: 123 MLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSMEKLLCDMYK 180
L + + +P QP RF +LLL R+I ++H+FF K + +T ++ L +M +
Sbjct: 172 SLEAYCKHKYPEQPGRFAKLLLRLPALRSIGLKCLEHLFFFKLIGDTPIDTFLMEMLE 229
>pdb|1XIU|A Chain A, Crystal Structure Of The Agonist-Bound Ligand-Binding
Domain Of Biomphalaria Glabrata Rxr
pdb|1XIU|B Chain B, Crystal Structure Of The Agonist-Bound Ligand-Binding
Domain Of Biomphalaria Glabrata Rxr
Length = 230
Score = 92.4 bits (228), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 52/179 (29%), Positives = 87/179 (48%), Gaps = 1/179 (0%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPNG 62
V+WAK +P F LP DQVI S+ + + L HV
Sbjct: 48 VEWAKRIPHFTELPLEDQVILLRAGWNELLIAGFSHRSI-MAKDGILLATGLHVHRSSAH 106
Query: 63 KASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQAQV 122
+A RVL ++ + R + +D E CL+AVVLF + +GL +VE L+++
Sbjct: 107 QAGVGTIFDRVLTELVAKMRDMKMDKTELGCLRAVVLFNPDAKGLTAVQEVEQLREKVYA 166
Query: 123 MLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSMEKLLCDMYKN 181
L ++ ++ +P +P RF +LLL R+I ++H+FF K + + ++ L +M +N
Sbjct: 167 SLEEYTKSRYPEEPGRFAKLLLRLPALRSIGLKCLEHLFFFKLIGDQPIDTFLMEMLEN 225
>pdb|3UVV|B Chain B, Crystal Structure Of The Ligand Binding Domains Of The
Thyroid Receptor:retinoid X Receptor Complexed With
3,3',5 Triiodo-L- Thyronine And 9-Cis Retinoic Acid
Length = 244
Score = 92.4 bits (228), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 53/178 (29%), Positives = 89/178 (50%), Gaps = 1/178 (0%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPNG 62
V+WAK +P F+ LP DQVI + S+ + + L HV
Sbjct: 60 VEWAKRIPHFSELPLDDQVILLRAGWNELLIASFSHRSIAV-KDGILLATGLHVHRNSAH 118
Query: 63 KASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQAQV 122
A A RVL ++ + R + +D E CL+A+VLF +++GL + +VE L+++
Sbjct: 119 SAGVGAIFDRVLTELVSKMRDMQMDKTELGCLRAIVLFNPDSKGLSNPAEVEALREKVYA 178
Query: 123 MLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSMEKLLCDMYK 180
L + + +P QP RF +LLL R+I ++H+FF K + +T ++ L +M +
Sbjct: 179 SLEAYCKHKYPEQPGRFAKLLLRLPALRSIGLKCLEHLFFFKLIGDTPIDTFLMEMLE 236
>pdb|1XLS|A Chain A, Crystal Structure Of The Mouse CarRXR LBD HETERODIMER
Bound To Tcpobop And 9cra And A Tif2 Peptide Containg
The Third Lxxll Motifs
pdb|1XLS|B Chain B, Crystal Structure Of The Mouse CarRXR LBD HETERODIMER
Bound To Tcpobop And 9cra And A Tif2 Peptide Containg
The Third Lxxll Motifs
pdb|1XLS|C Chain C, Crystal Structure Of The Mouse CarRXR LBD HETERODIMER
Bound To Tcpobop And 9cra And A Tif2 Peptide Containg
The Third Lxxll Motifs
pdb|1XLS|D Chain D, Crystal Structure Of The Mouse CarRXR LBD HETERODIMER
Bound To Tcpobop And 9cra And A Tif2 Peptide Containg
The Third Lxxll Motifs
Length = 232
Score = 92.4 bits (228), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 53/178 (29%), Positives = 89/178 (50%), Gaps = 1/178 (0%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPNG 62
V+WAK +P F+ LP DQVI + S+ + + L HV
Sbjct: 54 VEWAKRIPHFSELPLDDQVILLRAGWNELLIASFSHRSIAV-KDGILLATGLHVHRNSAH 112
Query: 63 KASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQAQV 122
A A RVL ++ + R + +D E CL+A+VLF +++GL + +VE L+++
Sbjct: 113 SAGVGAIFDRVLTELVSKMRDMQMDKTELGCLRAIVLFNPDSKGLSNPAEVEALREKVYA 172
Query: 123 MLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSMEKLLCDMYK 180
L + + +P QP RF +LLL R+I ++H+FF K + +T ++ L +M +
Sbjct: 173 SLEAYCKHKYPEQPGRFAKLLLRLPALRSIGLKCLEHLFFFKLIGDTPIDTFLMEMLE 230
>pdb|3H0A|A Chain A, Crystal Structure Of Peroxisome Proliferator-Activated
Receptor Gamma (Pparg) And Retinoic Acid Receptor Alpha
(Rxra) In Complex With 9-Cis Retinoic Acid, Co-Activator
Peptide, And A Partial Agonist
Length = 228
Score = 92.4 bits (228), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 53/176 (30%), Positives = 88/176 (50%), Gaps = 1/176 (0%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPNG 62
V+WAK +P F+ LP DQVI + S+ + + L HV
Sbjct: 53 VEWAKRIPHFSELPLDDQVILLRAGWNELLIASFSHRSIAV-KDGILLATGLHVHRNSAH 111
Query: 63 KASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQAQV 122
A A RVL ++ + R + +D E CL+A+VLF +++GL + +VE L+++
Sbjct: 112 SAGVGAIFDRVLTELVSKMRDMQMDKTELGCLRAIVLFNPDSKGLSNPAEVEALREKVYA 171
Query: 123 MLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSMEKLLCDM 178
L + + +P QP RF +LLL R+I ++H+FF K + +T ++ L +M
Sbjct: 172 SLEAYCKHKYPEQPGRFAKLLLRLPALRSIGLKCLEHLFFFKLIGDTPIDTFLMEM 227
>pdb|1FM6|A Chain A, The 2.1 Angstrom Resolution Crystal Structure Of The
Heterodimer Of The Human Rxralpha And Ppargamma Ligand
Binding Domains Respectively Bound With 9-Cis Retinoic
Acid And Rosiglitazone And Co-Activator Peptides.
pdb|1FM6|U Chain U, The 2.1 Angstrom Resolution Crystal Structure Of The
Heterodimer Of The Human Rxralpha And Ppargamma Ligand
Binding Domains Respectively Bound With 9-Cis Retinoic
Acid And Rosiglitazone And Co-Activator Peptides.
pdb|1FM9|A Chain A, The 2.1 Angstrom Resolution Crystal Structure Of The
Heterodimer Of The Human Rxralpha And Ppargamma Ligand
Binding Domains Respectively Bound With 9-Cis Retinoic
Acid And Gi262570 And Co-Activator Peptides.
pdb|1G5Y|A Chain A, The 2.0 Angstrom Resolution Crystal Structure Of The
Rxralpha Ligand Binding Domain Tetramer In The Presence
Of A Non-Activating Retinoic Acid Isomer.
pdb|1G5Y|B Chain B, The 2.0 Angstrom Resolution Crystal Structure Of The
Rxralpha Ligand Binding Domain Tetramer In The Presence
Of A Non-Activating Retinoic Acid Isomer.
pdb|1G5Y|C Chain C, The 2.0 Angstrom Resolution Crystal Structure Of The
Rxralpha Ligand Binding Domain Tetramer In The Presence
Of A Non-Activating Retinoic Acid Isomer.
pdb|1G5Y|D Chain D, The 2.0 Angstrom Resolution Crystal Structure Of The
Rxralpha Ligand Binding Domain Tetramer In The Presence
Of A Non-Activating Retinoic Acid Isomer.
pdb|1G1U|A Chain A, The 2.5 Angstrom Resolution Crystal Structure Of The
Rxralpha Ligand Binding Domain In Tetramer In The
Absence Of Ligand
pdb|1G1U|B Chain B, The 2.5 Angstrom Resolution Crystal Structure Of The
Rxralpha Ligand Binding Domain In Tetramer In The
Absence Of Ligand
pdb|1G1U|C Chain C, The 2.5 Angstrom Resolution Crystal Structure Of The
Rxralpha Ligand Binding Domain In Tetramer In The
Absence Of Ligand
pdb|1G1U|D Chain D, The 2.5 Angstrom Resolution Crystal Structure Of The
Rxralpha Ligand Binding Domain In Tetramer In The
Absence Of Ligand
pdb|1K74|A Chain A, The 2.3 Angstrom Resolution Crystal Structure Of The
Heterodimer Of The Human Ppargamma And Rxralpha Ligand
Binding Domains Respectively Bound With Gw409544 And
9-Cis Retinoic Acid And Co-Activator Peptides.
pdb|2ACL|A Chain A, Liver X-Receptor Alpha Ligand Binding Domain With Sb313987
pdb|2ACL|C Chain C, Liver X-Receptor Alpha Ligand Binding Domain With Sb313987
pdb|2ACL|E Chain E, Liver X-Receptor Alpha Ligand Binding Domain With Sb313987
pdb|2ACL|G Chain G, Liver X-Receptor Alpha Ligand Binding Domain With Sb313987
pdb|3OZJ|A Chain A, Crystal Structure Of Human Retinoic X Receptor Alpha
Complexed With Bigelovin And Coactivator Src-1
pdb|3OZJ|C Chain C, Crystal Structure Of Human Retinoic X Receptor Alpha
Complexed With Bigelovin And Coactivator Src-1
Length = 238
Score = 92.0 bits (227), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 53/178 (29%), Positives = 89/178 (50%), Gaps = 1/178 (0%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPNG 62
V+WAK +P F+ LP DQVI + S+ + + L HV
Sbjct: 56 VEWAKRIPHFSELPLDDQVILLRAGWNELLIASFSHRSIAV-KDGILLATGLHVHRNSAH 114
Query: 63 KASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQAQV 122
A A RVL ++ + R + +D E CL+A+VLF +++GL + +VE L+++
Sbjct: 115 SAGVGAIFDRVLTELVSKMRDMQMDKTELGCLRAIVLFNPDSKGLSNPAEVEALREKVYA 174
Query: 123 MLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSMEKLLCDMYK 180
L + + +P QP RF +LLL R+I ++H+FF K + +T ++ L +M +
Sbjct: 175 SLEAYCKHKYPEQPGRFAKLLLRLPALRSIGLKCLEHLFFFKLIGDTPIDTFLMEMLE 232
>pdb|1RDT|A Chain A, Crystal Structure Of A New Rexinoid Bound To The Rxralpha
Ligand Binding Doamin In The RxralphaPPARGAMMA
HETERODIMER
pdb|3FC6|A Chain A, Hrxralpha & Mlxralpha With An Indole Pharmacophore,
Sb786875
pdb|3FC6|C Chain C, Hrxralpha & Mlxralpha With An Indole Pharmacophore,
Sb786875
pdb|3FAL|A Chain A, Humanrxr Alpha & Mouse Lxr Alpha Complexed With Retenoic
Acid And Gsk2186
pdb|3FAL|C Chain C, Humanrxr Alpha & Mouse Lxr Alpha Complexed With Retenoic
Acid And Gsk2186
Length = 242
Score = 92.0 bits (227), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 53/178 (29%), Positives = 89/178 (50%), Gaps = 1/178 (0%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPNG 62
V+WAK +P F+ LP DQVI + S+ + + L HV
Sbjct: 60 VEWAKRIPHFSELPLDDQVILLRAGWNELLIASFSHRSIAV-KDGILLATGLHVHRNSAH 118
Query: 63 KASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQAQV 122
A A RVL ++ + R + +D E CL+A+VLF +++GL + +VE L+++
Sbjct: 119 SAGVGAIFDRVLTELVSKMRDMQMDKTELGCLRAIVLFNPDSKGLSNPAEVEALREKVYA 178
Query: 123 MLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSMEKLLCDMYK 180
L + + +P QP RF +LLL R+I ++H+FF K + +T ++ L +M +
Sbjct: 179 SLEAYCKHKYPEQPGRFAKLLLRLPALRSIGLKCLEHLFFFKLIGDTPIDTFLMEMLE 236
>pdb|1XDK|A Chain A, Crystal Structure Of The RarbetaRXRALPHA LIGAND BINDING
Domain Heterodimer In Complex With 9-Cis Retinoic Acid
And A Fragment Of The Trap220 Coactivator
pdb|1XDK|E Chain E, Crystal Structure Of The RarbetaRXRALPHA LIGAND BINDING
Domain Heterodimer In Complex With 9-Cis Retinoic Acid
And A Fragment Of The Trap220 Coactivator
Length = 238
Score = 92.0 bits (227), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 53/178 (29%), Positives = 89/178 (50%), Gaps = 1/178 (0%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPNG 62
V+WAK +P F+ LP DQVI + S+ + + L HV
Sbjct: 56 VEWAKRIPHFSELPLDDQVILLRAGWNELLIASFSHRSIAV-KDGILLATGLHVHRNSAH 114
Query: 63 KASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQAQV 122
A A RVL ++ + R + +D E CL+A+VLF +++GL + +VE L+++
Sbjct: 115 SAGVGAIFDRVLTELVSKMRDMQMDKTELGCLRAIVLFNPDSKGLSNPAEVEALREKVYA 174
Query: 123 MLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSMEKLLCDMYK 180
L + + +P QP RF +LLL R+I ++H+FF K + +T ++ L +M +
Sbjct: 175 SLEAYCKHKYPEQPGRFAKLLLRLPALRSIGLKCLEHLFFFKLIGDTPIDTFLMEMLE 232
>pdb|1FBY|A Chain A, Crystal Structure Of The Human Rxr Alpha Ligand Binding
Domain Bound To 9-Cis Retinoic Acid
pdb|1FBY|B Chain B, Crystal Structure Of The Human Rxr Alpha Ligand Binding
Domain Bound To 9-Cis Retinoic Acid
Length = 239
Score = 92.0 bits (227), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 53/178 (29%), Positives = 89/178 (50%), Gaps = 1/178 (0%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPNG 62
V+WAK +P F+ LP DQVI + S+ + + L HV
Sbjct: 57 VEWAKRIPHFSELPLDDQVILLRAGWNELLIASFSHRSIAV-KDGILLATGLHVHRNSAH 115
Query: 63 KASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQAQV 122
A A RVL ++ + R + +D E CL+A+VLF +++GL + +VE L+++
Sbjct: 116 SAGVGAIFDRVLTELVSKMRDMQMDKTELGCLRAIVLFNPDSKGLSNPAEVEALREKVYA 175
Query: 123 MLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSMEKLLCDMYK 180
L + + +P QP RF +LLL R+I ++H+FF K + +T ++ L +M +
Sbjct: 176 SLEAYCKHKYPEQPGRFAKLLLRLPALRSIGLKCLEHLFFFKLIGDTPIDTFLMEMLE 233
>pdb|1MV9|A Chain A, Crystal Structure Of The Human Rxr Alpha Ligand Binding
Domain Bound To The Eicosanoid Dha (Docosa Hexaenoic
Acid) And A Coactivator Peptide
pdb|1MVC|A Chain A, Crystal Structure Of The Human Rxr Alpha Ligand Binding
Domain Bound To The Synthetic Agonist Compound Bms 649
And A Coactivator Peptide
pdb|1MZN|A Chain A, Crystal Structure At 1.9 Angstroems Resolution Of The
Homodimer Of Human Rxr Alpha Ligand Binding Domain Bound
To The Synthetic Agonist Compound Bms 649 And A
Coactivator Peptide
pdb|1MZN|C Chain C, Crystal Structure At 1.9 Angstroems Resolution Of The
Homodimer Of Human Rxr Alpha Ligand Binding Domain Bound
To The Synthetic Agonist Compound Bms 649 And A
Coactivator Peptide
pdb|1MZN|E Chain E, Crystal Structure At 1.9 Angstroems Resolution Of The
Homodimer Of Human Rxr Alpha Ligand Binding Domain Bound
To The Synthetic Agonist Compound Bms 649 And A
Coactivator Peptide
pdb|1MZN|G Chain G, Crystal Structure At 1.9 Angstroems Resolution Of The
Homodimer Of Human Rxr Alpha Ligand Binding Domain Bound
To The Synthetic Agonist Compound Bms 649 And A
Coactivator Peptide
pdb|2P1T|A Chain A, Crystal Structure Of The Ligand Binding Domain Of The
Retinoid X Receptor Alpha In Complex With
3-(2'-Methoxy)- Tetrahydronaphtyl Cinnamic Acid And A
Fragment Of The Coactivator Tif-2
pdb|2P1U|A Chain A, Crystal Structure Of The Ligand Binding Domain Of The
Retinoid X Receptor Alpha In Complex With 3-(2'-Ethoxy)-
Tetrahydronaphtyl Cinnamic Acid And A Fragment Of The
Coactivator Tif-2
pdb|2P1V|A Chain A, Crystal Structure Of The Ligand Binding Domain Of The
Retinoid X Receptor Alpha In Complex With
3-(2'-Propoxy)- Tetrahydronaphtyl Cinnamic Acid And A
Fragment Of The Coactivator Tif-2
pdb|3FUG|A Chain A, Crystal Structure Of The Retinoid X Receptor Ligand
Binding Domain Bound To The Synthetic Agonist
3-[4-Hydroxy-3-(3,5,
5,8,8-Pentamethyl-5,6,7,8-Tetrahydronaphthalen-2-Yl)-
Phenyl]acrylic Acid
pdb|2ZXZ|A Chain A, Crystal Structure Of The Human Rxr Alpha Ligand Binding
Domain Bound To A Synthetic Agonist Compound And A
Coactivator Peptide
pdb|2ZY0|A Chain A, Crystal Structure Of The Human Rxr Alpha Ligand Binding
Domain Bound To A Synthetic Agonist Compound And A
Coactivator Peptide
pdb|2ZY0|C Chain C, Crystal Structure Of The Human Rxr Alpha Ligand Binding
Domain Bound To A Synthetic Agonist Compound And A
Coactivator Peptide
pdb|3NSP|A Chain A, Crystal Structure Of Tetrameric Rxralpha-Lbd
pdb|3NSP|B Chain B, Crystal Structure Of Tetrameric Rxralpha-Lbd
pdb|3NSQ|A Chain A, Crystal Structure Of Tetrameric Rxralpha-Lbd Complexed
With Antagonist Danthron
pdb|3NSQ|B Chain B, Crystal Structure Of Tetrameric Rxralpha-Lbd Complexed
With Antagonist Danthron
pdb|3R29|A Chain A, Crystal Structure Of Rxralpha Ligand-Binding Domain
Complexed With Corepressor Smrt2
pdb|3R29|B Chain B, Crystal Structure Of Rxralpha Ligand-Binding Domain
Complexed With Corepressor Smrt2
pdb|3R2A|A Chain A, Crystal Structure Of Rxralpha Ligand-Binding Domain
Complexed With Corepressor Smrt2 And Antagonist Rhein
pdb|3R2A|B Chain B, Crystal Structure Of Rxralpha Ligand-Binding Domain
Complexed With Corepressor Smrt2 And Antagonist Rhein
pdb|3R2A|C Chain C, Crystal Structure Of Rxralpha Ligand-Binding Domain
Complexed With Corepressor Smrt2 And Antagonist Rhein
pdb|3R2A|D Chain D, Crystal Structure Of Rxralpha Ligand-Binding Domain
Complexed With Corepressor Smrt2 And Antagonist Rhein
pdb|3R5M|A Chain A, Crystal Structure Of Rxralphalbd Complexed With The
Agonist Magnolol
pdb|3R5M|C Chain C, Crystal Structure Of Rxralphalbd Complexed With The
Agonist Magnolol
Length = 240
Score = 92.0 bits (227), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 53/178 (29%), Positives = 89/178 (50%), Gaps = 1/178 (0%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPNG 62
V+WAK +P F+ LP DQVI + S+ + + L HV
Sbjct: 58 VEWAKRIPHFSELPLDDQVILLRAGWNELLIASFSHRSIAV-KDGILLATGLHVHRNSAH 116
Query: 63 KASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQAQV 122
A A RVL ++ + R + +D E CL+A+VLF +++GL + +VE L+++
Sbjct: 117 SAGVGAIFDRVLTELVSKMRDMQMDKTELGCLRAIVLFNPDSKGLSNPAEVEALREKVYA 176
Query: 123 MLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSMEKLLCDMYK 180
L + + +P QP RF +LLL R+I ++H+FF K + +T ++ L +M +
Sbjct: 177 SLEAYCKHKYPEQPGRFAKLLLRLPALRSIGLKCLEHLFFFKLIGDTPIDTFLMEMLE 234
>pdb|3E94|A Chain A, Crystal Structure Of Rxralpha Ligand Binding Domain In
Complex With Tributyltin And A Coactivator Fragment
pdb|3KWY|A Chain A, Crystal Structure Of Rxralpha Ligand Binding Domain In
Complex With Triphenyltin And A Coactivator Fragment
Length = 244
Score = 92.0 bits (227), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 53/178 (29%), Positives = 89/178 (50%), Gaps = 1/178 (0%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPNG 62
V+WAK +P F+ LP DQVI + S+ + + L HV
Sbjct: 62 VEWAKRIPHFSELPLDDQVILLRAGWNELLIASFSHRSIAV-KDGILLATGLHVHRNSAH 120
Query: 63 KASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQAQV 122
A A RVL ++ + R + +D E CL+A+VLF +++GL + +VE L+++
Sbjct: 121 SAGVGAIFDRVLTELVSKMRDMQMDKTELGCLRAIVLFNPDSKGLSNPAEVEALREKVYA 180
Query: 123 MLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSMEKLLCDMYK 180
L + + +P QP RF +LLL R+I ++H+FF K + +T ++ L +M +
Sbjct: 181 SLEAYCKHKYPEQPGRFAKLLLRLPALRSIGLKCLEHLFFFKLIGDTPIDTFLMEMLE 238
>pdb|1XV9|A Chain A, Crystal Structure Of CarRXR HETERODIMER BOUND WITH SRC1
Peptide, Fatty Acid, And 5b-Pregnane-3,20-Dione.
pdb|1XV9|C Chain C, Crystal Structure Of CarRXR HETERODIMER BOUND WITH SRC1
Peptide, Fatty Acid, And 5b-Pregnane-3,20-Dione.
pdb|1XVP|A Chain A, Crystal Structure Of CarRXR HETERODIMER BOUND WITH SRC1
Peptide, Fatty Acid And Citco
pdb|1XVP|C Chain C, Crystal Structure Of CarRXR HETERODIMER BOUND WITH SRC1
Peptide, Fatty Acid And Citco
Length = 236
Score = 92.0 bits (227), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 53/178 (29%), Positives = 89/178 (50%), Gaps = 1/178 (0%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPNG 62
V+WAK +P F+ LP DQVI + S+ + + L HV
Sbjct: 54 VEWAKRIPHFSELPLDDQVILLRAGWNELLIASFSHRSIAV-KDGILLATGLHVHRNSAH 112
Query: 63 KASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQAQV 122
A A RVL ++ + R + +D E CL+A+VLF +++GL + +VE L+++
Sbjct: 113 SAGVGAIFDRVLTELVSKMRDMQMDKTELGCLRAIVLFNPDSKGLSNPAEVEALREKVYA 172
Query: 123 MLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSMEKLLCDMYK 180
L + + +P QP RF +LLL R+I ++H+FF K + +T ++ L +M +
Sbjct: 173 SLEAYCKHKYPEQPGRFAKLLLRLPALRSIGLKCLEHLFFFKLIGDTPIDTFLMEMLE 230
>pdb|3A9E|A Chain A, Crystal Structure Of A Mixed Agonist-Bound Rar-Alpha And
Antagonist- Bound Rxr-Alpha Heterodimer Ligand Binding
Domains
Length = 240
Score = 92.0 bits (227), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 53/178 (29%), Positives = 89/178 (50%), Gaps = 1/178 (0%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPNG 62
V+WAK +P F+ LP DQVI + S+ + + L HV
Sbjct: 58 VEWAKRIPHFSELPLDDQVILLRAGWNELLIASFSHRSIAV-KDGILLATGLHVHRNSAH 116
Query: 63 KASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQAQV 122
A A RVL ++ + R + +D E CL+A+VLF +++GL + +VE L+++
Sbjct: 117 SAGVGAIFDRVLTELVSKMRDMQMDKTELGCLRAIVLFNPDSKGLSNPAEVEALREKVYA 176
Query: 123 MLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSMEKLLCDMYK 180
L + + +P QP RF +LLL R+I ++H+FF K + +T ++ L +M +
Sbjct: 177 SLEAYCKHKYPEQPGRFAKLLLRLPALRSIGLKCLEHLFFFKLIGDTPIDTFLMEMLE 234
>pdb|1LBD|A Chain A, Ligand-Binding Domain Of The Human Nuclear Receptor
Rxr-Alpha
Length = 282
Score = 91.3 bits (225), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 53/178 (29%), Positives = 89/178 (50%), Gaps = 1/178 (0%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPNG 62
V+WAK +P F+ LP DQVI + S+ + + L HV
Sbjct: 100 VEWAKRIPHFSELPLDDQVILLRAGWNELLIASFSHRSIAV-KDGILLATGLHVHRNSAH 158
Query: 63 KASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQAQV 122
A A RVL ++ + R + +D E CL+A+VLF +++GL + +VE L+++
Sbjct: 159 SAGVGAIFDRVLTELVSKMRDMQMDKTELGCLRAIVLFNPDSKGLSNPAEVEALREKVYA 218
Query: 123 MLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSMEKLLCDMYK 180
L + + +P QP RF +LLL R+I ++H+FF K + +T ++ L +M +
Sbjct: 219 SLEAYCKHKYPEQPGRFAKLLLRLPALRSIGLKCLEHLFFFKLIGDTPIDTFLMEMLE 276
>pdb|3DZU|A Chain A, Intact Ppar Gamma - Rxr Alpha Nuclear Receptor Complex On
Dna Bound With Bvt.13, 9-Cis Retinoic Acid And Ncoa2
Peptide
pdb|3DZY|A Chain A, Intact Ppar Gamma - Rxr Alpha Nuclear Receptor Complex On
Dna Bound With Rosiglitazone, 9-Cis Retinoic Acid And
Ncoa2 Peptide
pdb|3E00|A Chain A, Intact Ppar Gamma - Rxr Alpha Nuclear Receptor Complex On
Dna Bound With Gw9662, 9-Cis Retinoic Acid And Ncoa2
Peptide
Length = 467
Score = 90.5 bits (223), Expect = 5e-19, Method: Compositional matrix adjust.
Identities = 53/176 (30%), Positives = 88/176 (50%), Gaps = 1/176 (0%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPNG 62
V+WAK +P F+ LP DQVI + S+ ++ L HV
Sbjct: 285 VEWAKRIPHFSELPLDDQVILLRAGWNELLIASFSHRSI-AVKDGILLATGLHVHRNSAH 343
Query: 63 KASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQAQV 122
A A RVL ++ + R + +D E CL+A+VLF +++GL + +VE L+++
Sbjct: 344 SAGVGAIFDRVLTELVSKMRDMQMDKTELGCLRAIVLFNPDSKGLSNPAEVEALREKVYA 403
Query: 123 MLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSMEKLLCDM 178
L + + +P QP RF +LLL R+I ++H+FF K + +T ++ L +M
Sbjct: 404 SLEAYCKHKYPEQPGRFAKLLLRLPALRSIGLKCLEHLFFFKLIGDTPIDTFLMEM 459
>pdb|2GL8|A Chain A, Human Retinoic Acid Receptor Rxr-Gamma Ligand-Binding
Domain
pdb|2GL8|B Chain B, Human Retinoic Acid Receptor Rxr-Gamma Ligand-Binding
Domain
pdb|2GL8|C Chain C, Human Retinoic Acid Receptor Rxr-Gamma Ligand-Binding
Domain
pdb|2GL8|D Chain D, Human Retinoic Acid Receptor Rxr-Gamma Ligand-Binding
Domain
Length = 241
Score = 88.6 bits (218), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 50/179 (27%), Positives = 88/179 (49%), Gaps = 1/179 (0%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPNG 62
V+WAK +P F+ L DQVI + S+ + + L HV
Sbjct: 59 VEWAKRIPHFSDLTLEDQVILLRAGWNELLIASFSHRSVSV-QDGILLATGLHVHRSSAH 117
Query: 63 KASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQAQV 122
A + RVL ++ + + + +D +E CL+A+VLF + +GL + +VE L+++
Sbjct: 118 SAGVGSIFDRVLTELVSKMKDMQMDKSELGCLRAIVLFNPDAKGLSNPSEVETLREKVYA 177
Query: 123 MLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSMEKLLCDMYKN 181
L + + +P QP RF +LLL R+I ++H+FF K + +T ++ L +M +
Sbjct: 178 TLEAYTKQKYPEQPGRFAKLLLRLPALRSIGLKCLEHLFFFKLIGDTPIDTFLMEMLET 236
>pdb|1UHL|A Chain A, Crystal Structure Of The Lxralfa-Rxrbeta Lbd Heterodimer
Length = 236
Score = 87.8 bits (216), Expect = 3e-18, Method: Compositional matrix adjust.
Identities = 51/178 (28%), Positives = 87/178 (48%), Gaps = 1/178 (0%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPNG 62
V+WAK +P F++LP DQVI + S+ + L HV
Sbjct: 54 VEWAKRIPHFSSLPLDDQVILLRAGWNELLIASFSHRSIDV-RDGILLATGLHVHRNSAH 112
Query: 63 KASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQAQV 122
A A RVL ++ + R + +D E CL+A++LF + +GL + +VE L+++
Sbjct: 113 SAGVGAIFDRVLTELVSKMRDMRMDKTELGCLRAIILFNPDAKGLSNPSEVEVLREKVYA 172
Query: 123 MLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSMEKLLCDMYK 180
L + + +P Q RF +LLL R+I ++H+FF K + +T ++ L +M +
Sbjct: 173 SLETYCKQKYPEQQGRFAKLLLRLPALRSIGLKCLEHLFFFKLIGDTPIDTFLMEMLE 230
>pdb|2NXX|A Chain A, Crystal Structure Of The Ligand-Binding Domains Of The
T.Castaneum (Coleoptera) Heterodimer Ecrusp Bound To
Ponasterone A
pdb|2NXX|B Chain B, Crystal Structure Of The Ligand-Binding Domains Of The
T.Castaneum (Coleoptera) Heterodimer Ecrusp Bound To
Ponasterone A
pdb|2NXX|C Chain C, Crystal Structure Of The Ligand-Binding Domains Of The
T.Castaneum (Coleoptera) Heterodimer Ecrusp Bound To
Ponasterone A
pdb|2NXX|D Chain D, Crystal Structure Of The Ligand-Binding Domains Of The
T.Castaneum (Coleoptera) Heterodimer Ecrusp Bound To
Ponasterone A
Length = 235
Score = 86.3 bits (212), Expect = 9e-18, Method: Compositional matrix adjust.
Identities = 51/189 (26%), Positives = 92/189 (48%), Gaps = 21/189 (11%)
Query: 3 VKWAKNLPSFAALPFRDQV----------IXXXXXXXXXXXXNAIQWSLPLLESSPLFNA 52
V+WAK +P F +LP DQV + +AI + L + +
Sbjct: 54 VQWAKLVPHFTSLPLTDQVQLLRAGWNELLIAAFSHRSMQAQDAIVLATGL----TVNKS 109
Query: 53 SEHVAAVPNGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQ 112
+ H V N RVL+ ++ + + + +D E CL+A++L+ + RG+K +
Sbjct: 110 TAHAVGVGNIYD-------RVLSELVNKMKEMKMDKTELGCLRAIILYNPDVRGIKSVQE 162
Query: 113 VENLQDQAQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSME 172
VE L+++ +L ++ RT HP +P RF +LLL R+I ++H+FF K + + ++
Sbjct: 163 VEMLREKIYGVLEEYTRTTHPNEPGRFAKLLLRLPALRSIGLKCLEHLFFFKLIGDVPID 222
Query: 173 KLLCDMYKN 181
L +M +
Sbjct: 223 TFLMEMLEG 231
>pdb|1H9U|A Chain A, The Structure Of The Human Retinoid-X-Receptor Beta Ligand
Binding Domain In Complex With The Specific Synthetic
Agonist Lg100268
pdb|1H9U|B Chain B, The Structure Of The Human Retinoid-X-Receptor Beta Ligand
Binding Domain In Complex With The Specific Synthetic
Agonist Lg100268
pdb|1H9U|C Chain C, The Structure Of The Human Retinoid-X-Receptor Beta Ligand
Binding Domain In Complex With The Specific Synthetic
Agonist Lg100268
pdb|1H9U|D Chain D, The Structure Of The Human Retinoid-X-Receptor Beta Ligand
Binding Domain In Complex With The Specific Synthetic
Agonist Lg100268
Length = 224
Score = 85.5 bits (210), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 50/173 (28%), Positives = 84/173 (48%), Gaps = 1/173 (0%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPNG 62
V+WAK +P F++LP DQVI + S+ + L HV
Sbjct: 53 VEWAKRIPHFSSLPLDDQVILLRAGWNELLIASFSHRSIDV-RDGILLATGLHVHRNSAH 111
Query: 63 KASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQAQV 122
A A RVL ++ + R + +D E CL+A++LF + +GL + +VE L+++
Sbjct: 112 SAGVGAIFDRVLTELVSKMRDMRMDKTELGCLRAIILFNPDAKGLSNPSEVEVLREKVYA 171
Query: 123 MLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSMEKLL 175
L + + +P Q RF +LLL R+I ++H+FF K + +T ++ L
Sbjct: 172 SLETYCKQKYPEQQGRFAKLLLRLPALRSIGLKCLEHLFFFKLIGDTPIDTFL 224
>pdb|1LV2|A Chain A, Hepatocyte Nuclear Factor 4 Is A Transcription Factor That
Constitutively Binds Fatty Acids
Length = 229
Score = 76.6 bits (187), Expect = 6e-15, Method: Compositional matrix adjust.
Identities = 48/176 (27%), Positives = 87/176 (49%), Gaps = 2/176 (1%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPNG 62
V+WAK +P+F LP DQV A + S+ + L + +V +
Sbjct: 52 VEWAKYIPAFCELPLDDQVALLRAHAGEHLLLGATKRSM--MYKDILLLGNNYVIHRNSC 109
Query: 63 KASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQAQV 122
+ + RVL+ +++ F+ + +D E+ACLKA+V F + +GL D ++++N++ Q Q+
Sbjct: 110 EVEISRVANRVLDELVRPFQEIQIDDNEYACLKAIVFFDPDAKGLSDPVKIKNMRFQVQI 169
Query: 123 MLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSMEKLLCDM 178
L ++ RFG LLL+ ++I ++ I F K ++ LL +M
Sbjct: 170 GLEDYINDRQYDSRGRFGELLLLLPTLQSITWQMIEQIQFVKLFGMVKIDNLLQEM 225
>pdb|3FS1|A Chain A, Crystal Structure Of Hnf4a Lbd In Complex With The Ligand
And The Coactivator Pgc-1a Fragment
Length = 230
Score = 68.9 bits (167), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 48/176 (27%), Positives = 82/176 (46%), Gaps = 1/176 (0%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPNG 62
V+WAK +P+F LP DQV A + S+ + L N P
Sbjct: 52 VEWAKYIPAFCELPLDDQVALLRAHAGEHLLLGATKRSMVFKDVLLLGNDYIVPRHCPE- 110
Query: 63 KASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQAQV 122
A + +R+L+ ++ F+ + +D E+A LKA++ F + +GL D +++ L+ Q QV
Sbjct: 111 LAEMSRVSIRILDELVLPFQELQIDDNEYAYLKAIIFFDPDAKGLSDPGKIKRLRSQVQV 170
Query: 123 MLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSMEKLLCDM 178
L ++ RFG LLL+ ++I ++ I F K ++ LL +M
Sbjct: 171 SLEDYINDRQYDSRGRFGELLLLLPTLQSITWQMIEQIQFIKLFGMAKIDNLLQEM 226
>pdb|1PZL|A Chain A, Crystal Structure Of Hnf4a Lbd In Complex With The Ligand
And The Coactivator Src-1 Peptide
Length = 237
Score = 68.9 bits (167), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 48/176 (27%), Positives = 82/176 (46%), Gaps = 1/176 (0%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPNG 62
V+WAK +P+F LP DQV A + S+ + L N P
Sbjct: 58 VEWAKYIPAFCELPLDDQVALLRAHAGEHLLLGATKRSMVFKDVLLLGNDYIVPRHCPE- 116
Query: 63 KASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQAQV 122
A + +R+L+ ++ F+ + +D E+A LKA++ F + +GL D +++ L+ Q QV
Sbjct: 117 LAEMSRVSIRILDELVLPFQELQIDDNEYAYLKAIIFFDPDAKGLSDPGKIKRLRSQVQV 176
Query: 123 MLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSMEKLLCDM 178
L ++ RFG LLL+ ++I ++ I F K ++ LL +M
Sbjct: 177 SLEDYINDRQYDSRGRFGELLLLLPTLQSITWQMIEQIQFIKLFGMAKIDNLLQEM 232
>pdb|1M7W|A Chain A, Hnf4a Ligand Binding Domain With Bound Fatty Acid
pdb|1M7W|B Chain B, Hnf4a Ligand Binding Domain With Bound Fatty Acid
pdb|1M7W|C Chain C, Hnf4a Ligand Binding Domain With Bound Fatty Acid
pdb|1M7W|D Chain D, Hnf4a Ligand Binding Domain With Bound Fatty Acid
Length = 250
Score = 68.9 bits (167), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 48/176 (27%), Positives = 82/176 (46%), Gaps = 1/176 (0%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPNG 62
V+WAK +P+F L DQV A + S+ + L N P
Sbjct: 58 VEWAKYIPAFCELLLDDQVALLRAHAGEHLLLGATKRSMVFKDVLLLGNDYIVPRHCPE- 116
Query: 63 KASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQAQV 122
A + +R+L+ ++ F+ + +D E+ACLKA++ F + +GL D +++ L+ Q QV
Sbjct: 117 LAEMSRVSIRILDELVLPFQELQIDDNEYACLKAIIFFDPDAKGLSDPGKIKRLRSQVQV 176
Query: 123 MLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSMEKLLCDM 178
L ++ RFG LLL+ ++I ++ I F K ++ LL +M
Sbjct: 177 SLEDYINDRQYDSRGRFGELLLLLPTLQSITWQMIEQIQFIKLFGMAKIDNLLQEM 232
>pdb|1HG4|A Chain A, Ultraspiracle Ligand Binding Domain From Drosophila
Melanogaster
pdb|1HG4|B Chain B, Ultraspiracle Ligand Binding Domain From Drosophila
Melanogaster
pdb|1HG4|C Chain C, Ultraspiracle Ligand Binding Domain From Drosophila
Melanogaster
pdb|1HG4|D Chain D, Ultraspiracle Ligand Binding Domain From Drosophila
Melanogaster
pdb|1HG4|E Chain E, Ultraspiracle Ligand Binding Domain From Drosophila
Melanogaster
pdb|1HG4|F Chain F, Ultraspiracle Ligand Binding Domain From Drosophila
Melanogaster
Length = 279
Score = 66.6 bits (161), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 48/192 (25%), Positives = 81/192 (42%), Gaps = 26/192 (13%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSL--------------------- 41
V++A+ +P FA +P DQVI N S+
Sbjct: 64 VEYARMMPHFAQVPLDDQVILLKAAWIELLIANVAWCSIVSLDDGGAGGGGGGLGHDGSF 123
Query: 42 ----PLLESSPLF-NASEHVAAVPNGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKA 96
P L+ LF N S KA +A R+L+ + + + + +D E +CLKA
Sbjct: 124 ERRSPGLQPQQLFLNQSFSYHRNSAIKAGVSAIFDRILSELSVKMKRLNLDRRELSCLKA 183
Query: 97 VVLFKSETRGLKDSLQVENLQDQAQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSAR 156
++L+ + RG+K ++E +++ L +H R HP RF +LLL R+I
Sbjct: 184 IILYNPDIRGIKSRAEIEMCREKVYACLDEHCRLEHPGDDGRFAQLLLRLPALRSISLKC 243
Query: 157 VQHIFFAKTVAN 168
H+F + ++
Sbjct: 244 QDHLFLFRITSD 255
>pdb|2EWP|A Chain A, Crystal Structure Of Estrogen Related Receptor-3
(Err-Gamma) Ligand Binding Domaind With Tamoxifen Analog
Gsk5182
pdb|2EWP|B Chain B, Crystal Structure Of Estrogen Related Receptor-3
(Err-Gamma) Ligand Binding Domaind With Tamoxifen Analog
Gsk5182
pdb|2EWP|C Chain C, Crystal Structure Of Estrogen Related Receptor-3
(Err-Gamma) Ligand Binding Domaind With Tamoxifen Analog
Gsk5182
pdb|2EWP|D Chain D, Crystal Structure Of Estrogen Related Receptor-3
(Err-Gamma) Ligand Binding Domaind With Tamoxifen Analog
Gsk5182
pdb|2EWP|E Chain E, Crystal Structure Of Estrogen Related Receptor-3
(Err-Gamma) Ligand Binding Domaind With Tamoxifen Analog
Gsk5182
Length = 226
Score = 62.8 bits (151), Expect = 9e-11, Method: Compositional matrix adjust.
Identities = 44/179 (24%), Positives = 77/179 (43%), Gaps = 8/179 (4%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPNG 62
+ WAK++P F+ L DQ+ + SL L A +++ +
Sbjct: 48 IGWAKHIPGFSTLSLADQMSLLQSAWMEILILGVVYRSLSF--EDELVYADDYIM---DE 102
Query: 63 KASQTAADVRVLNGVLQ---RFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQ 119
S+ A + + N +LQ +++ + ++ EF LKA+ L S++ ++D V+ LQD
Sbjct: 103 DQSKLAGLLDLNNAILQLVKKYKSMKLEKEEFVTLKAIALANSDSMHIEDVEAVQKLQDV 162
Query: 120 AQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSMEKLLCDM 178
L + H P R G++L+ R + VQH + K M KL +M
Sbjct: 163 LHEALQDYEAGQHMEDPRRAGKMLMTLPLLRQTSTKAVQHFYNIKLEGKVPMHKLFLEM 221
>pdb|1S9P|A Chain A, Crystal Structure Of The Ligand-Binding Domain Of The
Estrogen-Related Receptor Gamma In Complex With
Diethylstilbestrol
pdb|1S9P|B Chain B, Crystal Structure Of The Ligand-Binding Domain Of The
Estrogen-Related Receptor Gamma In Complex With
Diethylstilbestrol
pdb|1S9P|C Chain C, Crystal Structure Of The Ligand-Binding Domain Of The
Estrogen-Related Receptor Gamma In Complex With
Diethylstilbestrol
pdb|1S9P|D Chain D, Crystal Structure Of The Ligand-Binding Domain Of The
Estrogen-Related Receptor Gamma In Complex With
Diethylstilbestrol
Length = 227
Score = 62.8 bits (151), Expect = 9e-11, Method: Compositional matrix adjust.
Identities = 44/179 (24%), Positives = 77/179 (43%), Gaps = 8/179 (4%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPNG 62
+ WAK++P F+ L DQ+ + SL L A +++ +
Sbjct: 49 IGWAKHIPGFSTLSLADQMSLLQSAWMEILILGVVYRSLSF--EDELVYADDYIM---DE 103
Query: 63 KASQTAADVRVLNGVLQ---RFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQ 119
S+ A + + N +LQ +++ + ++ EF LKA+ L S++ ++D V+ LQD
Sbjct: 104 DQSKLAGLLDLNNAILQLVKKYKSMKLEKEEFVTLKAIALANSDSMHIEDVEAVQKLQDV 163
Query: 120 AQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSMEKLLCDM 178
L + H P R G++L+ R + VQH + K M KL +M
Sbjct: 164 LHEALQDYEAGQHMEDPRRAGKMLMTLPLLRQTSTKAVQHFYNIKLEGKVPMHKLFLEM 222
>pdb|1VJB|A Chain A, Crystal Structure Of The Ligand-Binding Domain Of The
Estrogen-Related Receptor Gamma In Complex With 4-
Hydroxytamoxifen
pdb|1VJB|B Chain B, Crystal Structure Of The Ligand-Binding Domain Of The
Estrogen-Related Receptor Gamma In Complex With 4-
Hydroxytamoxifen
pdb|1TFC|A Chain A, Crystal Structure Of The Ligand-Binding Domain Of The
Estrogen-Related Receptor Gamma In Complex With A
Steroid Receptor Coactivator-1 Peptide
pdb|1TFC|B Chain B, Crystal Structure Of The Ligand-Binding Domain Of The
Estrogen-Related Receptor Gamma In Complex With A
Steroid Receptor Coactivator-1 Peptide
pdb|2P7A|A Chain A, Crystal Structure Of Estrogen Related Receptor G In
Complex With 3-Methyl Phenol
pdb|2P7G|A Chain A, X-Ray Structure Of Estrogen Related Receptor G In Complex
With Bisphenol A.
pdb|2P7Z|A Chain A, Estrogen Related Receptor Gamma In Complex With 4-Hydroxy-
Tamoxifen
Length = 251
Score = 62.8 bits (151), Expect = 9e-11, Method: Compositional matrix adjust.
Identities = 44/179 (24%), Positives = 77/179 (43%), Gaps = 8/179 (4%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPNG 62
+ WAK++P F+ L DQ+ + SL L A +++ +
Sbjct: 73 IGWAKHIPGFSTLSLADQMSLLQSAWMEILILGVVYRSLSF--EDELVYADDYIM---DE 127
Query: 63 KASQTAADVRVLNGVLQ---RFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQ 119
S+ A + + N +LQ +++ + ++ EF LKA+ L S++ ++D V+ LQD
Sbjct: 128 DQSKLAGLLDLNNAILQLVKKYKSMKLEKEEFVTLKAIALANSDSMHIEDVEAVQKLQDV 187
Query: 120 AQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSMEKLLCDM 178
L + H P R G++L+ R + VQH + K M KL +M
Sbjct: 188 LHEALQDYEAGQHMEDPRRAGKMLMTLPLLRQTSTKAVQHFYNIKLEGKVPMHKLFLEM 246
>pdb|1S9Q|A Chain A, Crystal Structure Of The Ligand-Binding Domain Of The
Estrogen-Related Receptor Gamma In Complex With
4-Hydroxytamoxifen
pdb|1S9Q|B Chain B, Crystal Structure Of The Ligand-Binding Domain Of The
Estrogen-Related Receptor Gamma In Complex With
4-Hydroxytamoxifen
Length = 251
Score = 62.8 bits (151), Expect = 9e-11, Method: Compositional matrix adjust.
Identities = 44/179 (24%), Positives = 77/179 (43%), Gaps = 8/179 (4%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPNG 62
+ WAK++P F+ L DQ+ + SL L A +++ +
Sbjct: 73 IGWAKHIPGFSTLSLADQMSLLQSAWMEILILGVVYRSLSF--EDELVYADDYIM---DE 127
Query: 63 KASQTAADVRVLNGVLQ---RFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQ 119
S+ A + + N +LQ +++ + ++ EF LKA+ L S++ ++D V+ LQD
Sbjct: 128 DQSKLAGLLDLNNAILQLVKKYKSMKLEKEEFVTLKAIALANSDSMHIEDVEAVQKLQDV 187
Query: 120 AQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSMEKLLCDM 178
L + H P R G++L+ R + VQH + K M KL +M
Sbjct: 188 LHEALQDYEAGQHMEDPRRAGKMLMTLPLLRQTSTKAVQHFYNIKLEGKVPMHKLFLEM 246
>pdb|1KV6|A Chain A, X-Ray Structure Of The Orphan Nuclear Receptor Err3
Ligand- Binding Domain In The Constitutively Active
Conformation
pdb|1KV6|B Chain B, X-Ray Structure Of The Orphan Nuclear Receptor Err3
Ligand- Binding Domain In The Constitutively Active
Conformation
pdb|2GP7|A Chain A, Estrogen Related Receptor-Gamma Ligand Binding Domain
pdb|2GP7|B Chain B, Estrogen Related Receptor-Gamma Ligand Binding Domain
pdb|2GP7|C Chain C, Estrogen Related Receptor-Gamma Ligand Binding Domain
pdb|2GP7|D Chain D, Estrogen Related Receptor-Gamma Ligand Binding Domain
pdb|2GPO|A Chain A, Estrogen Related Receptor-Gamma Ligand Binding Domain
Complexed With A Synthetic Peptide From Rip140
pdb|2GPP|A Chain A, Estrogen Related Receptor-Gamma Ligand Binding Domain
Complexed With A Rip140 Peptide And Synthetic Ligand
Gsk4716
pdb|2GPP|B Chain B, Estrogen Related Receptor-Gamma Ligand Binding Domain
Complexed With A Rip140 Peptide And Synthetic Ligand
Gsk4716
pdb|2GPU|A Chain A, Estrogen Related Receptor-gamma Ligand Binding Domain
Complexed With 4-hydroxy-tamoxifen
pdb|2GPV|A Chain A, Estrogen Related Receptor-gamma Ligand Binding Domain
Complexed With 4-hydroxy-tamoxifen And A Smrt Peptide
pdb|2GPV|B Chain B, Estrogen Related Receptor-gamma Ligand Binding Domain
Complexed With 4-hydroxy-tamoxifen And A Smrt Peptide
pdb|2GPV|C Chain C, Estrogen Related Receptor-gamma Ligand Binding Domain
Complexed With 4-hydroxy-tamoxifen And A Smrt Peptide
pdb|2GPV|D Chain D, Estrogen Related Receptor-gamma Ligand Binding Domain
Complexed With 4-hydroxy-tamoxifen And A Smrt Peptide
pdb|2GPV|E Chain E, Estrogen Related Receptor-gamma Ligand Binding Domain
Complexed With 4-hydroxy-tamoxifen And A Smrt Peptide
pdb|2GPV|F Chain F, Estrogen Related Receptor-gamma Ligand Binding Domain
Complexed With 4-hydroxy-tamoxifen And A Smrt Peptide
Length = 230
Score = 62.8 bits (151), Expect = 9e-11, Method: Compositional matrix adjust.
Identities = 44/179 (24%), Positives = 77/179 (43%), Gaps = 8/179 (4%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPNG 62
+ WAK++P F+ L DQ+ + SL L A +++ +
Sbjct: 52 IGWAKHIPGFSTLSLADQMSLLQSAWMEILILGVVYRSLSF--EDELVYADDYIM---DE 106
Query: 63 KASQTAADVRVLNGVLQ---RFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQ 119
S+ A + + N +LQ +++ + ++ EF LKA+ L S++ ++D V+ LQD
Sbjct: 107 DQSKLAGLLDLNNAILQLVKKYKSMKLEKEEFVTLKAIALANSDSMHIEDVEAVQKLQDV 166
Query: 120 AQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSMEKLLCDM 178
L + H P R G++L+ R + VQH + K M KL +M
Sbjct: 167 LHEALQDYEAGQHMEDPRRAGKMLMTLPLLRQTSTKAVQHFYNIKLEGKVPMHKLFLEM 225
>pdb|2E2R|A Chain A, Crystal Structure Of Human Estrogen-Related Receptor Gamma
Ligand Binding Domain Complex With Bisphenol A
pdb|2ZAS|A Chain A, Crystal Structure Of Human Estrogen-Related Receptor Gamma
Ligand Binding Domain Complex With 4-Alpha-Cumylphenol,
A Bisphenol A Derivative
pdb|2ZBS|A Chain A, Crystal Structure Of Human Estrogen-Related Receptor Gamma
Ligand Binding Domain Apo Form
pdb|2ZKC|A Chain A, Crystal Structure Of Human Estrogen-Related Receptor Gamma
Ligand Binding Domain Complex With Bisphenol Z
Length = 244
Score = 62.8 bits (151), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 44/179 (24%), Positives = 77/179 (43%), Gaps = 8/179 (4%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPNG 62
+ WAK++P F+ L DQ+ + SL L A +++ +
Sbjct: 65 IGWAKHIPGFSTLSLADQMSLLQSAWMEILILGVVYRSLSF--EDELVYADDYIM---DE 119
Query: 63 KASQTAADVRVLNGVLQ---RFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQ 119
S+ A + + N +LQ +++ + ++ EF LKA+ L S++ ++D V+ LQD
Sbjct: 120 DQSKLAGLLDLNNAILQLVKKYKSMKLEKEEFVTLKAIALANSDSMHIEDVEAVQKLQDV 179
Query: 120 AQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSMEKLLCDM 178
L + H P R G++L+ R + VQH + K M KL +M
Sbjct: 180 LHEALQDYEAGQHMEDPRRAGKMLMTLPLLRQTSTKAVQHFYNIKLEGKVPMHKLFLEM 238
>pdb|1G2N|A Chain A, Crystal Structure Of The Ligand Binding Domain Of The
Ultraspiracle Protein Usp, The Ortholog Of Rxrs In
Insects
Length = 264
Score = 62.0 bits (149), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 54/197 (27%), Positives = 90/197 (45%), Gaps = 19/197 (9%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQW-SLPLL--ESSPLFNASEHVAAV 59
V WA+++P F+ L DQ++ AI W S+ L E + +
Sbjct: 59 VVWARDIPHFSQLEMEDQILLIKGSWNELLLF-AIAWRSMEFLTEERDGVDGTGNRTTSP 117
Query: 60 PN----------GKASQTAADV-----RVLNGVLQRFRLVGVDPAEFACLKAVVLFKSET 104
P + S A V RVL+ + + R + VD AE+ LKA++L +
Sbjct: 118 PQLMCLMPGMTLHRNSALQAGVGQIFDRVLSELSLKMRTLRVDQAEYVALKAIILLNPDV 177
Query: 105 RGLKDSLQVENLQDQAQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAK 164
+GLK+ +VE L+++ + L ++ R ++ RF LLL R+I +H+FF
Sbjct: 178 KGLKNRQEVEVLREKMFLCLDEYCRRSRSSEEGRFAALLLRLPALRSISLKSFEHLFFFH 237
Query: 165 TVANTSMEKLLCDMYKN 181
VA+TS+ + D +N
Sbjct: 238 LVADTSIAGYIRDALRN 254
>pdb|1R1K|A Chain A, Crystal Structure Of The Ligand-Binding Domains Of The
Heterodimer EcrUSP BOUND TO PONASTERONE A
pdb|1R20|A Chain A, Crystal Structure Of The Ligand-Binding Domains Of The
Heterodimer EcrUSP BOUND TO THE SYNTHETIC AGONIST
BYI06830
pdb|2R40|A Chain A, Crystal Structure Of 20e Bound Ecr/usp
pdb|3IXP|A Chain A, Crystal Structure Of The Ecdysone Receptor Bound To
Byi08346
Length = 263
Score = 62.0 bits (149), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 54/197 (27%), Positives = 90/197 (45%), Gaps = 19/197 (9%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQW-SLPLL--ESSPLFNASEHVAAV 59
V WA+++P F+ L DQ++ AI W S+ L E + +
Sbjct: 58 VVWARDIPHFSQLEMEDQILLIKGSWNELLLF-AIAWRSMEFLTEERDGVDGTGNRTTSP 116
Query: 60 PN----------GKASQTAADV-----RVLNGVLQRFRLVGVDPAEFACLKAVVLFKSET 104
P + S A V RVL+ + + R + VD AE+ LKA++L +
Sbjct: 117 PQLMCLMPGMTLHRNSALQAGVGQIFDRVLSELSLKMRTLRVDQAEYVALKAIILLNPDV 176
Query: 105 RGLKDSLQVENLQDQAQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAK 164
+GLK+ +VE L+++ + L ++ R ++ RF LLL R+I +H+FF
Sbjct: 177 KGLKNRQEVEVLREKMFLCLDEYCRRSRSSEEGRFAALLLRLPALRSISLKSFEHLFFFH 236
Query: 165 TVANTSMEKLLCDMYKN 181
VA+TS+ + D +N
Sbjct: 237 LVADTSIAGYIRDALRN 253
>pdb|1ZH7|A Chain A, Structural And Biochemical Basis For Selective Repression
Of The Orphan Nuclear Receptor Lrh-1 By Shp
pdb|1ZH7|B Chain B, Structural And Biochemical Basis For Selective Repression
Of The Orphan Nuclear Receptor Lrh-1 By Shp
Length = 243
Score = 58.5 bits (140), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 30/99 (30%), Positives = 50/99 (50%)
Query: 80 RFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQAQVMLAQHVRTHHPAQPARF 139
R R + D EF CLK +VLF S+ + L++ VE +Q+Q L + ++P Q +F
Sbjct: 139 RLRSLQFDQREFVCLKFLVLFSSDVKNLENLQLVEGVQEQVNAALLDYTVCNYPQQTEKF 198
Query: 140 GRLLLMTSQCRNIPSARVQHIFFAKTVANTSMEKLLCDM 178
G+LLL + R I ++++ + LL +M
Sbjct: 199 GQLLLRLPEIRAISKQAEDYLYYKHVNGDVPYNNLLIEM 237
>pdb|1PK5|A Chain A, Crystal Structure Of The Orphan Nuclear Receptor Lrh-1
pdb|1PK5|B Chain B, Crystal Structure Of The Orphan Nuclear Receptor Lrh-1
pdb|3F5C|A Chain A, Structure Of Dax-1:lrh-1 Complex
Length = 248
Score = 58.5 bits (140), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 30/99 (30%), Positives = 50/99 (50%)
Query: 80 RFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQAQVMLAQHVRTHHPAQPARF 139
R R + D EF CLK +VLF S+ + L++ VE +Q+Q L + ++P Q +F
Sbjct: 144 RLRSLQFDQREFVCLKFLVLFSSDVKNLENLQLVEGVQEQVNAALLDYTVCNYPQQTEKF 203
Query: 140 GRLLLMTSQCRNIPSARVQHIFFAKTVANTSMEKLLCDM 178
G+LLL + R I ++++ + LL +M
Sbjct: 204 GQLLLRLPELRAISKQAEDYLYYKHVNGDVPYNNLLIEM 242
>pdb|3P0U|A Chain A, Crystal Structure Of The Ligand Binding Domain Of Human
Testicular Receptor 4
pdb|3P0U|B Chain B, Crystal Structure Of The Ligand Binding Domain Of Human
Testicular Receptor 4
Length = 249
Score = 56.6 bits (135), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 27/92 (29%), Positives = 49/92 (53%)
Query: 84 VGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQAQVMLAQHVRTHHPAQPARFGRLL 143
+ +D E+A LKA+VLF + GL + Q+E Q+ AQ+ L +V+ + R R+L
Sbjct: 138 LDIDGYEYAYLKAIVLFSPDHPGLTSTSQIEKFQEAAQMELQDYVQATYSEDTYRLARIL 197
Query: 144 LMTSQCRNIPSARVQHIFFAKTVANTSMEKLL 175
+ R + S + +FF + N S++ ++
Sbjct: 198 VRLPALRLMSSNITEELFFTGLIGNVSIDSII 229
>pdb|3TX7|B Chain B, Crystal Structure Of Lrh-1BETA-Catenin Complex
Length = 352
Score = 55.5 bits (132), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 33/119 (27%), Positives = 58/119 (48%), Gaps = 4/119 (3%)
Query: 64 ASQTAADVRVL----NGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQ 119
ASQ A + L ++ + R + D EF CLK +VLF + + L++ VE +Q+Q
Sbjct: 228 ASQAGATLNNLMSHAQELVAKLRSLQFDQREFVCLKFLVLFSLDVKNLENFQLVEGVQEQ 287
Query: 120 AQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSMEKLLCDM 178
L + ++P Q +FG+LLL + R I +++++ + LL +M
Sbjct: 288 VNAALLDYTMCNYPQQTEKFGQLLLRLPEIRAISMQAEEYLYYKHLNGDVPYNNLLIEM 346
>pdb|1ZDU|A Chain A, The Crystal Structure Of Human Liver Receptor Homologue-1
Length = 245
Score = 55.1 bits (131), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 33/119 (27%), Positives = 58/119 (48%), Gaps = 4/119 (3%)
Query: 64 ASQTAADVRVL----NGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQ 119
ASQ A + L ++ + R + D EF CLK +VLF + + L++ VE +Q+Q
Sbjct: 121 ASQAGATLNNLMSHAQELVAKLRSLQFDQREFVCLKFLVLFSLDVKNLENFQLVEGVQEQ 180
Query: 120 AQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSMEKLLCDM 178
L + ++P Q +FG+LLL + R I +++++ + LL +M
Sbjct: 181 VNAALLDYTMCNYPQQTEKFGQLLLRLPEIRAISMQAEEYLYYKHLNGDVPYNNLLIEM 239
>pdb|1YUC|A Chain A, Human Nuclear Receptor Liver Receptor Homologue-1, Lrh-1,
Bound To Phospholipid And A Fragment Of Human Shp
pdb|1YUC|B Chain B, Human Nuclear Receptor Liver Receptor Homologue-1, Lrh-1,
Bound To Phospholipid And A Fragment Of Human Shp
pdb|4DOR|A Chain A, Human Nuclear Receptor Liver Receptor Homologue-1, Lrh-1,
In Its Apo State Bound To A Fragment Of Human Shp Box1
pdb|4DOR|B Chain B, Human Nuclear Receptor Liver Receptor Homologue-1, Lrh-1,
In Its Apo State Bound To A Fragment Of Human Shp Box1
Length = 255
Score = 55.1 bits (131), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 33/119 (27%), Positives = 58/119 (48%), Gaps = 4/119 (3%)
Query: 64 ASQTAADVRVL----NGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQ 119
ASQ A + L ++ + R + D EF CLK +VLF + + L++ VE +Q+Q
Sbjct: 131 ASQAGATLNNLMSHAQELVAKLRSLQFDQREFVCLKFLVLFSLDVKNLENFQLVEGVQEQ 190
Query: 120 AQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSMEKLLCDM 178
L + ++P Q +FG+LLL + R I +++++ + LL +M
Sbjct: 191 VNAALLDYTMCNYPQQTEKFGQLLLRLPEIRAISMQAEEYLYYKHLNGDVPYNNLLIEM 249
>pdb|4DOS|A Chain A, Human Nuclear Receptor Liver Receptor Homologue-1, Lrh-1,
Bound To Dlpc And A Fragment Of Tif-2
Length = 242
Score = 55.1 bits (131), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 28/99 (28%), Positives = 50/99 (50%)
Query: 80 RFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQAQVMLAQHVRTHHPAQPARF 139
+ R + D EF CLK +VLF + + L++ VE +Q+Q L + ++P Q +F
Sbjct: 141 KLRSLQFDQREFVCLKFLVLFSLDVKNLENFQLVEGVQEQVNAALLDYTMCNYPQQTEKF 200
Query: 140 GRLLLMTSQCRNIPSARVQHIFFAKTVANTSMEKLLCDM 178
G+LLL + R I +++++ + LL +M
Sbjct: 201 GQLLLRLPEIRAISMQAEEYLYYKHLNGDVPYNNLLIEM 239
>pdb|3PLZ|A Chain A, Human Lrh1 Lbd Bound To Gr470
pdb|3PLZ|B Chain B, Human Lrh1 Lbd Bound To Gr470
Length = 257
Score = 55.1 bits (131), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 33/119 (27%), Positives = 58/119 (48%), Gaps = 4/119 (3%)
Query: 64 ASQTAADVRVL----NGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQ 119
ASQ A + L ++ + R + D EF CLK +VLF + + L++ VE +Q+Q
Sbjct: 133 ASQAGATLNNLMSHAQELVAKLRSLQFDQREFVCLKFLVLFSLDVKNLENFQLVEGVQEQ 192
Query: 120 AQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSMEKLLCDM 178
L + ++P Q +FG+LLL + R I +++++ + LL +M
Sbjct: 193 VNAALLDYTMCNYPQQTEKFGQLLLRLPEIRAISMQAEEYLYYKHLNGDVPYNNLLIEM 251
>pdb|1YOK|A Chain A, Crystal Structure Of Human Lrh-1 Bound With Tif-2 Peptide
And Phosphatidylglycerol
Length = 256
Score = 55.1 bits (131), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 33/119 (27%), Positives = 58/119 (48%), Gaps = 4/119 (3%)
Query: 64 ASQTAADVRVL----NGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQ 119
ASQ A + L ++ + R + D EF CLK +VLF + + L++ VE +Q+Q
Sbjct: 132 ASQAGATLNNLMSHAQELVAKLRSLQFDQREFVCLKFLVLFSLDVKNLENFQLVEGVQEQ 191
Query: 120 AQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSMEKLLCDM 178
L + ++P Q +FG+LLL + R I +++++ + LL +M
Sbjct: 192 VNAALLDYTMCNYPQQTEKFGQLLLRLPEIRAISMQAEEYLYYKHLNGDVPYNNLLIEM 250
>pdb|2ACL|B Chain B, Liver X-Receptor Alpha Ligand Binding Domain With Sb313987
pdb|2ACL|D Chain D, Liver X-Receptor Alpha Ligand Binding Domain With Sb313987
pdb|2ACL|F Chain F, Liver X-Receptor Alpha Ligand Binding Domain With Sb313987
pdb|2ACL|H Chain H, Liver X-Receptor Alpha Ligand Binding Domain With Sb313987
Length = 244
Score = 54.3 bits (129), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 49/186 (26%), Positives = 86/186 (46%), Gaps = 20/186 (10%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFN-ASEHVAAVPN 61
V +AK LP F L DQ+ +AI+ + LLE+S +N SE + + +
Sbjct: 66 VDFAKQLPGFLQLSREDQI--------ALLKTSAIE--VMLLETSRRYNPGSESITFLKD 115
Query: 62 -----GKASQTAADVRVLNGVLQRFRLVG---VDPAEFACLKAVVLFKSETRGLKDSLQV 113
++ V +N + + R + ++ AEFA L A+ +F ++ ++D LQV
Sbjct: 116 FSYNREDFAKAGLQVEFINPIFEFSRAMNELQLNDAEFALLIAISIFSADRPNVQDQLQV 175
Query: 114 ENLQDQAQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSMEK 173
E LQ L +V +HP P F R+L+ R + S + + FA + + +
Sbjct: 176 ERLQHTYVEALHAYVSINHPHDPLMFPRMLMKLVSLRTLSSVHSEQV-FALRLQDKKLPP 234
Query: 174 LLCDMY 179
LL +++
Sbjct: 235 LLSEIW 240
>pdb|3FC6|B Chain B, Hrxralpha & Mlxralpha With An Indole Pharmacophore,
Sb786875
pdb|3FC6|D Chain D, Hrxralpha & Mlxralpha With An Indole Pharmacophore,
Sb786875
pdb|3FAL|B Chain B, Humanrxr Alpha & Mouse Lxr Alpha Complexed With Retenoic
Acid And Gsk2186
pdb|3FAL|D Chain D, Humanrxr Alpha & Mouse Lxr Alpha Complexed With Retenoic
Acid And Gsk2186
Length = 266
Score = 54.3 bits (129), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 49/186 (26%), Positives = 86/186 (46%), Gaps = 20/186 (10%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFN-ASEHVAAVPN 61
V +AK LP F L DQ+ +AI+ + LLE+S +N SE + + +
Sbjct: 88 VDFAKQLPGFLQLSREDQI--------ALLKTSAIE--VMLLETSRRYNPGSESITFLKD 137
Query: 62 -----GKASQTAADVRVLNGVLQRFRLVG---VDPAEFACLKAVVLFKSETRGLKDSLQV 113
++ V +N + + R + ++ AEFA L A+ +F ++ ++D LQV
Sbjct: 138 FSYNREDFAKAGLQVEFINPIFEFSRAMNELQLNDAEFALLIAISIFSADRPNVQDQLQV 197
Query: 114 ENLQDQAQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSMEK 173
E LQ L +V +HP P F R+L+ R + S + + FA + + +
Sbjct: 198 ERLQHTYVEALHAYVSINHPHDPLMFPRMLMKLVSLRTLSSVHSEQV-FALRLQDKKLPP 256
Query: 174 LLCDMY 179
LL +++
Sbjct: 257 LLSEIW 262
>pdb|1UHL|B Chain B, Crystal Structure Of The Lxralfa-Rxrbeta Lbd Heterodimer
Length = 242
Score = 53.5 bits (127), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 49/186 (26%), Positives = 85/186 (45%), Gaps = 20/186 (10%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFN-ASEHVAAVPN 61
V +AK LP F L DQ+ +AI+ + LLE+S +N SE + + +
Sbjct: 64 VDFAKQLPGFLQLSREDQI--------ALLKTSAIE--VMLLETSRRYNPGSESITFLKD 113
Query: 62 -----GKASQTAADVRVLNGVLQRFRLVG---VDPAEFACLKAVVLFKSETRGLKDSLQV 113
++ V +N + + R + ++ AEFA L A+ +F ++ ++D LQV
Sbjct: 114 FSYNREDFAKAGLQVEFINPIFEFSRAMNELQLNDAEFALLIAISIFSADRPNVQDQLQV 173
Query: 114 ENLQDQAQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSMEK 173
E LQ L +V HHP F R+L+ R + S + + FA + + +
Sbjct: 174 ERLQHTYVEALHAYVSIHHPHDRLMFPRMLMKLVSLRTLSSVHSEQV-FALRLQDKKLPP 232
Query: 174 LLCDMY 179
LL +++
Sbjct: 233 LLSEIW 238
>pdb|3IPQ|A Chain A, X-Ray Structure Of Gw3965 Synthetic Agonist Bound To The
Lxr
pdb|3IPS|A Chain A, X-Ray Structure Of Benzisoxazole Synthetic Agonist Bound
To Alpha
pdb|3IPS|B Chain B, X-Ray Structure Of Benzisoxazole Synthetic Agonist Bound
To Alpha
pdb|3IPU|A Chain A, X-Ray Structure Of Benzisoxazole Urea Synthetic Agonist
Boun Lxr-Alpha
pdb|3IPU|B Chain B, X-Ray Structure Of Benzisoxazole Urea Synthetic Agonist
Boun Lxr-Alpha
Length = 283
Score = 52.4 bits (124), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 49/186 (26%), Positives = 85/186 (45%), Gaps = 20/186 (10%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFN-ASEHVAAVPN 61
V +AK LP F L DQ+ +AI+ + LLE+S +N SE + + +
Sbjct: 105 VDFAKQLPGFLQLSREDQI--------ALLKTSAIE--VMLLETSRRYNPGSESITFLKD 154
Query: 62 -----GKASQTAADVRVLNGVLQRFRLVG---VDPAEFACLKAVVLFKSETRGLKDSLQV 113
++ V +N + + R + ++ AEFA L A+ +F ++ ++D LQV
Sbjct: 155 FSYNREDFAKAGLQVEFINPIFEFSRAMNELQLNDAEFALLIAISIFSADRPNVQDQLQV 214
Query: 114 ENLQDQAQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSMEK 173
E LQ L +V HHP F R+L+ R + S + + FA + + +
Sbjct: 215 ERLQHTYVEALHAYVSIHHPHDRLMFPRMLMKLVSLRTLSSVHSEQV-FALRLQDKKLPP 273
Query: 174 LLCDMY 179
LL +++
Sbjct: 274 LLSEIW 279
>pdb|2YAT|A Chain A, Crystal Structure Of Estradiol Derived Metal Chelate And
Estrogen Receptor-Ligand Binding Domain Complex
Length = 252
Score = 46.6 bits (109), Expect = 7e-06, Method: Compositional matrix adjust.
Identities = 48/198 (24%), Positives = 83/198 (41%), Gaps = 34/198 (17%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAV--- 59
+ WAK +P F L DQV W L +L ++ + EH +
Sbjct: 59 INWAKRVPGFVDLTLHDQVHLLESA-----------W-LEILMIGLVWRSMEHPGKLLFA 106
Query: 60 PN-------GKASQTAADV-RVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRG-LKDS 110
PN GK+ + ++ +L RFR++ + EF CLK+++L S L +
Sbjct: 107 PNLLLDRNQGKSVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSST 166
Query: 111 LQVENLQDQAQVMLAQHVRT--HHPA--------QPARFGRLLLMTSQCRNIPSARVQHI 160
L+ +D +L + T H A Q R +LLL+ S R++ + ++H+
Sbjct: 167 LKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHL 226
Query: 161 FFAKTVANTSMEKLLCDM 178
+ K+ + LL +M
Sbjct: 227 YSMKSKNVVPLYDLLLEM 244
>pdb|3L0E|A Chain A, X-Ray Crystal Structure Of A Potent Liver X Receptor
Modulator
Length = 253
Score = 46.6 bits (109), Expect = 8e-06, Method: Compositional matrix adjust.
Identities = 44/186 (23%), Positives = 83/186 (44%), Gaps = 20/186 (10%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFN-ASEHVAAVPN 61
V +AK +P F L DQ+ A + LLE++ +N +E + + +
Sbjct: 75 VDFAKQVPGFLQLGREDQI----------ALLKASTIEIMLLETARRYNHETESITFLKD 124
Query: 62 GKASQ-----TAADVRVLNGVLQRFRL---VGVDPAEFACLKAVVLFKSETRGLKDSLQV 113
S+ V +N + + R +G+D AE+A L A+ +F ++ +++ +V
Sbjct: 125 FTYSKDDFHRAGLQVEFINPIFEFSRAMSSLGLDDAEYALLIAINIFSADRPNVQEPGRV 184
Query: 114 ENLQDQAQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSMEK 173
E LQ L + R P RF R+L+ R + S + + FA +A+ ++
Sbjct: 185 EALQQPYVEALLSYTRIKRPQDQLRFPRMLMKLVSLRTLSSVHSEQV-FALRLADAALPP 243
Query: 174 LLCDMY 179
LL +++
Sbjct: 244 LLSEIW 249
>pdb|1QKT|A Chain A, Mutant Estrogen Nuclear Receptor Ligand Binding Domain
Complexed With Estradiol
pdb|2AYR|A Chain A, A Serm Designed For The Treatment Of Uterine Leiomyoma
With Unique Tissue Specificity For Uterus And Ovaries In
Rats
pdb|2Q70|A Chain A, Estrogen Receptor Alpha Ligand-Binding Domain Complxed To
A Benzopyran Ligand
pdb|2Q70|B Chain B, Estrogen Receptor Alpha Ligand-Binding Domain Complxed To
A Benzopyran Ligand
pdb|2POG|A Chain A, Benzopyrans As Selective Estrogen Receptor B Agonists
(Serbas). Part 2: Structure Activity Relationship
Studies On The Benzopyran Scaffold.
pdb|2POG|B Chain B, Benzopyrans As Selective Estrogen Receptor B Agonists
(Serbas). Part 2: Structure Activity Relationship
Studies On The Benzopyran Scaffold.
pdb|2QE4|A Chain A, Estrogen Receptor Alpha Ligand-Binding Domain In Complex
With A Benzopyran Agonist
pdb|2QE4|B Chain B, Estrogen Receptor Alpha Ligand-Binding Domain In Complex
With A Benzopyran Agonist
pdb|2R6W|A Chain A, Estrogen Receptor Alpha Ligand-Binding Domain Complexed To
A Serm
pdb|2R6W|B Chain B, Estrogen Receptor Alpha Ligand-Binding Domain Complexed To
A Serm
pdb|2R6Y|A Chain A, Estrogen Receptor Alpha Ligand-Binding Domain In Complex
With A Serm
pdb|2R6Y|B Chain B, Estrogen Receptor Alpha Ligand-Binding Domain In Complex
With A Serm
Length = 248
Score = 46.6 bits (109), Expect = 8e-06, Method: Compositional matrix adjust.
Identities = 48/198 (24%), Positives = 83/198 (41%), Gaps = 34/198 (17%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAV--- 59
+ WAK +P F L DQV W L +L ++ + EH +
Sbjct: 55 INWAKRVPGFVDLTLHDQVHLLESA-----------W-LEILMIGLVWRSMEHPGKLLFA 102
Query: 60 PN-------GKASQTAADV-RVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRG-LKDS 110
PN GK+ + ++ +L RFR++ + EF CLK+++L S L +
Sbjct: 103 PNLLLDRNQGKSVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSST 162
Query: 111 LQVENLQDQAQVMLAQHVRT--HHPA--------QPARFGRLLLMTSQCRNIPSARVQHI 160
L+ +D +L + T H A Q R +LLL+ S R++ + ++H+
Sbjct: 163 LKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHL 222
Query: 161 FFAKTVANTSMEKLLCDM 178
+ K+ + LL +M
Sbjct: 223 YSMKSKNVVPLYDLLLEM 240
>pdb|1PCG|A Chain A, Helix-Stabilized Cyclic Peptides As Selective Inhibitors
Of Steroid Receptor-Coactivator Interactions
pdb|1PCG|B Chain B, Helix-Stabilized Cyclic Peptides As Selective Inhibitors
Of Steroid Receptor-Coactivator Interactions
pdb|2I0J|A Chain A, Benzopyrans Are Selective Estrogen Receptor Beta Agonists
(Serbas) With Novel Activity In Models Of Benign
Prostatic Hyperplasia
pdb|2I0J|B Chain B, Benzopyrans Are Selective Estrogen Receptor Beta Agonists
(Serbas) With Novel Activity In Models Of Benign
Prostatic Hyperplasia
pdb|2I0J|C Chain C, Benzopyrans Are Selective Estrogen Receptor Beta Agonists
(Serbas) With Novel Activity In Models Of Benign
Prostatic Hyperplasia
pdb|2I0J|D Chain D, Benzopyrans Are Selective Estrogen Receptor Beta Agonists
(Serbas) With Novel Activity In Models Of Benign
Prostatic Hyperplasia
Length = 244
Score = 46.6 bits (109), Expect = 8e-06, Method: Compositional matrix adjust.
Identities = 48/198 (24%), Positives = 83/198 (41%), Gaps = 34/198 (17%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAV--- 59
+ WAK +P F L DQV W L +L ++ + EH +
Sbjct: 55 INWAKRVPGFVDLTLHDQVHLLESA-----------W-LEILMIGLVWRSMEHPGKLLFA 102
Query: 60 PN-------GKASQTAADV-RVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRG-LKDS 110
PN GK+ + ++ +L RFR++ + EF CLK+++L S L +
Sbjct: 103 PNLLLDRNQGKSVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSST 162
Query: 111 LQVENLQDQAQVMLAQHVRT--HHPA--------QPARFGRLLLMTSQCRNIPSARVQHI 160
L+ +D +L + T H A Q R +LLL+ S R++ + ++H+
Sbjct: 163 LKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHL 222
Query: 161 FFAKTVANTSMEKLLCDM 178
+ K+ + LL +M
Sbjct: 223 YSMKSKNVVPLYDLLLEM 240
>pdb|1UOM|A Chain A, The Structure Of Estrogen Receptor In Complex With A
Selective And Potent Tetrahydroisochiolin Ligand.
pdb|1XQC|A Chain A, X-Ray Structure Of Eralpha Lbd Bound To A
Tetrahydroisoquinoline Serm Ligand At 2.05a Resolution
pdb|1XQC|B Chain B, X-Ray Structure Of Eralpha Lbd Bound To A
Tetrahydroisoquinoline Serm Ligand At 2.05a Resolution
pdb|1XQC|C Chain C, X-Ray Structure Of Eralpha Lbd Bound To A
Tetrahydroisoquinoline Serm Ligand At 2.05a Resolution
pdb|1XQC|D Chain D, X-Ray Structure Of Eralpha Lbd Bound To A
Tetrahydroisoquinoline Serm Ligand At 2.05a Resolution
Length = 254
Score = 46.6 bits (109), Expect = 8e-06, Method: Compositional matrix adjust.
Identities = 48/198 (24%), Positives = 83/198 (41%), Gaps = 34/198 (17%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAV--- 59
+ WAK +P F L DQV W L +L ++ + EH +
Sbjct: 59 INWAKRVPGFVDLTLHDQVHLLESA-----------W-LEILMIGLVWRSMEHPGKLLFA 106
Query: 60 PN-------GKASQTAADV-RVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRG-LKDS 110
PN GK+ + ++ +L RFR++ + EF CLK+++L S L +
Sbjct: 107 PNLLLDRNQGKSVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSST 166
Query: 111 LQVENLQDQAQVMLAQHVRT--HHPA--------QPARFGRLLLMTSQCRNIPSARVQHI 160
L+ +D +L + T H A Q R +LLL+ S R++ + ++H+
Sbjct: 167 LKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHL 226
Query: 161 FFAKTVANTSMEKLLCDM 178
+ K+ + LL +M
Sbjct: 227 YSMKSKNVVPLYDLLLEM 244
>pdb|3BC5|A Chain A, X-Ray Crystal Structure Of Human Ppar Gamma With
2-(5-(3-(2-
(5-Methyl-2-Phenyloxazol-4-Yl)ethoxy)benzyl)-2-Phenyl-
2h-1, 2,3-Triazol-4-Yl)acetic Acid
Length = 296
Score = 46.6 bits (109), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 41/184 (22%), Positives = 77/184 (41%), Gaps = 12/184 (6%)
Query: 4 KWAKNLPSFAALPFRDQVIXXXX---XXXXXXXXNAIQWSLPLLESSPLFNASEHVAAV- 59
++AK++P F L DQV + + L+ F E + ++
Sbjct: 117 EYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLR 176
Query: 60 -PNGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQD 118
P G + + V +F + +D ++ A AV++ + GL + +E++QD
Sbjct: 177 KPFGDFMEPKFEFAV------KFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQD 230
Query: 119 QAQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHI-FFAKTVANTSMEKLLCD 177
L ++ +HP F +LL + R I + VQ + KT + S+ LL +
Sbjct: 231 NLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQE 290
Query: 178 MYKN 181
+YK+
Sbjct: 291 IYKD 294
>pdb|3ET3|A Chain A, Structure Of Ppargamma With 3-[5-Methoxy-1-(4-Methoxy-
Benzenesulfonyl)-1h-Indol-3-Yl]-Propionic Acid
Length = 292
Score = 46.2 bits (108), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 41/184 (22%), Positives = 77/184 (41%), Gaps = 12/184 (6%)
Query: 4 KWAKNLPSFAALPFRDQVIXXXX---XXXXXXXXNAIQWSLPLLESSPLFNASEHVAAV- 59
++AK++P F L DQV + + L+ F E + ++
Sbjct: 113 EYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLR 172
Query: 60 -PNGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQD 118
P G + + V +F + +D ++ A AV++ + GL + +E++QD
Sbjct: 173 KPFGDFMEPKFEFAV------KFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQD 226
Query: 119 QAQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHI-FFAKTVANTSMEKLLCD 177
L ++ +HP F +LL + R I + VQ + KT + S+ LL +
Sbjct: 227 NLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQE 286
Query: 178 MYKN 181
+YK+
Sbjct: 287 IYKD 290
>pdb|1KNU|A Chain A, Ligand Binding Domain Of The Human Peroxisome Proliferator
Activated Receptor Gamma In Complex With A Synthetic
Agonist
pdb|1KNU|B Chain B, Ligand Binding Domain Of The Human Peroxisome Proliferator
Activated Receptor Gamma In Complex With A Synthetic
Agonist
pdb|2XKW|A Chain A, Ligand Binding Domain Of Human Ppar-Gamma In Complex With
The Agonist Pioglitazone
pdb|2XKW|B Chain B, Ligand Binding Domain Of Human Ppar-Gamma In Complex With
The Agonist Pioglitazone
pdb|3R5N|A Chain A, Crystal Structure Of Ppargammalbd Complexed With The
Agonist Magnolol
Length = 274
Score = 46.2 bits (108), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 41/184 (22%), Positives = 77/184 (41%), Gaps = 12/184 (6%)
Query: 4 KWAKNLPSFAALPFRDQVIXXXX---XXXXXXXXNAIQWSLPLLESSPLFNASEHVAAV- 59
++AK++P F L DQV + + L+ F E + ++
Sbjct: 95 EYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLR 154
Query: 60 -PNGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQD 118
P G + + V +F + +D ++ A AV++ + GL + +E++QD
Sbjct: 155 KPFGDFMEPKFEFAV------KFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQD 208
Query: 119 QAQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHI-FFAKTVANTSMEKLLCD 177
L ++ +HP F +LL + R I + VQ + KT + S+ LL +
Sbjct: 209 NLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQE 268
Query: 178 MYKN 181
+YK+
Sbjct: 269 IYKD 272
>pdb|3T03|A Chain A, Crystal Structure Of Ppar Gamma Ligand Binding Domain In
Complex With A Novel Partial Agonist Gq-16
pdb|3T03|B Chain B, Crystal Structure Of Ppar Gamma Ligand Binding Domain In
Complex With A Novel Partial Agonist Gq-16
Length = 284
Score = 46.2 bits (108), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 41/184 (22%), Positives = 77/184 (41%), Gaps = 12/184 (6%)
Query: 4 KWAKNLPSFAALPFRDQVIXXXX---XXXXXXXXNAIQWSLPLLESSPLFNASEHVAAV- 59
++AK++P F L DQV + + L+ F E + ++
Sbjct: 105 EYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLR 164
Query: 60 -PNGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQD 118
P G + + V +F + +D ++ A AV++ + GL + +E++QD
Sbjct: 165 KPFGDFMEPKFEFAV------KFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQD 218
Query: 119 QAQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHI-FFAKTVANTSMEKLLCD 177
L ++ +HP F +LL + R I + VQ + KT + S+ LL +
Sbjct: 219 NLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQE 278
Query: 178 MYKN 181
+YK+
Sbjct: 279 IYKD 282
>pdb|3U9Q|A Chain A, Ligand Binding Domain Of Ppargamma Complexed With Decanoic
Acid And Pgc-1a Peptide
Length = 269
Score = 46.2 bits (108), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 41/184 (22%), Positives = 77/184 (41%), Gaps = 12/184 (6%)
Query: 4 KWAKNLPSFAALPFRDQVIXXXX---XXXXXXXXNAIQWSLPLLESSPLFNASEHVAAV- 59
++AK++P F L DQV + + L+ F E + ++
Sbjct: 91 EYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLR 150
Query: 60 -PNGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQD 118
P G + + V +F + +D ++ A AV++ + GL + +E++QD
Sbjct: 151 KPFGDFMEPKFEFAV------KFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQD 204
Query: 119 QAQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHI-FFAKTVANTSMEKLLCD 177
L ++ +HP F +LL + R I + VQ + KT + S+ LL +
Sbjct: 205 NLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQE 264
Query: 178 MYKN 181
+YK+
Sbjct: 265 IYKD 268
>pdb|3B0Q|A Chain A, Human Ppar Gamma Ligand Binding Domain In Complex With
Mcc555
pdb|3B0Q|B Chain B, Human Ppar Gamma Ligand Binding Domain In Complex With
Mcc555
pdb|3B0R|A Chain A, Human Ppar Gamma Ligand Binding Dmain Complexed With
Gw9662 In A Covalent Bonded Form
pdb|3B0R|B Chain B, Human Ppar Gamma Ligand Binding Dmain Complexed With
Gw9662 In A Covalent Bonded Form
Length = 274
Score = 46.2 bits (108), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 41/184 (22%), Positives = 77/184 (41%), Gaps = 12/184 (6%)
Query: 4 KWAKNLPSFAALPFRDQVIXXXX---XXXXXXXXNAIQWSLPLLESSPLFNASEHVAAV- 59
++AK++P F L DQV + + L+ F E + ++
Sbjct: 96 EYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLR 155
Query: 60 -PNGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQD 118
P G + + V +F + +D ++ A AV++ + GL + +E++QD
Sbjct: 156 KPFGDFMEPKFEFAV------KFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQD 209
Query: 119 QAQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHI-FFAKTVANTSMEKLLCD 177
L ++ +HP F +LL + R I + VQ + KT + S+ LL +
Sbjct: 210 NLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQE 269
Query: 178 MYKN 181
+YK+
Sbjct: 270 IYKD 273
>pdb|3F5C|B Chain B, Structure Of Dax-1:lrh-1 Complex
pdb|3F5C|C Chain C, Structure Of Dax-1:lrh-1 Complex
Length = 268
Score = 46.2 bits (108), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 31/111 (27%), Positives = 50/111 (45%)
Query: 68 AADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQAQVMLAQH 127
AA V+ + + + +D E+A LK VLF + GL+ +E LQ + Q +L +H
Sbjct: 153 AAAVQAIKSFFFKCWSLNIDTKEYAYLKGTVLFNPDLPGLQCVKYIEGLQWRTQQILTEH 212
Query: 128 VRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSMEKLLCDM 178
+R R L R I S V +FF + SM+ ++ +M
Sbjct: 213 IRMMQREYQIRSAELNSALFLLRFINSDVVTELFFRPIIGAVSMDDMMLEM 263
>pdb|2OM9|A Chain A, Ajulemic Acid, A Synthetic Cannabinoid Bound To Ppar Gamma
pdb|2OM9|B Chain B, Ajulemic Acid, A Synthetic Cannabinoid Bound To Ppar Gamma
pdb|2OM9|C Chain C, Ajulemic Acid, A Synthetic Cannabinoid Bound To Ppar Gamma
pdb|2OM9|D Chain D, Ajulemic Acid, A Synthetic Cannabinoid Bound To Ppar Gamma
pdb|3SZ1|A Chain A, Human Ppar Gamma Ligand Binding Domain In Complex With
Luteolin And Myristic Acid
pdb|3SZ1|B Chain B, Human Ppar Gamma Ligand Binding Domain In Complex With
Luteolin And Myristic Acid
Length = 278
Score = 46.2 bits (108), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 41/184 (22%), Positives = 77/184 (41%), Gaps = 12/184 (6%)
Query: 4 KWAKNLPSFAALPFRDQVIXXXX---XXXXXXXXNAIQWSLPLLESSPLFNASEHVAAV- 59
++AK++P F L DQV + + L+ F E + ++
Sbjct: 99 EYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLR 158
Query: 60 -PNGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQD 118
P G + + V +F + +D ++ A AV++ + GL + +E++QD
Sbjct: 159 KPFGDFMEPKFEFAV------KFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQD 212
Query: 119 QAQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHI-FFAKTVANTSMEKLLCD 177
L ++ +HP F +LL + R I + VQ + KT + S+ LL +
Sbjct: 213 NLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQE 272
Query: 178 MYKN 181
+YK+
Sbjct: 273 IYKD 276
>pdb|1K74|D Chain D, The 2.3 Angstrom Resolution Crystal Structure Of The
Heterodimer Of The Human Ppargamma And Rxralpha Ligand
Binding Domains Respectively Bound With Gw409544 And
9-Cis Retinoic Acid And Co-Activator Peptides
Length = 283
Score = 46.2 bits (108), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 41/184 (22%), Positives = 77/184 (41%), Gaps = 12/184 (6%)
Query: 4 KWAKNLPSFAALPFRDQVIXXXX---XXXXXXXXNAIQWSLPLLESSPLFNASEHVAAV- 59
++AK++P F L DQV + + L+ F E + ++
Sbjct: 104 EYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLR 163
Query: 60 -PNGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQD 118
P G + + V +F + +D ++ A AV++ + GL + +E++QD
Sbjct: 164 KPFGDFMEPKFEFAV------KFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQD 217
Query: 119 QAQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHI-FFAKTVANTSMEKLLCD 177
L ++ +HP F +LL + R I + VQ + KT + S+ LL +
Sbjct: 218 NLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQE 277
Query: 178 MYKN 181
+YK+
Sbjct: 278 IYKD 281
>pdb|3R8A|A Chain A, X-Ray Crystal Structure Of The Nuclear Hormone Receptor
Ppar-Gamma In A Complex With A Compound With Dual Ppar
Gamma Agonism And Angiotensin Ii Type I Receptor
Antagonism Activity
pdb|3R8A|B Chain B, X-Ray Crystal Structure Of The Nuclear Hormone Receptor
Ppar-Gamma In A Complex With A Compound With Dual Ppar
Gamma Agonism And Angiotensin Ii Type I Receptor
Antagonism Activity
Length = 282
Score = 46.2 bits (108), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 41/184 (22%), Positives = 77/184 (41%), Gaps = 12/184 (6%)
Query: 4 KWAKNLPSFAALPFRDQVIXXXX---XXXXXXXXNAIQWSLPLLESSPLFNASEHVAAV- 59
++AK++P F L DQV + + L+ F E + ++
Sbjct: 103 EYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLR 162
Query: 60 -PNGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQD 118
P G + + V +F + +D ++ A AV++ + GL + +E++QD
Sbjct: 163 KPFGDFMEPKFEFAV------KFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQD 216
Query: 119 QAQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHI-FFAKTVANTSMEKLLCD 177
L ++ +HP F +LL + R I + VQ + KT + S+ LL +
Sbjct: 217 NLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQE 276
Query: 178 MYKN 181
+YK+
Sbjct: 277 IYKD 280
>pdb|3OSI|A Chain A, Crystal Structure Of Ppargamma Ligand Binding Domain In
Complex With Tetrachloro-Bisphenol A (Tcbpa)
pdb|3OSI|B Chain B, Crystal Structure Of Ppargamma Ligand Binding Domain In
Complex With Tetrachloro-Bisphenol A (Tcbpa)
pdb|3OSW|A Chain A, Crystal Structure Of Ppargamma Ligand Binding Domain In
Complex With Tetrabromo-Bisphenol A (Tbbpa)
pdb|3OSW|B Chain B, Crystal Structure Of Ppargamma Ligand Binding Domain In
Complex With Tetrabromo-Bisphenol A (Tbbpa)
Length = 285
Score = 46.2 bits (108), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 41/184 (22%), Positives = 77/184 (41%), Gaps = 12/184 (6%)
Query: 4 KWAKNLPSFAALPFRDQVIXXXX---XXXXXXXXNAIQWSLPLLESSPLFNASEHVAAV- 59
++AK++P F L DQV + + L+ F E + ++
Sbjct: 107 EYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLR 166
Query: 60 -PNGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQD 118
P G + + V +F + +D ++ A AV++ + GL + +E++QD
Sbjct: 167 KPFGDFMEPKFEFAV------KFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQD 220
Query: 119 QAQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHI-FFAKTVANTSMEKLLCD 177
L ++ +HP F +LL + R I + VQ + KT + S+ LL +
Sbjct: 221 NLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQE 280
Query: 178 MYKN 181
+YK+
Sbjct: 281 IYKD 284
>pdb|3CWD|A Chain A, Molecular Recognition Of Nitro-Fatty Acids By Ppar Gamma
pdb|3CWD|B Chain B, Molecular Recognition Of Nitro-Fatty Acids By Ppar Gamma
Length = 270
Score = 46.2 bits (108), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 41/184 (22%), Positives = 77/184 (41%), Gaps = 12/184 (6%)
Query: 4 KWAKNLPSFAALPFRDQVIXXXX---XXXXXXXXNAIQWSLPLLESSPLFNASEHVAAV- 59
++AK++P F L DQV + + L+ F E + ++
Sbjct: 91 EYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLR 150
Query: 60 -PNGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQD 118
P G + + V +F + +D ++ A AV++ + GL + +E++QD
Sbjct: 151 KPFGDFMEPKFEFAV------KFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQD 204
Query: 119 QAQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHI-FFAKTVANTSMEKLLCD 177
L ++ +HP F +LL + R I + VQ + KT + S+ LL +
Sbjct: 205 NLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQE 264
Query: 178 MYKN 181
+YK+
Sbjct: 265 IYKD 268
>pdb|2PRG|A Chain A, Ligand-Binding Domain Of The Human Peroxisome Proliferator
Activated Receptor Gamma
pdb|2PRG|B Chain B, Ligand-Binding Domain Of The Human Peroxisome Proliferator
Activated Receptor Gamma
pdb|2F4B|A Chain A, Crystal Structure Of The Ligand Binding Domain Of Human
Ppar-Gamma In Complex With An Agonist
pdb|2F4B|B Chain B, Crystal Structure Of The Ligand Binding Domain Of Human
Ppar-Gamma In Complex With An Agonist
pdb|2FVJ|A Chain A, A Novel Anti-adipogenic Partial Agonist Of Peroxisome
Proliferator- Activated Receptor-gamma (pparg) Recruits
Pparg-coactivator-1 Alpha (pgc1a) But Potentiates
Insulin Signaling In Vitro
pdb|2G0G|A Chain A, Structure-based Drug Design Of A Novel Family Of Ppar
Partial Agonists: Virtual Screening, X-ray
Crystallography And In Vitro/in Vivo Biological
Activities
pdb|2G0G|B Chain B, Structure-based Drug Design Of A Novel Family Of Ppar
Partial Agonists: Virtual Screening, X-ray
Crystallography And In Vitro/in Vivo Biological
Activities
pdb|2G0H|A Chain A, Structure-Based Drug Design Of A Novel Family Of Ppar
Partial Agonists: Virtual Screening, X-Ray
Crystallography And In VitroIN VIVO BIOLOGICAL
ACTIVITIES
pdb|2G0H|B Chain B, Structure-Based Drug Design Of A Novel Family Of Ppar
Partial Agonists: Virtual Screening, X-Ray
Crystallography And In VitroIN VIVO BIOLOGICAL
ACTIVITIES
pdb|2ATH|A Chain A, Crystal Structure Of The Ligand Binding Domain Of Human
Ppar-Gamma Im Complex With An Agonist
pdb|2ATH|B Chain B, Crystal Structure Of The Ligand Binding Domain Of Human
Ppar-Gamma Im Complex With An Agonist
pdb|2GTK|A Chain A, Structure-Based Design Of Indole Propionic Acids As Novel
Pparag Co-Agonists
pdb|2HWQ|A Chain A, Structural Basis For The Structure-Activity Relationships
Of Peroxisome Proliferator-Activated Receptor Agonists
pdb|2HWQ|B Chain B, Structural Basis For The Structure-Activity Relationships
Of Peroxisome Proliferator-Activated Receptor Agonists
pdb|2HWR|A Chain A, Structural Basis For The Structure-Activity Relationships
Of Peroxisome Proliferator-Activated Receptor Agonists
pdb|2HWR|B Chain B, Structural Basis For The Structure-Activity Relationships
Of Peroxisome Proliferator-Activated Receptor Agonists
pdb|2Q8S|A Chain A, X-Ray Crystal Structure Of The Nuclear Hormone Receptor
Ppar-Gamma In A Complex With A Ppar GammaALPHA DUAL
AGONIST
pdb|2Q8S|B Chain B, X-Ray Crystal Structure Of The Nuclear Hormone Receptor
Ppar-Gamma In A Complex With A Ppar GammaALPHA DUAL
AGONIST
pdb|3G9E|A Chain A, Aleglitaar. A New. Potent, And Balanced Dual PparaG
AGONIST For The Treatment Of Type Ii Diabetes
pdb|3IA6|A Chain A, X-Ray Crystal Structure Of The Nuclear Hormone Receptor
Ppar-Gamma In A Complex With A Ppar GammaALPHA DUAL
Agonist
pdb|3IA6|B Chain B, X-Ray Crystal Structure Of The Nuclear Hormone Receptor
Ppar-Gamma In A Complex With A Ppar GammaALPHA DUAL
Agonist
pdb|3FEJ|A Chain A, Design And Biological Evaluation Of Novel, Balanced Dual
PparaG AGONISTS
pdb|3GBK|A Chain A, Crystal Structure Of Human Ppar-Gamma Ligand Binding
Domain Complexed With A Potent And Selective Agonist
pdb|3GBK|B Chain B, Crystal Structure Of Human Ppar-Gamma Ligand Binding
Domain Complexed With A Potent And Selective Agonist
pdb|3NOA|A Chain A, Crystal Structure Of Human Ppar-Gamma Ligand Binding
Domain Complex With A Potency Improved Agonist
pdb|3NOA|B Chain B, Crystal Structure Of Human Ppar-Gamma Ligand Binding
Domain Complex With A Potency Improved Agonist
pdb|3QT0|A Chain A, Revealing A Steroid Receptor Ligand As A Unique Ppargamma
Agonist
Length = 271
Score = 46.2 bits (108), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 41/184 (22%), Positives = 77/184 (41%), Gaps = 12/184 (6%)
Query: 4 KWAKNLPSFAALPFRDQVIXXXX---XXXXXXXXNAIQWSLPLLESSPLFNASEHVAAV- 59
++AK++P F L DQV + + L+ F E + ++
Sbjct: 92 EYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLR 151
Query: 60 -PNGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQD 118
P G + + V +F + +D ++ A AV++ + GL + +E++QD
Sbjct: 152 KPFGDFMEPKFEFAV------KFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQD 205
Query: 119 QAQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHI-FFAKTVANTSMEKLLCD 177
L ++ +HP F +LL + R I + VQ + KT + S+ LL +
Sbjct: 206 NLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQE 265
Query: 178 MYKN 181
+YK+
Sbjct: 266 IYKD 269
>pdb|3PRG|A Chain A, Ligand Binding Domain Of Human Peroxisome Proliferator
Activated Receptor
Length = 278
Score = 46.2 bits (108), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 41/184 (22%), Positives = 77/184 (41%), Gaps = 12/184 (6%)
Query: 4 KWAKNLPSFAALPFRDQVIXXXX---XXXXXXXXNAIQWSLPLLESSPLFNASEHVAAV- 59
++AK++P F L DQV + + L+ F E + ++
Sbjct: 99 EYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLR 158
Query: 60 -PNGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQD 118
P G + + V +F + +D ++ A AV++ + GL + +E++QD
Sbjct: 159 KPFGDFMEPKFEFAV------KFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQD 212
Query: 119 QAQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHI-FFAKTVANTSMEKLLCD 177
L ++ +HP F +LL + R I + VQ + KT + S+ LL +
Sbjct: 213 NLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQE 272
Query: 178 MYKN 181
+YK+
Sbjct: 273 IYKD 276
>pdb|3S9S|A Chain A, Ligand Binding Domain Of Ppargamma Complexed With A
Benzimidazole Partial Agonist
Length = 284
Score = 46.2 bits (108), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 41/184 (22%), Positives = 77/184 (41%), Gaps = 12/184 (6%)
Query: 4 KWAKNLPSFAALPFRDQVIXXXX---XXXXXXXXNAIQWSLPLLESSPLFNASEHVAAV- 59
++AK++P F L DQV + + L+ F E + ++
Sbjct: 105 EYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLR 164
Query: 60 -PNGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQD 118
P G + + V +F + +D ++ A AV++ + GL + +E++QD
Sbjct: 165 KPFGDFMEPKFEFAV------KFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQD 218
Query: 119 QAQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHI-FFAKTVANTSMEKLLCD 177
L ++ +HP F +LL + R I + VQ + KT + S+ LL +
Sbjct: 219 NLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQE 278
Query: 178 MYKN 181
+YK+
Sbjct: 279 IYKD 282
>pdb|1FM6|D Chain D, The 2.1 Angstrom Resolution Crystal Structure Of The
Heterodimer Of The Human Rxralpha And Ppargamma Ligand
Binding Domains Respectively Bound With 9-Cis Retinoic
Acid And Rosiglitazone And Co-Activator Peptides.
pdb|1FM6|X Chain X, The 2.1 Angstrom Resolution Crystal Structure Of The
Heterodimer Of The Human Rxralpha And Ppargamma Ligand
Binding Domains Respectively Bound With 9-Cis Retinoic
Acid And Rosiglitazone And Co-Activator Peptides.
pdb|1FM9|D Chain D, The 2.1 Angstrom Resolution Crystal Structure Of The
Heterodimer Of The Human Rxralpha And Ppargamma Ligand
Binding Domains Respectively Bound With 9-Cis Retinoic
Acid And Gi262570 And Co-Activator Peptides.
pdb|1ZGY|A Chain A, Structural And Biochemical Basis For Selective Repression
Of The Orphan Nuclear Receptor Lrh-1 By Shp
pdb|2POB|A Chain A, Ppargamma Ligand Binding Domain Complexed With A
Farglitazar Analogue Gw4709
pdb|2POB|B Chain B, Ppargamma Ligand Binding Domain Complexed With A
Farglitazar Analogue Gw4709
pdb|3FUR|A Chain A, Crystal Structure Of Pparg In Complex With Int131
pdb|3H0A|D Chain D, Crystal Structure Of Peroxisome Proliferator-Activated
Receptor Gamma (Pparg) And Retinoic Acid Receptor Alpha
(Rxra) In Complex With 9-Cis Retinoic Acid, Co-Activator
Peptide, And A Partial Agonist
pdb|3K8S|A Chain A, Crystal Structure Of Pparg In Complex With T2384
pdb|3K8S|B Chain B, Crystal Structure Of Pparg In Complex With T2384
pdb|3KMG|A Chain A, The X-Ray Crystal Structure Of Ppar-Gamma In Complex With
An Indole Derivative Modulator, Gsk538, And An Src-1
Peptide
pdb|3KMG|D Chain D, The X-Ray Crystal Structure Of Ppar-Gamma In Complex With
An Indole Derivative Modulator, Gsk538, And An Src-1
Peptide
Length = 272
Score = 46.2 bits (108), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 41/184 (22%), Positives = 77/184 (41%), Gaps = 12/184 (6%)
Query: 4 KWAKNLPSFAALPFRDQVIXXXX---XXXXXXXXNAIQWSLPLLESSPLFNASEHVAAV- 59
++AK++P F L DQV + + L+ F E + ++
Sbjct: 93 EYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLR 152
Query: 60 -PNGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQD 118
P G + + V +F + +D ++ A AV++ + GL + +E++QD
Sbjct: 153 KPFGDFMEPKFEFAV------KFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQD 206
Query: 119 QAQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHI-FFAKTVANTSMEKLLCD 177
L ++ +HP F +LL + R I + VQ + KT + S+ LL +
Sbjct: 207 NLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQE 266
Query: 178 MYKN 181
+YK+
Sbjct: 267 IYKD 270
>pdb|3VN2|A Chain A, Crystal Structure Of Ppargamma Complexed With Telmisartan
Length = 285
Score = 46.2 bits (108), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 41/184 (22%), Positives = 77/184 (41%), Gaps = 12/184 (6%)
Query: 4 KWAKNLPSFAALPFRDQVIXXXX---XXXXXXXXNAIQWSLPLLESSPLFNASEHVAAV- 59
++AK++P F L DQV + + L+ F E + ++
Sbjct: 106 EYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLR 165
Query: 60 -PNGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQD 118
P G + + V +F + +D ++ A AV++ + GL + +E++QD
Sbjct: 166 KPFGDFMEPKFEFAV------KFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQD 219
Query: 119 QAQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHI-FFAKTVANTSMEKLLCD 177
L ++ +HP F +LL + R I + VQ + KT + S+ LL +
Sbjct: 220 NLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQE 279
Query: 178 MYKN 181
+YK+
Sbjct: 280 IYKD 283
>pdb|3ET0|A Chain A, Structure Of Ppargamma With 3-(5-Methoxy-1h-Indol-3-Yl)-
Propionic Acid
pdb|3ET0|B Chain B, Structure Of Ppargamma With 3-(5-Methoxy-1h-Indol-3-Yl)-
Propionic Acid
Length = 292
Score = 46.2 bits (108), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 41/184 (22%), Positives = 77/184 (41%), Gaps = 12/184 (6%)
Query: 4 KWAKNLPSFAALPFRDQVIXXXX---XXXXXXXXNAIQWSLPLLESSPLFNASEHVAAV- 59
++AK++P F L DQV + + L+ F E + ++
Sbjct: 113 EYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLR 172
Query: 60 -PNGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQD 118
P G + + V +F + +D ++ A AV++ + GL + +E++QD
Sbjct: 173 KPFGDFMEPKFEFAV------KFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQD 226
Query: 119 QAQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHI-FFAKTVANTSMEKLLCD 177
L ++ +HP F +LL + R I + VQ + KT + S+ LL +
Sbjct: 227 NLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQE 286
Query: 178 MYKN 181
+YK+
Sbjct: 287 IYKD 290
>pdb|4PRG|A Chain A, 0072 Partial Agonist Ppar Gamma Cocrystal
pdb|4PRG|B Chain B, 0072 Partial Agonist Ppar Gamma Cocrystal
pdb|4PRG|C Chain C, 0072 Partial Agonist Ppar Gamma Cocrystal
pdb|4PRG|D Chain D, 0072 Partial Agonist Ppar Gamma Cocrystal
pdb|1PRG|A Chain A, Ligand Binding Domain Of The Human Peroxisome Proliferator
Activated Receptor Gamma
pdb|1PRG|B Chain B, Ligand Binding Domain Of The Human Peroxisome Proliferator
Activated Receptor Gamma
pdb|2QMV|A Chain A, High Resolution Structure Of Peroxisone
Proliferation-Activated Receptor Gamma And
Characterisation Of Its Interaction With The Co-
Activator Transcriptional Intermediary Factor 2
Length = 270
Score = 46.2 bits (108), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 41/184 (22%), Positives = 77/184 (41%), Gaps = 12/184 (6%)
Query: 4 KWAKNLPSFAALPFRDQVIXXXX---XXXXXXXXNAIQWSLPLLESSPLFNASEHVAAV- 59
++AK++P F L DQV + + L+ F E + ++
Sbjct: 92 EYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLR 151
Query: 60 -PNGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQD 118
P G + + V +F + +D ++ A AV++ + GL + +E++QD
Sbjct: 152 KPFGDFMEPKFEFAV------KFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQD 205
Query: 119 QAQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHI-FFAKTVANTSMEKLLCD 177
L ++ +HP F +LL + R I + VQ + KT + S+ LL +
Sbjct: 206 NLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQE 265
Query: 178 MYKN 181
+YK+
Sbjct: 266 IYKD 269
>pdb|1WM0|X Chain X, Ppargamma In Complex With A 2-Baba Compound
Length = 292
Score = 46.2 bits (108), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 41/184 (22%), Positives = 77/184 (41%), Gaps = 12/184 (6%)
Query: 4 KWAKNLPSFAALPFRDQVIXXXX---XXXXXXXXNAIQWSLPLLESSPLFNASEHVAAV- 59
++AK++P F L DQV + + L+ F E + ++
Sbjct: 113 EYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLR 172
Query: 60 -PNGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQD 118
P G + + V +F + +D ++ A AV++ + GL + +E++QD
Sbjct: 173 KPFGDFMEPKFEFAV------KFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQD 226
Query: 119 QAQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHI-FFAKTVANTSMEKLLCD 177
L ++ +HP F +LL + R I + VQ + KT + S+ LL +
Sbjct: 227 NLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQE 286
Query: 178 MYKN 181
+YK+
Sbjct: 287 IYKD 290
>pdb|1NYX|A Chain A, Ligand Binding Domain Of The Human Peroxisome Proliferator
Activated Receptor Gamma In Complex With An Agonist
pdb|1NYX|B Chain B, Ligand Binding Domain Of The Human Peroxisome Proliferator
Activated Receptor Gamma In Complex With An Agonist
Length = 276
Score = 46.2 bits (108), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 41/184 (22%), Positives = 77/184 (41%), Gaps = 12/184 (6%)
Query: 4 KWAKNLPSFAALPFRDQVIXXXX---XXXXXXXXNAIQWSLPLLESSPLFNASEHVAAV- 59
++AK++P F L DQV + + L+ F E + ++
Sbjct: 97 EYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLR 156
Query: 60 -PNGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQD 118
P G + + V +F + +D ++ A AV++ + GL + +E++QD
Sbjct: 157 KPFGDFMEPKFEFAV------KFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQD 210
Query: 119 QAQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHI-FFAKTVANTSMEKLLCD 177
L ++ +HP F +LL + R I + VQ + KT + S+ LL +
Sbjct: 211 NLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQE 270
Query: 178 MYKN 181
+YK+
Sbjct: 271 IYKD 274
>pdb|2VSR|A Chain A, Hppargamma Ligand Binding Domain In Complex With
9-(S)-Hode
pdb|2VSR|B Chain B, Hppargamma Ligand Binding Domain In Complex With
9-(S)-Hode
pdb|2VST|A Chain A, Hppargamma Ligand Binding Domain In Complex With 13-(S)-
Hode
pdb|2VST|B Chain B, Hppargamma Ligand Binding Domain In Complex With 13-(S)-
Hode
pdb|2VV0|A Chain A, Hppargamma Ligand Binding Domain In Complex With Dha
pdb|2VV0|B Chain B, Hppargamma Ligand Binding Domain In Complex With Dha
pdb|2VV1|A Chain A, Hppargamma Ligand Binding Domain In Complex With 4-Hdha
pdb|2VV2|A Chain A, Hppargamma Ligand Binding Domain In Complex With 5-Hepa
pdb|2VV2|B Chain B, Hppargamma Ligand Binding Domain In Complex With 5-Hepa
pdb|2VV3|A Chain A, Hppargamma Ligand Binding Domain In Complex With 4-Oxodha
pdb|2VV3|B Chain B, Hppargamma Ligand Binding Domain In Complex With 4-Oxodha
pdb|2VV4|A Chain A, Hppargamma Ligand Binding Domain In Complex With 6-Oxoote
Length = 276
Score = 46.2 bits (108), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 41/184 (22%), Positives = 77/184 (41%), Gaps = 12/184 (6%)
Query: 4 KWAKNLPSFAALPFRDQVIXXXX---XXXXXXXXNAIQWSLPLLESSPLFNASEHVAAV- 59
++AK++P F L DQV + + L+ F E + ++
Sbjct: 97 EYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLR 156
Query: 60 -PNGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQD 118
P G + + V +F + +D ++ A AV++ + GL + +E++QD
Sbjct: 157 KPFGDFMEPKFEFAV------KFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQD 210
Query: 119 QAQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHI-FFAKTVANTSMEKLLCD 177
L ++ +HP F +LL + R I + VQ + KT + S+ LL +
Sbjct: 211 NLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQE 270
Query: 178 MYKN 181
+YK+
Sbjct: 271 IYKD 274
>pdb|1RDT|D Chain D, Crystal Structure Of A New Rexinoid Bound To The Rxralpha
Ligand Binding Doamin In The RxralphaPPARGAMMA
HETERODIMER
Length = 284
Score = 46.2 bits (108), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 41/184 (22%), Positives = 77/184 (41%), Gaps = 12/184 (6%)
Query: 4 KWAKNLPSFAALPFRDQVIXXXX---XXXXXXXXNAIQWSLPLLESSPLFNASEHVAAV- 59
++AK++P F L DQV + + L+ F E + ++
Sbjct: 105 EYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLR 164
Query: 60 -PNGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQD 118
P G + + V +F + +D ++ A AV++ + GL + +E++QD
Sbjct: 165 KPFGDFMEPKFEFAV------KFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQD 218
Query: 119 QAQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHI-FFAKTVANTSMEKLLCD 177
L ++ +HP F +LL + R I + VQ + KT + S+ LL +
Sbjct: 219 NLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQE 278
Query: 178 MYKN 181
+YK+
Sbjct: 279 IYKD 282
>pdb|2Q59|A Chain A, Crystal Structure Of Ppargamma Lbd Bound To Full Agonist
Mrl20
Length = 274
Score = 46.2 bits (108), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 41/184 (22%), Positives = 77/184 (41%), Gaps = 12/184 (6%)
Query: 4 KWAKNLPSFAALPFRDQVIXXXX---XXXXXXXXNAIQWSLPLLESSPLFNASEHVAAV- 59
++AK++P F L DQV + + L+ F E + ++
Sbjct: 95 EYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLR 154
Query: 60 -PNGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQD 118
P G + + V +F + +D ++ A AV++ + GL + +E++QD
Sbjct: 155 KPFGDFMEPKFEFAV------KFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQD 208
Query: 119 QAQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHI-FFAKTVANTSMEKLLCD 177
L ++ +HP F +LL + R I + VQ + KT + S+ LL +
Sbjct: 209 NLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQE 268
Query: 178 MYKN 181
+YK+
Sbjct: 269 IYKD 272
>pdb|3PBA|A Chain A, Crystal Structure Of Ppargamma Ligand Binding Domain In
Complex With Monosulfate Tetrabromo-Bisphenol A
(Monotbbpa)
pdb|3PBA|B Chain B, Crystal Structure Of Ppargamma Ligand Binding Domain In
Complex With Monosulfate Tetrabromo-Bisphenol A
(Monotbbpa)
pdb|3PO9|A Chain A, Crystal Structure Of Ppargamma Ligand Binding Domain In
Complex With Tripropyltin
pdb|3PO9|B Chain B, Crystal Structure Of Ppargamma Ligand Binding Domain In
Complex With Tripropyltin
Length = 286
Score = 46.2 bits (108), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 41/184 (22%), Positives = 77/184 (41%), Gaps = 12/184 (6%)
Query: 4 KWAKNLPSFAALPFRDQVIXXXX---XXXXXXXXNAIQWSLPLLESSPLFNASEHVAAV- 59
++AK++P F L DQV + + L+ F E + ++
Sbjct: 107 EYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLR 166
Query: 60 -PNGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQD 118
P G + + V +F + +D ++ A AV++ + GL + +E++QD
Sbjct: 167 KPFGDFMEPKFEFAV------KFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQD 220
Query: 119 QAQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHI-FFAKTVANTSMEKLLCD 177
L ++ +HP F +LL + R I + VQ + KT + S+ LL +
Sbjct: 221 NLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQE 280
Query: 178 MYKN 181
+YK+
Sbjct: 281 IYKD 284
>pdb|1ZEO|A Chain A, Crystal Structure Of Human Ppar-Gamma Ligand Binding
Domain Complexed With An Alpha-Aryloxyphenylacetic Acid
Agonist
pdb|1ZEO|B Chain B, Crystal Structure Of Human Ppar-Gamma Ligand Binding
Domain Complexed With An Alpha-Aryloxyphenylacetic Acid
Agonist
pdb|2P4Y|A Chain A, Crystal Structure Of Human Ppar-Gamma-Ligand Binding
Domain Complexed With An Indole-Based Modulator
pdb|2P4Y|B Chain B, Crystal Structure Of Human Ppar-Gamma-Ligand Binding
Domain Complexed With An Indole-Based Modulator
pdb|3TY0|A Chain A, Structure Of Ppargamma Ligand Binding Domain In Complex
With (R)-5-(3-
((3-(6-Methoxybenzo[d]isoxazol-3-Yl)-2-Oxo-2,
3-Dihydro-1h-
Benzo[d]imidazol-1-Yl)methyl)phenyl)-5-
Methyloxazolidine-2,4-Dione
pdb|3TY0|B Chain B, Structure Of Ppargamma Ligand Binding Domain In Complex
With (R)-5-(3-
((3-(6-Methoxybenzo[d]isoxazol-3-Yl)-2-Oxo-2,
3-Dihydro-1h-
Benzo[d]imidazol-1-Yl)methyl)phenyl)-5-
Methyloxazolidine-2,4-Dione
Length = 277
Score = 46.2 bits (108), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 41/184 (22%), Positives = 77/184 (41%), Gaps = 12/184 (6%)
Query: 4 KWAKNLPSFAALPFRDQVIXXXX---XXXXXXXXNAIQWSLPLLESSPLFNASEHVAAV- 59
++AK++P F L DQV + + L+ F E + ++
Sbjct: 98 EYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLR 157
Query: 60 -PNGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQD 118
P G + + V +F + +D ++ A AV++ + GL + +E++QD
Sbjct: 158 KPFGDFMEPKFEFAV------KFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQD 211
Query: 119 QAQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHI-FFAKTVANTSMEKLLCD 177
L ++ +HP F +LL + R I + VQ + KT + S+ LL +
Sbjct: 212 NLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQE 271
Query: 178 MYKN 181
+YK+
Sbjct: 272 IYKD 275
>pdb|2VV1|B Chain B, Hppargamma Ligand Binding Domain In Complex With 4-Hdha
Length = 276
Score = 46.2 bits (108), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 41/184 (22%), Positives = 77/184 (41%), Gaps = 12/184 (6%)
Query: 4 KWAKNLPSFAALPFRDQVIXXXX---XXXXXXXXNAIQWSLPLLESSPLFNASEHVAAV- 59
++AK++P F L DQV + + L+ F E + ++
Sbjct: 97 EYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLR 156
Query: 60 -PNGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQD 118
P G + + V +F + +D ++ A AV++ + GL + +E++QD
Sbjct: 157 KPFGDFMEPKFEFAV------KFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQD 210
Query: 119 QAQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHI-FFAKTVANTSMEKLLCD 177
L ++ +HP F +LL + R I + VQ + KT + S+ LL +
Sbjct: 211 NLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQE 270
Query: 178 MYKN 181
+YK+
Sbjct: 271 IYKD 274
>pdb|2VV4|B Chain B, Hppargamma Ligand Binding Domain In Complex With 6-Oxoote
Length = 276
Score = 46.2 bits (108), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 41/184 (22%), Positives = 77/184 (41%), Gaps = 12/184 (6%)
Query: 4 KWAKNLPSFAALPFRDQVIXXXX---XXXXXXXXNAIQWSLPLLESSPLFNASEHVAAV- 59
++AK++P F L DQV + + L+ F E + ++
Sbjct: 97 EYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLR 156
Query: 60 -PNGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQD 118
P G + + V +F + +D ++ A AV++ + GL + +E++QD
Sbjct: 157 KPFGDFMEPKFEFAV------KFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQD 210
Query: 119 QAQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHI-FFAKTVANTSMEKLLCD 177
L ++ +HP F +LL + R I + VQ + KT + S+ LL +
Sbjct: 211 NLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQE 270
Query: 178 MYKN 181
+YK+
Sbjct: 271 IYKD 274
>pdb|3CS8|A Chain A, Structural And Biochemical Basis For The Binding
Selectivity Of Pparg To Pgc-1a
Length = 275
Score = 46.2 bits (108), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 41/184 (22%), Positives = 77/184 (41%), Gaps = 12/184 (6%)
Query: 4 KWAKNLPSFAALPFRDQVIXXXX---XXXXXXXXNAIQWSLPLLESSPLFNASEHVAAV- 59
++AK++P F L DQV + + L+ F E + ++
Sbjct: 97 EYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLR 156
Query: 60 -PNGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQD 118
P G + + V +F + +D ++ A AV++ + GL + +E++QD
Sbjct: 157 KPFGDFMEPKFEFAV------KFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQD 210
Query: 119 QAQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHI-FFAKTVANTSMEKLLCD 177
L ++ +HP F +LL + R I + VQ + KT + S+ LL +
Sbjct: 211 NLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQE 270
Query: 178 MYKN 181
+YK+
Sbjct: 271 IYKD 274
>pdb|2I4J|A Chain A, Crystal Structure Of The Complex Between Ppargamma And The
Agonist Lt160 (Ureidofibrate Derivative)
pdb|2I4J|B Chain B, Crystal Structure Of The Complex Between Ppargamma And The
Agonist Lt160 (Ureidofibrate Derivative)
pdb|2I4P|A Chain A, Crystal Structure Of The Complex Between Ppargamma And The
Partial Agonist Lt127 (Ureidofibrate Derivative).
Structure Obtained From Crystals Of The Apo-Form Soaked
For 30 Days.
pdb|2I4P|B Chain B, Crystal Structure Of The Complex Between Ppargamma And The
Partial Agonist Lt127 (Ureidofibrate Derivative).
Structure Obtained From Crystals Of The Apo-Form Soaked
For 30 Days.
pdb|2I4Z|A Chain A, Crystal Structure Of The Complex Between Ppargamma And The
Partial Agonist Lt127 (Ureidofibrate Derivative). This
Structure Has Been Obtained From Crystals Soaked For 6
Hours.
pdb|2I4Z|B Chain B, Crystal Structure Of The Complex Between Ppargamma And The
Partial Agonist Lt127 (Ureidofibrate Derivative). This
Structure Has Been Obtained From Crystals Soaked For 6
Hours.
pdb|3B3K|A Chain A, Crystal Structure Of The Complex Between Ppargamma And The
Full Agonist Lt175
pdb|3B3K|B Chain B, Crystal Structure Of The Complex Between Ppargamma And The
Full Agonist Lt175
pdb|3CDS|A Chain A, Crystal Structure Of The Complex Between Ppar-Gamma And
The Agonist Lt248 (Clofibric Acid Analogue)
pdb|3CDS|B Chain B, Crystal Structure Of The Complex Between Ppar-Gamma And
The Agonist Lt248 (Clofibric Acid Analogue)
pdb|3D6D|A Chain A, Crystal Structure Of The Complex Between Ppargamma Lbd And
The Lt175(R-Enantiomer)
pdb|3D6D|B Chain B, Crystal Structure Of The Complex Between Ppargamma Lbd And
The Lt175(R-Enantiomer)
pdb|3CDP|A Chain A, Crystal Structure Of Ppar-Gamma Lbd Complexed With A
Partial Agonist, Analogue Of Clofibric Acid
pdb|3CDP|B Chain B, Crystal Structure Of Ppar-Gamma Lbd Complexed With A
Partial Agonist, Analogue Of Clofibric Acid
pdb|2ZK0|A Chain A, Human Peroxisome Proliferator-Activated Receptor Gamma
Ligand Binding Domain
pdb|2ZK0|B Chain B, Human Peroxisome Proliferator-Activated Receptor Gamma
Ligand Binding Domain
pdb|2ZK1|A Chain A, Human Peroxisome Proliferator-Activated Receptor Gamma
Ligand Binding Domain Complexed With
15-Deoxy-Delta12,14- Prostaglandin J2
pdb|2ZK1|B Chain B, Human Peroxisome Proliferator-Activated Receptor Gamma
Ligand Binding Domain Complexed With
15-Deoxy-Delta12,14- Prostaglandin J2
pdb|2ZK2|A Chain A, Human Peroxisome Proliferator-Activated Receptor Gamma
Ligand Binding Domain Complexed With Glutathion
Conjugated 15-Deoxy-Delta12,14-Prostaglandin J2
pdb|2ZK2|B Chain B, Human Peroxisome Proliferator-Activated Receptor Gamma
Ligand Binding Domain Complexed With Glutathion
Conjugated 15-Deoxy-Delta12,14-Prostaglandin J2
pdb|2ZK3|A Chain A, Human Peroxisome Proliferator-Activated Receptor Gamma
Ligand Binding Domain Complexed With 8-Oxo-
Eicosatetraenoic Acid
pdb|2ZK3|B Chain B, Human Peroxisome Proliferator-Activated Receptor Gamma
Ligand Binding Domain Complexed With 8-Oxo-
Eicosatetraenoic Acid
pdb|2ZK4|A Chain A, Human Peroxisome Proliferator-Activated Receptor Gamma
Ligand Binding Domain Complexed With 15-Oxo-
Eicosatetraenoic Acid
pdb|2ZK4|B Chain B, Human Peroxisome Proliferator-Activated Receptor Gamma
Ligand Binding Domain Complexed With 15-Oxo-
Eicosatetraenoic Acid
pdb|2ZK5|A Chain A, Human Peroxisome Proliferator-Activated Receptor Gamma
Ligand Binding Domain Complexed With Nitro-233
pdb|2ZK5|B Chain B, Human Peroxisome Proliferator-Activated Receptor Gamma
Ligand Binding Domain Complexed With Nitro-233
pdb|2ZK6|A Chain A, Human Peroxisome Proliferator-Activated Receptor Gamma
Ligand Binding Domain Complexed With C8-Bodipy
pdb|2ZK6|B Chain B, Human Peroxisome Proliferator-Activated Receptor Gamma
Ligand Binding Domain Complexed With C8-Bodipy
pdb|2ZNO|A Chain A, Human Pprr Gamma Ligand Binding Domain In Complex With A
Synthetic Agonist Tipp703
pdb|2ZNO|B Chain B, Human Pprr Gamma Ligand Binding Domain In Complex With A
Synthetic Agonist Tipp703
pdb|3HO0|A Chain A, Crystal Structure Of The Ppargamma-Lbd Complexed With A
New Aryloxy-3phenylpropanoic Acid
pdb|3HO0|B Chain B, Crystal Structure Of The Ppargamma-Lbd Complexed With A
New Aryloxy-3phenylpropanoic Acid
pdb|3HOD|A Chain A, Crystal Structure Of The Ppargamma-Lbd Complexed With A
New Aryloxy-3phenylpropanoic Acid
pdb|3HOD|B Chain B, Crystal Structure Of The Ppargamma-Lbd Complexed With A
New Aryloxy-3phenylpropanoic Acid
pdb|3AN3|A Chain A, Human Ppar Gamma Ligand Binding Domain In Complex With A
Gamma Selective Agonist Mo3s
pdb|3AN3|B Chain B, Human Ppar Gamma Ligand Binding Domain In Complex With A
Gamma Selective Agonist Mo3s
pdb|3AN4|A Chain A, Human Ppar Gamma Ligand Binding Domain In Complex With A
Gamma Selective Agonist Mo4r
pdb|3AN4|B Chain B, Human Ppar Gamma Ligand Binding Domain In Complex With A
Gamma Selective Agonist Mo4r
pdb|3VJH|A Chain A, Human Ppar Gamma Ligand Binding Domain In Complex With
Jkpl35
pdb|3VJH|B Chain B, Human Ppar Gamma Ligand Binding Domain In Complex With
Jkpl35
pdb|3VJI|A Chain A, Human Ppar Gamma Ligand Binding Domain In Complex With
Jkpl53
pdb|3VJI|B Chain B, Human Ppar Gamma Ligand Binding Domain In Complex With
Jkpl53
Length = 286
Score = 46.2 bits (108), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 41/184 (22%), Positives = 77/184 (41%), Gaps = 12/184 (6%)
Query: 4 KWAKNLPSFAALPFRDQVIXXXX---XXXXXXXXNAIQWSLPLLESSPLFNASEHVAAV- 59
++AK++P F L DQV + + L+ F E + ++
Sbjct: 108 EYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLR 167
Query: 60 -PNGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQD 118
P G + + V +F + +D ++ A AV++ + GL + +E++QD
Sbjct: 168 KPFGDFMEPKFEFAV------KFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQD 221
Query: 119 QAQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHI-FFAKTVANTSMEKLLCD 177
L ++ +HP F +LL + R I + VQ + KT + S+ LL +
Sbjct: 222 NLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQE 281
Query: 178 MYKN 181
+YK+
Sbjct: 282 IYKD 285
>pdb|2Q59|B Chain B, Crystal Structure Of Ppargamma Lbd Bound To Full Agonist
Mrl20
pdb|2Q5P|A Chain A, Crystal Structure Of Ppargamma Bound To Partial Agonist
Mrl24
pdb|2Q5P|B Chain B, Crystal Structure Of Ppargamma Bound To Partial Agonist
Mrl24
pdb|2Q5S|A Chain A, Crystal Structure Of Ppargamma Bound To Partial Agonist
Ntzdpa
pdb|2Q5S|B Chain B, Crystal Structure Of Ppargamma Bound To Partial Agonist
Ntzdpa
pdb|2Q61|A Chain A, Crystal Structure Of Ppargamma Ligand Binding Domain Bound
To Partial Agonist Sr145
pdb|2Q61|B Chain B, Crystal Structure Of Ppargamma Ligand Binding Domain Bound
To Partial Agonist Sr145
pdb|2Q6R|A Chain A, Crystal Structure Of Ppar Gamma Complexed With Partial
Agonist Sf147
pdb|2Q6R|B Chain B, Crystal Structure Of Ppar Gamma Complexed With Partial
Agonist Sf147
pdb|2Q6S|A Chain A, 2.4 Angstrom Crystal Structure Of Ppar Gamma Complexed To
Bvt.13 Without Co-Activator Peptides
pdb|2Q6S|B Chain B, 2.4 Angstrom Crystal Structure Of Ppar Gamma Complexed To
Bvt.13 Without Co-Activator Peptides
Length = 274
Score = 46.2 bits (108), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 41/184 (22%), Positives = 77/184 (41%), Gaps = 12/184 (6%)
Query: 4 KWAKNLPSFAALPFRDQVIXXXX---XXXXXXXXNAIQWSLPLLESSPLFNASEHVAAV- 59
++AK++P F L DQV + + L+ F E + ++
Sbjct: 95 EYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLR 154
Query: 60 -PNGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQD 118
P G + + V +F + +D ++ A AV++ + GL + +E++QD
Sbjct: 155 KPFGDFMEPKFEFAV------KFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQD 208
Query: 119 QAQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHI-FFAKTVANTSMEKLLCD 177
L ++ +HP F +LL + R I + VQ + KT + S+ LL +
Sbjct: 209 NLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQE 268
Query: 178 MYKN 181
+YK+
Sbjct: 269 IYKD 272
>pdb|2HFP|A Chain A, Crystal Structure Of Ppar Gamma With N-Sulfonyl-2-Indole
Carboxamide Ligands
Length = 282
Score = 46.2 bits (108), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 41/184 (22%), Positives = 77/184 (41%), Gaps = 12/184 (6%)
Query: 4 KWAKNLPSFAALPFRDQVIXXXX---XXXXXXXXNAIQWSLPLLESSPLFNASEHVAAV- 59
++AK++P F L DQV + + L+ F E + ++
Sbjct: 103 EYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLR 162
Query: 60 -PNGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQD 118
P G + + V +F + +D ++ A AV++ + GL + +E++QD
Sbjct: 163 KPFGDFMEPKFEFAV------KFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQD 216
Query: 119 QAQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHI-FFAKTVANTSMEKLLCD 177
L ++ +HP F +LL + R I + VQ + KT + S+ LL +
Sbjct: 217 NLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQE 276
Query: 178 MYKN 181
+YK+
Sbjct: 277 IYKD 280
>pdb|3ADS|A Chain A, Human Ppargamma Ligand-Binding Domain In Complex With
Indomethacin
pdb|3ADS|B Chain B, Human Ppargamma Ligand-Binding Domain In Complex With
Indomethacin
pdb|3ADT|A Chain A, Human Ppargamma Ligand-Binding Domain In Complex With
5-Hydroxy-Indole Acetate
pdb|3ADT|B Chain B, Human Ppargamma Ligand-Binding Domain In Complex With
5-Hydroxy-Indole Acetate
pdb|3ADU|A Chain A, Human Ppargamma Ligand-Binding Domain In Complex With
5-Methoxy-Indole Acetate
pdb|3ADU|B Chain B, Human Ppargamma Ligand-Binding Domain In Complex With
5-Methoxy-Indole Acetate
pdb|3ADV|A Chain A, Human Ppargamma Ligand-Binding Domain In Complex With
Serotonin
pdb|3ADV|B Chain B, Human Ppargamma Ligand-Binding Domain In Complex With
Serotonin
pdb|3ADW|A Chain A, Human Ppargamma Ligand-Binding Domain In Complex With
5-Methoxy-Indole Acetate And 15-Oxo-Eicosatetraenoic
Acid
pdb|3ADW|B Chain B, Human Ppargamma Ligand-Binding Domain In Complex With
5-Methoxy-Indole Acetate And 15-Oxo-Eicosatetraenoic
Acid
pdb|3ADX|A Chain A, Human Ppargamma Ligand-Binding Domain In Complex With
Indomethacin And Nitro-233
pdb|3ADX|B Chain B, Human Ppargamma Ligand-Binding Domain In Complex With
Indomethacin And Nitro-233
pdb|3R8I|A Chain A, Crystal Structure Of Ppargamma With An Achiral
Ureidofibrate Derivative (Rt86)
pdb|3R8I|B Chain B, Crystal Structure Of Ppargamma With An Achiral
Ureidofibrate Derivative (Rt86)
pdb|2YFE|A Chain A, Ligand Binding Domain Of Human Ppar Gamma In Complex With
Amorfrutin 1
pdb|2YFE|B Chain B, Ligand Binding Domain Of Human Ppar Gamma In Complex With
Amorfrutin 1
pdb|4A4V|A Chain A, Ligand Binding Domain Of Human Ppar Gamma In Complex With
Amorfrutin 2
pdb|4A4V|B Chain B, Ligand Binding Domain Of Human Ppar Gamma In Complex With
Amorfrutin 2
pdb|4A4W|A Chain A, Ligand Binding Domain Of Human Ppar Gamma In Complex With
Amorfrutin 2
pdb|4A4W|B Chain B, Ligand Binding Domain Of Human Ppar Gamma In Complex With
Amorfrutin 2
pdb|4E4K|A Chain A, Crystal Structure Of Ppargamma With The Ligand Jo21
pdb|4E4K|B Chain B, Crystal Structure Of Ppargamma With The Ligand Jo21
pdb|4E4Q|A Chain A, Crystal Structure Of Ppargamma With The Ligand Fs214
pdb|4E4Q|B Chain B, Crystal Structure Of Ppargamma With The Ligand Fs214
Length = 287
Score = 46.2 bits (108), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 41/184 (22%), Positives = 77/184 (41%), Gaps = 12/184 (6%)
Query: 4 KWAKNLPSFAALPFRDQVIXXXX---XXXXXXXXNAIQWSLPLLESSPLFNASEHVAAV- 59
++AK++P F L DQV + + L+ F E + ++
Sbjct: 108 EYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLR 167
Query: 60 -PNGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQD 118
P G + + V +F + +D ++ A AV++ + GL + +E++QD
Sbjct: 168 KPFGDFMEPKFEFAV------KFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQD 221
Query: 119 QAQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHI-FFAKTVANTSMEKLLCD 177
L ++ +HP F +LL + R I + VQ + KT + S+ LL +
Sbjct: 222 NLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQE 281
Query: 178 MYKN 181
+YK+
Sbjct: 282 IYKD 285
>pdb|1I7I|A Chain A, Crystal Structure Of The Ligand Binding Domain Of Human
Ppar-Gamma In Complex With The Agonist Az 242
pdb|1I7I|B Chain B, Crystal Structure Of The Ligand Binding Domain Of Human
Ppar-Gamma In Complex With The Agonist Az 242
Length = 292
Score = 46.2 bits (108), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 41/184 (22%), Positives = 77/184 (41%), Gaps = 12/184 (6%)
Query: 4 KWAKNLPSFAALPFRDQVIXXXX---XXXXXXXXNAIQWSLPLLESSPLFNASEHVAAV- 59
++AK++P F L DQV + + L+ F E + ++
Sbjct: 113 EYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLR 172
Query: 60 -PNGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQD 118
P G + + V +F + +D ++ A AV++ + GL + +E++QD
Sbjct: 173 KPFGDFMEPKFEFAV------KFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQD 226
Query: 119 QAQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHI-FFAKTVANTSMEKLLCD 177
L ++ +HP F +LL + R I + VQ + KT + S+ LL +
Sbjct: 227 NLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQE 286
Query: 178 MYKN 181
+YK+
Sbjct: 287 IYKD 290
>pdb|2ZVT|A Chain A, Cys285ser Mutant Ppargamma Ligand-Binding Domain Complexed
With 15-Deoxy-Delta12,14-Prostaglandin J2
pdb|2ZVT|B Chain B, Cys285ser Mutant Ppargamma Ligand-Binding Domain Complexed
With 15-Deoxy-Delta12,14-Prostaglandin J2
Length = 286
Score = 46.2 bits (108), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 41/184 (22%), Positives = 77/184 (41%), Gaps = 12/184 (6%)
Query: 4 KWAKNLPSFAALPFRDQVIXXXX---XXXXXXXXNAIQWSLPLLESSPLFNASEHVAAV- 59
++AK++P F L DQV + + L+ F E + ++
Sbjct: 108 EYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLR 167
Query: 60 -PNGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQD 118
P G + + V +F + +D ++ A AV++ + GL + +E++QD
Sbjct: 168 KPFGDFMEPKFEFAV------KFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQD 221
Query: 119 QAQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHI-FFAKTVANTSMEKLLCD 177
L ++ +HP F +LL + R I + VQ + KT + S+ LL +
Sbjct: 222 NLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQE 281
Query: 178 MYKN 181
+YK+
Sbjct: 282 IYKD 285
>pdb|3LMP|A Chain A, Crystal Structure Of The Ppargamma-Lbd Complexed With A
Cercosporamide Derivative Modulator
pdb|3B1M|A Chain A, Crystal Structure Of The Ppargamma-Lbd Complexed With A
Cercosporamide Derivative Modulator Cerco-A
pdb|3V9T|A Chain A, Crystal Structure Of The Ppargamma-Lbd Complexed With A
Cercosporamide Derivative Modulator
pdb|3V9V|A Chain A, Crystal Structure Of The Ppargamma-Lbd Complexed With A
Cercosporamide Derivative Modulator
pdb|3V9Y|A Chain A, Crystal Structure Of The Ppargamma-Lbd Complexed With A
Cercosporamide Derivative Modulator
pdb|4F9M|A Chain A, Crystal Structure Of The Ppargamma-Lbd Complexed With A
Cercosporamide Derivative Modulator
Length = 283
Score = 46.2 bits (108), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 41/184 (22%), Positives = 77/184 (41%), Gaps = 12/184 (6%)
Query: 4 KWAKNLPSFAALPFRDQVIXXXX---XXXXXXXXNAIQWSLPLLESSPLFNASEHVAAV- 59
++AK++P F L DQV + + L+ F E + ++
Sbjct: 104 EYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLR 163
Query: 60 -PNGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQD 118
P G + + V +F + +D ++ A AV++ + GL + +E++QD
Sbjct: 164 KPFGDFMEPKFEFAV------KFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQD 217
Query: 119 QAQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHI-FFAKTVANTSMEKLLCD 177
L ++ +HP F +LL + R I + VQ + KT + S+ LL +
Sbjct: 218 NLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQE 277
Query: 178 MYKN 181
+YK+
Sbjct: 278 IYKD 281
>pdb|3HM1|A Chain A, Crystal Structure Of Human Estrogen Receptor Alpha
Ligand-Bi Domain In Complex With A Glucocorticoid
Receptor Interactin 1 Nr Box Ii Peptide And Estrone
((8r,9s,13s,14s)-3-Hydroxy-
7,8,9,11,12,14,15,
16-Octahydro-6h-Cyclopenta[a]phenanthren-
pdb|3HM1|B Chain B, Crystal Structure Of Human Estrogen Receptor Alpha
Ligand-Bi Domain In Complex With A Glucocorticoid
Receptor Interactin 1 Nr Box Ii Peptide And Estrone
((8r,9s,13s,14s)-3-Hydroxy-
7,8,9,11,12,14,15,
16-Octahydro-6h-Cyclopenta[a]phenanthren-
Length = 253
Score = 45.4 bits (106), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 49/198 (24%), Positives = 82/198 (41%), Gaps = 34/198 (17%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAV--- 59
+ WAK +P F L DQV W L +L ++ + EH +
Sbjct: 61 INWAKRVPGFVDLTLHDQVHLLEXA-----------W-LEILMIGLVWRSMEHPGKLLFA 108
Query: 60 PN-------GKASQTAADV-RVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRG-LKDS 110
PN GK + ++ +L RFR++ + EF CLK+++L S L +
Sbjct: 109 PNLLLDRNQGKXVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSST 168
Query: 111 LQVENLQDQAQVMLAQHVRT--HHPA--------QPARFGRLLLMTSQCRNIPSARVQHI 160
L+ +D +L + T H A Q R +LLL+ S R++ + ++H+
Sbjct: 169 LKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHL 228
Query: 161 FFAKTVANTSMEKLLCDM 178
+ K + LL +M
Sbjct: 229 YSMKXKNVVPLSDLLLEM 246
>pdb|1ZKY|A Chain A, Human Estrogen Receptor Alpha Ligand-Binding Domain In
Complex With Obcp-3m And A Glucocorticoid Receptor
Interacting Protein 1 Nr Box Ii Peptide
pdb|1ZKY|B Chain B, Human Estrogen Receptor Alpha Ligand-Binding Domain In
Complex With Obcp-3m And A Glucocorticoid Receptor
Interacting Protein 1 Nr Box Ii Peptide
pdb|2B1V|A Chain A, Human Estrogen Receptor Alpha Ligand-Binding Domain In
Complex With Obcp-1m And A Glucocorticoid Receptor
Interacting Protein 1 Nr Box Ii Peptide
pdb|2B1V|B Chain B, Human Estrogen Receptor Alpha Ligand-Binding Domain In
Complex With Obcp-1m And A Glucocorticoid Receptor
Interacting Protein 1 Nr Box Ii Peptide
pdb|2FAI|A Chain A, Human Estrogen Receptor Alpha Ligand-Binding Domain In
Complex With Obcp-2m And A Glucocorticoid Receptor
Interacting Protein 1 Nr Box Ii Peptide
pdb|2FAI|B Chain B, Human Estrogen Receptor Alpha Ligand-Binding Domain In
Complex With Obcp-2m And A Glucocorticoid Receptor
Interacting Protein 1 Nr Box Ii Peptide
pdb|2B1Z|A Chain A, Human Estrogen Receptor Alpha Ligand-Binding Domain In
Complex With 17methyl-17alpha-Dihydroequilenin And A
Glucoc Interacting Protein 1 Nr Box Ii Peptide
pdb|2B1Z|B Chain B, Human Estrogen Receptor Alpha Ligand-Binding Domain In
Complex With 17methyl-17alpha-Dihydroequilenin And A
Glucoc Interacting Protein 1 Nr Box Ii Peptide
pdb|2B23|A Chain A, Human Estrogen Receptor Alpha Ligand-Binding Domain And A
Glucocorticoid Receptor-Interacting Protein 1 Nr Box Ii
Peptide
pdb|2B23|B Chain B, Human Estrogen Receptor Alpha Ligand-Binding Domain And A
Glucocorticoid Receptor-Interacting Protein 1 Nr Box Ii
Peptide
pdb|2G44|A Chain A, Human Estrogen Receptor Alpha Ligand-Binding Domain In
Complex With Obcp-1m-G And A Glucocorticoid Receptor
Interacting Protein 1 Nr Box Ii Peptide
pdb|2G44|B Chain B, Human Estrogen Receptor Alpha Ligand-Binding Domain In
Complex With Obcp-1m-G And A Glucocorticoid Receptor
Interacting Protein 1 Nr Box Ii Peptide
pdb|2G5O|A Chain A, Human Estrogen Receptor Alpha Ligand-Binding Domain In
Complex With 2- (But-1-Enyl)-17beta-Estradiol And A
Glucocorticoid Receptor Interacting Protein 1 Nr Box Ii
Peptide
pdb|2G5O|B Chain B, Human Estrogen Receptor Alpha Ligand-Binding Domain In
Complex With 2- (But-1-Enyl)-17beta-Estradiol And A
Glucocorticoid Receptor Interacting Protein 1 Nr Box Ii
Peptide
Length = 257
Score = 45.4 bits (106), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 49/198 (24%), Positives = 82/198 (41%), Gaps = 34/198 (17%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAV--- 59
+ WAK +P F L DQV W L +L ++ + EH +
Sbjct: 61 INWAKRVPGFVDLTLHDQVHLLEXA-----------W-LEILMIGLVWRSMEHPGKLLFA 108
Query: 60 PN-------GKASQTAADV-RVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRG-LKDS 110
PN GK + ++ +L RFR++ + EF CLK+++L S L +
Sbjct: 109 PNLLLDRNQGKXVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSST 168
Query: 111 LQVENLQDQAQVMLAQHVRT--HHPA--------QPARFGRLLLMTSQCRNIPSARVQHI 160
L+ +D +L + T H A Q R +LLL+ S R++ + ++H+
Sbjct: 169 LKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHL 228
Query: 161 FFAKTVANTSMEKLLCDM 178
+ K + LL +M
Sbjct: 229 YSMKXKNVVPLSDLLLEM 246
>pdb|3UU7|B Chain B, Crystal Structure Of Hera-Lbd (Y537s) In Complex With
Bisphenol-A
Length = 251
Score = 45.4 bits (106), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 49/198 (24%), Positives = 82/198 (41%), Gaps = 34/198 (17%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAV--- 59
+ WAK +P F L DQV W L +L ++ + EH +
Sbjct: 57 INWAKRVPGFVDLTLHDQVHLLEXA-----------W-LEILMIGLVWRSMEHPGKLLFA 104
Query: 60 PN-------GKASQTAADV-RVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRG-LKDS 110
PN GK + ++ +L RFR++ + EF CLK+++L S L +
Sbjct: 105 PNLLLDRNQGKXVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSST 164
Query: 111 LQVENLQDQAQVMLAQHVRT--HHPA--------QPARFGRLLLMTSQCRNIPSARVQHI 160
L+ +D +L + T H A Q R +LLL+ S R++ + ++H+
Sbjct: 165 LKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHL 224
Query: 161 FFAKTVANTSMEKLLCDM 178
+ K + LL +M
Sbjct: 225 YSMKXKNVVPLSDLLLEM 242
>pdb|3Q97|A Chain A, Crystal Structure Of Human Estrogen Receptor Alpha Lbd In
Complex With Grip Peptide And Two Isomers Of Ethoxy
Triphenylethylene
Length = 260
Score = 45.4 bits (106), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 49/198 (24%), Positives = 82/198 (41%), Gaps = 34/198 (17%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAV--- 59
+ WAK +P F L DQV W L +L ++ + EH +
Sbjct: 64 INWAKRVPGFVDLTLHDQVHLLEXA-----------W-LEILMIGLVWRSMEHPGKLLFA 111
Query: 60 PN-------GKASQTAADV-RVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRG-LKDS 110
PN GK + ++ +L RFR++ + EF CLK+++L S L +
Sbjct: 112 PNLLLDRNQGKXVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSST 171
Query: 111 LQVENLQDQAQVMLAQHVRT--HHPA--------QPARFGRLLLMTSQCRNIPSARVQHI 160
L+ +D +L + T H A Q R +LLL+ S R++ + ++H+
Sbjct: 172 LKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHL 231
Query: 161 FFAKTVANTSMEKLLCDM 178
+ K + LL +M
Sbjct: 232 YSMKXKNVVPLSDLLLEM 249
>pdb|2QZO|B Chain B, Crystal Structure Of The Estrogen Receptor Alpha Ligand
Binding Domain Complexed With Way-169916
Length = 258
Score = 45.1 bits (105), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 49/198 (24%), Positives = 82/198 (41%), Gaps = 34/198 (17%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAV--- 59
+ WAK +P F L DQV W L +L ++ + EH +
Sbjct: 62 INWAKRVPGFVDLTLHDQVHLLEXA-----------W-LEILMIGLVWRSMEHPGKLLFA 109
Query: 60 PN-------GKASQTAADV-RVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRG-LKDS 110
PN GK + ++ +L RFR++ + EF CLK+++L S L +
Sbjct: 110 PNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSST 169
Query: 111 LQVENLQDQAQVMLAQHVRT--HHPA--------QPARFGRLLLMTSQCRNIPSARVQHI 160
L+ +D +L + T H A Q R +LLL+ S R++ + ++H+
Sbjct: 170 LKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHL 229
Query: 161 FFAKTVANTSMEKLLCDM 178
+ K + LL +M
Sbjct: 230 YSMKXKNVVPLSDLLLEM 247
>pdb|3UUA|B Chain B, Crystal Structure Of Hera-Lbd (Y537s) In Complex With
Bisphenol-Af
pdb|3UUD|A Chain A, Crystal Structure Of Hera-Lbd (Y537s) In Complex With
Estradiol
Length = 251
Score = 45.1 bits (105), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 49/198 (24%), Positives = 82/198 (41%), Gaps = 34/198 (17%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAV--- 59
+ WAK +P F L DQV W L +L ++ + EH +
Sbjct: 57 INWAKRVPGFVDLTLHDQVHLLEXA-----------W-LEILMIGLVWRSMEHPGKLLFA 104
Query: 60 PN-------GKASQTAADV-RVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRG-LKDS 110
PN GK + ++ +L RFR++ + EF CLK+++L S L +
Sbjct: 105 PNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSST 164
Query: 111 LQVENLQDQAQVMLAQHVRT--HHPA--------QPARFGRLLLMTSQCRNIPSARVQHI 160
L+ +D +L + T H A Q R +LLL+ S R++ + ++H+
Sbjct: 165 LKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHL 224
Query: 161 FFAKTVANTSMEKLLCDM 178
+ K + LL +M
Sbjct: 225 YSMKXKNVVPLSDLLLEM 242
>pdb|3L03|A Chain A, Crystal Structure Of Human Estrogen Receptor Alpha
Ligand-Binding Domain In Complex With A Glucocorticoid
Receptor Interacting Protein 1 Nr Box Ii Peptide And
Estetrol (Estra-1,3,5(10)-Triene-3,15 Alpha,
16alpha,17beta-Tetrol)
pdb|3L03|B Chain B, Crystal Structure Of Human Estrogen Receptor Alpha
Ligand-Binding Domain In Complex With A Glucocorticoid
Receptor Interacting Protein 1 Nr Box Ii Peptide And
Estetrol (Estra-1,3,5(10)-Triene-3,15 Alpha,
16alpha,17beta-Tetrol)
Length = 253
Score = 45.1 bits (105), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 48/198 (24%), Positives = 81/198 (40%), Gaps = 34/198 (17%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAV--- 59
+ WAK +P F L DQV W L +L ++ + EH +
Sbjct: 61 INWAKRVPGFVDLTLHDQVHLL-----------ECAW-LEILMIGLVWRSMEHPGKLLFA 108
Query: 60 PN-------GKASQTAADV-RVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRG-LKDS 110
PN GK + ++ +L RFR++ + EF CLK+++L S L +
Sbjct: 109 PNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSST 168
Query: 111 LQVENLQDQAQVMLAQHVRT--HHPA--------QPARFGRLLLMTSQCRNIPSARVQHI 160
L+ +D +L + T H A Q R +LLL+ S R++ + ++H+
Sbjct: 169 LKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHL 228
Query: 161 FFAKTVANTSMEKLLCDM 178
+ K + LL +M
Sbjct: 229 YSMKXKNVVPLSDLLLEM 246
>pdb|3HLV|A Chain A, Crystal Structure Of Human Estrogen Receptor Alpha
Ligand-Bi Domain In Complex With A Glucocorticoid
Receptor Interactin 1 Nr Box Ii Peptide And
16-Alpha-Hydroxy-Estrone ((8s,9r,13
16r)-3,16-Dihydroxy-13-Methyl-7,8,9,11,12,14,15,
16-Octahyd Cyclopenta[a]phenanthren-17-One
pdb|3HLV|B Chain B, Crystal Structure Of Human Estrogen Receptor Alpha
Ligand-Bi Domain In Complex With A Glucocorticoid
Receptor Interactin 1 Nr Box Ii Peptide And
16-Alpha-Hydroxy-Estrone ((8s,9r,13
16r)-3,16-Dihydroxy-13-Methyl-7,8,9,11,12,14,15,
16-Octahyd Cyclopenta[a]phenanthren-17-One
Length = 253
Score = 45.1 bits (105), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 48/198 (24%), Positives = 81/198 (40%), Gaps = 34/198 (17%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAV--- 59
+ WAK +P F L DQV W L +L ++ + EH +
Sbjct: 61 INWAKRVPGFVDLTLHDQV-----------HLLECAW-LEILMIGLVWRSMEHPGKLLFA 108
Query: 60 PN-------GKASQTAADV-RVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRG-LKDS 110
PN GK + ++ +L RFR++ + EF CLK+++L S L +
Sbjct: 109 PNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSST 168
Query: 111 LQVENLQDQAQVMLAQHVRT--HHPA--------QPARFGRLLLMTSQCRNIPSARVQHI 160
L+ +D +L + T H A Q R +LLL+ S R++ + ++H+
Sbjct: 169 LKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHL 228
Query: 161 FFAKTVANTSMEKLLCDM 178
+ K + LL +M
Sbjct: 229 YSMKCKNVVPLSDLLLEM 246
>pdb|3UUA|A Chain A, Crystal Structure Of Hera-Lbd (Y537s) In Complex With
Bisphenol-Af
Length = 251
Score = 45.1 bits (105), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 49/198 (24%), Positives = 82/198 (41%), Gaps = 34/198 (17%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAV--- 59
+ WAK +P F L DQV W L +L ++ + EH +
Sbjct: 57 INWAKRVPGFVDLTLHDQVHLLEXA-----------W-LEILMIGLVWRSMEHPGKLLFA 104
Query: 60 PN-------GKASQTAADV-RVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRG-LKDS 110
PN GK + ++ +L RFR++ + EF CLK+++L S L +
Sbjct: 105 PNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSST 164
Query: 111 LQVENLQDQAQVMLAQHVRT--HHPA--------QPARFGRLLLMTSQCRNIPSARVQHI 160
L+ +D +L + T H A Q R +LLL+ S R++ + ++H+
Sbjct: 165 LKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHL 224
Query: 161 FFAKTVANTSMEKLLCDM 178
+ K + LL +M
Sbjct: 225 YSMKCKNVVPLSDLLLEM 242
>pdb|1XB7|A Chain A, X-Ray Structure Of Erralpha Lbd In Complex With A Pgc-
1alpha Peptide At 2.5a Resolution
Length = 247
Score = 45.1 bits (105), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 44/184 (23%), Positives = 77/184 (41%), Gaps = 6/184 (3%)
Query: 1 MAVKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVP 60
+ + WAK++P F++L DQ+ Q SLPL L A + V
Sbjct: 62 VTISWAKSIPGFSSLSLSDQMSVLQSVWMEVLVLGVAQRSLPL--QDELAFAEDLVLDEE 119
Query: 61 NGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQA 120
+A+ L +++R + + ++ E+ LKA+ L S++ ++D+ VE L++
Sbjct: 120 GARAAGLGELGAALLQLVRRLQALRLEREEYVLLKALALANSDSVHIEDAEAVEQLREAL 179
Query: 121 QVMLAQH----VRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSMEKLLC 176
L ++ A+ R GRLLL R + H + K M KL
Sbjct: 180 HEALLEYEAGRAGPGGGAERRRAGRLLLTLPLLRQTAGKVLAHFYGVKLEGKVPMHKLFL 239
Query: 177 DMYK 180
+M +
Sbjct: 240 EMLE 243
>pdb|2QA8|B Chain B, Crystal Structure Of The Estrogen Receptor Alpha Ligand
Binding Domain Mutant 537s Complexed With Genistein
pdb|2QZO|A Chain A, Crystal Structure Of The Estrogen Receptor Alpha Ligand
Binding Domain Complexed With Way-169916
Length = 258
Score = 45.1 bits (105), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 49/198 (24%), Positives = 82/198 (41%), Gaps = 34/198 (17%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAV--- 59
+ WAK +P F L DQV W L +L ++ + EH +
Sbjct: 62 INWAKRVPGFVDLTLHDQVHLLEXA-----------W-LEILMIGLVWRSMEHPGKLLFA 109
Query: 60 PN-------GKASQTAADV-RVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRG-LKDS 110
PN GK + ++ +L RFR++ + EF CLK+++L S L +
Sbjct: 110 PNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSST 169
Query: 111 LQVENLQDQAQVMLAQHVRT--HHPA--------QPARFGRLLLMTSQCRNIPSARVQHI 160
L+ +D +L + T H A Q R +LLL+ S R++ + ++H+
Sbjct: 170 LKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHL 229
Query: 161 FFAKTVANTSMEKLLCDM 178
+ K + LL +M
Sbjct: 230 YSMKCKNVVPLSDLLLEM 247
>pdb|3Q95|A Chain A, Crystal Structure Of Human Estrogen Receptor Alpha Lbd In
Complex With Grip Peptide And Estriol
Length = 260
Score = 45.1 bits (105), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 49/198 (24%), Positives = 82/198 (41%), Gaps = 34/198 (17%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAV--- 59
+ WAK +P F L DQV W L +L ++ + EH +
Sbjct: 64 INWAKRVPGFVDLTLHDQVHLLEXA-----------W-LEILMIGLVWRSMEHPGKLLFA 111
Query: 60 PN-------GKASQTAADV-RVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRG-LKDS 110
PN GK + ++ +L RFR++ + EF CLK+++L S L +
Sbjct: 112 PNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSST 171
Query: 111 LQVENLQDQAQVMLAQHVRT--HHPA--------QPARFGRLLLMTSQCRNIPSARVQHI 160
L+ +D +L + T H A Q R +LLL+ S R++ + ++H+
Sbjct: 172 LKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHL 231
Query: 161 FFAKTVANTSMEKLLCDM 178
+ K + LL +M
Sbjct: 232 YSMKCKNVVPLSDLLLEM 249
>pdb|3UU7|A Chain A, Crystal Structure Of Hera-Lbd (Y537s) In Complex With
Bisphenol-A
pdb|3UUD|B Chain B, Crystal Structure Of Hera-Lbd (Y537s) In Complex With
Estradiol
Length = 251
Score = 45.1 bits (105), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 49/198 (24%), Positives = 82/198 (41%), Gaps = 34/198 (17%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAV--- 59
+ WAK +P F L DQV W L +L ++ + EH +
Sbjct: 57 INWAKRVPGFVDLTLHDQVHLLEXA-----------W-LEILMIGLVWRSMEHPGKLLFA 104
Query: 60 PN-------GKASQTAADV-RVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRG-LKDS 110
PN GK + ++ +L RFR++ + EF CLK+++L S L +
Sbjct: 105 PNLLLDRNQGKXVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSST 164
Query: 111 LQVENLQDQAQVMLAQHVRT--HHPA--------QPARFGRLLLMTSQCRNIPSARVQHI 160
L+ +D +L + T H A Q R +LLL+ S R++ + ++H+
Sbjct: 165 LKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHL 224
Query: 161 FFAKTVANTSMEKLLCDM 178
+ K + LL +M
Sbjct: 225 YSMKCKNVVPLSDLLLEM 242
>pdb|3Q95|B Chain B, Crystal Structure Of Human Estrogen Receptor Alpha Lbd In
Complex With Grip Peptide And Estriol
pdb|3Q97|B Chain B, Crystal Structure Of Human Estrogen Receptor Alpha Lbd In
Complex With Grip Peptide And Two Isomers Of Ethoxy
Triphenylethylene
Length = 260
Score = 45.1 bits (105), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 49/198 (24%), Positives = 82/198 (41%), Gaps = 34/198 (17%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAV--- 59
+ WAK +P F L DQV W L +L ++ + EH +
Sbjct: 64 INWAKRVPGFVDLTLHDQVHLLEXA-----------W-LEILMIGLVWRSMEHPGKLLFA 111
Query: 60 PN-------GKASQTAADV-RVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRG-LKDS 110
PN GK + ++ +L RFR++ + EF CLK+++L S L +
Sbjct: 112 PNLLLDRNQGKXVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSST 171
Query: 111 LQVENLQDQAQVMLAQHVRT--HHPA--------QPARFGRLLLMTSQCRNIPSARVQHI 160
L+ +D +L + T H A Q R +LLL+ S R++ + ++H+
Sbjct: 172 LKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHL 231
Query: 161 FFAKTVANTSMEKLLCDM 178
+ K + LL +M
Sbjct: 232 YSMKCKNVVPLSDLLLEM 249
>pdb|3K6P|A Chain A, Estrogen Related Receptor Alpha In Complex With An Ether
Based Ligand
Length = 248
Score = 45.1 bits (105), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 44/184 (23%), Positives = 77/184 (41%), Gaps = 6/184 (3%)
Query: 1 MAVKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVP 60
+ + WAK++P F++L DQ+ Q SLPL L A + V
Sbjct: 63 VTISWAKSIPGFSSLSLSDQMSVLQSVWMEVLVLGVAQRSLPL--QDELAFAEDLVLDEE 120
Query: 61 NGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQA 120
+A+ L +++R + + ++ E+ LKA+ L S++ ++D+ VE L++
Sbjct: 121 GARAAGLGELGAALLQLVRRLQALRLEREEYVLLKALALANSDSVHIEDAEAVEQLREAL 180
Query: 121 QVMLAQH----VRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSMEKLLC 176
L ++ A+ R GRLLL R + H + K M KL
Sbjct: 181 HEALLEYEAGRAGPGGGAERRRAGRLLLTLPLLRQTAGKVLAHFYGVKLEGKVPMHKLFL 240
Query: 177 DMYK 180
+M +
Sbjct: 241 EMLE 244
>pdb|2PJL|A Chain A, Crystal Structure Of Human Estrogen-Related Receptor Alpha
In Complex With A Synthetic Inverse Agonist Reveals Its
Novel Molecular Mechanism
pdb|2PJL|B Chain B, Crystal Structure Of Human Estrogen-Related Receptor Alpha
In Complex With A Synthetic Inverse Agonist Reveals Its
Novel Molecular Mechanism
Length = 247
Score = 45.1 bits (105), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 44/184 (23%), Positives = 77/184 (41%), Gaps = 6/184 (3%)
Query: 1 MAVKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVP 60
+ + WAK++P F++L DQ+ Q SLPL L A + V
Sbjct: 62 VTISWAKSIPGFSSLSLSDQMSVLQSVWMEVLVLGVAQRSLPL--QDELAFAEDLVLDEE 119
Query: 61 NGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQA 120
+A+ L +++R + + ++ E+ LKA+ L S++ ++D+ VE L++
Sbjct: 120 GARAAGLGELGAALLQLVRRLQALRLEREEYVLLKALALANSDSVHIEDAEAVEQLREAL 179
Query: 121 QVMLAQH----VRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSMEKLLC 176
L ++ A+ R GRLLL R + H + K M KL
Sbjct: 180 HEALLEYEAGRAGPGGGAERRRAGRLLLTLPLLRQTAGKVLAHFYGVKLEGKVPMHKLFL 239
Query: 177 DMYK 180
+M +
Sbjct: 240 EMLE 243
>pdb|2QA8|A Chain A, Crystal Structure Of The Estrogen Receptor Alpha Ligand
Binding Domain Mutant 537s Complexed With Genistein
Length = 258
Score = 45.1 bits (105), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 48/198 (24%), Positives = 81/198 (40%), Gaps = 34/198 (17%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAV--- 59
+ WAK +P F L DQV W L +L ++ + EH +
Sbjct: 62 INWAKRVPGFVDLTLHDQVHLL-----------ECAW-LEILMIGLVWRSMEHPGKLLFA 109
Query: 60 PN-------GKASQTAADV-RVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRG-LKDS 110
PN GK + ++ +L RFR++ + EF CLK+++L S L +
Sbjct: 110 PNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSST 169
Query: 111 LQVENLQDQAQVMLAQHVRT--HHPA--------QPARFGRLLLMTSQCRNIPSARVQHI 160
L+ +D +L + T H A Q R +LLL+ S R++ + ++H+
Sbjct: 170 LKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHL 229
Query: 161 FFAKTVANTSMEKLLCDM 178
+ K + LL +M
Sbjct: 230 YSMKXKNVVPLSDLLLEM 247
>pdb|1A52|A Chain A, Estrogen Receptor Alpha Ligand-Binding Domain Complexed To
Estradiol
pdb|1A52|B Chain B, Estrogen Receptor Alpha Ligand-Binding Domain Complexed To
Estradiol
Length = 258
Score = 45.1 bits (105), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 48/198 (24%), Positives = 81/198 (40%), Gaps = 34/198 (17%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAV--- 59
+ WAK +P F L DQV W L +L ++ + EH +
Sbjct: 62 INWAKRVPGFVDLTLHDQV-----------HLLECAW-LEILMIGLVWRSMEHPGKLLFA 109
Query: 60 PN-------GKASQTAADV-RVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRG-LKDS 110
PN GK + ++ +L RFR++ + EF CLK+++L S L +
Sbjct: 110 PNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSST 169
Query: 111 LQVENLQDQAQVMLAQHVRT--HHPA--------QPARFGRLLLMTSQCRNIPSARVQHI 160
L+ +D +L + T H A Q R +LLL+ S R++ + ++H+
Sbjct: 170 LKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHERLAQLLLILSHIRHMSNKGMEHL 229
Query: 161 FFAKTVANTSMEKLLCDM 178
+ K + LL +M
Sbjct: 230 YSMKCKNVVPLYDLLLEM 247
>pdb|2OCF|A Chain A, Human Estrogen Receptor Alpha Ligand-Binding Domain In
Complex With Estradiol And The E2#23 Fn3 Monobody
Length = 298
Score = 45.1 bits (105), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 49/198 (24%), Positives = 82/198 (41%), Gaps = 34/198 (17%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAV--- 59
+ WAK +P F L DQV W L +L ++ + EH +
Sbjct: 61 INWAKRVPGFVDLTLHDQVHLLEXA-----------W-LEILMIGLVWRSMEHPGKLLFA 108
Query: 60 PN-------GKASQTAADV-RVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRG-LKDS 110
PN GK + ++ +L RFR++ + EF CLK+++L S L +
Sbjct: 109 PNLLLDRNQGKXVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSST 168
Query: 111 LQVENLQDQAQVMLAQHVRT--HHPA--------QPARFGRLLLMTSQCRNIPSARVQHI 160
L+ +D +L + T H A Q R +LLL+ S R++ + ++H+
Sbjct: 169 LKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHL 228
Query: 161 FFAKTVANTSMEKLLCDM 178
+ K + LL +M
Sbjct: 229 YSMKCKNVVPLSDLLLEM 246
>pdb|2P15|A Chain A, Crystal Structure Of The Er Alpha Ligand Binding Domain
With The Agonist Ortho-Trifluoromethylphenylvinyl
Estradiol
pdb|2P15|B Chain B, Crystal Structure Of The Er Alpha Ligand Binding Domain
With The Agonist Ortho-Trifluoromethylphenylvinyl
Estradiol
pdb|2Q6J|A Chain A, Crystal Structure Of Estrogen Receptor Alpha Complexed To
A B-N Substituted Ligand
pdb|2Q6J|B Chain B, Crystal Structure Of Estrogen Receptor Alpha Complexed To
A B-N Substituted Ligand
pdb|2QA6|A Chain A, Crystal Structure Of Estrogen Receptor Alpha Mutant 537s
Complexed With
4-(6-Hydroxy-1h-Indazol-3-Yl)benzene-1,3-Diol
pdb|2QA6|B Chain B, Crystal Structure Of Estrogen Receptor Alpha Mutant 537s
Complexed With
4-(6-Hydroxy-1h-Indazol-3-Yl)benzene-1,3-Diol
pdb|2QAB|A Chain A, Crystal Structure Of Estrogen Receptor Alpha Ligand
Binding Domain Mutant 537s Complexed With An Ethyl
Indazole Compound
pdb|2QAB|B Chain B, Crystal Structure Of Estrogen Receptor Alpha Ligand
Binding Domain Mutant 537s Complexed With An Ethyl
Indazole Compound
pdb|2QGT|A Chain A, Crystal Structure Of The Estrogen Receptor Alpha Ligand
Binding Domain Complexed To An Ether Estradiol Compound
pdb|2QGT|B Chain B, Crystal Structure Of The Estrogen Receptor Alpha Ligand
Binding Domain Complexed To An Ether Estradiol Compound
pdb|2QGW|A Chain A, Crystal Structure Of The Estrogen Receptor Alpha Ligand
Binding Domain Complexed With A Chloro-Indazole Compound
pdb|2QGW|B Chain B, Crystal Structure Of The Estrogen Receptor Alpha Ligand
Binding Domain Complexed With A Chloro-Indazole Compound
pdb|2QH6|A Chain A, Crystal Structure Of The Estrogen Receptor Alpha Ligand
Binding Domain Complexed With An Oxabicyclic
Diarylethylene Compound
pdb|2QH6|B Chain B, Crystal Structure Of The Estrogen Receptor Alpha Ligand
Binding Domain Complexed With An Oxabicyclic
Diarylethylene Compound
pdb|2QR9|A Chain A, Crystal Structure Of The Estrogen Receptor Alpha Ligand
Binding Domain Complexed With An Oxabicyclic Derivative
Compound
pdb|2QR9|B Chain B, Crystal Structure Of The Estrogen Receptor Alpha Ligand
Binding Domain Complexed With An Oxabicyclic Derivative
Compound
pdb|2QSE|A Chain A, Crystal Structure Of The Estrogen Receptor Alpha Ligand
Binding Domain Complexed With Burned Meat Compound
4-Oh-Phip
pdb|2QSE|B Chain B, Crystal Structure Of The Estrogen Receptor Alpha Ligand
Binding Domain Complexed With Burned Meat Compound
4-Oh-Phip
pdb|2QXM|A Chain A, Crystal Structure Of The Estrogen Receptor Alpha Ligand
Binding Domain Complexed To Burned Meat Compound Phip
pdb|2QXM|B Chain B, Crystal Structure Of The Estrogen Receptor Alpha Ligand
Binding Domain Complexed To Burned Meat Compound Phip
Length = 258
Score = 44.7 bits (104), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 48/198 (24%), Positives = 81/198 (40%), Gaps = 34/198 (17%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAV--- 59
+ WAK +P F L DQV W L +L ++ + EH +
Sbjct: 62 INWAKRVPGFVDLTLHDQV-----------HLLECAW-LEILMIGLVWRSMEHPGKLLFA 109
Query: 60 PN-------GKASQTAADV-RVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRG-LKDS 110
PN GK + ++ +L RFR++ + EF CLK+++L S L +
Sbjct: 110 PNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSST 169
Query: 111 LQVENLQDQAQVMLAQHVRT--HHPA--------QPARFGRLLLMTSQCRNIPSARVQHI 160
L+ +D +L + T H A Q R +LLL+ S R++ + ++H+
Sbjct: 170 LKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHL 229
Query: 161 FFAKTVANTSMEKLLCDM 178
+ K + LL +M
Sbjct: 230 YSMKCKNVVPLSDLLLEM 247
>pdb|3DZU|D Chain D, Intact Ppar Gamma - Rxr Alpha Nuclear Receptor Complex On
Dna Bound With Bvt.13, 9-Cis Retinoic Acid And Ncoa2
Peptide
pdb|3DZY|D Chain D, Intact Ppar Gamma - Rxr Alpha Nuclear Receptor Complex On
Dna Bound With Rosiglitazone, 9-Cis Retinoic Acid And
Ncoa2 Peptide
pdb|3E00|D Chain D, Intact Ppar Gamma - Rxr Alpha Nuclear Receptor Complex On
Dna Bound With Gw9662, 9-Cis Retinoic Acid And Ncoa2
Peptide
Length = 419
Score = 44.7 bits (104), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 41/185 (22%), Positives = 77/185 (41%), Gaps = 12/185 (6%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXX---XXXXXXXXNAIQWSLPLLESSPLFNASEHVAAV 59
++AK++P F L DQV + + L+ F E + ++
Sbjct: 239 TEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSL 298
Query: 60 --PNGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQ 117
P G + + V +F + +D ++ A AV++ + GL + +E++Q
Sbjct: 299 RKPFGDFMEPKFEFAV------KFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQ 352
Query: 118 DQAQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHI-FFAKTVANTSMEKLLC 176
D L ++ +HP F +LL + R I + VQ + KT + S+ LL
Sbjct: 353 DNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQ 412
Query: 177 DMYKN 181
++YK+
Sbjct: 413 EIYKD 417
>pdb|3UUC|A Chain A, Crystal Structure Of Hera-Lbd (Wt) In Complex With
Bisphenol-C
pdb|3UUC|B Chain B, Crystal Structure Of Hera-Lbd (Wt) In Complex With
Bisphenol-C
pdb|3UUC|C Chain C, Crystal Structure Of Hera-Lbd (Wt) In Complex With
Bisphenol-C
pdb|3UUC|D Chain D, Crystal Structure Of Hera-Lbd (Wt) In Complex With
Bisphenol-C
Length = 251
Score = 44.7 bits (104), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 49/198 (24%), Positives = 82/198 (41%), Gaps = 34/198 (17%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAV--- 59
+ WAK +P F L DQV W L +L ++ + EH +
Sbjct: 57 INWAKRVPGFVDLTLHDQVHLLEXA-----------W-LEILMIGLVWRSMEHPGKLLFA 104
Query: 60 PN-------GKASQTAADV-RVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRG-LKDS 110
PN GK + ++ +L RFR++ + EF CLK+++L S L +
Sbjct: 105 PNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSST 164
Query: 111 LQVENLQDQAQVMLAQHVRT--HHPA--------QPARFGRLLLMTSQCRNIPSARVQHI 160
L+ +D +L + T H A Q R +LLL+ S R++ + ++H+
Sbjct: 165 LKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHL 224
Query: 161 FFAKTVANTSMEKLLCDM 178
+ K + LL +M
Sbjct: 225 YSMKCKNVVPLYDLLLEM 242
>pdb|3DT3|A Chain A, Human Estrogen Receptor Alpha Lbd With Gw368
pdb|3DT3|B Chain B, Human Estrogen Receptor Alpha Lbd With Gw368
pdb|2YJA|B Chain B, Stapled Peptides Binding To Estrogen Receptor Alpha
Length = 255
Score = 44.7 bits (104), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 48/198 (24%), Positives = 81/198 (40%), Gaps = 34/198 (17%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAV--- 59
+ WAK +P F L DQV W L +L ++ + EH +
Sbjct: 62 INWAKRVPGFVDLTLHDQVHLL-----------ECAW-LEILMIGLVWRSMEHPGKLLFA 109
Query: 60 PN-------GKASQTAADV-RVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRG-LKDS 110
PN GK + ++ +L RFR++ + EF CLK+++L S L +
Sbjct: 110 PNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSST 169
Query: 111 LQVENLQDQAQVMLAQHVRT--HHPA--------QPARFGRLLLMTSQCRNIPSARVQHI 160
L+ +D +L + T H A Q R +LLL+ S R++ + ++H+
Sbjct: 170 LKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHL 229
Query: 161 FFAKTVANTSMEKLLCDM 178
+ K + LL +M
Sbjct: 230 YSMKCKNVVPLYDLLLEM 247
>pdb|1GWQ|A Chain A, Human Oestrogen Receptor Alpha Ligand-Binding Domain In
Complex With Raloxifene Core And Tif2 Nrbox2 Peptide
pdb|1GWQ|B Chain B, Human Oestrogen Receptor Alpha Ligand-Binding Domain In
Complex With Raloxifene Core And Tif2 Nrbox2 Peptide
Length = 248
Score = 44.7 bits (104), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 48/198 (24%), Positives = 81/198 (40%), Gaps = 34/198 (17%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAV--- 59
+ WAK +P F L DQV W L +L ++ + EH +
Sbjct: 58 INWAKRVPGFVDLTLHDQVHLL-----------ECAW-LEILMIGLVWRSMEHPGKLLFA 105
Query: 60 PN-------GKASQTAADV-RVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRG-LKDS 110
PN GK + ++ +L RFR++ + EF CLK+++L S L +
Sbjct: 106 PNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSST 165
Query: 111 LQVENLQDQAQVMLAQHVRT--HHPA--------QPARFGRLLLMTSQCRNIPSARVQHI 160
L+ +D +L + T H A Q R +LLL+ S R++ + ++H+
Sbjct: 166 LKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHL 225
Query: 161 FFAKTVANTSMEKLLCDM 178
+ K + LL +M
Sbjct: 226 YSMKCKNVVPLYDLLLEM 243
>pdb|1QKU|A Chain A, Wild Type Estrogen Nuclear Receptor Ligand Binding Domain
Complexed With Estradiol
pdb|1QKU|B Chain B, Wild Type Estrogen Nuclear Receptor Ligand Binding Domain
Complexed With Estradiol
pdb|1QKU|C Chain C, Wild Type Estrogen Nuclear Receptor Ligand Binding Domain
Complexed With Estradiol
Length = 250
Score = 44.7 bits (104), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 48/198 (24%), Positives = 81/198 (40%), Gaps = 34/198 (17%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAV--- 59
+ WAK +P F L DQV W L +L ++ + EH +
Sbjct: 58 INWAKRVPGFVDLTLHDQVHLL-----------ECAW-LEILMIGLVWRSMEHPGKLLFA 105
Query: 60 PN-------GKASQTAADV-RVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRG-LKDS 110
PN GK + ++ +L RFR++ + EF CLK+++L S L +
Sbjct: 106 PNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSST 165
Query: 111 LQVENLQDQAQVMLAQHVRT--HHPA--------QPARFGRLLLMTSQCRNIPSARVQHI 160
L+ +D +L + T H A Q R +LLL+ S R++ + ++H+
Sbjct: 166 LKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHL 225
Query: 161 FFAKTVANTSMEKLLCDM 178
+ K + LL +M
Sbjct: 226 YSMKCKNVVPLYDLLLEM 243
>pdb|3D24|A Chain A, Crystal Structure Of Ligand-Binding Domain Of Estrogen-
Related Receptor Alpha (Erralpha) In Complex With The
Peroxisome Proliferators-Activated Receptor Coactivator-
1alpha Box3 Peptide (Pgc-1alpha)
pdb|3D24|C Chain C, Crystal Structure Of Ligand-Binding Domain Of Estrogen-
Related Receptor Alpha (Erralpha) In Complex With The
Peroxisome Proliferators-Activated Receptor Coactivator-
1alpha Box3 Peptide (Pgc-1alpha)
Length = 253
Score = 44.7 bits (104), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 44/184 (23%), Positives = 77/184 (41%), Gaps = 6/184 (3%)
Query: 1 MAVKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVP 60
+ + WAK++P F++L DQ+ Q SLPL L A + V
Sbjct: 68 VTISWAKSIPGFSSLSLSDQMSVLQSVWMEVLVLGVAQRSLPL--QDELAFAEDLVLDEE 125
Query: 61 NGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQA 120
+A+ L +++R + + ++ E+ LKA+ L S++ ++D+ VE L++
Sbjct: 126 GARAAGLGELGAALLQLVRRLQALRLEREEYVLLKALALANSDSVHIEDAEAVEQLREAL 185
Query: 121 QVMLAQH----VRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSMEKLLC 176
L ++ A+ R GRLLL R + H + K M KL
Sbjct: 186 HEALLEYEAGRAGPGGGAERRRAGRLLLTLPLLRQTAGKVLAHFYGVKLEGKVPMHKLFL 245
Query: 177 DMYK 180
+M +
Sbjct: 246 EMLE 249
>pdb|1ERR|A Chain A, Human Estrogen Receptor Ligand-Binding Domain In Complex
With Raloxifene
pdb|1ERR|B Chain B, Human Estrogen Receptor Ligand-Binding Domain In Complex
With Raloxifene
Length = 253
Score = 44.7 bits (104), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 49/198 (24%), Positives = 82/198 (41%), Gaps = 34/198 (17%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAV--- 59
+ WAK +P F L DQV W L +L ++ + EH +
Sbjct: 58 INWAKRVPGFVDLTLHDQVHLLEXA-----------W-LEILMIGLVWRSMEHPGKLLFA 105
Query: 60 PN-------GKASQTAADV-RVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRG-LKDS 110
PN GK + ++ +L RFR++ + EF CLK+++L S L +
Sbjct: 106 PNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSST 165
Query: 111 LQVENLQDQAQVMLAQHVRT--HHPA--------QPARFGRLLLMTSQCRNIPSARVQHI 160
L+ +D +L + T H A Q R +LLL+ S R++ + ++H+
Sbjct: 166 LKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHL 225
Query: 161 FFAKTVANTSMEKLLCDM 178
+ K + LL +M
Sbjct: 226 YSMKCKNVVPLYDLLLEM 243
>pdb|4DMA|A Chain A, Crystal Structure Of Era Lbd In Complex With Ru100132
pdb|4DMA|B Chain B, Crystal Structure Of Era Lbd In Complex With Ru100132
Length = 247
Score = 44.7 bits (104), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 48/198 (24%), Positives = 81/198 (40%), Gaps = 34/198 (17%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAV--- 59
+ WAK +P F L DQV W L +L ++ + EH +
Sbjct: 56 INWAKRVPGFVDLTLHDQV-----------HLLECAW-LEILMIGLVWRSMEHPGKLLFA 103
Query: 60 PN-------GKASQTAADV-RVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRG-LKDS 110
PN GK + ++ +L RFR++ + EF CLK+++L S L +
Sbjct: 104 PNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSST 163
Query: 111 LQVENLQDQAQVMLAQHVRT--HHPA--------QPARFGRLLLMTSQCRNIPSARVQHI 160
L+ +D +L + T H A Q R +LLL+ S R++ + ++H+
Sbjct: 164 LKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHL 223
Query: 161 FFAKTVANTSMEKLLCDM 178
+ K + LL +M
Sbjct: 224 YSMKAKNVVPLYDLLLEM 241
>pdb|1G50|A Chain A, Crystal Structure Of A Wild Type Her Alpha Lbd At 2.9
Angstrom Resolution
pdb|1G50|B Chain B, Crystal Structure Of A Wild Type Her Alpha Lbd At 2.9
Angstrom Resolution
pdb|1G50|C Chain C, Crystal Structure Of A Wild Type Her Alpha Lbd At 2.9
Angstrom Resolution
Length = 247
Score = 44.7 bits (104), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 48/198 (24%), Positives = 81/198 (40%), Gaps = 34/198 (17%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAV--- 59
+ WAK +P F L DQV W L +L ++ + EH +
Sbjct: 55 INWAKRVPGFVDLTLHDQV-----------HLLECAW-LEILMIGLVWRSMEHPGKLLFA 102
Query: 60 PN-------GKASQTAADV-RVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRG-LKDS 110
PN GK + ++ +L RFR++ + EF CLK+++L S L +
Sbjct: 103 PNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSST 162
Query: 111 LQVENLQDQAQVMLAQHVRT--HHPA--------QPARFGRLLLMTSQCRNIPSARVQHI 160
L+ +D +L + T H A Q R +LLL+ S R++ + ++H+
Sbjct: 163 LKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHL 222
Query: 161 FFAKTVANTSMEKLLCDM 178
+ K + LL +M
Sbjct: 223 YSMKCKNVVPLYDLLLEM 240
>pdb|1GWR|A Chain A, Human Oestrogen Receptor Alpha Ligand-Binding Domain In
Complex With 17beta-Oestradiol And Tif2 Nrbox3 Peptide
pdb|1GWR|B Chain B, Human Oestrogen Receptor Alpha Ligand-Binding Domain In
Complex With 17beta-Oestradiol And Tif2 Nrbox3 Peptide
Length = 245
Score = 44.7 bits (104), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 48/198 (24%), Positives = 81/198 (40%), Gaps = 34/198 (17%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAV--- 59
+ WAK +P F L DQV W L +L ++ + EH +
Sbjct: 54 INWAKRVPGFVDLTLHDQV-----------HLLECAW-LEILMIGLVWRSMEHPGKLLFA 101
Query: 60 PN-------GKASQTAADV-RVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRG-LKDS 110
PN GK + ++ +L RFR++ + EF CLK+++L S L +
Sbjct: 102 PNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSST 161
Query: 111 LQVENLQDQAQVMLAQHVRT--HHPA--------QPARFGRLLLMTSQCRNIPSARVQHI 160
L+ +D +L + T H A Q R +LLL+ S R++ + ++H+
Sbjct: 162 LKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHL 221
Query: 161 FFAKTVANTSMEKLLCDM 178
+ K + LL +M
Sbjct: 222 YSMKCKNVVPLYDLLLEM 239
>pdb|1ERE|A Chain A, Human Estrogen Receptor Ligand-Binding Domain In Complex
With 17beta-Estradiol
pdb|1ERE|B Chain B, Human Estrogen Receptor Ligand-Binding Domain In Complex
With 17beta-Estradiol
pdb|1ERE|C Chain C, Human Estrogen Receptor Ligand-Binding Domain In Complex
With 17beta-Estradiol
pdb|1ERE|D Chain D, Human Estrogen Receptor Ligand-Binding Domain In Complex
With 17beta-Estradiol
pdb|1ERE|E Chain E, Human Estrogen Receptor Ligand-Binding Domain In Complex
With 17beta-Estradiol
pdb|1ERE|F Chain F, Human Estrogen Receptor Ligand-Binding Domain In Complex
With 17beta-Estradiol
pdb|2OUZ|A Chain A, Crystal Structure Of Estrogen Receptor Alpha-Lasofoxifene
Complex
Length = 253
Score = 44.7 bits (104), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 48/198 (24%), Positives = 81/198 (40%), Gaps = 34/198 (17%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAV--- 59
+ WAK +P F L DQV W L +L ++ + EH +
Sbjct: 58 INWAKRVPGFVDLTLHDQVHLL-----------ECAW-LEILMIGLVWRSMEHPGKLLFA 105
Query: 60 PN-------GKASQTAADV-RVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRG-LKDS 110
PN GK + ++ +L RFR++ + EF CLK+++L S L +
Sbjct: 106 PNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSST 165
Query: 111 LQVENLQDQAQVMLAQHVRT--HHPA--------QPARFGRLLLMTSQCRNIPSARVQHI 160
L+ +D +L + T H A Q R +LLL+ S R++ + ++H+
Sbjct: 166 LKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHL 225
Query: 161 FFAKTVANTSMEKLLCDM 178
+ K + LL +M
Sbjct: 226 YSMKCKNVVPLYDLLLEM 243
>pdb|2IOG|A Chain A, Human Estrogen Receptor Alpha Ligand-Binding Domain In
Complex With Compound 11f
Length = 246
Score = 44.7 bits (104), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 48/198 (24%), Positives = 81/198 (40%), Gaps = 34/198 (17%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAV--- 59
+ WAK +P F L DQV W L +L ++ + EH +
Sbjct: 50 INWAKRVPGFVDLTLHDQV-----------HLLECAW-LEILMIGLVWRSMEHPGKLLFA 97
Query: 60 PN-------GKASQTAADV-RVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRG-LKDS 110
PN GK + ++ +L RFR++ + EF CLK+++L S L +
Sbjct: 98 PNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSST 157
Query: 111 LQVENLQDQAQVMLAQHVRT--HHPA--------QPARFGRLLLMTSQCRNIPSARVQHI 160
L+ +D +L + T H A Q R +LLL+ S R++ + ++H+
Sbjct: 158 LKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHL 217
Query: 161 FFAKTVANTSMEKLLCDM 178
+ K + LL +M
Sbjct: 218 YSMKCKNVVPLYDLLLEM 235
>pdb|3ERD|A Chain A, Human Estrogen Receptor Alpha Ligand-Binding Domain In
Complex With Diethylstilbestrol And A Glucocorticoid
Receptor Interacting Protein 1 Nr Box Ii Peptide
pdb|3ERD|B Chain B, Human Estrogen Receptor Alpha Ligand-Binding Domain In
Complex With Diethylstilbestrol And A Glucocorticoid
Receptor Interacting Protein 1 Nr Box Ii Peptide
pdb|3ERT|A Chain A, Human Estrogen Receptor Alpha Ligand-Binding Domain In
Complex With 4- Hydroxytamoxifen
pdb|1R5K|A Chain A, Human Estrogen Receptor Alpha Ligand-Binding Domain In
Complex With Gw5638
pdb|1R5K|B Chain B, Human Estrogen Receptor Alpha Ligand-Binding Domain In
Complex With Gw5638
pdb|1R5K|C Chain C, Human Estrogen Receptor Alpha Ligand-Binding Domain In
Complex With Gw5638
Length = 261
Score = 44.7 bits (104), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 48/198 (24%), Positives = 81/198 (40%), Gaps = 34/198 (17%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAV--- 59
+ WAK +P F L DQV W L +L ++ + EH +
Sbjct: 65 INWAKRVPGFVDLTLHDQV-----------HLLECAW-LEILMIGLVWRSMEHPGKLLFA 112
Query: 60 PN-------GKASQTAADV-RVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRG-LKDS 110
PN GK + ++ +L RFR++ + EF CLK+++L S L +
Sbjct: 113 PNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSST 172
Query: 111 LQVENLQDQAQVMLAQHVRT--HHPA--------QPARFGRLLLMTSQCRNIPSARVQHI 160
L+ +D +L + T H A Q R +LLL+ S R++ + ++H+
Sbjct: 173 LKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHL 232
Query: 161 FFAKTVANTSMEKLLCDM 178
+ K + LL +M
Sbjct: 233 YSMKCKNVVPLYDLLLEM 250
>pdb|4DK8|A Chain A, Crystal Structure Of Lxr Ligand Binding Domain In Complex
With Partial Agonist 5
pdb|4DK8|C Chain C, Crystal Structure Of Lxr Ligand Binding Domain In Complex
With Partial Agonist 5
Length = 247
Score = 44.7 bits (104), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 43/186 (23%), Positives = 81/186 (43%), Gaps = 20/186 (10%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFN-ASEHVAAVPN 61
V +AK +P F L DQ+ A + LLE++ +N +E + + +
Sbjct: 69 VDFAKQVPGFLQLGREDQI----------ALLKASTIEIMLLETARRYNHETECITFLKD 118
Query: 62 GKASQ-----TAADVRVLNGVLQ---RFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQV 113
S+ V +N + + R +G+D AE+A L A+ +F ++ +++ +V
Sbjct: 119 FTYSKDDFHRAGLQVEFINPIFEFSRAMRRLGLDDAEYALLIAINIFSADRPNVQEPGRV 178
Query: 114 ENLQDQAQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSMEK 173
E LQ L + R P RF R+L+ R + S + + FA + + +
Sbjct: 179 EALQQPYVEALLSYTRIKRPQDQLRFPRMLMKLVSLRTLSSVHSEQV-FALRLQDKKLPP 237
Query: 174 LLCDMY 179
LL +++
Sbjct: 238 LLSEIW 243
>pdb|1SJ0|A Chain A, Human Estrogen Receptor Alpha Ligand-binding Domain In
Complex With The Antagonist Ligand 4-d
pdb|1XP1|A Chain A, Human Estrogen Receptor Alpha Ligand-binding Domain In
Complex With Compound 15
pdb|1XP6|A Chain A, Human Estrogen Receptor Alpha Ligand-binding Domain In
Complex With Compound 16
pdb|1XP9|A Chain A, Human Estrogen Receptor Alpha Ligand-binding Domain In
Complex With Compound 18
pdb|1XPC|A Chain A, Human Estrogen Receptor Alpha Ligand-Binding Domain In
Complex With Compound 19
pdb|1YIM|A Chain A, Human Estrogen Receptor Alpha Ligand-Binding Domain In
Complex With Compound 4
pdb|1YIN|A Chain A, Human Estrogen Receptor Alpha Ligand-Binding Domain In
Complex With Compound 3f
Length = 248
Score = 44.7 bits (104), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 48/198 (24%), Positives = 81/198 (40%), Gaps = 34/198 (17%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAV--- 59
+ WAK +P F L DQV W L +L ++ + EH +
Sbjct: 52 INWAKRVPGFVDLTLHDQV-----------HLLECAW-LEILMIGLVWRSMEHPGKLLFA 99
Query: 60 PN-------GKASQTAADV-RVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRG-LKDS 110
PN GK + ++ +L RFR++ + EF CLK+++L S L +
Sbjct: 100 PNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSST 159
Query: 111 LQVENLQDQAQVMLAQHVRT--HHPA--------QPARFGRLLLMTSQCRNIPSARVQHI 160
L+ +D +L + T H A Q R +LLL+ S R++ + ++H+
Sbjct: 160 LKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHL 219
Query: 161 FFAKTVANTSMEKLLCDM 178
+ K + LL +M
Sbjct: 220 YSMKCKNVVPLYDLLLEM 237
>pdb|1X7E|A Chain A, Crystal Structure Of Estrogen Receptor Alpha Complexed
With Way-244
pdb|1X7E|B Chain B, Crystal Structure Of Estrogen Receptor Alpha Complexed
With Way-244
pdb|1X7R|A Chain A, Crystal Structure Of Estrogen Receptor Alpha Complexed
With Genistein
Length = 245
Score = 44.3 bits (103), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 48/198 (24%), Positives = 81/198 (40%), Gaps = 34/198 (17%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEH---VAAV 59
+ WAK +P F L DQV W L +L ++ + EH +
Sbjct: 54 INWAKRVPGFVDLTLHDQV-----------HLLECAW-LEILMIGLVWRSMEHPVKLLFA 101
Query: 60 PN-------GKASQTAADV-RVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRG-LKDS 110
PN GK + ++ +L RFR++ + EF CLK+++L S L +
Sbjct: 102 PNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSST 161
Query: 111 LQVENLQDQAQVMLAQHVRT--HHPA--------QPARFGRLLLMTSQCRNIPSARVQHI 160
L+ +D +L + T H A Q R +LLL+ S R++ + ++H+
Sbjct: 162 LKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHL 221
Query: 161 FFAKTVANTSMEKLLCDM 178
+ K + LL +M
Sbjct: 222 YSMKCKNVVPLYDLLLEM 239
>pdb|2IOK|A Chain A, Human Estrogen Receptor Alpha Ligand-binding Domain In
Complex With Compound 1d
pdb|2IOK|B Chain B, Human Estrogen Receptor Alpha Ligand-binding Domain In
Complex With Compound 1d
Length = 254
Score = 44.3 bits (103), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 48/198 (24%), Positives = 81/198 (40%), Gaps = 34/198 (17%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAV--- 59
+ WAK +P F L DQV W L +L ++ + EH +
Sbjct: 58 INWAKRVPGFVDLTLHDQVHLL-----------ECAW-LEILMIGLVWRSMEHPGKLLFA 105
Query: 60 PN-------GKASQTAADV-RVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRG-LKDS 110
PN GK + ++ +L RFR++ + EF CLK+++L S L +
Sbjct: 106 PNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSST 165
Query: 111 LQVENLQDQAQVMLAQHVRT--HHPA--------QPARFGRLLLMTSQCRNIPSARVQHI 160
L+ +D +L + T H A Q R +LLL+ S R++ + ++H+
Sbjct: 166 LKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHL 225
Query: 161 FFAKTVANTSMEKLLCDM 178
+ K + LL +M
Sbjct: 226 YSMKCKNVVPLYDLLLEM 243
>pdb|1UPV|A Chain A, Crystal Structure Of The Human Liver X Receptor Beta
Ligand Binding Domain In Complex With A Synthetic
Agonist
pdb|1UPW|A Chain A, Crystal Structure Of The Human Liver X Receptor Beta
Ligand Binding Domain In Complex With A Synthetic
Agonist
Length = 257
Score = 44.3 bits (103), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 43/186 (23%), Positives = 81/186 (43%), Gaps = 20/186 (10%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFN-ASEHVAAVPN 61
V +AK +P F L DQ+ A + LLE++ +N +E + + +
Sbjct: 79 VDFAKQVPGFLQLGREDQI----------ALLKASTIEIMLLETARRYNHETECITFLKD 128
Query: 62 GKASQ-----TAADVRVLNGVLQ---RFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQV 113
S+ V +N + + R +G+D AE+A L A+ +F ++ +++ +V
Sbjct: 129 FTYSKDDFHRAGLQVEFINPIFEFSRAMRRLGLDDAEYALLIAINIFSADRPNVQEPGRV 188
Query: 114 ENLQDQAQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSMEK 173
E LQ L + R P RF R+L+ R + S + + FA + + +
Sbjct: 189 EALQQPYVEALLSYTRIKRPQDQLRFPRMLMKLVSLRTLSSVHSEQV-FALRLQDKKLPP 247
Query: 174 LLCDMY 179
LL +++
Sbjct: 248 LLSEIW 253
>pdb|1P8D|A Chain A, X-Ray Crystal Structure Of Lxr Ligand Binding Domain With
24(S),25- Epoxycholesterol
pdb|1P8D|B Chain B, X-Ray Crystal Structure Of Lxr Ligand Binding Domain With
24(S),25- Epoxycholesterol
Length = 250
Score = 44.3 bits (103), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 43/186 (23%), Positives = 81/186 (43%), Gaps = 20/186 (10%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFN-ASEHVAAVPN 61
V +AK +P F L DQ+ A + LLE++ +N +E + + +
Sbjct: 72 VDFAKQVPGFLQLGREDQI----------ALLKASTIEIMLLETARRYNHETECITFLKD 121
Query: 62 GKASQ-----TAADVRVLNGVLQ---RFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQV 113
S+ V +N + + R +G+D AE+A L A+ +F ++ +++ +V
Sbjct: 122 FTYSKDDFHRAGLQVEFINPIFEFSRAMRRLGLDDAEYALLIAINIFSADRPNVQEPGRV 181
Query: 114 ENLQDQAQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSMEK 173
E LQ L + R P RF R+L+ R + S + + FA + + +
Sbjct: 182 EALQQPYVEALLSYTRIKRPQDQLRFPRMLMKLVSLRTLSSVHSEQV-FALRLQDKKLPP 240
Query: 174 LLCDMY 179
LL +++
Sbjct: 241 LLSEIW 246
>pdb|1PQ6|A Chain A, Human Lxr Beta Hormone Receptor / Gw3965 Complex
pdb|1PQ6|B Chain B, Human Lxr Beta Hormone Receptor / Gw3965 Complex
pdb|1PQ6|C Chain C, Human Lxr Beta Hormone Receptor / Gw3965 Complex
pdb|1PQ6|D Chain D, Human Lxr Beta Hormone Receptor / Gw3965 Complex
pdb|1PQ9|A Chain A, Human Lxr Beta Hormone Receptor Complexed With T0901317
Complex
pdb|1PQ9|B Chain B, Human Lxr Beta Hormone Receptor Complexed With T0901317
Complex
pdb|1PQ9|C Chain C, Human Lxr Beta Hormone Receptor Complexed With T0901317
Complex
pdb|1PQ9|D Chain D, Human Lxr Beta Hormone Receptor Complexed With T0901317
Complex
pdb|1PQC|A Chain A, Human Lxr Beta Hormone Receptor Complexed With T0901317
pdb|1PQC|B Chain B, Human Lxr Beta Hormone Receptor Complexed With T0901317
pdb|1PQC|C Chain C, Human Lxr Beta Hormone Receptor Complexed With T0901317
pdb|1PQC|D Chain D, Human Lxr Beta Hormone Receptor Complexed With T0901317
pdb|3KFC|A Chain A, Complex Structure Of Lxr With An Agonist
pdb|3KFC|B Chain B, Complex Structure Of Lxr With An Agonist
pdb|3KFC|C Chain C, Complex Structure Of Lxr With An Agonist
pdb|3KFC|D Chain D, Complex Structure Of Lxr With An Agonist
Length = 253
Score = 44.3 bits (103), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 43/186 (23%), Positives = 81/186 (43%), Gaps = 20/186 (10%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFN-ASEHVAAVPN 61
V +AK +P F L DQ+ A + LLE++ +N +E + + +
Sbjct: 75 VDFAKQVPGFLQLGREDQI----------ALLKASTIEIMLLETARRYNHETECITFLKD 124
Query: 62 GKASQ-----TAADVRVLNGVLQ---RFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQV 113
S+ V +N + + R +G+D AE+A L A+ +F ++ +++ +V
Sbjct: 125 FTYSKDDFHRAGLQVEFINPIFEFSRAMRRLGLDDAEYALLIAINIFSADRPNVQEPGRV 184
Query: 114 ENLQDQAQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSMEK 173
E LQ L + R P RF R+L+ R + S + + FA + + +
Sbjct: 185 EALQQPYVEALLSYTRIKRPQDQLRFPRMLMKLVSLRTLSSVHSEQV-FALRLQDKKLPP 243
Query: 174 LLCDMY 179
LL +++
Sbjct: 244 LLSEIW 249
>pdb|1L2I|A Chain A, Human Estrogen Receptor Alpha Ligand-Binding Domain In
Complex With (R,R)-5,11-Cis-Diethyl-5,6,11,12-
Tetrahydrochrysene-2,8-Diol And A Glucocorticoid
Receptor Interacting Protein 1 Nr Box Ii Peptide
pdb|1L2I|B Chain B, Human Estrogen Receptor Alpha Ligand-Binding Domain In
Complex With (R,R)-5,11-Cis-Diethyl-5,6,11,12-
Tetrahydrochrysene-2,8-Diol And A Glucocorticoid
Receptor Interacting Protein 1 Nr Box Ii Peptide
Length = 261
Score = 44.3 bits (103), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 48/198 (24%), Positives = 81/198 (40%), Gaps = 34/198 (17%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAV--- 59
+ WAK +P F L DQV W L +L ++ + EH +
Sbjct: 65 INWAKRVPGFVDLTLHDQV-----------HLLECAW-LEILMIGLVWRSMEHPGKLLFA 112
Query: 60 PN-------GKASQTAADV-RVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRG-LKDS 110
PN GK + ++ +L RFR++ + EF CLK+++L S L +
Sbjct: 113 PNLLLDRNQGKXVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSST 172
Query: 111 LQVENLQDQAQVMLAQHVRT--HHPA--------QPARFGRLLLMTSQCRNIPSARVQHI 160
L+ +D +L + T H A Q R +LLL+ S R++ + ++H+
Sbjct: 173 LKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHL 232
Query: 161 FFAKTVANTSMEKLLCDM 178
+ K + LL +M
Sbjct: 233 YSMKCKNVVPLYDLLLEM 250
>pdb|3FXV|A Chain A, Identification Of An N-Oxide Pyridine Gw4064 Analogue As A
Potent Fxr Agonist
pdb|3OKH|A Chain A, Crystal Structure Of Human Fxr In Complex With
2-(4-Chlorophenyl)-1-
[(1s)-1-Cyclohexyl-2-(Cyclohexylamino)-2-Oxoethyl]-1h-
Benzimidazole- 6-Carboxylic Acid
pdb|3OKI|A Chain A, Crystal Structure Of Human Fxr In Complex With
(2s)-2-[2-(4-
Chlorophenyl)-1h-Benzimidazol-1-Yl]-N,
2-Dicyclohexylethanamide
pdb|3OKI|C Chain C, Crystal Structure Of Human Fxr In Complex With
(2s)-2-[2-(4-
Chlorophenyl)-1h-Benzimidazol-1-Yl]-N,
2-Dicyclohexylethanamide
pdb|3OLF|A Chain A, Crystal Structure Of Human Fxr In Complex With
4-({(2s)-2-[2-(4-
Chlorophenyl)-5,6-Difluoro-1h-Benzimidazol-1-Yl]-2-
Cyclohexylacetyl}amino)-3-Methylbenzoic Acid
pdb|3OLF|C Chain C, Crystal Structure Of Human Fxr In Complex With
4-({(2s)-2-[2-(4-
Chlorophenyl)-5,6-Difluoro-1h-Benzimidazol-1-Yl]-2-
Cyclohexylacetyl}amino)-3-Methylbenzoic Acid
pdb|3OMK|A Chain A, Crystal Structure Of Human Fxr In Complex With
(2s)-2-[2-(4-
Chlorophenyl)-5,
6-Difluoro-1h-Benzimidazol-1-Yl]-2-Cyclohexyl-N-(2-
Methylphenyl)ethanamide
pdb|3OMK|C Chain C, Crystal Structure Of Human Fxr In Complex With
(2s)-2-[2-(4-
Chlorophenyl)-5,
6-Difluoro-1h-Benzimidazol-1-Yl]-2-Cyclohexyl-N-(2-
Methylphenyl)ethanamide
pdb|3OMM|A Chain A, Crystal Structure Of Human Fxr In Complex With
4-({(2s)-2-[2-(4-
Chlorophenyl)-5,6-Difluoro-1h-Benzimidazol-1-Yl]-2-
Cyclohexylacetyl}amino)-3-Fluorobenzoic Acid
pdb|3OMM|C Chain C, Crystal Structure Of Human Fxr In Complex With
4-({(2s)-2-[2-(4-
Chlorophenyl)-5,6-Difluoro-1h-Benzimidazol-1-Yl]-2-
Cyclohexylacetyl}amino)-3-Fluorobenzoic Acid
pdb|3OOF|A Chain A, Crystal Structure Of Human Fxr In Complex With
4-({(2s)-2-[2-(4-
Chlorophenyl)-5,6-Difluoro-1h-Benzimidazol-1-Yl]-2-
Cyclohexylacetyl}amino)benzoic Acid
pdb|3OOF|C Chain C, Crystal Structure Of Human Fxr In Complex With
4-({(2s)-2-[2-(4-
Chlorophenyl)-5,6-Difluoro-1h-Benzimidazol-1-Yl]-2-
Cyclohexylacetyl}amino)benzoic Acid
pdb|3OOK|A Chain A, Crystal Structure Of Human Fxr In Complex With
4-({(2s)-2-[2-(4-
Chlorophenyl)-5,6-Difluoro-1h-Benzimidazol-1-Yl]-2-
Cyclohexylacetyl}amino)-3,5-Difluorobenzoic Acid
pdb|3OOK|C Chain C, Crystal Structure Of Human Fxr In Complex With
4-({(2s)-2-[2-(4-
Chlorophenyl)-5,6-Difluoro-1h-Benzimidazol-1-Yl]-2-
Cyclohexylacetyl}amino)-3,5-Difluorobenzoic Acid
Length = 233
Score = 43.5 bits (101), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 40/187 (21%), Positives = 74/187 (39%), Gaps = 26/187 (13%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPNG 62
V++ K LP F L DQ+ L S+ +FN +P+G
Sbjct: 60 VEFTKKLPGFQTLDHEDQIALLKGSAVEAM----------FLRSAEIFNKK-----LPSG 104
Query: 63 KASQTAADVR-------VLNGVLQRFRLVG---VDPAEFACLKAVVLFKSETRGLKDSLQ 112
+ A +R + + ++ +G + E+A L A+V+ + + +KD
Sbjct: 105 HSDLLEARIRNSGISDEYITPMFSFYKSIGELKMTQEEYALLTAIVILSPDRQYIKDREA 164
Query: 113 VENLQDQAQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSME 172
VE LQ+ +L + + H P P F LL ++ R + + + V +
Sbjct: 165 VEKLQEPLLDVLQKLCKIHQPENPQHFACLLGRLTELRTFNHHHAE-MLMSWRVNDHKFT 223
Query: 173 KLLCDMY 179
LLC+++
Sbjct: 224 PLLCEIW 230
>pdb|2BJ4|A Chain A, Estrogen Receptor Alpha Lbd In Complex With A
Phage-Display Derived Peptide Antagonist
pdb|2JF9|A Chain A, Estrogen Receptor Alpha Lbd In Complex With A Tamoxifen-
Specific Peptide Antagonist
pdb|2JF9|B Chain B, Estrogen Receptor Alpha Lbd In Complex With A Tamoxifen-
Specific Peptide Antagonist
pdb|2JF9|C Chain C, Estrogen Receptor Alpha Lbd In Complex With A Tamoxifen-
Specific Peptide Antagonist
pdb|2JFA|A Chain A, Estrogen Receptor Alpha Lbd In Complex With An Affinity-
Selected Corepressor Peptide
Length = 252
Score = 43.5 bits (101), Expect = 7e-05, Method: Compositional matrix adjust.
Identities = 45/184 (24%), Positives = 76/184 (41%), Gaps = 34/184 (18%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAV--- 59
+ WAK +P F L DQV W L +L ++ + EH +
Sbjct: 77 INWAKRVPGFVDLTLHDQVHLL-----------ECAW-LEILMIGLVWRSMEHPGKLLFA 124
Query: 60 PN-------GKASQTAADV-RVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRG-LKDS 110
PN GK + ++ +L RFR++ + EF CLK+++L S L +
Sbjct: 125 PNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSST 184
Query: 111 LQVENLQDQAQVMLAQHVRT--HHPA--------QPARFGRLLLMTSQCRNIPSARVQHI 160
L+ +D +L + T H A Q R +LLL+ S R++ + ++H+
Sbjct: 185 LKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHL 244
Query: 161 FFAK 164
+ K
Sbjct: 245 YSMK 248
>pdb|2JFA|B Chain B, Estrogen Receptor Alpha Lbd In Complex With An Affinity-
Selected Corepressor Peptide
pdb|2BJ4|B Chain B, Estrogen Receptor Alpha Lbd In Complex With A
Phage-Display Derived Peptide Antagonist
Length = 252
Score = 43.5 bits (101), Expect = 7e-05, Method: Compositional matrix adjust.
Identities = 45/184 (24%), Positives = 76/184 (41%), Gaps = 34/184 (18%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAV--- 59
+ WAK +P F L DQV W L +L ++ + EH +
Sbjct: 77 INWAKRVPGFVDLTLHDQVHLL-----------ECAW-LEILMIGLVWRSMEHPGKLLFA 124
Query: 60 PN-------GKASQTAADV-RVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRG-LKDS 110
PN GK + ++ +L RFR++ + EF CLK+++L S L +
Sbjct: 125 PNLLLDRNQGKXVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSST 184
Query: 111 LQVENLQDQAQVMLAQHVRT--HHPA--------QPARFGRLLLMTSQCRNIPSARVQHI 160
L+ +D +L + T H A Q R +LLL+ S R++ + ++H+
Sbjct: 185 LKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHL 244
Query: 161 FFAK 164
+ K
Sbjct: 245 YSMK 248
>pdb|2QXS|A Chain A, Crystal Structure Of Antagonizing Mutant 536s Of The
Estrogen Receptor Alpha Ligand Binding Domain Complexed
To Raloxifene
pdb|2QXS|B Chain B, Crystal Structure Of Antagonizing Mutant 536s Of The
Estrogen Receptor Alpha Ligand Binding Domain Complexed
To Raloxifene
Length = 258
Score = 43.1 bits (100), Expect = 8e-05, Method: Compositional matrix adjust.
Identities = 45/184 (24%), Positives = 76/184 (41%), Gaps = 34/184 (18%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAV--- 59
+ WAK +P F L DQV W L +L ++ + EH +
Sbjct: 62 INWAKRVPGFVDLTLHDQVHLL-----------ECAW-LEILMIGLVWRSMEHPGKLLFA 109
Query: 60 PN-------GKASQTAADV-RVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRG-LKDS 110
PN GK + ++ +L RFR++ + EF CLK+++L S L +
Sbjct: 110 PNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSST 169
Query: 111 LQVENLQDQAQVMLAQHVRT--HHPA--------QPARFGRLLLMTSQCRNIPSARVQHI 160
L+ +D +L + T H A Q R +LLL+ S R++ + ++H+
Sbjct: 170 LKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHL 229
Query: 161 FFAK 164
+ K
Sbjct: 230 YSMK 233
>pdb|3F7D|A Chain A, Sf-1 Lbd Bound By Phosphatidylcholine
Length = 244
Score = 42.4 bits (98), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 23/83 (27%), Positives = 44/83 (53%), Gaps = 1/83 (1%)
Query: 86 VDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQAQVMLAQHVRTHHPAQPARFGRLLLM 145
+D EF CLK ++LF + + L + V++ Q++A L + +H+P +F +LLL
Sbjct: 146 LDRQEFVCLKFLILFSLDVKFLNNHSLVKDAQEKANAALLDYTLSHYPHSGDKFQQLLLS 205
Query: 146 TSQCRNIPSARVQHIFFAKTVAN 168
+ R + S + + + K + N
Sbjct: 206 LVEVRAL-SMQAKEYLYHKHLGN 227
>pdb|1ZDT|A Chain A, The Crystal Structure Of Human Steroidogenic Factor-1
pdb|1ZDT|B Chain B, The Crystal Structure Of Human Steroidogenic Factor-1
Length = 241
Score = 42.4 bits (98), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 22/79 (27%), Positives = 42/79 (53%), Gaps = 1/79 (1%)
Query: 90 EFACLKAVVLFKSETRGLKDSLQVENLQDQAQVMLAQHVRTHHPAQPARFGRLLLMTSQC 149
EF CLK ++LF + + L + + V++ Q++A L + H+P +F +LLL +
Sbjct: 147 EFVCLKFIILFSLDLKFLNNHILVKDAQEKANAALLDYTLCHYPHSGDKFQQLLLCLVEV 206
Query: 150 RNIPSARVQHIFFAKTVAN 168
R + S + + + K + N
Sbjct: 207 RAL-SMQAKEYLYHKHLGN 224
>pdb|1YMT|A Chain A, Mouse Sf-1 Lbd
Length = 246
Score = 42.4 bits (98), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 23/83 (27%), Positives = 44/83 (53%), Gaps = 1/83 (1%)
Query: 86 VDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQAQVMLAQHVRTHHPAQPARFGRLLLM 145
+D EF CLK ++LF + + L + V++ Q++A L + +H+P +F +LLL
Sbjct: 148 LDRQEFVCLKFLILFSLDVKFLNNHSLVKDAQEKANAALLDYTLSHYPHSGDKFQQLLLS 207
Query: 146 TSQCRNIPSARVQHIFFAKTVAN 168
+ R + S + + + K + N
Sbjct: 208 LVEVRAL-SMQAKEYLYHKHLGN 229
>pdb|1OSH|A Chain A, A Chemical, Genetic, And Structural Analysis Of The
Nuclear Bile Acid Receptor Fxr
Length = 232
Score = 42.0 bits (97), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 39/187 (20%), Positives = 73/187 (39%), Gaps = 26/187 (13%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPNG 62
V++ K LP F L DQ+ L S+ +FN +P+G
Sbjct: 59 VEFTKKLPGFQTLDHEDQIALLKGSAVEAM----------FLRSAEIFNKK-----LPSG 103
Query: 63 KASQTAADVR-------VLNGVLQRFRLVG---VDPAEFACLKAVVLFKSETRGLKDSLQ 112
+ +R + + ++ +G + E+A L A+V+ + + +KD
Sbjct: 104 HSDLLEERIRNSGISDEYITPMFSFYKSIGELKMTQEEYALLTAIVILSPDRQYIKDREA 163
Query: 113 VENLQDQAQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSME 172
VE LQ+ +L + + H P P F LL ++ R + + + V +
Sbjct: 164 VEKLQEPLLDVLQKLCKIHQPENPQHFACLLGRLTELRTFNHHHAE-MLMSWRVNDHKFT 222
Query: 173 KLLCDMY 179
LLC+++
Sbjct: 223 PLLCEIW 229
>pdb|3L1B|A Chain A, Complex Structure Of Fxr Ligand-Binding Domain With A
Tetrahydroazepinoindole Compound
Length = 233
Score = 42.0 bits (97), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 39/187 (20%), Positives = 73/187 (39%), Gaps = 26/187 (13%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPNG 62
V++ K LP F L DQ+ L S+ +FN +P+G
Sbjct: 60 VEFTKKLPGFQTLDHEDQIALLKGSAVEAM----------FLRSAEIFNKK-----LPSG 104
Query: 63 KASQTAADVR-------VLNGVLQRFRLVG---VDPAEFACLKAVVLFKSETRGLKDSLQ 112
+ +R + + ++ +G + E+A L A+V+ + + +KD
Sbjct: 105 HSDLLEERIRNSGISDEYITPMFSFYKSIGELKMTQEEYALLTAIVILSPDRQYIKDREA 164
Query: 113 VENLQDQAQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSME 172
VE LQ+ +L + + H P P F LL ++ R + + + V +
Sbjct: 165 VEKLQEPLLDVLQKLCKIHQPENPQHFACLLGRLTELRTFNHHHAE-MLMSWRVNDHKFT 223
Query: 173 KLLCDMY 179
LLC+++
Sbjct: 224 PLLCEIW 230
>pdb|3RUT|A Chain A, Fxr With Src1 And Gsk359
pdb|3RUU|A Chain A, Fxr With Src1 And Gsk237
Length = 229
Score = 42.0 bits (97), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 39/187 (20%), Positives = 73/187 (39%), Gaps = 26/187 (13%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPNG 62
V++ K LP F L DQ+ L S+ +FN +P+G
Sbjct: 56 VEFTKKLPGFQTLDHEDQIALLKGSAVEAM----------FLRSAEIFNKK-----LPSG 100
Query: 63 KASQTAADVR-------VLNGVLQRFRLVG---VDPAEFACLKAVVLFKSETRGLKDSLQ 112
+ +R + + ++ +G + E+A L A+V+ + + +KD
Sbjct: 101 HSDLLEERIRNSGISDEYITPMFSFYKSIGELKMTQEEYALLTAIVILSPDRQYIKDREA 160
Query: 113 VENLQDQAQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSME 172
VE LQ+ +L + + H P P F LL ++ R + + + V +
Sbjct: 161 VEKLQEPLLDVLQKLCKIHQPENPQHFACLLGRLTELRTFNHHHAE-MLMSWRVNDHKFT 219
Query: 173 KLLCDMY 179
LLC+++
Sbjct: 220 PLLCEIW 226
>pdb|3FLI|A Chain A, Discovery Of Xl335, A Highly Potent, Selective And Orally-
Active Agonist Of The Farnesoid X Receptor (Fxr)
Length = 231
Score = 42.0 bits (97), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 39/187 (20%), Positives = 73/187 (39%), Gaps = 26/187 (13%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPNG 62
V++ K LP F L DQ+ L S+ +FN +P+G
Sbjct: 58 VEFTKKLPGFQTLDHEDQIALLKGSAVEAM----------FLRSAEIFNKK-----LPSG 102
Query: 63 KASQTAADVR-------VLNGVLQRFRLVG---VDPAEFACLKAVVLFKSETRGLKDSLQ 112
+ +R + + ++ +G + E+A L A+V+ + + +KD
Sbjct: 103 HSDLLEERIRNSGISDEYITPMFSFYKSIGELKMTQEEYALLTAIVILSPDRQYIKDREA 162
Query: 113 VENLQDQAQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSME 172
VE LQ+ +L + + H P P F LL ++ R + + + V +
Sbjct: 163 VEKLQEPLLDVLQKLCKIHQPENPQHFACLLGRLTELRTFNHHHAE-MLMSWRVNDHKFT 221
Query: 173 KLLCDMY 179
LLC+++
Sbjct: 222 PLLCEIW 228
>pdb|3HC5|A Chain A, Fxr With Src1 And Gsk826
pdb|3RVF|A Chain A, Fxr With Src1 And Gsk2034
Length = 232
Score = 42.0 bits (97), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 39/187 (20%), Positives = 73/187 (39%), Gaps = 26/187 (13%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPNG 62
V++ K LP F L DQ+ L S+ +FN +P+G
Sbjct: 59 VEFTKKLPGFQTLDHEDQIALLKGSAVEAM----------FLRSAEIFNKK-----LPSG 103
Query: 63 KASQTAADVR-------VLNGVLQRFRLVG---VDPAEFACLKAVVLFKSETRGLKDSLQ 112
+ +R + + ++ +G + E+A L A+V+ + + +KD
Sbjct: 104 HSDLLEERIRNSGISDEYITPMFSFYKSIGELKMTQEEYALLTAIVILSPDRQYIKDREA 163
Query: 113 VENLQDQAQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSME 172
VE LQ+ +L + + H P P F LL ++ R + + + V +
Sbjct: 164 VEKLQEPLLDVLQKLCKIHQPENPQHFACLLGRLTELRTFNHHHAE-MLMSWRVNDHKFT 222
Query: 173 KLLCDMY 179
LLC+++
Sbjct: 223 PLLCEIW 229
>pdb|3DCT|A Chain A, Fxr With Src1 And Gw4064
pdb|3DCU|A Chain A, Fxr With Src1 And Gsk8062
Length = 235
Score = 41.6 bits (96), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 39/187 (20%), Positives = 73/187 (39%), Gaps = 26/187 (13%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPNG 62
V++ K LP F L DQ+ L S+ +FN +P+G
Sbjct: 62 VEFTKKLPGFQTLDHEDQIALLKGSAVEAM----------FLRSAEIFNKK-----LPSG 106
Query: 63 KASQTAADVR-------VLNGVLQRFRLVG---VDPAEFACLKAVVLFKSETRGLKDSLQ 112
+ +R + + ++ +G + E+A L A+V+ + + +KD
Sbjct: 107 HSDLLEERIRNSGISDEYITPMFSFYKSIGELKMTQEEYALLTAIVILSPDRQYIKDREA 166
Query: 113 VENLQDQAQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSME 172
VE LQ+ +L + + H P P F LL ++ R + + + V +
Sbjct: 167 VEKLQEPLLDVLQKLCKIHQPENPQHFACLLGRLTELRTFNHHHAE-MLMSWRVNDHKFT 225
Query: 173 KLLCDMY 179
LLC+++
Sbjct: 226 PLLCEIW 232
>pdb|3BEJ|A Chain A, Structure Of Human Fxr In Complex With Mfa-1 And Co-
Activator Peptide
pdb|3BEJ|B Chain B, Structure Of Human Fxr In Complex With Mfa-1 And Co-
Activator Peptide
Length = 238
Score = 41.6 bits (96), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 39/187 (20%), Positives = 73/187 (39%), Gaps = 26/187 (13%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPNG 62
V++ K LP F L DQ+ L S+ +FN +P+G
Sbjct: 65 VEFTKKLPGFQTLDHEDQIALLKGSAVEAM----------FLRSAEIFNKK-----LPSG 109
Query: 63 KASQTAADVR-------VLNGVLQRFRLVG---VDPAEFACLKAVVLFKSETRGLKDSLQ 112
+ +R + + ++ +G + E+A L A+V+ + + +KD
Sbjct: 110 HSDLLEERIRNSGISDEYITPMFSFYKSIGELKMTQEEYALLTAIVILSPDRQYIKDREA 169
Query: 113 VENLQDQAQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSME 172
VE LQ+ +L + + H P P F LL ++ R + + + V +
Sbjct: 170 VEKLQEPLLDVLQKLCKIHQPENPQHFACLLGRLTELRTFNHHHAE-MLMSWRVNDHKFT 228
Query: 173 KLLCDMY 179
LLC+++
Sbjct: 229 PLLCEIW 235
>pdb|3OS8|C Chain C, Estrogen Receptor
pdb|3OS8|D Chain D, Estrogen Receptor
pdb|3OS9|A Chain A, Estrogen Receptor
pdb|3OS9|B Chain B, Estrogen Receptor
pdb|3OS9|C Chain C, Estrogen Receptor
pdb|3OS9|D Chain D, Estrogen Receptor
pdb|3OSA|A Chain A, Estrogen Receptor
pdb|3OSA|B Chain B, Estrogen Receptor
pdb|3OSA|C Chain C, Estrogen Receptor
pdb|3OSA|D Chain D, Estrogen Receptor
Length = 258
Score = 41.6 bits (96), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 45/184 (24%), Positives = 76/184 (41%), Gaps = 34/184 (18%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAV--- 59
+ WAK +P F L DQV W L +L ++ + EH +
Sbjct: 63 INWAKRVPGFVDLTRHDQVHLL-----------ECAW-LEILMIGLVWRSMEHPGKLLFA 110
Query: 60 PN-------GKASQTAADV-RVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRG-LKDS 110
PN GK + ++ +L RFR++ + EF CLK+++L S L +
Sbjct: 111 PNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSST 170
Query: 111 LQVENLQDQAQVMLAQHVRT--HHPA--------QPARFGRLLLMTSQCRNIPSARVQHI 160
L+ +D +L + T H A Q R +LLL+ S R++ + ++H+
Sbjct: 171 LKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHL 230
Query: 161 FFAK 164
+ K
Sbjct: 231 YSMK 234
>pdb|4DK7|A Chain A, Crystal Structure Of Lxr Ligand Binding Domain In Complex
With Full Agonist 1
pdb|4DK7|C Chain C, Crystal Structure Of Lxr Ligand Binding Domain In Complex
With Full Agonist 1
Length = 247
Score = 41.6 bits (96), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 43/186 (23%), Positives = 79/186 (42%), Gaps = 20/186 (10%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFN-ASEHVAAVPN 61
V +AK +P F L DQ+ A + LLE++ +N +E + + +
Sbjct: 69 VDFAKQVPGFLQLGREDQI----------ALLKASTIEIXLLETARRYNHETECITFLKD 118
Query: 62 GKASQ-----TAADVRVLNGVLQ---RFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQV 113
S+ V +N + + R +G+D AE+A L A+ +F ++ +++ +V
Sbjct: 119 FTYSKDDFHRAGLQVEFINPIFEFSRAXRRLGLDDAEYALLIAINIFSADRPNVQEPGRV 178
Query: 114 ENLQDQAQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSMEK 173
E LQ L + R P RF R L R + S + + FA + + +
Sbjct: 179 EALQQPYVEALLSYTRIKRPQDQLRFPRXLXKLVSLRTLSSVHSEQV-FALRLQDKKLPP 237
Query: 174 LLCDMY 179
LL +++
Sbjct: 238 LLSEIW 243
>pdb|3OS8|A Chain A, Estrogen Receptor
pdb|3OS8|B Chain B, Estrogen Receptor
Length = 258
Score = 41.6 bits (96), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 45/184 (24%), Positives = 76/184 (41%), Gaps = 34/184 (18%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAV--- 59
+ WAK +P F L DQV W L +L ++ + EH +
Sbjct: 63 INWAKRVPGFVDLTRHDQVHLL-----------ECAW-LEILMIGLVWRSMEHPGKLLFA 110
Query: 60 PN-------GKASQTAADV-RVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRG-LKDS 110
PN GK + ++ +L RFR++ + EF CLK+++L S L +
Sbjct: 111 PNLLLDRNQGKXVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSST 170
Query: 111 LQVENLQDQAQVMLAQHVRT--HHPA--------QPARFGRLLLMTSQCRNIPSARVQHI 160
L+ +D +L + T H A Q R +LLL+ S R++ + ++H+
Sbjct: 171 LKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHL 230
Query: 161 FFAK 164
+ K
Sbjct: 231 YSMK 234
>pdb|3GD2|A Chain A, Isoxazole Ligand Bound To Farnesoid X Receptor (Fxr)
Length = 229
Score = 41.2 bits (95), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 35/158 (22%), Positives = 62/158 (39%), Gaps = 25/158 (15%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPNG 62
V++ K LP F L DQ+ L S+ +FN +P+G
Sbjct: 56 VEFTKKLPGFQTLDHEDQIALLKGSAVEAM----------FLRSAEIFNKK-----LPSG 100
Query: 63 KASQTAADVR-------VLNGVLQRFRLVG---VDPAEFACLKAVVLFKSETRGLKDSLQ 112
+ +R + + ++ +G + E+A L A+V+ + + +KD
Sbjct: 101 HSDLLEERIRNSGISDEYITPMFSFYKSIGELKMTQEEYALLTAIVILSPDRQYIKDREA 160
Query: 113 VENLQDQAQVMLAQHVRTHHPAQPARFGRLLLMTSQCR 150
VE LQ+ +L + + H P P F LL ++ R
Sbjct: 161 VEKLQEPLLDVLQKLCKIHQPENPQHFAELLGRLTELR 198
>pdb|1YOW|A Chain A, Human Steroidogenic Factor 1 Lbd With Bound Co-Factor
Peptide
Length = 242
Score = 41.2 bits (95), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 22/79 (27%), Positives = 42/79 (53%), Gaps = 1/79 (1%)
Query: 90 EFACLKAVVLFKSETRGLKDSLQVENLQDQAQVMLAQHVRTHHPAQPARFGRLLLMTSQC 149
EF CLK ++LF + + L + + V++ Q++A L + H+P +F +LLL +
Sbjct: 148 EFVCLKFIILFSLDLKFLNNHILVKDAQEKANAALLDYTLCHYPHCGDKFQQLLLCLVEV 207
Query: 150 RNIPSARVQHIFFAKTVAN 168
R + S + + + K + N
Sbjct: 208 RAL-SMQAKEYLYHKHLGN 225
>pdb|3P89|A Chain A, Fxr Bound To A Quinolinecarboxylic Acid
Length = 229
Score = 41.2 bits (95), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 35/158 (22%), Positives = 62/158 (39%), Gaps = 25/158 (15%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPNG 62
V++ K LP F L DQ+ L S+ +FN +P+G
Sbjct: 56 VEFTKKLPGFQTLDHEDQIALLKGSAVEAM----------FLRSAEIFNKK-----LPSG 100
Query: 63 KASQTAADVR-------VLNGVLQRFRLVG---VDPAEFACLKAVVLFKSETRGLKDSLQ 112
+ +R + + ++ +G + E+A L A+V+ + + +KD
Sbjct: 101 HSDLLEERIRNSGISDEYITPMFSFYKSIGELKMTQEEYALLTAIVILSPDRQYIKDREA 160
Query: 113 VENLQDQAQVMLAQHVRTHHPAQPARFGRLLLMTSQCR 150
VE LQ+ +L + + H P P F LL ++ R
Sbjct: 161 VEKLQEPLLDVLQKLCKIHQPENPQHFAELLGRLTELR 198
>pdb|3P88|A Chain A, Fxr Bound To Isoquinolinecarboxylic Acid
Length = 229
Score = 41.2 bits (95), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 35/158 (22%), Positives = 62/158 (39%), Gaps = 25/158 (15%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPNG 62
V++ K LP F L DQ+ L S+ +FN +P+G
Sbjct: 56 VEFTKKLPGFQTLDHEDQIALLKGSAVEAM----------FLRSAEIFNKK-----LPSG 100
Query: 63 KASQTAADVR-------VLNGVLQRFRLVG---VDPAEFACLKAVVLFKSETRGLKDSLQ 112
+ +R + + ++ +G + E+A L A+V+ + + +KD
Sbjct: 101 HSDLLEERIRNSGISDEYITPMFSFYKSIGELKMTQEEYALLTAIVILSPDRQYIKDREA 160
Query: 113 VENLQDQAQVMLAQHVRTHHPAQPARFGRLLLMTSQCR 150
VE LQ+ +L + + H P P F LL ++ R
Sbjct: 161 VEKLQEPLLDVLQKLCKIHQPENPQHFAELLGRLTELR 198
>pdb|3HC6|A Chain A, Fxr With Src1 And Gsk088
Length = 232
Score = 41.2 bits (95), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 35/158 (22%), Positives = 62/158 (39%), Gaps = 25/158 (15%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPNG 62
V++ K LP F L DQ+ L S+ +FN +P+G
Sbjct: 59 VEFTKKLPGFQTLDHEDQIALLKGSAVEAM----------FLRSAEIFNKK-----LPSG 103
Query: 63 KASQTAADVR-------VLNGVLQRFRLVG---VDPAEFACLKAVVLFKSETRGLKDSLQ 112
+ +R + + ++ +G + E+A L A+V+ + + +KD
Sbjct: 104 HSDLLEERIRNSGISDEYITPMFSFYKSIGELKMTQEEYALLTAIVILSPDRQYIKDREA 163
Query: 113 VENLQDQAQVMLAQHVRTHHPAQPARFGRLLLMTSQCR 150
VE LQ+ +L + + H P P F LL ++ R
Sbjct: 164 VEKLQEPLLDVLQKLCKIHQPENPQHFAELLGRLTELR 201
>pdb|1YJE|A Chain A, Crystal Structure Of The Rngfi-B Ligand-Binding Domain
Length = 264
Score = 40.8 bits (94), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 30/83 (36%), Positives = 44/83 (53%), Gaps = 3/83 (3%)
Query: 84 VGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQAQVMLAQHV-RTHHPAQPAR-FGR 141
+GVD FACL A+VL ++ GL+D +VE LQ++ L +H+ QPA R
Sbjct: 162 LGVDVPAFACLSALVLI-TDRHGLQDPRRVEELQNRIASCLKEHMAAVAGDPQPASCLSR 220
Query: 142 LLLMTSQCRNIPSARVQHIFFAK 164
LL + R + + +Q IF K
Sbjct: 221 LLGKLPELRTLCTQGLQRIFCLK 243
>pdb|1YP0|A Chain A, Structure Of The Steroidogenic Factor-1 Ligand Binding
Domain Bound To Phospholipid And A Shp Peptide Motif
Length = 239
Score = 40.4 bits (93), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 23/83 (27%), Positives = 43/83 (51%), Gaps = 1/83 (1%)
Query: 86 VDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQAQVMLAQHVRTHHPAQPARFGRLLLM 145
+D EF CLK ++LF + + L + V++ Q++A L + H+P +F +LLL
Sbjct: 142 LDRQEFVCLKFLILFSLDVKFLNNHSLVKDAQEKANAALLDYTLCHYPHCGDKFQQLLLC 201
Query: 146 TSQCRNIPSARVQHIFFAKTVAN 168
+ R + S + + + K + N
Sbjct: 202 LVEVRAL-SMQAKEYLYHKHLGN 223
>pdb|1DKF|B Chain B, Crystal Structure Of A Heterodimeric Complex Of Rar And
Rxr Ligand-Binding Domains
Length = 235
Score = 40.4 bits (93), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 25/96 (26%), Positives = 47/96 (48%)
Query: 86 VDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQAQVMLAQHVRTHHPAQPARFGRLLLM 145
+D AE L A+ L + + L+ +V+ LQ+ L +VR P++P F ++L+
Sbjct: 140 MDDAETGLLSAICLICGDRQDLEQPDRVDMLQEPLLEALKVYVRKRRPSRPHMFPKMLMK 199
Query: 146 TSQCRNIPSARVQHIFFAKTVANTSMEKLLCDMYKN 181
+ R+I + + + K SM L+ +M +N
Sbjct: 200 ITDLRSISAKGAERVITLKMEIPGSMPPLIQEMLEN 235
>pdb|1Y0S|A Chain A, Crystal Structure Of Ppar Delta Complexed With Gw2331
pdb|1Y0S|B Chain B, Crystal Structure Of Ppar Delta Complexed With Gw2331
Length = 272
Score = 40.4 bits (93), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 27/103 (26%), Positives = 50/103 (48%), Gaps = 1/103 (0%)
Query: 80 RFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQAQVMLAQHVRTHHPAQPARF 139
+F + +D ++ A A ++ + GL + +VE +QD L H++ +HP F
Sbjct: 168 KFNALELDDSDLALFIAAIILCGDRPGLMNVPRVEAIQDTILRALEFHLQANHPDAQYLF 227
Query: 140 GRLLLMTSQCRNIPSARVQHI-FFAKTVANTSMEKLLCDMYKN 181
+LL + R + + Q + KT TS+ LL ++YK+
Sbjct: 228 PKLLQKMADLRQLVTEHAQMMQRIKKTETETSLHPLLQEIYKD 270
>pdb|3KMR|A Chain A, Crystal Structure Of Raralpha Ligand Binding Domain In
Complex With An Agonist Ligand (Am580) And A Coactivator
Fragment
pdb|3KMZ|B Chain B, Crystal Structure Of Raralpha Ligand Binding Domain In
Complex With The Inverse Agonist Bms493 And A
Corepressor Fragment
pdb|3KMZ|A Chain A, Crystal Structure Of Raralpha Ligand Binding Domain In
Complex With The Inverse Agonist Bms493 And A
Corepressor Fragment
Length = 266
Score = 40.4 bits (93), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 25/96 (26%), Positives = 47/96 (48%)
Query: 86 VDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQAQVMLAQHVRTHHPAQPARFGRLLLM 145
+D AE L A+ L + + L+ +V+ LQ+ L +VR P++P F ++L+
Sbjct: 166 MDDAETGLLSAICLICGDRQDLEQPDRVDMLQEPLLEALKVYVRKRRPSRPHMFPKMLMK 225
Query: 146 TSQCRNIPSARVQHIFFAKTVANTSMEKLLCDMYKN 181
+ R+I + + + K SM L+ +M +N
Sbjct: 226 ITDLRSISAKGAERVITLKMEIPGSMPPLIQEMLEN 261
>pdb|2Q5G|A Chain A, Ligand Binding Domain Of Ppar Delta Receptor In Complex
With A Partial Agonist
pdb|2Q5G|B Chain B, Ligand Binding Domain Of Ppar Delta Receptor In Complex
With A Partial Agonist
Length = 283
Score = 40.4 bits (93), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 27/103 (26%), Positives = 50/103 (48%), Gaps = 1/103 (0%)
Query: 80 RFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQAQVMLAQHVRTHHPAQPARF 139
+F + +D ++ A A ++ + GL + +VE +QD L H++ +HP F
Sbjct: 179 KFNALELDDSDLALFIAAIILCGDRPGLMNVPRVEAIQDTILRALEFHLQANHPDAQYLF 238
Query: 140 GRLLLMTSQCRNIPSARVQHI-FFAKTVANTSMEKLLCDMYKN 181
+LL + R + + Q + KT TS+ LL ++YK+
Sbjct: 239 PKLLQKMADLRQLVTEHAQMMQRIKKTETETSLHPLLQEIYKD 281
>pdb|2B50|A Chain A, Human Nuclear Receptor-Ligand Complex 2
pdb|2B50|B Chain B, Human Nuclear Receptor-Ligand Complex 2
Length = 272
Score = 40.4 bits (93), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 27/103 (26%), Positives = 50/103 (48%), Gaps = 1/103 (0%)
Query: 80 RFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQAQVMLAQHVRTHHPAQPARF 139
+F + +D ++ A A ++ + GL + +VE +QD L H++ +HP F
Sbjct: 169 KFNALELDDSDLALFIAAIILCGDRPGLMNVPRVEAIQDTILRALEFHLQANHPDAQQLF 228
Query: 140 GRLLLMTSQCRNIPSARVQHI-FFAKTVANTSMEKLLCDMYKN 181
+LL + R + + Q + KT TS+ LL ++YK+
Sbjct: 229 PKLLQKMADLRQLVTEHAQMMQRIKKTETETSLHPLLQEIYKD 271
>pdb|1GWX|A Chain A, Molecular Recognition Of Fatty Acids By Peroxisome
Proliferator-Activated Receptors
pdb|1GWX|B Chain B, Molecular Recognition Of Fatty Acids By Peroxisome
Proliferator-Activated Receptors
pdb|3GWX|A Chain A, Molecular Recognition Of Fatty Acids By Peroxisome
Proliferator-activated Receptors
pdb|3GWX|B Chain B, Molecular Recognition Of Fatty Acids By Peroxisome
Proliferator-activated Receptors
pdb|3DY6|A Chain A, Ppardelta Complexed With An Anthranilic Acid Partial
Agonist
pdb|3DY6|B Chain B, Ppardelta Complexed With An Anthranilic Acid Partial
Agonist
pdb|3PEQ|A Chain A, Ppard Complexed With A Phenoxyacetic Acid Partial Agonist
pdb|3PEQ|B Chain B, Ppard Complexed With A Phenoxyacetic Acid Partial Agonist
Length = 271
Score = 40.0 bits (92), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 27/103 (26%), Positives = 50/103 (48%), Gaps = 1/103 (0%)
Query: 80 RFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQAQVMLAQHVRTHHPAQPARF 139
+F + +D ++ A A ++ + GL + +VE +QD L H++ +HP F
Sbjct: 167 KFNALELDDSDLALFIAAIILCGDRPGLMNVPRVEAIQDTILRALEFHLQANHPDAQYLF 226
Query: 140 GRLLLMTSQCRNIPSARVQHI-FFAKTVANTSMEKLLCDMYKN 181
+LL + R + + Q + KT TS+ LL ++YK+
Sbjct: 227 PKLLQKMADLRQLVTEHAQMMQRIKKTETETSLHPLLQEIYKD 269
>pdb|3SP9|A Chain A, Structural Basis For Iloprost As A Dual PparalphaDELTA
AGONIST
pdb|3SP9|B Chain B, Structural Basis For Iloprost As A Dual PparalphaDELTA
AGONIST
Length = 281
Score = 40.0 bits (92), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 27/103 (26%), Positives = 50/103 (48%), Gaps = 1/103 (0%)
Query: 80 RFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQAQVMLAQHVRTHHPAQPARF 139
+F + +D ++ A A ++ + GL + +VE +QD L H++ +HP F
Sbjct: 177 KFNALELDDSDLALFIAAIILCGDRPGLMNVPRVEAIQDTILRALEFHLQANHPDAQYLF 236
Query: 140 GRLLLMTSQCRNIPSARVQHI-FFAKTVANTSMEKLLCDMYKN 181
+LL + R + + Q + KT TS+ LL ++YK+
Sbjct: 237 PKLLQKMADLRQLVTEHAQMMQRIKKTETETSLHPLLQEIYKD 279
>pdb|3GZ9|A Chain A, Crystal Structure Of Peroxisome Proliferator-Activated
Receptor Delta (Ppard) In Complex With A Full Agonist
Length = 269
Score = 40.0 bits (92), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 48/191 (25%), Positives = 83/191 (43%), Gaps = 24/191 (12%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPNG 62
++AK++PSF +L DQV AI +L S L N + A NG
Sbjct: 91 TEFAKSIPSFGSLFLNDQV-----TLLKYGVHEAI---FAMLAS--LVNKDGLLVA--NG 138
Query: 63 KASQTAADVRVL----NGVLQ-------RFRLVGVDPAEFACLKAVVLFKSETRGLKDSL 111
T +R L + +++ +F + +D ++ A A ++ + GL +
Sbjct: 139 SGFVTREFLRSLRKPFSDIIEPKFEFAVKFNALELDDSDLALFIAAIILCGDRPGLMNVP 198
Query: 112 QVENLQDQAQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHI-FFAKTVANTS 170
+VE +QD L H++ +HP F +LL + R + + Q + KT TS
Sbjct: 199 RVEAIQDTILRALEFHLQANHPDAQYLFPKLLQKMADLRQLVTEHAQMMQRIKKTETETS 258
Query: 171 MEKLLCDMYKN 181
+ LL ++YK+
Sbjct: 259 LHPLLQEIYKD 269
>pdb|2ZNP|A Chain A, Human Pprr Delta Ligand Binding Domain In Complex With A
Synthetic Agonist Tipp204
pdb|2ZNP|B Chain B, Human Pprr Delta Ligand Binding Domain In Complex With A
Synthetic Agonist Tipp204
pdb|2ZNQ|A Chain A, Human Pprr Delta Ligand Binding Domain In Complex With A
Synthetic Agonist Tipp401
pdb|2ZNQ|B Chain B, Human Pprr Delta Ligand Binding Domain In Complex With A
Synthetic Agonist Tipp401
Length = 276
Score = 40.0 bits (92), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 27/103 (26%), Positives = 50/103 (48%), Gaps = 1/103 (0%)
Query: 80 RFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQAQVMLAQHVRTHHPAQPARF 139
+F + +D ++ A A ++ + GL + +VE +QD L H++ +HP F
Sbjct: 172 KFNALELDDSDLALFIAAIILCGDRPGLMNVPRVEAIQDTILRALEFHLQANHPDAQYLF 231
Query: 140 GRLLLMTSQCRNIPSARVQHI-FFAKTVANTSMEKLLCDMYKN 181
+LL + R + + Q + KT TS+ LL ++YK+
Sbjct: 232 PKLLQKMADLRQLVTEHAQMMQRIKKTETETSLHPLLQEIYKD 274
>pdb|2J14|A Chain A, 3,4,5-Trisubstituted Isoxazoles As Novel Ppardelta
Agonists: Part2
pdb|2J14|B Chain B, 3,4,5-Trisubstituted Isoxazoles As Novel Ppardelta
Agonists: Part2
pdb|3OZ0|A Chain A, Ppar Delta In Complex With Azppard02
Length = 285
Score = 40.0 bits (92), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 27/103 (26%), Positives = 50/103 (48%), Gaps = 1/103 (0%)
Query: 80 RFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQAQVMLAQHVRTHHPAQPARF 139
+F + +D ++ A A ++ + GL + +VE +QD L H++ +HP F
Sbjct: 181 KFNALELDDSDLALFIAAIILCGDRPGLMNVPRVEAIQDTILRALEFHLQANHPDAQYLF 240
Query: 140 GRLLLMTSQCRNIPSARVQHI-FFAKTVANTSMEKLLCDMYKN 181
+LL + R + + Q + KT TS+ LL ++YK+
Sbjct: 241 PKLLQKMADLRQLVTEHAQMMQRIKKTETETSLHPLLQEIYKD 283
>pdb|2XYJ|A Chain A, Novel Sulfonylthiadiazoles With An Unusual Binding Mode As
Partial Dual Peroxisome Proliferator-Activated Receptor
(Ppar) Gamma-Delta Agonists With High Potency And
In-Vivo Efficacy
pdb|2XYJ|B Chain B, Novel Sulfonylthiadiazoles With An Unusual Binding Mode As
Partial Dual Peroxisome Proliferator-Activated Receptor
(Ppar) Gamma-Delta Agonists With High Potency And
In-Vivo Efficacy
pdb|2XYW|A Chain A, Novel Sulfonylthiadiazoles With An Unusual Binding Mode As
Partial Dual Peroxisome Proliferator-Activated Receptor
(Ppar) Gamma-Delta Agonists With High Potency And
In-Vivo Efficacy
pdb|2XYW|B Chain B, Novel Sulfonylthiadiazoles With An Unusual Binding Mode As
Partial Dual Peroxisome Proliferator-Activated Receptor
(Ppar) Gamma-Delta Agonists With High Potency And
In-Vivo Efficacy
pdb|2XYX|A Chain A, Novel Sulfonylthiadiazoles With An Unusual Binding Mode As
Partial Dual Peroxisome Proliferator-Activated Receptor
(Ppar) Gamma-Delta Agonists With High Potency And
In-Vivo Efficacy
pdb|2XYX|B Chain B, Novel Sulfonylthiadiazoles With An Unusual Binding Mode As
Partial Dual Peroxisome Proliferator-Activated Receptor
(Ppar) Gamma-Delta Agonists With High Potency And
In-Vivo Efficacy
Length = 288
Score = 40.0 bits (92), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 27/103 (26%), Positives = 50/103 (48%), Gaps = 1/103 (0%)
Query: 80 RFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQAQVMLAQHVRTHHPAQPARF 139
+F + +D ++ A A ++ + GL + +VE +QD L H++ +HP F
Sbjct: 184 KFNALELDDSDLALFIAAIILCGDRPGLMNVPRVEAIQDTILRALEFHLQANHPDAQYLF 243
Query: 140 GRLLLMTSQCRNIPSARVQHI-FFAKTVANTSMEKLLCDMYKN 181
+LL + R + + Q + KT TS+ LL ++YK+
Sbjct: 244 PKLLQKMADLRQLVTEHAQMMQRIKKTETETSLHPLLQEIYKD 286
>pdb|3TKM|A Chain A, Crystal Structure Ppar Delta Binding Gw0742
Length = 275
Score = 40.0 bits (92), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 27/103 (26%), Positives = 50/103 (48%), Gaps = 1/103 (0%)
Query: 80 RFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQAQVMLAQHVRTHHPAQPARF 139
+F + +D ++ A A ++ + GL + +VE +QD L H++ +HP F
Sbjct: 171 KFNALELDDSDLALFIAAIILCGDRPGLMNVPRVEAIQDTILRALEFHLQANHPDAQYLF 230
Query: 140 GRLLLMTSQCRNIPSARVQHI-FFAKTVANTSMEKLLCDMYKN 181
+LL + R + + Q + KT TS+ LL ++YK+
Sbjct: 231 PKLLQKMADLRQLVTEHAQMMQRIKKTETETSLHPLLQEIYKD 273
>pdb|3ET2|A Chain A, Structure Of Ppardelta With 3-[5-Methoxy-1-(4-Methoxy-
Benzenesulfonyl)-1h-Indol-3-Yl]-Propionic Acid
pdb|3ET2|B Chain B, Structure Of Ppardelta With 3-[5-Methoxy-1-(4-Methoxy-
Benzenesulfonyl)-1h-Indol-3-Yl]-Propionic Acid
Length = 287
Score = 40.0 bits (92), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 27/103 (26%), Positives = 50/103 (48%), Gaps = 1/103 (0%)
Query: 80 RFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQAQVMLAQHVRTHHPAQPARF 139
+F + +D ++ A A ++ + GL + +VE +QD L H++ +HP F
Sbjct: 183 KFNALELDDSDLALFIAAIILCGDRPGLMNVPRVEAIQDTILRALEFHLQANHPDAQYLF 242
Query: 140 GRLLLMTSQCRNIPSARVQHI-FFAKTVANTSMEKLLCDMYKN 181
+LL + R + + Q + KT TS+ LL ++YK+
Sbjct: 243 PKLLQKMADLRQLVTEHAQMMQRIKKTETETSLHPLLQEIYKD 285
>pdb|1NUO|A Chain A, Two Rth Mutants With Impaired Hormone Binding
Length = 261
Score = 40.0 bits (92), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 45/173 (26%), Positives = 66/173 (38%), Gaps = 10/173 (5%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHV--AAVP 60
V +AK LP F LP DQ+I +A P E+ L N V +
Sbjct: 84 VDFAKKLPMFCELPCEDQIILLKGCCMEIMSLHAAVRYDPESETLTL-NGEMAVTRGQLK 142
Query: 61 NGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQA 120
NG + + L L F L D E A L+AV+L S+ GL ++E QD
Sbjct: 143 NGGLGVVSDAIFDLGMSLSSFNL---DDTEVALLQAVLLMSSDRPGLACVERIEKYQDSF 199
Query: 121 QVMLAQHV--RTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSM 171
+ ++ R HH + +LL+ + R I + K T +
Sbjct: 200 LLAFEHYINYRKHHVTH--FWPKLLMKVTDLRMIGACHASRFLHMKVECPTEL 250
>pdb|2J4A|A Chain A, Human Thyroid Hormone Receptor Beta Ligand Binding Domain
In Complex With Kb131084
Length = 253
Score = 40.0 bits (92), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 45/174 (25%), Positives = 65/174 (37%), Gaps = 12/174 (6%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAA---V 59
V +AK LP F LP DQ+I A P ES L + E +
Sbjct: 76 VDFAKKLPMFCELPCEDQIILLKGCCMEIMSLRAAVRYDP--ESETLTLSGEMAVTRGQL 133
Query: 60 PNGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQ 119
NG + + L L F L D E A L+AV+L S+ GL ++E QD
Sbjct: 134 KNGGLGVVSDAIFDLGMSLSSFNL---DDTEVALLQAVLLMSSDRPGLACVERIEKYQDS 190
Query: 120 AQVMLAQHV--RTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSM 171
+ ++ R HH + +LL+ + R I + K T +
Sbjct: 191 FLLAFEHYINYRKHHVTH--FWPKLLMKVTDLRMIGACHASRFLHMKVECPTEL 242
>pdb|2AWH|A Chain A, Human Nuclear Receptor-Ligand Complex 1
pdb|2AWH|B Chain B, Human Nuclear Receptor-Ligand Complex 1
Length = 268
Score = 40.0 bits (92), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 27/103 (26%), Positives = 50/103 (48%), Gaps = 1/103 (0%)
Query: 80 RFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQAQVMLAQHVRTHHPAQPARF 139
+F + +D ++ A A ++ + GL + +VE +QD L H++ +HP F
Sbjct: 164 KFNALELDDSDLALFIAAIILCGDRPGLMNVPRVEAIQDTILRALEFHLQANHPDAQQLF 223
Query: 140 GRLLLMTSQCRNIPSARVQHI-FFAKTVANTSMEKLLCDMYKN 181
+LL + R + + Q + KT TS+ LL ++YK+
Sbjct: 224 PKLLQKMADLRQLVTEHAQMMQRIKKTETETSLHPLLQEIYKD 266
>pdb|2GWX|A Chain A, Molecular Recognition Of Fatty Acids By Peroxisome
Proliferator-Activated Receptors
pdb|2GWX|B Chain B, Molecular Recognition Of Fatty Acids By Peroxisome
Proliferator-Activated Receptors
pdb|2BAW|A Chain A, Human Nuclear Receptor-Ligand Complex 1
pdb|2BAW|B Chain B, Human Nuclear Receptor-Ligand Complex 1
pdb|3D5F|A Chain A, Crystal Structure Of Ppar-Delta Complex
pdb|3D5F|B Chain B, Crystal Structure Of Ppar-Delta Complex
Length = 267
Score = 40.0 bits (92), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 27/103 (26%), Positives = 50/103 (48%), Gaps = 1/103 (0%)
Query: 80 RFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQAQVMLAQHVRTHHPAQPARF 139
+F + +D ++ A A ++ + GL + +VE +QD L H++ +HP F
Sbjct: 163 KFNALELDDSDLALFIAAIILCGDRPGLMNVPRVEAIQDTILRALEFHLQANHPDAQQLF 222
Query: 140 GRLLLMTSQCRNIPSARVQHI-FFAKTVANTSMEKLLCDMYKN 181
+LL + R + + Q + KT TS+ LL ++YK+
Sbjct: 223 PKLLQKMADLRQLVTEHAQMMQRIKKTETETSLHPLLQEIYKD 265
>pdb|3A9E|B Chain B, Crystal Structure Of A Mixed Agonist-Bound Rar-Alpha And
Antagonist- Bound Rxr-Alpha Heterodimer Ligand Binding
Domains
Length = 269
Score = 40.0 bits (92), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 25/96 (26%), Positives = 47/96 (48%)
Query: 86 VDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQAQVMLAQHVRTHHPAQPARFGRLLLM 145
+D AE L A+ L + + L+ +V+ LQ+ L +VR P++P F ++L+
Sbjct: 169 MDDAETGLLSAICLICGDRQDLEQPDRVDMLQEPLLEALKVYVRKRRPSRPHMFPKMLMK 228
Query: 146 TSQCRNIPSARVQHIFFAKTVANTSMEKLLCDMYKN 181
+ R+I + + + K SM L+ +M +N
Sbjct: 229 ITDLRSISAKGAERVITLKMEIPGSMPPLIQEMLEN 264
>pdb|2QW4|A Chain A, Human Nr4a1 Ligand-Binding Domain
pdb|2QW4|B Chain B, Human Nr4a1 Ligand-Binding Domain
pdb|2QW4|C Chain C, Human Nr4a1 Ligand-Binding Domain
pdb|2QW4|D Chain D, Human Nr4a1 Ligand-Binding Domain
Length = 273
Score = 39.7 bits (91), Expect = 9e-04, Method: Compositional matrix adjust.
Identities = 27/81 (33%), Positives = 42/81 (51%), Gaps = 3/81 (3%)
Query: 86 VDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQAQVMLAQHVR--THHPAQPARFGRLL 143
VD FACL A+VL ++ GL++ +VE LQ++ L +HV P + RLL
Sbjct: 173 VDVPAFACLSALVLI-TDRHGLQEPRRVEELQNRIASCLKEHVAAVAGEPQPASCLSRLL 231
Query: 144 LMTSQCRNIPSARVQHIFFAK 164
+ R + + +Q IF+ K
Sbjct: 232 GKLPELRTLCTQGLQRIFYLK 252
>pdb|3V3E|B Chain B, Crystal Structure Of The Human Nur77 Ligand-Binding Domain
pdb|3V3E|A Chain A, Crystal Structure Of The Human Nur77 Ligand-Binding Domain
pdb|3V3Q|A Chain A, Crystal Structure Of Human Nur77 Ligand-Binding Domain In
Complex With Ethyl 2-[2,3,4
Trimethoxy-6(1-Octanoyl)phenyl]acetate
pdb|3V3Q|B Chain B, Crystal Structure Of Human Nur77 Ligand-Binding Domain In
Complex With Ethyl 2-[2,3,4
Trimethoxy-6(1-Octanoyl)phenyl]acetate
Length = 257
Score = 39.7 bits (91), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 27/81 (33%), Positives = 42/81 (51%), Gaps = 3/81 (3%)
Query: 86 VDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQAQVMLAQHVR--THHPAQPARFGRLL 143
VD FACL A+VL ++ GL++ +VE LQ++ L +HV P + RLL
Sbjct: 149 VDVPAFACLSALVLI-TDRHGLQEPRRVEELQNRIASCLKEHVAAVAGEPQPASCLSRLL 207
Query: 144 LMTSQCRNIPSARVQHIFFAK 164
+ R + + +Q IF+ K
Sbjct: 208 GKLPELRTLCTQGLQRIFYLK 228
>pdb|1N46|A Chain A, Crystal Structure Of Human Tr Beta Ligand-Binding Domain
Complexed With A Potent Subtype-Selective Thyromimetic
pdb|1N46|B Chain B, Crystal Structure Of Human Tr Beta Ligand-Binding Domain
Complexed With A Potent Subtype-Selective Thyromimetic
Length = 258
Score = 39.7 bits (91), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 45/173 (26%), Positives = 65/173 (37%), Gaps = 10/173 (5%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHV--AAVP 60
V +AK LP F LP DQ+I A P E+ L N V +
Sbjct: 81 VDFAKKLPMFCELPCEDQIILLKGCCMEIMSLRAAVRYDPESETLTL-NGEMAVTRGQLK 139
Query: 61 NGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQA 120
NG + + L L F L D E A L+AV+L S+ GL ++E QD
Sbjct: 140 NGGLGVVSDAIFDLGMSLSSFNL---DDTEVALLQAVLLMSSDRPGLACVERIEKYQDSF 196
Query: 121 QVMLAQHV--RTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSM 171
+ ++ R HH + +LL+ + R I + K T +
Sbjct: 197 LLAFEHYINYRKHHVTH--FWPKLLMKVTDLRMIGACHASRFLHMKVECPTEL 247
>pdb|1NAX|A Chain A, Thyroid Receptor Beta1 In Complex With A Beta-Selective
Ligand
Length = 252
Score = 39.7 bits (91), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 45/173 (26%), Positives = 65/173 (37%), Gaps = 10/173 (5%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHV--AAVP 60
V +AK LP F LP DQ+I A P E+ L N V +
Sbjct: 76 VDFAKKLPMFCELPCEDQIILLKGCCMEIMSLRAAVRYDPESETLTL-NGEMAVTRGQLK 134
Query: 61 NGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQA 120
NG + + L L F L D E A L+AV+L S+ GL ++E QD
Sbjct: 135 NGGLGVVSDAIFDLGMSLSSFNL---DDTEVALLQAVLLMSSDRPGLACVERIEKYQDSF 191
Query: 121 QVMLAQHV--RTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSM 171
+ ++ R HH + +LL+ + R I + K T +
Sbjct: 192 LLAFEHYINYRKHHVTH--FWPKLLMKVTDLRMIGACHASRFLHMKVECPTEL 242
>pdb|1OT7|A Chain A, Structural Basis For 3-Deoxy-Cdca Binding And Activation
Of Fxr
pdb|1OT7|B Chain B, Structural Basis For 3-Deoxy-Cdca Binding And Activation
Of Fxr
Length = 229
Score = 39.7 bits (91), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 40/187 (21%), Positives = 72/187 (38%), Gaps = 26/187 (13%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPNG 62
V++ K LP F L DQ+ L S+ +FN +P G
Sbjct: 57 VEFTKRLPGFQTLDHEDQIALLKGSAVEAM----------FLRSAEIFNKK-----LPAG 101
Query: 63 KASQTAADVR-------VLNGVLQRFRLVG---VDPAEFACLKAVVLFKSETRGLKDSLQ 112
A +R + + ++ VG + E+A L A+V+ + + +KD
Sbjct: 102 HADLLEERIRKSGISDEYITPMFSFYKSVGELKMTQEEYALLTAIVILSPDRQYIKDREA 161
Query: 113 VENLQDQAQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSME 172
VE LQ+ +L + + + P P F LL ++ R + + + V +
Sbjct: 162 VEKLQEPLLDVLQKLCKIYQPENPQHFACLLGRLTELRTFNHHHAE-MLMSWRVNDHKFT 220
Query: 173 KLLCDMY 179
LLC+++
Sbjct: 221 PLLCEIW 227
>pdb|2PIN|A Chain A, Thyroid Receptor Beta In Complex With Inhibitor
pdb|2PIN|B Chain B, Thyroid Receptor Beta In Complex With Inhibitor
Length = 253
Score = 39.7 bits (91), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 45/173 (26%), Positives = 65/173 (37%), Gaps = 10/173 (5%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHV--AAVP 60
V +AK LP F LP DQ+I A P E+ L N V +
Sbjct: 76 VDFAKKLPMFCELPCEDQIILLKGCCMEIMSLRAAVRYDPESETLTL-NGEMAVTRGQLK 134
Query: 61 NGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQA 120
NG + + L L F L D E A L+AV+L S+ GL ++E QD
Sbjct: 135 NGGLGVVSDAIFRLGMSLSSFNL---DDTEVALLQAVLLMSSDRPGLACVERIEKYQDSF 191
Query: 121 QVMLAQHV--RTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSM 171
+ ++ R HH + +LL+ + R I + K T +
Sbjct: 192 LLAFEHYINYRKHHVTH--FWPKLLMKVTDLRMIGACHASRFLHMKVECPTEL 242
>pdb|1Q4X|A Chain A, Crystal Structure Of Human Thyroid Hormone Receptor Beta
Lbd In Complex With Specific Agonist Gc-24
Length = 253
Score = 39.7 bits (91), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 45/173 (26%), Positives = 65/173 (37%), Gaps = 10/173 (5%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHV--AAVP 60
V +AK LP F LP DQ+I A P E+ L N V +
Sbjct: 76 VDFAKKLPMFCELPCEDQIILLKGCCMEIMSLRAAVRYDPESETLTL-NGEMAVTRGQLK 134
Query: 61 NGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQA 120
NG + + L L F L D E A L+AV+L S+ GL ++E QD
Sbjct: 135 NGGLGVVSDAIFDLGMSLSSFNL---DDTEVALLQAVLLMSSDRPGLACVERIEKYQDSF 191
Query: 121 QVMLAQHV--RTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSM 171
+ ++ R HH + +LL+ + R I + K T +
Sbjct: 192 LLAFEHYINYRKHHVTH--FWPKLLMKVTDLRMIGACHASRFLHMKVECPTEL 242
>pdb|1OSV|A Chain A, Structural Basis For Bile Acid Binding And Activation Of
The Nuclear Receptor Fxr
pdb|1OSV|B Chain B, Structural Basis For Bile Acid Binding And Activation Of
The Nuclear Receptor Fxr
Length = 230
Score = 39.3 bits (90), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 40/187 (21%), Positives = 72/187 (38%), Gaps = 26/187 (13%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPNG 62
V++ K LP F L DQ+ L S+ +FN +P G
Sbjct: 57 VEFTKRLPGFQTLDHEDQIALLKGSAVEAM----------FLRSAEIFNKK-----LPAG 101
Query: 63 KASQTAADVR-------VLNGVLQRFRLVG---VDPAEFACLKAVVLFKSETRGLKDSLQ 112
A +R + + ++ VG + E+A L A+V+ + + +KD
Sbjct: 102 HADLLEERIRKSGISDEYITPMFSFYKSVGELKMTQEEYALLTAIVILSPDRQYIKDREA 161
Query: 113 VENLQDQAQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSME 172
VE LQ+ +L + + + P P F LL ++ R + + + V +
Sbjct: 162 VEKLQEPLLDVLQKLCKIYQPENPQHFACLLGRLTELRTFNHHHAE-MLMSWRVNDHKFT 220
Query: 173 KLLCDMY 179
LLC+++
Sbjct: 221 PLLCEIW 227
>pdb|1R6G|A Chain A, Crystal Structure Of The Thyroid Hormone Receptor Beta
Ligand Binding Domain In Complex With A Beta Selective
Compound
Length = 259
Score = 39.3 bits (90), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 45/173 (26%), Positives = 65/173 (37%), Gaps = 10/173 (5%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHV--AAVP 60
V +AK LP F LP DQ+I A P E+ L N V +
Sbjct: 82 VDFAKKLPMFCELPCEDQIILLKGCCMEIMSLRAAVRYDPESETLTL-NGEMAVTRGQLK 140
Query: 61 NGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQA 120
NG + + L L F L D E A L+AV+L S+ GL ++E QD
Sbjct: 141 NGGLGVVSDAIFDLGMSLSSFNL---DDTEVALLQAVLLMSSDRPGLACVERIEKYQDSF 197
Query: 121 QVMLAQHV--RTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSM 171
+ ++ R HH + +LL+ + R I + K T +
Sbjct: 198 LLAFEHYINYRKHHVTH--FWPKLLMKVTDLRMIGACHASRFLHMKVECPTEL 248
>pdb|1NQ1|A Chain A, Tr Receptor Mutations Conferring Hormone Resistance And
Reduced Corepressor Release Exhibit Decreased Stability
In The Nterminal Lbd
Length = 263
Score = 39.3 bits (90), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 45/173 (26%), Positives = 65/173 (37%), Gaps = 10/173 (5%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHV--AAVP 60
V +AK LP F LP DQ+I A P E+ L N V +
Sbjct: 86 VDFAKKLPMFCELPCEDQIILLKGCCMEIMSLRAAVRYDPESETLTL-NGEMAVTRGQLK 144
Query: 61 NGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQA 120
NG + + L L F L D E A L+AV+L S+ GL ++E QD
Sbjct: 145 NGGLGVVSDAIFDLGMSLSSFNL---DDTEVALLQAVLLMSSDRPGLACVERIEKYQDSF 201
Query: 121 QVMLAQHV--RTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSM 171
+ ++ R HH + +LL+ + R I + K T +
Sbjct: 202 LLAFEHYINYRKHHVTH--FWPKLLMKVTDLRMIGACHASRFLHMKVECPTEL 252
>pdb|1XZX|X Chain X, Thyroxine-Thyroid Hormone Receptor Interactions
pdb|1Y0X|X Chain X, Thyroxine-Thyroid Hormone Receptor Interactions
Length = 281
Score = 39.3 bits (90), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 45/173 (26%), Positives = 65/173 (37%), Gaps = 10/173 (5%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHV--AAVP 60
V +AK LP F LP DQ+I A P E+ L N V +
Sbjct: 104 VDFAKKLPMFCELPCEDQIILLKGCCMEIMSLRAAVRYDPESETLTL-NGEMAVTRGQLK 162
Query: 61 NGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQA 120
NG + + L L F L D E A L+AV+L S+ GL ++E QD
Sbjct: 163 NGGLGVVSDAIFDLGMSLSSFNL---DDTEVALLQAVLLMSSDRPGLACVERIEKYQDSF 219
Query: 121 QVMLAQHV--RTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSM 171
+ ++ R HH + +LL+ + R I + K T +
Sbjct: 220 LLAFEHYINYRKHHVTH--FWPKLLMKVTDLRMIGACHASRFLHMKVECPTEL 270
>pdb|1BSX|A Chain A, Structure And Specificity Of Nuclear Receptor-Coactivator
Interactions
pdb|1BSX|B Chain B, Structure And Specificity Of Nuclear Receptor-Coactivator
Interactions
Length = 260
Score = 39.3 bits (90), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 45/173 (26%), Positives = 65/173 (37%), Gaps = 10/173 (5%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHV--AAVP 60
V +AK LP F LP DQ+I A P E+ L N V +
Sbjct: 83 VDFAKKLPMFCELPCEDQIILLKGCCMEIMSLRAAVRYDPESETLTL-NGEMAVTRGQLK 141
Query: 61 NGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQA 120
NG + + L L F L D E A L+AV+L S+ GL ++E QD
Sbjct: 142 NGGLGVVSDAIFDLGMSLSSFNL---DDTEVALLQAVLLMSSDRPGLACVERIEKYQDSF 198
Query: 121 QVMLAQHV--RTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSM 171
+ ++ R HH + +LL+ + R I + K T +
Sbjct: 199 LLAFEHYINYRKHHVTH--FWPKLLMKVTDLRMIGACHASRFLHMKVECPTEL 249
>pdb|3JZC|A Chain A, Crystal Structure Of Tr-Beta Bound To The Selective
Thyromimetic Triac
Length = 263
Score = 39.3 bits (90), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 45/173 (26%), Positives = 65/173 (37%), Gaps = 10/173 (5%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHV--AAVP 60
V +AK LP F LP DQ+I A P E+ L N V +
Sbjct: 86 VDFAKKLPMFXELPXEDQIILLKGCCMEIMSLRAAVRYDPESETLTL-NGEMAVTRGQLK 144
Query: 61 NGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQA 120
NG + + L L F L D E A L+AV+L S+ GL ++E QD
Sbjct: 145 NGGLGVVSDAIFDLGMSLSSFNL---DDTEVALLQAVLLMSSDRPGLAXVERIEKYQDSF 201
Query: 121 QVMLAQHV--RTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSM 171
+ ++ R HH + +LL+ + R I + K T +
Sbjct: 202 LLAFEHYINYRKHHVTH--FWPKLLMKVTDLRMIGAXHASRFLHMKVECPTEL 252
>pdb|3D57|A Chain A, Tr Variant D355r
pdb|3D57|B Chain B, Tr Variant D355r
Length = 266
Score = 39.3 bits (90), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 45/173 (26%), Positives = 65/173 (37%), Gaps = 10/173 (5%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHV--AAVP 60
V +AK LP F LP DQ+I A P E+ L N V +
Sbjct: 90 VDFAKKLPMFCELPCEDQIILLKGCCMEIMSLRAAVRYDPESETLTL-NGEMAVTRGQLK 148
Query: 61 NGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQA 120
NG + + L L F L D E A L+AV+L S+ GL ++E QD
Sbjct: 149 NGGLGVVSDAIFRLGMSLSSFNL---DDTEVALLQAVLLMSSDRPGLACVERIEKYQDSF 205
Query: 121 QVMLAQHV--RTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSM 171
+ ++ R HH + +LL+ + R I + K T +
Sbjct: 206 LLAFEHYINYRKHHVTH--FWPKLLMKVTDLRMIGACHASRFLHMKVECPTEL 256
>pdb|1NQ0|A Chain A, Tr Receptor Mutations Conferring Hormone Resistance And
Reduced Corepressor Release Exhibit Decreased Stability
In The Nterminal Lbd
Length = 263
Score = 39.3 bits (90), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 45/173 (26%), Positives = 65/173 (37%), Gaps = 10/173 (5%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHV--AAVP 60
V +AK LP F LP DQ+I A P E+ L N V +
Sbjct: 86 VDFAKKLPMFCELPCEDQIILLKGCCMEIMSLRAAVRYDPESETLTL-NGEMAVTRGQLK 144
Query: 61 NGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQA 120
NG + + L L F L D E A L+AV+L S+ GL ++E QD
Sbjct: 145 NGGLGVVSDAIFDLGMSLSSFNL---DDTEVALLQAVLLMSSDRPGLACVERIEKYQDSF 201
Query: 121 QVMLAQHV--RTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSM 171
+ ++ R HH + +LL+ + R I + K T +
Sbjct: 202 LLAFEHYINYRKHHVTH--FWPKLLMKVTDLRMIGACHASRFLHMKVECPTEL 252
>pdb|1PDU|A Chain A, Ligand-Binding Domain Of Drosophila Orphan Nuclear
Receptor Dhr38
pdb|1PDU|B Chain B, Ligand-Binding Domain Of Drosophila Orphan Nuclear
Receptor Dhr38
Length = 244
Score = 39.3 bits (90), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 28/81 (34%), Positives = 43/81 (53%), Gaps = 3/81 (3%)
Query: 86 VDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQAQVMLAQHVRTHHPAQPAR--FGRLL 143
+D + FACL A+ L +E GL++ +VE LQ + L HV + AQ + F RLL
Sbjct: 144 IDISAFACLCALTLI-TERHGLREPKKVEQLQMKIIGSLRDHVTYNAEAQKKQHYFSRLL 202
Query: 144 LMTSQCRNIPSARVQHIFFAK 164
+ R++ +Q IF+ K
Sbjct: 203 GKLPELRSLSVQGLQRIFYLK 223
>pdb|3IMY|A Chain A, Structure Of Tr-Beta Bound To Selective Thyromimetic Gc-1
Length = 261
Score = 39.3 bits (90), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 45/173 (26%), Positives = 65/173 (37%), Gaps = 10/173 (5%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHV--AAVP 60
V +AK LP F LP DQ+I A P E+ L N V +
Sbjct: 84 VDFAKKLPMFXELPCEDQIILLKGCCMEIMSLRAAVRYDPESETLTL-NGEMAVTRGQLK 142
Query: 61 NGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQA 120
NG + + L L F L D E A L+AV+L S+ GL ++E QD
Sbjct: 143 NGGLGVVSDAIFDLGMSLSSFNL---DDTEVALLQAVLLMSSDRPGLAXVERIEKYQDSF 199
Query: 121 QVMLAQHV--RTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSM 171
+ ++ R HH + +LL+ + R I + K T +
Sbjct: 200 LLAFEHYINYRKHHVTH--FWPKLLMKVTDLRMIGAXHASRFLHMKVECPTEL 250
>pdb|3GWS|X Chain X, Crystal Structure Of T3-Bound Thyroid Hormone Receptor
Length = 259
Score = 39.3 bits (90), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 45/173 (26%), Positives = 65/173 (37%), Gaps = 10/173 (5%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHV--AAVP 60
V +AK LP F LP DQ+I A P E+ L N V +
Sbjct: 83 VDFAKKLPMFXELPCEDQIILLKGCCMEIMSLRAAVRYDPESETLTL-NGEMAVTRGQLK 141
Query: 61 NGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQA 120
NG + + L L F L D E A L+AV+L S+ GL ++E QD
Sbjct: 142 NGGLGVVSDAIFDLGMSLSSFNL---DDTEVALLQAVLLMSSDRPGLAXVERIEKYQDSF 198
Query: 121 QVMLAQHV--RTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSM 171
+ ++ R HH + +LL+ + R I + K T +
Sbjct: 199 LLAFEHYINYRKHHVTH--FWPKLLMKVTDLRMIGAXHASRFLHMKVECPTEL 249
>pdb|1QKN|A Chain A, Rat Oestrogen Receptor Beta Ligand-Binding Domain In
Complex With Antagonist Raloxifene
pdb|1HJ1|A Chain A, Rat Oestrogen Receptor Beta Ligand-Binding Domain In
Complex With Pure Antioestrogen Ici164,384
Length = 255
Score = 39.3 bits (90), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 42/187 (22%), Positives = 69/187 (36%), Gaps = 13/187 (6%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPNG 62
+ WAK +P F L DQV + S+ L A + V G
Sbjct: 56 IGWAKKIPGFVELSLLDQVRLLESCWMEVLMVGLMWRSID--HPGKLIFAPDLVLDRDEG 113
Query: 63 KASQTAADV-RVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQ--------- 112
K + ++ +L RFR + + E+ C+KA++L S L + Q
Sbjct: 114 KCVEGILEIFDMLLATTSRFRELKLQHKEYLCVKAMILLNSSMYPLASANQEAESSRKLT 173
Query: 113 -VENLQDQAQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSM 171
+ N A V + Q R LL++ S R+I + ++H+ K +
Sbjct: 174 HLLNAVTDALVWVIAKSGISSQQQSVRLANLLMLLSHVRHISNKGMEHLLSMKCKNVVPV 233
Query: 172 EKLLCDM 178
LL +M
Sbjct: 234 YDLLLEM 240
>pdb|2J7X|A Chain A, Structure Of Estradiol-bound Estrogen Receptor Beta Lbd In
Complex With Lxxll Motif From Ncoa5
pdb|2J7Y|A Chain A, Structure Of 17-Epiestriol-Bound Estrogen Receptor Beta
Lbd In Complex With Lxxll Motif From Ncoa5
Length = 255
Score = 39.3 bits (90), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 42/187 (22%), Positives = 69/187 (36%), Gaps = 13/187 (6%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPNG 62
+ WAK +P F L DQV + S+ L A + V G
Sbjct: 56 IGWAKKIPGFVELSLLDQVRLLESCWMEVLMVGLMWRSID--HPGKLIFAPDLVLDRDEG 113
Query: 63 KASQTAADV-RVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQ--------- 112
K + ++ +L RFR + + E+ C+KA++L S L + Q
Sbjct: 114 KCVEGILEIFDMLLATTSRFRELKLQHKEYLCVKAMILLNSSMYPLASANQEAESSRKLT 173
Query: 113 -VENLQDQAQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSM 171
+ N A V + Q R LL++ S R+I + ++H+ K +
Sbjct: 174 HLLNAVTDALVWVIAKSGISSQQQSVRLANLLMLLSHVRHISNKGMEHLLSMKCKNVVPV 233
Query: 172 EKLLCDM 178
LL +M
Sbjct: 234 YDLLLEM 240
>pdb|3UVV|A Chain A, Crystal Structure Of The Ligand Binding Domains Of The
Thyroid Receptor:retinoid X Receptor Complexed With
3,3',5 Triiodo-L- Thyronine And 9-Cis Retinoic Acid
Length = 265
Score = 38.9 bits (89), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 42/172 (24%), Positives = 64/172 (37%), Gaps = 8/172 (4%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAA---V 59
V +AK LP F+ LP DQ+I A P ES L + E +
Sbjct: 85 VDFAKKLPMFSELPCEDQIILLKGCCMEIMSLRAAVRYDP--ESETLTLSGEMAVKREQL 142
Query: 60 PNGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQ 119
NG + + L L F L D E A L+AV+L S+ GL ++E Q+
Sbjct: 143 KNGGLGVVSDAIFDLGKSLSAFNL---DDTEVALLQAVLLMSSDRTGLICVDKIEKCQET 199
Query: 120 AQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSM 171
+ ++ P + +LL+ + R I + K T +
Sbjct: 200 YLLAFEHYINYRKHNIPHFWPKLLMKVTDLRMIGACHASRFLHMKVECPTEL 251
>pdb|1NQ2|A Chain A, Two Rth Mutants With Impaired Hormone Binding
Length = 264
Score = 38.1 bits (87), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 44/173 (25%), Positives = 64/173 (36%), Gaps = 10/173 (5%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHV--AAVP 60
V +AK LP F LP DQ+I P E+ L N V +
Sbjct: 87 VDFAKKLPMFCELPCEDQIILLKGCCMEIMSLRTAVRYEPESETLTL-NGEMAVTRGQLK 145
Query: 61 NGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQA 120
NG + + L L F L D E A L+AV+L S+ GL ++E QD
Sbjct: 146 NGGLGVVSDAIFDLGMSLSSFNL---DDTEVALLQAVLLMSSDRPGLACVERIEKYQDSF 202
Query: 121 QVMLAQHV--RTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSM 171
+ ++ R HH + +LL+ + R I + K T +
Sbjct: 203 LLAFEHYINYRKHHVTH--FWPKLLMKVTDLRMIGACHASRFLHMKVECPTEL 253
>pdb|2FSZ|A Chain A, A Second Binding Site For Hydroxytamoxifen Within The
Coactivator-Binding Groove Of Estrogen Receptor Beta
pdb|2FSZ|B Chain B, A Second Binding Site For Hydroxytamoxifen Within The
Coactivator-Binding Groove Of Estrogen Receptor Beta
Length = 246
Score = 37.7 bits (86), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 41/187 (21%), Positives = 70/187 (37%), Gaps = 13/187 (6%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPNG 62
+ WAK +P F L DQV + S+ L A + V G
Sbjct: 54 ISWAKKIPGFVELSLFDQVRLLESSWMEVLMMGLMWRSID--HPGKLIFAPDLVLDRDEG 111
Query: 63 KASQTAADV-RVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQ--------- 112
K+ + ++ +L RFR + + E+ C+KA++L S L + Q
Sbjct: 112 KSVEGILEIFDMLLATTSRFRELKLQHKEYLCVKAMILLNSSMYPLVTATQDADSSRKLA 171
Query: 113 -VENLQDQAQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSM 171
+ N A V + Q R LL++ S R+ + ++H+ K+ +
Sbjct: 172 HLLNAVTDALVWVIAKSGISSQQQSMRLANLLMLLSHVRHASNKGMEHLLNMKSKNVVPV 231
Query: 172 EKLLCDM 178
LL +M
Sbjct: 232 YDLLLEM 238
>pdb|4DQM|A Chain A, Revealing A Marine Natural Product As A Novel Agonist For
Retinoic Acid Receptors With A Unique Binding Mode And
Antitumor Activity
pdb|4DQM|C Chain C, Revealing A Marine Natural Product As A Novel Agonist For
Retinoic Acid Receptors With A Unique Binding Mode And
Antitumor Activity
Length = 234
Score = 37.7 bits (86), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 24/95 (25%), Positives = 46/95 (48%)
Query: 86 VDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQAQVMLAQHVRTHHPAQPARFGRLLLM 145
+D AE L A+ L + + L+ +V+ LQ+ L +VR P++P F ++L+
Sbjct: 140 MDDAETGLLSAICLICGDRQDLEQPDRVDMLQEPLLEALKVYVRKRRPSRPHMFPKMLMK 199
Query: 146 TSQCRNIPSARVQHIFFAKTVANTSMEKLLCDMYK 180
+ R+I + + + K SM L+ +M +
Sbjct: 200 ITDLRSISAKGAERVITLKMEIPGSMPPLIQEMLE 234
>pdb|2H79|A Chain A, Crystal Structure Of Human Tr Alpha Bound T3 In
Orthorhombic Space Group
Length = 269
Score = 37.4 bits (85), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 42/172 (24%), Positives = 64/172 (37%), Gaps = 8/172 (4%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAA---V 59
V +AK LP F+ LP DQ+I A P ES L + E +
Sbjct: 89 VDFAKKLPMFSELPXEDQIILLKGCCMEIMSLRAAVRYDP--ESDTLTLSGEMAVKREQL 146
Query: 60 PNGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQ 119
NG + + L L F L D E A L+AV+L ++ GL ++E Q+
Sbjct: 147 KNGGLGVVSDAIFELGKSLSAFNL---DDTEVALLQAVLLMSTDRSGLLXVDKIEKSQEA 203
Query: 120 AQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSM 171
+ +V P + +LL+ + R I + K T +
Sbjct: 204 YLLAFEHYVNHRKHNIPHFWPKLLMKVTDLRMIGAXHASRFLHXKVEXPTEL 255
>pdb|2V0V|A Chain A, Crystal Structure Of Rev-Erb Beta
pdb|2V0V|B Chain B, Crystal Structure Of Rev-Erb Beta
pdb|2V0V|C Chain C, Crystal Structure Of Rev-Erb Beta
pdb|2V0V|D Chain D, Crystal Structure Of Rev-Erb Beta
Length = 194
Score = 37.4 bits (85), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 38/160 (23%), Positives = 67/160 (41%), Gaps = 22/160 (13%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPNG 62
V++AK +P F L DQV A + + ++ + LF+A E
Sbjct: 32 VEFAKRIPGFRDLSQHDQV----------NLLKAGTFEVLMVRFASLFDAKERTVTFLGS 81
Query: 63 KA-------SQTAADVRVLNGVLQ---RFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQ 112
K S A D+ LN + + + + + E + AVVL ++ G+++
Sbjct: 82 KKYSVDDLHSMGAGDL--LNSMFEFSEKLNALQLSDEEMSLFTAVVLVSADRSGIENVNS 139
Query: 113 VENLQDQAQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNI 152
VE LQ+ L + +HP + + F +LLL R++
Sbjct: 140 VEALQETLIRALRTLIMKNHPNEASIFTKLLLKLPDLRSL 179
>pdb|3CQV|A Chain A, Crystal Structure Of Reverb Beta In Complex With Heme
Length = 199
Score = 37.4 bits (85), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 39/160 (24%), Positives = 67/160 (41%), Gaps = 22/160 (13%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPNG 62
V++AK +P F L DQV A + + + + LF+A E +G
Sbjct: 37 VEFAKRIPGFRDLSQHDQV----------NLLKAGTFEVLXVRFASLFDAKERTVTFLSG 86
Query: 63 KA-------SQTAADVRVLNGVLQ---RFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQ 112
K S A D+ LN + + + + E + AVVL ++ G+++
Sbjct: 87 KKYSVDDLHSXGAGDL--LNSXFEFSEKLNALQLSDEEXSLFTAVVLVSADRSGIENVNS 144
Query: 113 VENLQDQAQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNI 152
VE LQ+ L + +HP + + F +LLL R++
Sbjct: 145 VEALQETLIRALRTLIXKNHPNEASIFTKLLLKLPDLRSL 184
>pdb|2V7C|A Chain A, Crystal Structure Of Rev-Erb Beta
pdb|2V7C|B Chain B, Crystal Structure Of Rev-Erb Beta
Length = 194
Score = 37.4 bits (85), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 39/160 (24%), Positives = 67/160 (41%), Gaps = 22/160 (13%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPNG 62
V++AK +P F L DQV A + + + + LF+A E +G
Sbjct: 32 VEFAKRIPGFRDLSQHDQV----------NLLKAGTFEVLXVRFASLFDAKERTVTFLSG 81
Query: 63 KA-------SQTAADVRVLNGVLQ---RFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQ 112
K S A D+ LN + + + + E + AVVL ++ G+++
Sbjct: 82 KKYSVDDLHSXGAGDL--LNSXFEFSEKLNALQLSDEEXSLFTAVVLVSADRSGIENVNS 139
Query: 113 VENLQDQAQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNI 152
VE LQ+ L + +HP + + F +LLL R++
Sbjct: 140 VEALQETLIRALRTLIXKNHPNEASIFTKLLLKLPDLRSL 179
>pdb|3JZB|A Chain A, Crystal Structure Of Tr-Alfa Bound To The Selective
Thyromimetic Triac
pdb|3ILZ|A Chain A, Structure Of Tr-Alfa Bound To Selective Thyromimetic Gc-1
In Space Group
Length = 267
Score = 37.0 bits (84), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 42/172 (24%), Positives = 64/172 (37%), Gaps = 8/172 (4%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAA---V 59
V +AK LP F+ LP DQ+I A P ES L + E +
Sbjct: 87 VDFAKKLPMFSELPXEDQIILLKGCCMEIMSLRAAVRYDP--ESDTLTLSGEMAVKREQL 144
Query: 60 PNGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQ 119
NG + + L L F L D E A L+AV+L ++ GL ++E Q+
Sbjct: 145 KNGGLGVVSDAIFELGKSLSAFNL---DDTEVALLQAVLLMSTDRSGLLXVDKIEKSQEA 201
Query: 120 AQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSM 171
+ +V P + +LL+ + R I + K T +
Sbjct: 202 YLLAFEHYVNHRKHNIPHFWPKLLMKVTDLRMIGAXHASRFLHMKVEXPTEL 253
>pdb|2YLY|A Chain A, Sulfonamides As Selective Estrogen Receptor Beta Agonists.
pdb|2YLY|B Chain B, Sulfonamides As Selective Estrogen Receptor Beta Agonists
Length = 240
Score = 37.0 bits (84), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 41/186 (22%), Positives = 68/186 (36%), Gaps = 12/186 (6%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPNG 62
+ WAK +P F L DQV + S+ L A + V G
Sbjct: 51 ISWAKKIPGFVELSLFDQVRLLESCWMEVLMMGLMWRSID--HPGKLIFAPDLVLDRDEG 108
Query: 63 KASQTAADV-RVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVE------- 114
K + ++ +L RFR + + E+ C+KA++L S L + Q +
Sbjct: 109 KCVEGILEIFDMLLATTSRFRELKLQHKEYLCVKAMILLNSSMYPLVTATQDDSSRKLAH 168
Query: 115 --NLQDQAQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSME 172
N A V + Q R LL++ S R+ + ++H+ K +
Sbjct: 169 LLNAVTDALVWVIAKSGISSQQQSMRLANLLMLLSHVRHASNKGMEHLLNMKCKNVVPVY 228
Query: 173 KLLCDM 178
LL +M
Sbjct: 229 DLLLEM 234
>pdb|1NAV|A Chain A, Thyroid Receptor Alpha In Complex With An Agonist
Selective For Thyroid Receptor Beta1
Length = 263
Score = 37.0 bits (84), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 42/172 (24%), Positives = 64/172 (37%), Gaps = 8/172 (4%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAA---V 59
V +AK LP F+ LP DQ+I A P ES L + E +
Sbjct: 85 VDFAKKLPMFSELPCEDQIILLKGCCMEIMSLRAAVRYDP--ESDTLTLSGEMAVKREQL 142
Query: 60 PNGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQ 119
NG + + L L F L D E A L+AV+L ++ GL ++E Q+
Sbjct: 143 KNGGLGVVSDAIFELGKSLSAFNL---DDTEVALLQAVLLMSTDRSGLLCVDKIEKSQEA 199
Query: 120 AQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSM 171
+ +V P + +LL+ + R I + K T +
Sbjct: 200 YLLAFEHYVNHRKHNIPHFWPKLLMKVTDLRMIGACHASRFLHMKVECPTEL 251
>pdb|2H77|A Chain A, Crystal Structure Of Human Tr Alpha Bound T3 In Monoclinic
Space Group
Length = 269
Score = 37.0 bits (84), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 42/172 (24%), Positives = 64/172 (37%), Gaps = 8/172 (4%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAA---V 59
V +AK LP F+ LP DQ+I A P ES L + E +
Sbjct: 89 VDFAKKLPMFSELPCEDQIILLKGCCMEIMSLRAAVRYDP--ESDTLTLSGEMAVKREQL 146
Query: 60 PNGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQ 119
NG + + L L F L D E A L+AV+L ++ GL ++E Q+
Sbjct: 147 KNGGLGVVSDAIFELGKSLSAFNL---DDTEVALLQAVLLMSTDRSGLLXVDKIEKSQEA 203
Query: 120 AQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSM 171
+ +V P + +LL+ + R I + K T +
Sbjct: 204 YLLAFEHYVNHRKHNIPHFWPKLLMKVTDLRMIGAXHASRFLHXKVEXPTEL 255
>pdb|3HZF|A Chain A, Structure Of Tr-alfa Bound To Selective Thyromimetic Gc-1
In C2 Space Group
Length = 269
Score = 37.0 bits (84), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 42/172 (24%), Positives = 64/172 (37%), Gaps = 8/172 (4%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAA---V 59
V +AK LP F+ LP DQ+I A P ES L + E +
Sbjct: 89 VDFAKKLPMFSELPXEDQIILLKGCCMEIMSLRAAVRYDP--ESDTLTLSGEMAVKREQL 146
Query: 60 PNGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQ 119
NG + + L L F L D E A L+AV+L ++ GL ++E Q+
Sbjct: 147 KNGGLGVVSDAIFELGKSLSAFNL---DDTEVALLQAVLLMSTDRSGLLXVDKIEKSQEA 203
Query: 120 AQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSM 171
+ +V P + +LL+ + R I + K T +
Sbjct: 204 YLLAFEHYVNHRKHNIPHFWPKLLMKVTDLRMIGAXHASRFLHMKVEXPTEL 255
>pdb|2AX8|A Chain A, Crystal Structure Of The Androgen Receptor Ligand Binding
Domain W741l Mutant In Complex With S-1
Length = 256
Score = 37.0 bits (84), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 29/100 (29%), Positives = 43/100 (43%), Gaps = 2/100 (2%)
Query: 2 AVKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQW-SLPLLESSPLFNASEHVAAVP 60
VKWAK LP F L DQ + A+ W S + S L+ A + V
Sbjct: 52 VVKWAKALPGFRNLHVDDQ-MAVIQYSLMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEY 110
Query: 61 NGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLF 100
S+ + + + Q F + + P EF C+KA++LF
Sbjct: 111 RMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLF 150
>pdb|1Z95|A Chain A, Crystal Structure Of The Androgen Receptor Ligand-Binding
Domain W741l Mutant Complex With R-Bicalutamide
Length = 246
Score = 37.0 bits (84), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 32/110 (29%), Positives = 47/110 (42%), Gaps = 3/110 (2%)
Query: 2 AVKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQW-SLPLLESSPLFNASEHVAAVP 60
VKWAK LP F L DQ + A+ W S + S L+ A + V
Sbjct: 44 VVKWAKALPGFRNLHVDDQ-MAVIQYSLMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEY 102
Query: 61 NGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFK-SETRGLKD 109
S+ + + + Q F + + P EF C+KA++LF GLK+
Sbjct: 103 RMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKN 152
>pdb|1I37|A Chain A, Crystal Structure Of The Rat Androgen Receptor Ligand
Binding Domain Complex With Dihydrotestosterone
pdb|2IHQ|A Chain A, Crystal Structure Of The Rat Androgen Receptor Ligand
Binding Domian Complex With An N-Aryl-
Hydroxybicyclohydantoin
pdb|2NW4|A Chain A, Crystal Structure Of The Rat Androgen Receptor Ligand
Binding Domain Complex With Bms-564929
pdb|3G0W|A Chain A, Crystal Structure Of The Rat Androgen Receptor Ligand
Binding Domain Complex With An N-Aryl-Oxazolidin 2-Imine
Inhibitor
Length = 260
Score = 36.6 bits (83), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 29/100 (29%), Positives = 43/100 (43%), Gaps = 2/100 (2%)
Query: 2 AVKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQW-SLPLLESSPLFNASEHVAAVP 60
VKWAK LP F L DQ + A+ W S + S L+ A + V
Sbjct: 56 VVKWAKALPGFRNLHVDDQ-MAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEY 114
Query: 61 NGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLF 100
S+ + + + Q F + + P EF C+KA++LF
Sbjct: 115 RMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLF 154
>pdb|2AM9|A Chain A, Crystal Structure Of Human Androgen Receptor Ligand
Binding Domain In Complex With Testosterone
pdb|2AMA|A Chain A, Crystal Structure Of Human Androgen Receptor Ligand
Binding Domain In Complex With Dihydrotestosterone
pdb|2AMB|A Chain A, Crystal Structure Of Human Androgen Receptor Ligand
Binding Domain In Complex With Tetrahydrogestrinone
pdb|2PNU|A Chain A, Crystal Structure Of Human Androgen Receptor
Ligand-Binding Domain In Complex With Em-5744
pdb|3V49|A Chain A, Structure Of Ar Lbd With Activator Peptide And Sarm
Inhibitor 1
Length = 266
Score = 36.6 bits (83), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 29/100 (29%), Positives = 43/100 (43%), Gaps = 2/100 (2%)
Query: 2 AVKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQW-SLPLLESSPLFNASEHVAAVP 60
VKWAK LP F L DQ + A+ W S + S L+ A + V
Sbjct: 62 VVKWAKALPGFRNLHVDDQ-MAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEY 120
Query: 61 NGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLF 100
S+ + + + Q F + + P EF C+KA++LF
Sbjct: 121 RMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLF 160
>pdb|1E3G|A Chain A, Human Androgen Receptor Ligand Binding In Complex With The
Ligand Metribolone (R1881)
Length = 263
Score = 36.6 bits (83), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 29/100 (29%), Positives = 43/100 (43%), Gaps = 2/100 (2%)
Query: 2 AVKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQW-SLPLLESSPLFNASEHVAAVP 60
VKWAK LP F L DQ + A+ W S + S L+ A + V
Sbjct: 59 VVKWAKALPGFRNLHVDDQ-MAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEY 117
Query: 61 NGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLF 100
S+ + + + Q F + + P EF C+KA++LF
Sbjct: 118 RMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLF 157
>pdb|1I38|A Chain A, Crystal Structure Of The Rat Androgen Receptor Ligand
Binding Domain T877a Mutant Complex With
Dihydrotestosterone
pdb|1XNN|A Chain A, Crystal Structure Of The Rat Androgen Receptor Ligand
Binding Domain T877a Mutant Complex With (3a-Alpha-,4-
Alpha
7-Alpha-,7a-Alpha-)-3a,4,7,7a-Tetrahydro-2-(4-Nitro-
1-Naphthalenyl)-4,7-Ethano-1h-Isoindole-1,3(2h)-Dione
Length = 260
Score = 36.6 bits (83), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 32/110 (29%), Positives = 47/110 (42%), Gaps = 3/110 (2%)
Query: 2 AVKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQW-SLPLLESSPLFNASEHVAAVP 60
VKWAK LP F L DQ + A+ W S + S L+ A + V
Sbjct: 56 VVKWAKALPGFRNLHVDDQ-MAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEY 114
Query: 61 NGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFK-SETRGLKD 109
S+ + + + Q F + + P EF C+KA++LF GLK+
Sbjct: 115 RMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKN 164
>pdb|1XJ7|A Chain A, Complex Androgen Receptor Lbd And Rac3 Peptide
pdb|2Q7I|A Chain A, The Wild Type Androgen Receptor Ligand Binding Domain
Bound With Testosterone And An Ar 20-30 Peptide
pdb|2Q7J|A Chain A, The Wild Type Androgen Receptor Ligand Binding Domain
Bound With Testosterone And A Tif2 Box 3 Coactivator
Peptide 740-753
Length = 257
Score = 36.6 bits (83), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 29/100 (29%), Positives = 43/100 (43%), Gaps = 2/100 (2%)
Query: 2 AVKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQW-SLPLLESSPLFNASEHVAAVP 60
VKWAK LP F L DQ + A+ W S + S L+ A + V
Sbjct: 53 VVKWAKALPGFRNLHVDDQ-MAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEY 111
Query: 61 NGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLF 100
S+ + + + Q F + + P EF C+KA++LF
Sbjct: 112 RMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLF 151
>pdb|1T73|A Chain A, Crystal Structure Of The Androgen Receptor Ligand Binding
Domain In Complex With A Fxxff Motif
pdb|1T74|A Chain A, Crystal Structure Of The Androgen Receptor Ligand Binding
Domain In Complex With A Wxxlf Motif
pdb|1T76|A Chain A, Crystal Structure Of The Androgen Receptor Ligand Binding
Domain In Complex With A Wxxvw Motif
pdb|1T79|A Chain A, Crystal Structure Of The Androgen Receptor Ligand Binding
Domain In Complex With A Fxxlw Motif
pdb|1T7F|A Chain A, Crystal Structure Of The Androgen Receptor Ligand Binding
Domain In Complex With A Lxxll Motif
pdb|1T7M|A Chain A, Crystal Structure Of The Androgen Receptor Ligand Binding
Domain In Complex With A Fxxyf Motif
pdb|1T7R|A Chain A, Crystal Structure Of The Androgen Receptor Ligand Binding
Domain In Complex With A Fxxlf Motif
pdb|1T7T|A Chain A, Crystal Structure Of The Androgen Receptor Ligand Binding
Domain In Complex With 5-Alpha Dihydrotestosterone
Length = 269
Score = 36.6 bits (83), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 29/100 (29%), Positives = 43/100 (43%), Gaps = 2/100 (2%)
Query: 2 AVKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQW-SLPLLESSPLFNASEHVAAVP 60
VKWAK LP F L DQ + A+ W S + S L+ A + V
Sbjct: 65 VVKWAKALPGFRNLHVDDQ-MAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEY 123
Query: 61 NGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLF 100
S+ + + + Q F + + P EF C+KA++LF
Sbjct: 124 RMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLF 163
>pdb|2Q7K|A Chain A, The Androgen Receptor Prostate Cancer Mutant H874y Ligand
Binding Domain Bound With Testosterone And An Ar 20-30
Peptide
pdb|2Q7L|A Chain A, The Androgen Receptor Prostate Cancer Mutant H874y Ligand
Binding Domain Bound With Testosterone And A Tif2 Box3
Coactivator Peptide 740-753
Length = 257
Score = 36.6 bits (83), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 32/110 (29%), Positives = 47/110 (42%), Gaps = 3/110 (2%)
Query: 2 AVKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQW-SLPLLESSPLFNASEHVAAVP 60
VKWAK LP F L DQ + A+ W S + S L+ A + V
Sbjct: 53 VVKWAKALPGFRNLHVDDQ-MAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEY 111
Query: 61 NGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFK-SETRGLKD 109
S+ + + + Q F + + P EF C+KA++LF GLK+
Sbjct: 112 RMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKN 161
>pdb|2AX9|A Chain A, Crystal Structure Of The Androgen Receptor Ligand Binding
Domain In Complex With R-3
pdb|2AXA|A Chain A, Crystal Structure Of The Androgen Receptor Ligand Binding
Domain In Complex With S-1
pdb|2YLO|A Chain A, Targeting The Binding Function 3 Site Of The Androgen
Receptor Through In Silico Molecular Modeling
pdb|2YLP|A Chain A, Targeting The Binding Function 3 Site Of The Androgen
Receptor Through In Silico Molecular Modeling
pdb|2YLQ|A Chain A, Targeting The Binding Function 3 Site Of The Androgen
Receptor Through In Silico Molecular Modeling
pdb|3ZQT|A Chain A, Targeting The Binding Function 3 Site Of The Androgen
Receptor Through In Silico Molecular Modeling
pdb|4HLW|A Chain A, Targeting The Binding Function 3 (bf3) Site Of The Human
Androgen Receptor Through Virtual Screening. 2.
Development Of 2-((2- Phenoxyethyl)
Thio)-1h-benzoimidazole Derivatives
Length = 256
Score = 36.6 bits (83), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 29/100 (29%), Positives = 43/100 (43%), Gaps = 2/100 (2%)
Query: 2 AVKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQW-SLPLLESSPLFNASEHVAAVP 60
VKWAK LP F L DQ + A+ W S + S L+ A + V
Sbjct: 52 VVKWAKALPGFRNLHVDDQ-MAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEY 110
Query: 61 NGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLF 100
S+ + + + Q F + + P EF C+KA++LF
Sbjct: 111 RMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLF 150
>pdb|2I0G|A Chain A, Benzopyrans Are Selective Estrogen Receptor Beta Agonists
(Serbas) With Novel Activity In Models Of Benign
Prostatic Hyperplasia
pdb|2I0G|B Chain B, Benzopyrans Are Selective Estrogen Receptor Beta Agonists
(Serbas) With Novel Activity In Models Of Benign
Prostatic Hyperplasia
pdb|2JJ3|A Chain A, Estrogen Receptor Beta Ligand Binding Domain In Complex
With A Benzopyran Agonist
pdb|2JJ3|B Chain B, Estrogen Receptor Beta Ligand Binding Domain In Complex
With A Benzopyran Agonist
pdb|2Z4B|A Chain A, Estrogen Receptor Beta Ligand-Binding Domain Complexed To
A Benzopyran Ligand
pdb|2Z4B|B Chain B, Estrogen Receptor Beta Ligand-Binding Domain Complexed To
A Benzopyran Ligand
pdb|2QTU|A Chain A, Estrogen Receptor Beta Ligand-Binding Domain Complexed To
A Benzopyran Ligand
pdb|2QTU|B Chain B, Estrogen Receptor Beta Ligand-Binding Domain Complexed To
A Benzopyran Ligand
Length = 257
Score = 36.6 bits (83), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 41/187 (21%), Positives = 68/187 (36%), Gaps = 13/187 (6%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPNG 62
+ WAK +P F L DQV + S+ L A + V G
Sbjct: 62 ISWAKKIPGFVELSLFDQVRLLESCWMEVLMMGLMWRSID--HPGKLIFAPDLVLDRDEG 119
Query: 63 KASQTAADV-RVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQ--------- 112
K + ++ +L RFR + + E+ C+KA++L S L + Q
Sbjct: 120 KCVEGILEIFDMLLATTSRFRELKLQHKEYLCVKAMILLNSSMYPLVTATQDADSSRKLA 179
Query: 113 -VENLQDQAQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSM 171
+ N A V + Q R LL++ S R+ + ++H+ K +
Sbjct: 180 HLLNAVTDALVWVIAKSGISSQQQSMRLANLLMLLSHVRHASNKGMEHLLNMKCKNVVPV 239
Query: 172 EKLLCDM 178
LL +M
Sbjct: 240 YDLLLEM 246
>pdb|2HVC|A Chain A, The Crystal Structure Of Ligand-Binding Domain (Lbd) Of
Human Androgen Receptor In Complex With A Selective
Modulator Lgd2226
Length = 250
Score = 36.6 bits (83), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 32/110 (29%), Positives = 47/110 (42%), Gaps = 3/110 (2%)
Query: 2 AVKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQW-SLPLLESSPLFNASEHVAAVP 60
VKWAK LP F L DQ + A+ W S + S L+ A + V
Sbjct: 47 VVKWAKALPGFRNLHVDDQ-MAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEY 105
Query: 61 NGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFK-SETRGLKD 109
S+ + + + Q F + + P EF C+KA++LF GLK+
Sbjct: 106 RMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKN 155
>pdb|2AX6|A Chain A, Crystal Structure Of The Androgen Receptor Ligand Binding
Domain T877a Mutant In Complex With Hydroxyflutamide
pdb|2AX7|A Chain A, Crystal Structure Of The Androgen Receptor Ligand Binding
Domain T877a Mutant In Complex With S-1
Length = 256
Score = 36.6 bits (83), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 32/110 (29%), Positives = 47/110 (42%), Gaps = 3/110 (2%)
Query: 2 AVKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQW-SLPLLESSPLFNASEHVAAVP 60
VKWAK LP F L DQ + A+ W S + S L+ A + V
Sbjct: 52 VVKWAKALPGFRNLHVDDQ-MAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEY 110
Query: 61 NGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFK-SETRGLKD 109
S+ + + + Q F + + P EF C+KA++LF GLK+
Sbjct: 111 RMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKN 160
>pdb|1X76|A Chain A, Crystal Structure Of Estrogen Receptor Beta Complexed With
Way-697
pdb|1X76|B Chain B, Crystal Structure Of Estrogen Receptor Beta Complexed With
Way-697
pdb|1X78|A Chain A, Crystal Structure Of Estrogen Receptor Beta Complexed With
Way-244
pdb|1X78|B Chain B, Crystal Structure Of Estrogen Receptor Beta Complexed With
Way-244
pdb|1X7B|A Chain A, Crystal Structure Of Estrogen Receptor Beta Complexed With
Erb-041
pdb|1X7B|B Chain B, Crystal Structure Of Estrogen Receptor Beta Complexed With
Erb-041
pdb|1X7J|A Chain A, Crystal Structure Of Estrogen Receptor Beta Complexed With
Genistein
pdb|1X7J|B Chain B, Crystal Structure Of Estrogen Receptor Beta Complexed With
Genistein
pdb|1U3Q|A Chain A, Crystal Structure Of Estrogen Receptor Beta Complexed With
Cl-272
pdb|1U3Q|B Chain B, Crystal Structure Of Estrogen Receptor Beta Complexed With
Cl-272
pdb|1U3Q|C Chain C, Crystal Structure Of Estrogen Receptor Beta Complexed With
Cl-272
pdb|1U3Q|D Chain D, Crystal Structure Of Estrogen Receptor Beta Complexed With
Cl-272
pdb|1U3S|A Chain A, Crystal Structure Of Estrogen Receptor Beta Complexed With
Way-797
pdb|1U3S|B Chain B, Crystal Structure Of Estrogen Receptor Beta Complexed With
Way-797
pdb|3OLS|A Chain A, Crystal Structure Of Estrogen Receptor Beta Ligand Binding
Domain
pdb|3OLS|B Chain B, Crystal Structure Of Estrogen Receptor Beta Ligand Binding
Domain
pdb|3OMO|A Chain A, Fragment-Based Design Of Novel Estrogen Receptor Ligands
pdb|3OMO|B Chain B, Fragment-Based Design Of Novel Estrogen Receptor Ligands
pdb|3OMP|A Chain A, Fragment-Based Design Of Novel Estrogen Receptor Ligands
pdb|3OMP|B Chain B, Fragment-Based Design Of Novel Estrogen Receptor Ligands
pdb|3OMQ|A Chain A, Fragment-Based Design Of Novel Estrogen Receptor Ligands
pdb|3OMQ|B Chain B, Fragment-Based Design Of Novel Estrogen Receptor Ligands
pdb|2YJD|A Chain A, Stapled Peptide Bound To Estrogen Receptor Beta
pdb|2YJD|B Chain B, Stapled Peptide Bound To Estrogen Receptor Beta
Length = 240
Score = 36.6 bits (83), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 41/187 (21%), Positives = 68/187 (36%), Gaps = 13/187 (6%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPNG 62
+ WAK +P F L DQV + S+ L A + V G
Sbjct: 50 ISWAKKIPGFVELSLFDQVRLLESCWMEVLMMGLMWRSID--HPGKLIFAPDLVLDRDEG 107
Query: 63 KASQTAADV-RVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQ--------- 112
K + ++ +L RFR + + E+ C+KA++L S L + Q
Sbjct: 108 KCVEGILEIFDMLLATTSRFRELKLQHKEYLCVKAMILLNSSMYPLVTATQDADSSRKLA 167
Query: 113 -VENLQDQAQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSM 171
+ N A V + Q R LL++ S R+ + ++H+ K +
Sbjct: 168 HLLNAVTDALVWVIAKSGISSQQQSMRLANLLMLLSHVRHASNKGMEHLLNMKCKNVVPV 227
Query: 172 EKLLCDM 178
LL +M
Sbjct: 228 YDLLLEM 234
>pdb|1T5Z|A Chain A, Crystal Structure Of The Androgen Receptor Ligand Binding
Domain (Lbd) With Dht And A Peptide Derived From Its
Physiological Coactivator Ara70
pdb|1T63|A Chain A, Crystal Structure Of The Androgen Receptor Ligand Binding
Domain With Dht And A Peptide Derived From Its
Physiological Coactivator Grip1 Nr Box3
pdb|1T65|A Chain A, Crystal Structure Of The Androgen Receptor Ligand Binding
Domain With Dht And A Peptide Derived Form Its
Physiological Coactivator Grip1 Nr Box 2 Bound In A Non-
Helical Conformation
pdb|2PIO|A Chain A, Androgen Receptor Lbd With Small Molecule
pdb|2PIP|L Chain L, Androgen Receptor Lbd With Small Molecule
pdb|2PIQ|A Chain A, Androgen Receptor Lbd With Small Molecule
pdb|2PIR|A Chain A, Androgen Receptor Lbd With Small Molecule
pdb|2PIT|A Chain A, Androgen Receptor Lbd With Small Molecule
pdb|2PIU|A Chain A, Androgen Receptor Lbd With Small Molecule
pdb|2PIV|A Chain A, Androgen Receptor With Small Molecule
pdb|2PIW|A Chain A, Androgen Receptor With Small Molecule
pdb|2PIX|A Chain A, Ar Lbd With Small Molecule
pdb|2PKL|A Chain A, Androgen Receptor Lbd With Small Molecule
pdb|2QPY|A Chain A, Ar Lbd With Small Molecule
Length = 251
Score = 36.6 bits (83), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 32/110 (29%), Positives = 47/110 (42%), Gaps = 3/110 (2%)
Query: 2 AVKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQW-SLPLLESSPLFNASEHVAAVP 60
VKWAK LP F L DQ + A+ W S + S L+ A + V
Sbjct: 47 VVKWAKALPGFRNLHVDDQ-MAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEY 105
Query: 61 NGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFK-SETRGLKD 109
S+ + + + Q F + + P EF C+KA++LF GLK+
Sbjct: 106 RMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKN 155
>pdb|3OLL|A Chain A, Crystal Structure Of Phosphorylated Estrogen Receptor Beta
Ligand Binding Domain
pdb|3OLL|B Chain B, Crystal Structure Of Phosphorylated Estrogen Receptor Beta
Ligand Binding Domain
Length = 240
Score = 36.6 bits (83), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 41/187 (21%), Positives = 68/187 (36%), Gaps = 13/187 (6%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPNG 62
+ WAK +P F L DQV + S+ L A + V G
Sbjct: 50 ISWAKKIPGFVELSLFDQVRLLESCWMEVLMMGLMWRSID--HPGKLIFAPDLVLDRDEG 107
Query: 63 KASQTAADV-RVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQ--------- 112
K + ++ +L RFR + + E+ C+KA++L S L + Q
Sbjct: 108 KCVEGILEIFDMLLATTSRFRELKLQHKEYLCVKAMILLNSSMYPLVTATQDADSSRKLA 167
Query: 113 -VENLQDQAQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSM 171
+ N A V + Q R LL++ S R+ + ++H+ K +
Sbjct: 168 HLLNAVTDALVWVIAKSGISSQQQSMRLANLLMLLSHVRHASNKGMEHLLNMKCKNVVPV 227
Query: 172 EKLLCDM 178
LL +M
Sbjct: 228 XDLLLEM 234
>pdb|1L2J|A Chain A, Human Estrogen Receptor Beta Ligand-Binding Domain In
Complex With (R,
R)-5,11-Cis-Diethyl-5,6,11,12-Tetrahydrochrysene-2,
8-Diol
pdb|1L2J|B Chain B, Human Estrogen Receptor Beta Ligand-Binding Domain In
Complex With (R,
R)-5,11-Cis-Diethyl-5,6,11,12-Tetrahydrochrysene-2,
8-Diol
Length = 271
Score = 36.6 bits (83), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 41/187 (21%), Positives = 68/187 (36%), Gaps = 13/187 (6%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPNG 62
+ WAK +P F L DQV + S+ L A + V G
Sbjct: 76 ISWAKKIPGFVELSLFDQVRLLESCWMEVLMMGLMWRSID--HPGKLIFAPDLVLDRDEG 133
Query: 63 KASQTAADV-RVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQ--------- 112
K + ++ +L RFR + + E+ C+KA++L S L + Q
Sbjct: 134 KCVEGILEIFDMLLATTSRFRELKLQHKEYLCVKAMILLNSSMYPLVTATQDADSSRKLA 193
Query: 113 -VENLQDQAQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSM 171
+ N A V + Q R LL++ S R+ + ++H+ K +
Sbjct: 194 HLLNAVTDALVWVIAKSGISSQQQSMRLANLLMLLSHVRHASNKGMEHLLNMKCKNVVPV 253
Query: 172 EKLLCDM 178
LL +M
Sbjct: 254 YDLLLEM 260
>pdb|1GS4|A Chain A, Structural Basis For The Glucocorticoid Response In A
Mutant Human Androgen Receptor (Arccr) Derived From An
Androgen-Independent Prostate Cancer
Length = 248
Score = 36.6 bits (83), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 32/110 (29%), Positives = 47/110 (42%), Gaps = 3/110 (2%)
Query: 2 AVKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQW-SLPLLESSPLFNASEHVAAVP 60
VKWAK LP F L DQ + A+ W S + S L+ A + V
Sbjct: 46 VVKWAKALPGFRNLHVDDQ-MAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEY 104
Query: 61 NGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFK-SETRGLKD 109
S+ + + + Q F + + P EF C+KA++LF GLK+
Sbjct: 105 RMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKN 154
>pdb|2Z4J|A Chain A, Crystal Structure Of Ar Lbd With Shp Peptide Nr Box 2
Length = 248
Score = 36.6 bits (83), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 32/110 (29%), Positives = 47/110 (42%), Gaps = 3/110 (2%)
Query: 2 AVKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQW-SLPLLESSPLFNASEHVAAVP 60
VKWAK LP F L DQ + A+ W S + S L+ A + V
Sbjct: 45 VVKWAKALPGFRNLHVDDQ-MAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEY 103
Query: 61 NGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFK-SETRGLKD 109
S+ + + + Q F + + P EF C+KA++LF GLK+
Sbjct: 104 RMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKN 153
>pdb|1U9E|A Chain A, Crystal Structure Of Estrogen Receptor Beta Complexed With
Way-397
pdb|1U9E|B Chain B, Crystal Structure Of Estrogen Receptor Beta Complexed With
Way-397
pdb|1U3R|A Chain A, Crystal Structure Of Estrogen Receptor Beta Complexed With
Way-338
pdb|1U3R|B Chain B, Crystal Structure Of Estrogen Receptor Beta Complexed With
Way-338
Length = 241
Score = 36.6 bits (83), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 41/187 (21%), Positives = 68/187 (36%), Gaps = 13/187 (6%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPNG 62
+ WAK +P F L DQV + S+ L A + V G
Sbjct: 50 ISWAKKIPGFVELSLFDQVRLLESCWMEVLMMGLMWRSID--HPGKLIFAPDLVLDRDEG 107
Query: 63 KASQTAADV-RVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQ--------- 112
K + ++ +L RFR + + E+ C+KA++L S L + Q
Sbjct: 108 KCVEGILEIFDMLLATTSRFRELKLQHKEYLCVKAMILLNSSMYPLVTATQDADSSRKLA 167
Query: 113 -VENLQDQAQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSM 171
+ N A V + Q R LL++ S R+ + ++H+ K +
Sbjct: 168 HLLNAVTDALVWVIAKSGISSQQQSMRLANLLMLLSHVRHASNKGMEHLLNMKCKNVVPV 227
Query: 172 EKLLCDM 178
LL +M
Sbjct: 228 YDLLLEM 234
>pdb|1NDE|A Chain A, Estrogen Receptor Beta With Selective Triazine Modulator
Length = 255
Score = 36.6 bits (83), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 41/187 (21%), Positives = 68/187 (36%), Gaps = 13/187 (6%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPNG 62
+ WAK +P F L DQV + S+ L A + V G
Sbjct: 64 ISWAKKIPGFVELSLFDQVRLLESCWMEVLMMGLMWRSID--HPGKLIFAPDLVLDRDEG 121
Query: 63 KASQTAADV-RVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQ--------- 112
K + ++ +L RFR + + E+ C+KA++L S L + Q
Sbjct: 122 KCVEGILEIFDMLLATTSRFRELKLQHKEYLCVKAMILLNSSMYPLVTATQDADSSRKLA 181
Query: 113 -VENLQDQAQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSM 171
+ N A V + Q R LL++ S R+ + ++H+ K +
Sbjct: 182 HLLNAVTDALVWVIAKSGISSQQQSMRLANLLMLLSHVRHASNKGMEHLLNMKCKNVVPV 241
Query: 172 EKLLCDM 178
LL +M
Sbjct: 242 YDLLLEM 248
>pdb|3RLL|A Chain A, Crystal Structure Of The T877a Androgen Receptor Ligand
Binding Domain In Complex With
(S)-N-(4-Cyano-3-(Trifluoromethyl)phenyl)-3-(4-
Cyanonaphthalen-1-Yloxy)-2-Hydroxy-2-Methylpropanamide
Length = 247
Score = 36.6 bits (83), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 32/110 (29%), Positives = 47/110 (42%), Gaps = 3/110 (2%)
Query: 2 AVKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQW-SLPLLESSPLFNASEHVAAVP 60
VKWAK LP F L DQ + A+ W S + S L+ A + V
Sbjct: 45 VVKWAKALPGFRNLHVDDQ-MAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEY 103
Query: 61 NGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFK-SETRGLKD 109
S+ + + + Q F + + P EF C+KA++LF GLK+
Sbjct: 104 RMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKN 153
>pdb|3RLJ|A Chain A, Crystal Structure Of The Androgen Receptor Ligand Binding
Domain In Complex With Sarm S-22
Length = 247
Score = 36.6 bits (83), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 32/110 (29%), Positives = 47/110 (42%), Gaps = 3/110 (2%)
Query: 2 AVKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQW-SLPLLESSPLFNASEHVAAVP 60
VKWAK LP F L DQ + A+ W S + S L+ A + V
Sbjct: 45 VVKWAKALPGFRNLHVDDQ-MAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEY 103
Query: 61 NGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFK-SETRGLKD 109
S+ + + + Q F + + P EF C+KA++LF GLK+
Sbjct: 104 RMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKN 153
>pdb|2GIU|A Chain A, Human Estrogen Receptor Beta Ligand-Binding Domain In
Complex With Compound 45
Length = 241
Score = 36.6 bits (83), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 41/187 (21%), Positives = 68/187 (36%), Gaps = 13/187 (6%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPNG 62
+ WAK +P F L DQV + S+ L A + V G
Sbjct: 51 ISWAKKIPGFVELSLFDQVRLLESCWMEVLMMGLMWRSID--HPGKLIFAPDLVLDRDEG 108
Query: 63 KASQTAADV-RVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQ--------- 112
K + ++ +L RFR + + E+ C+KA++L S L + Q
Sbjct: 109 KCVEGILEIFDMLLATTSRFRELKLQHKEYLCVKAMILLNSSMYPLVTATQDADSSRKLA 168
Query: 113 -VENLQDQAQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSM 171
+ N A V + Q R LL++ S R+ + ++H+ K +
Sbjct: 169 HLLNAVTDALVWVIAKSGISSQQQSMRLANLLMLLSHVRHASNKGMEHLLNMKCKNVVPV 228
Query: 172 EKLLCDM 178
LL +M
Sbjct: 229 YDLLLEM 235
>pdb|3L3X|A Chain A, Crystal Structure Of Dht-Bound Androgen Receptor In
Complex With The First Motif Of Steroid Receptor
Coactivator 3
pdb|3L3Z|A Chain A, Crystal Structure Of Dht-Bound Androgen Receptor In
Complex With The Third Motif Of Steroid Receptor
Coactivator 3
Length = 250
Score = 36.6 bits (83), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 32/110 (29%), Positives = 47/110 (42%), Gaps = 3/110 (2%)
Query: 2 AVKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQW-SLPLLESSPLFNASEHVAAVP 60
VKWAK LP F L DQ + A+ W S + S L+ A + V
Sbjct: 47 VVKWAKALPGFRNLHVDDQ-MAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEY 105
Query: 61 NGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFK-SETRGLKD 109
S+ + + + Q F + + P EF C+KA++LF GLK+
Sbjct: 106 RMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKN 155
>pdb|2NV7|A Chain A, Crystal Structure Of Estrogen Receptor Beta Complexed With
Way-555
pdb|2NV7|B Chain B, Crystal Structure Of Estrogen Receptor Beta Complexed With
Way-555
Length = 238
Score = 36.6 bits (83), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 41/187 (21%), Positives = 68/187 (36%), Gaps = 13/187 (6%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPNG 62
+ WAK +P F L DQV + S+ L A + V G
Sbjct: 48 ISWAKKIPGFVELSLFDQVRLLESCWMEVLMMGLMWRSID--HPGKLIFAPDLVLDRDEG 105
Query: 63 KASQTAADV-RVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQ--------- 112
K + ++ +L RFR + + E+ C+KA++L S L + Q
Sbjct: 106 KCVEGILEIFDMLLATTSRFRELKLQHKEYLCVKAMILLNSSMYPLVTATQDADSSRKLA 165
Query: 113 -VENLQDQAQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSM 171
+ N A V + Q R LL++ S R+ + ++H+ K +
Sbjct: 166 HLLNAVTDALVWVIAKSGISSQQQSMRLANLLMLLSHVRHASNKGMEHLLNMKCKNVVPV 225
Query: 172 EKLLCDM 178
LL +M
Sbjct: 226 YDLLLEM 232
>pdb|2OZ7|A Chain A, Crystal Structure Of The Human Androgen Receptor T877a
Mutant Ligand- Binding Domain With Cyproterone Acetate
Length = 249
Score = 36.2 bits (82), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 32/110 (29%), Positives = 47/110 (42%), Gaps = 3/110 (2%)
Query: 2 AVKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQW-SLPLLESSPLFNASEHVAAVP 60
VKWAK LP F L DQ + A+ W S + S L+ A + V
Sbjct: 45 VVKWAKALPGFRNLHVDDQ-MAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEY 103
Query: 61 NGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFK-SETRGLKD 109
S+ + + + Q F + + P EF C+KA++LF GLK+
Sbjct: 104 RMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKN 153
>pdb|1XOW|A Chain A, Crystal Structure Of The Human Androgen Receptor Ligand
Binding Domain Bound With An Androgen Receptor Nh2-
Terminal Peptide, Ar20-30, And R1881
pdb|1XQ3|A Chain A, Crystal Structure Of The Human Androgen Receptor Ligand
Binding Domain Bound With R1881
pdb|2AO6|A Chain A, Crystal Structure Of The Human Androgen Receptor Ligand
Binding Domain Bound With Tif2(Iii) 740-753 Peptide And
R1881
pdb|3B5R|A Chain A, Crystal Structure Of The Androgen Receptor Ligand Binding
Domain In Complex With Sarm C-31
pdb|3B65|A Chain A, Crystal Structure Of The Androgen Receptor Ligand Binding
Domain In Complex With Sarm S-24
pdb|3B66|A Chain A, Crystal Structure Of The Androgen Receptor Ligand Binding
Domain In Complex With Sarm S-21
pdb|3B67|A Chain A, Crystal Structure Of The Androgen Receptor Ligand Binding
Domain In Complex With Sarm C-23
pdb|3B68|A Chain A, Crystal Structure Of The Androgen Receptor Ligand Binding
Domain In Complex With Sarm S-4
pdb|2YHD|A Chain A, Human Androgen Receptor In Complex With Af2 Small Molecule
Inhibitor
pdb|3V4A|A Chain A, Structure Of Ar Lbd With Activator Peptide And Sarm
Inhibitor 2
Length = 249
Score = 36.2 bits (82), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 32/110 (29%), Positives = 47/110 (42%), Gaps = 3/110 (2%)
Query: 2 AVKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQW-SLPLLESSPLFNASEHVAAVP 60
VKWAK LP F L DQ + A+ W S + S L+ A + V
Sbjct: 45 VVKWAKALPGFRNLHVDDQ-MAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEY 103
Query: 61 NGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFK-SETRGLKD 109
S+ + + + Q F + + P EF C+KA++LF GLK+
Sbjct: 104 RMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKN 153
>pdb|1QKM|A Chain A, Human Oestrogen Receptor Beta Ligand-Binding Domain In
Complex With Partial Agonist Genistein
Length = 255
Score = 36.2 bits (82), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 41/187 (21%), Positives = 68/187 (36%), Gaps = 13/187 (6%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPNG 62
+ WAK +P F L DQV + S+ L A + V G
Sbjct: 56 ISWAKKIPGFVELSLFDQVRLLESCWMEVLMMGLMWRSID--HPGKLIFAPDLVLDRDEG 113
Query: 63 KASQTAADV-RVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQ--------- 112
K + ++ +L RFR + + E+ C+KA++L S L + Q
Sbjct: 114 KCVEGILEIFDMLLATTSRFRELKLQHKEYLCVKAMILLNSSMYPLVTATQDADSSRKLA 173
Query: 113 -VENLQDQAQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSM 171
+ N A V + Q R LL++ S R+ + ++H+ K +
Sbjct: 174 HLLNAVTDALVWVIAKSGISSQQQSMRLANLLMLLSHVRHASNKGMEHLLNMKCKNVVPV 233
Query: 172 EKLLCDM 178
LL +M
Sbjct: 234 YDLLLEM 240
>pdb|1OVL|B Chain B, Crystal Structure Of Nurr1 Lbd
pdb|1OVL|C Chain C, Crystal Structure Of Nurr1 Lbd
pdb|1OVL|E Chain E, Crystal Structure Of Nurr1 Lbd
pdb|1OVL|F Chain F, Crystal Structure Of Nurr1 Lbd
Length = 271
Score = 36.2 bits (82), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 23/81 (28%), Positives = 42/81 (51%), Gaps = 3/81 (3%)
Query: 86 VDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQAQVMLAQHVRTHHPA--QPARFGRLL 143
+D + F+C+ A+ +E GLK+ +VE LQ++ L HV ++ +P +LL
Sbjct: 171 IDISAFSCIAALAXV-TERHGLKEPKRVEELQNKIVNCLKDHVTFNNGGLNRPNYLSKLL 229
Query: 144 LMTSQCRNIPSARVQHIFFAK 164
+ R + + +Q IF+ K
Sbjct: 230 GKLPELRTLCTQGLQRIFYLK 250
>pdb|1ZAF|A Chain A, Crystal Structure Of Estrogen Receptor Beta Complexed With
3-Bromo-6-Hydroxy-2-(4-Hydroxy-Phenyl)-Inden-1-One
pdb|1ZAF|B Chain B, Crystal Structure Of Estrogen Receptor Beta Complexed With
3-Bromo-6-Hydroxy-2-(4-Hydroxy-Phenyl)-Inden-1-One
Length = 238
Score = 36.2 bits (82), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 41/187 (21%), Positives = 68/187 (36%), Gaps = 13/187 (6%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPNG 62
+ WAK +P F L DQV + S+ L A + V G
Sbjct: 48 ISWAKKIPGFVELSLFDQVRLLESCWMEVLMMGLMWRSID--HPGKLIFAPDLVLDRDEG 105
Query: 63 KASQTAADV-RVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQ--------- 112
K + ++ +L RFR + + E+ C+KA++L S L + Q
Sbjct: 106 KCVEGILEIFDMLLATTSRFRELKLQHKEYLCVKAMILLNSAMYPLVTATQDADSSRKLA 165
Query: 113 -VENLQDQAQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSM 171
+ N A V + Q R LL++ S R+ + ++H+ K +
Sbjct: 166 HLLNAVTDALVWVIAKSGISSQQQSMRLANLLMLLSHVRHASNKGMEHLLNMKCKNVVPV 225
Query: 172 EKLLCDM 178
LL +M
Sbjct: 226 YDLLLEM 232
>pdb|1OVL|A Chain A, Crystal Structure Of Nurr1 Lbd
pdb|1OVL|D Chain D, Crystal Structure Of Nurr1 Lbd
Length = 271
Score = 36.2 bits (82), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 23/81 (28%), Positives = 42/81 (51%), Gaps = 3/81 (3%)
Query: 86 VDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQAQVMLAQHVRTHHPA--QPARFGRLL 143
+D + F+C+ A+ +E GLK+ +VE LQ++ L HV ++ +P +LL
Sbjct: 171 IDISAFSCIAALAXV-TERHGLKEPKRVEELQNKIVNCLKDHVTFNNGGLNRPNYLSKLL 229
Query: 144 LMTSQCRNIPSARVQHIFFAK 164
+ R + + +Q IF+ K
Sbjct: 230 GKLPELRTLCTQGLQRIFYLK 250
>pdb|1YY4|A Chain A, Crystal Structure Of Estrogen Receptor Beta Complexed With
1-Chloro-6-(4-Hydroxy-Phenyl)-Naphthalen-2-Ol
pdb|1YY4|B Chain B, Crystal Structure Of Estrogen Receptor Beta Complexed With
1-Chloro-6-(4-Hydroxy-Phenyl)-Naphthalen-2-Ol
pdb|1YYE|A Chain A, Crystal Structure Of Estrogen Receptor Beta Complexed With
Way-202196
pdb|1YYE|B Chain B, Crystal Structure Of Estrogen Receptor Beta Complexed With
Way-202196
Length = 268
Score = 35.8 bits (81), Expect = 0.014, Method: Compositional matrix adjust.
Identities = 41/187 (21%), Positives = 68/187 (36%), Gaps = 13/187 (6%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPNG 62
+ WAK +P F L DQV + S+ L A + V G
Sbjct: 48 ISWAKKIPGFVELSLFDQVRLLESCWMEVLMMGLMWRSID--HPGKLIFAPDLVLDRDEG 105
Query: 63 KASQTAADV-RVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQ--------- 112
K + ++ +L RFR + + E+ C+KA++L S L + Q
Sbjct: 106 KCVEGILEIFDMLLATTSRFRELKLQHKEYLCVKAMILLNSSMYPLVTATQDADSSRKLA 165
Query: 113 -VENLQDQAQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSM 171
+ N A V + Q R LL++ S R+ + ++H+ K +
Sbjct: 166 HLLNAVTDALVWVIAKSGISSQQQSMRLANLLMLLSHVRHASNKGMEHLLNMKCKNVVPV 225
Query: 172 EKLLCDM 178
LL +M
Sbjct: 226 YDLLLEM 232
>pdb|3N00|A Chain A, Crystal Structure Of A Deletion Mutant Of Human Reverba
Ligand Binding Domain Bound With An Ncor Id1 Peptide
Determined To 2.60a
Length = 245
Score = 35.8 bits (81), Expect = 0.014, Method: Compositional matrix adjust.
Identities = 36/162 (22%), Positives = 65/162 (40%), Gaps = 26/162 (16%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPNG 62
V++AK++P F L DQV A + + ++ + LFN +
Sbjct: 82 VEFAKHIPGFRDLSQHDQVTLL----------KAGTFEVLMVRFASLFNVKDQTVMF--- 128
Query: 63 KASQTAADVRVLNGV------------LQRFRLVGVDPAEFACLKAVVLFKSETRGLKDS 110
S+T ++ L + ++ + + E AVVL ++ G+++S
Sbjct: 129 -LSRTTYSLQELGAMGMGDLLSAMFDFSEKLNSLALTEEELGLFTAVVLVSADRSGMENS 187
Query: 111 LQVENLQDQAQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNI 152
VE LQ+ L V + P + +RF +LLL R +
Sbjct: 188 ASVEQLQETLLRALRALVLKNRPLETSRFTKLLLKLPDLRTL 229
>pdb|1R1K|D Chain D, Crystal Structure Of The Ligand-Binding Domains Of The
Heterodimer EcrUSP BOUND TO PONASTERONE A
pdb|2R40|D Chain D, Crystal Structure Of 20e Bound Ecr/usp
Length = 266
Score = 33.9 bits (76), Expect = 0.050, Method: Compositional matrix adjust.
Identities = 38/163 (23%), Positives = 70/163 (42%), Gaps = 22/163 (13%)
Query: 1 MAVKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVP 60
+ V++AK LP FA + DQ+ A + +L + ++A+
Sbjct: 83 LIVEFAKGLPGFAKISQSDQI----------TLLKACSSEVMMLRVARRYDAATDSVLFA 132
Query: 61 NGKA-----SQTAADVRVLNGVLQRFRLVG---VDPAEFACLKAVVLFKSETRGLKDSLQ 112
N +A + A V+ +L R + +D +A L A+V+F S+ GL+ L
Sbjct: 133 NNQAYTRDNYRKAGMAYVIEDLLHFCRCMYSMMMDNVHYALLTAIVIF-SDRPGLEQPLL 191
Query: 113 VENLQDQAQVMLAQHVRTHHPAQP---ARFGRLLLMTSQCRNI 152
VE +Q L ++ + A P FG++L + ++ R +
Sbjct: 192 VEEIQRYYLNTLRVYILNQNSASPRCAVIFGKILGILTEIRTL 234
>pdb|2NXX|E Chain E, Crystal Structure Of The Ligand-Binding Domains Of The
T.Castaneum (Coleoptera) Heterodimer Ecrusp Bound To
Ponasterone A
pdb|2NXX|F Chain F, Crystal Structure Of The Ligand-Binding Domains Of The
T.Castaneum (Coleoptera) Heterodimer Ecrusp Bound To
Ponasterone A
pdb|2NXX|G Chain G, Crystal Structure Of The Ligand-Binding Domains Of The
T.Castaneum (Coleoptera) Heterodimer Ecrusp Bound To
Ponasterone A
pdb|2NXX|H Chain H, Crystal Structure Of The Ligand-Binding Domains Of The
T.Castaneum (Coleoptera) Heterodimer Ecrusp Bound To
Ponasterone A
Length = 248
Score = 33.5 bits (75), Expect = 0.059, Method: Compositional matrix adjust.
Identities = 41/171 (23%), Positives = 73/171 (42%), Gaps = 16/171 (9%)
Query: 1 MAVKWAKNLPSFAALPFRDQV-IXXXXXXXXXXXXNAIQW-----SLPLLESSPLFNASE 54
+ V++AK LP F L DQ+ + A ++ S+ + + P S
Sbjct: 67 LIVEFAKRLPGFDKLLREDQIALLKACSSEVMMFRMARRYDVQTDSILFVNNQPYSRDSY 126
Query: 55 HVAAVPNGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVE 114
++A + +T D+ + R VD AE+A L A+V+F SE L + +VE
Sbjct: 127 NLAGM-----GETIEDLLHFCRTMYSMR---VDNAEYALLTAIVIF-SERPALIEGWKVE 177
Query: 115 NLQDQAQVMLAQHVRTHHPAQPAR-FGRLLLMTSQCRNIPSARVQHIFFAK 164
+Q+ L +V +P F +LL + ++ R + + + F K
Sbjct: 178 KIQEIYLEALRAYVDNRRKPKPGTIFAKLLSVLTELRTLGNQNSEMCFSLK 228
>pdb|4FHH|A Chain A, Development Of Synthetically Accessible Non-Secosteroidal
Hybrid Molecules Combining Vitamin D Receptor Agonism
And Histone Deacetylase Inhibition
pdb|4FHI|A Chain A, Development Of Synthetically Accessible Non-Secosteroidal
Hybrid Molecules Combining Vitamin D Receptor Agonism
And Histone Deacetylase Inhibition
pdb|4G1D|A Chain A, Structural Basis For The Accommodation Of Bis- And
Tris-Aromatic Derivatives In Vitamin D Nuclear Receptor
pdb|4G1Y|A Chain A, Structural Basis For The Accommodation Of Bis- And
Tris-Aromatic Derivatives In Vitamin D Nuclear Receptor
pdb|4G1Z|A Chain A, Structural Basis For The Accommodation Of Bis- And
Tris-Aromatic Derivatives In Vitamin D Nuclear Receptor
pdb|4G20|A Chain A, Structural Basis For The Accommodation Of Bis- And
Tris-Aromatic Derivatives In Vitamin D Nuclear Receptor
pdb|4G21|A Chain A, Structural Basis For The Accommodation Of Bis- And
Tris-Aromatic Derivatives In Vitamin D Nuclear Receptor
pdb|4G2H|A Chain A, Structural Basis For The Accommodation Of Bis- And
Tris-Aromatic Derivatives In Vitamin D Nuclear Receptor
Length = 300
Score = 33.1 bits (74), Expect = 0.084, Method: Compositional matrix adjust.
Identities = 18/54 (33%), Positives = 29/54 (53%), Gaps = 5/54 (9%)
Query: 90 EFACLKAVVLFKSETRGLKDSLQVENLQDQAQVMLAQHVRTHHPAQPARFGRLL 143
E L A+ L + G++D +++E LQD+ +L ++R HP GRLL
Sbjct: 204 EHVLLMAICLLSPDRPGVQDHVRIEALQDRLCDVLQAYIRIQHPG-----GRLL 252
>pdb|2HBH|A Chain A, Crystal Structure Of Vitamin D Nuclear Receptor Ligand
Binding Domain Bound To A Locked Side-Chain Analog Of
Calcitriol And Src-1 Peptide
pdb|2HC4|A Chain A, Crystal Structure Of The Lbd Of Vdr Of Danio Rerio In
Complex With Calcitriol
pdb|2HCD|A Chain A, Crystal Structure Of The Ligand Binding Domain Of The
Vitamin D Nuclear Receptor In Complex With Gemini And A
Coactivator Peptide
pdb|3DR1|A Chain A, Side-Chain Fluorine Atoms Of Non-Steroidal Vitamin D3
Analogs Stabilize Helix 12 Of Vitamin D Receptor
pdb|3O1D|A Chain A, Structure-Function Study Of Gemini Derivatives With Two
Different Side Chains At C-20, Gemini-0072 And
Gemini-0097.
pdb|3O1E|A Chain A, Structure-Function Of Gemini Derivatives With Two
Different Side Chains At C-20, Gemini-0072 And
Gemini-0097
Length = 302
Score = 33.1 bits (74), Expect = 0.085, Method: Compositional matrix adjust.
Identities = 18/54 (33%), Positives = 29/54 (53%), Gaps = 5/54 (9%)
Query: 90 EFACLKAVVLFKSETRGLKDSLQVENLQDQAQVMLAQHVRTHHPAQPARFGRLL 143
E L A+ L + G++D +++E LQD+ +L ++R HP GRLL
Sbjct: 206 EHVLLMAICLLSPDRPGVQDHVRIEALQDRLCDVLQAYIRIQHPG-----GRLL 254
>pdb|2LBD|A Chain A, Ligand-Binding Domain Of The Human Retinoic Acid Receptor
Gamma Bound To All-Trans Retinoic Acid
pdb|3LBD|A Chain A, Ligand-binding Domain Of The Human Retinoic Acid Receptor
Gamma Bound To 9-cis Retinoic Acid
pdb|4LBD|A Chain A, Ligand-binding Domain Of The Human Retinoic Acid Receptor
Gamma Bound To The Synthetic Agonist Bms961
Length = 267
Score = 33.1 bits (74), Expect = 0.097, Method: Compositional matrix adjust.
Identities = 24/96 (25%), Positives = 42/96 (43%)
Query: 86 VDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQAQVMLAQHVRTHHPAQPARFGRLLLM 145
+D E L A+ L + L++ +V+ LQ+ L + R P+QP F R+L+
Sbjct: 167 MDDTETGLLSAICLICGDRMDLEEPEKVDKLQEPLLEALRLYARRRRPSQPYMFPRMLMK 226
Query: 146 TSQCRNIPSARVQHIFFAKTVANTSMEKLLCDMYKN 181
+ R I + + K M L+ +M +N
Sbjct: 227 ITDLRGISTKGAERAITLKMEIPGPMPPLIREMLEN 262
>pdb|2W8Y|A Chain A, Ru486 Bound To The Progesterone Receptor In A Destabilized
Agonistic Conformation
pdb|2W8Y|B Chain B, Ru486 Bound To The Progesterone Receptor In A Destabilized
Agonistic Conformation
pdb|3ZR7|A Chain A, Structural Basis For Agonism And Antagonism For A Set Of
Chemically Related Progesterone Receptor Modulators
pdb|3ZR7|B Chain B, Structural Basis For Agonism And Antagonism For A Set Of
Chemically Related Progesterone Receptor Modulators
pdb|3ZRA|A Chain A, Structural Basis For Agonism And Antagonism For A Set Of
Chemically Related Progesterone Receptor Modulators
pdb|3ZRA|B Chain B, Structural Basis For Agonism And Antagonism For A Set Of
Chemically Related Progesterone Receptor Modulators
pdb|3ZRB|A Chain A, Structural Basis For Agonism And Antagonism For A Set Of
Chemically Related Progesterone Receptor Modulators
pdb|3ZRB|B Chain B, Structural Basis For Agonism And Antagonism For A Set Of
Chemically Related Progesterone Receptor Modulators
pdb|4A2J|A Chain A, Pr X-Ray Structures In Agonist Conformations Reveal Two
Different Mechanisms For Partial Agonism In 11beta-
Substituted Steroids
pdb|4A2J|B Chain B, Pr X-Ray Structures In Agonist Conformations Reveal Two
Different Mechanisms For Partial Agonism In 11beta-
Substituted Steroids
pdb|4APU|A Chain A, Pr X-Ray Structures In Agonist Conformations Reveal Two
Different Mechanisms For Partial Agonism In
11beta-Substituted Steroid
pdb|4APU|B Chain B, Pr X-Ray Structures In Agonist Conformations Reveal Two
Different Mechanisms For Partial Agonism In
11beta-Substituted Steroid
Length = 260
Score = 33.1 bits (74), Expect = 0.097, Method: Compositional matrix adjust.
Identities = 27/117 (23%), Positives = 45/117 (38%), Gaps = 1/117 (0%)
Query: 2 AVKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPN 61
VKW+K+LP F L DQ+ S + L+ A + +
Sbjct: 56 VVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQR 115
Query: 62 GKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKS-ETRGLKDSLQVENLQ 117
K S + + + Q F + V EF C+K ++L + GL+ Q E ++
Sbjct: 116 MKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMR 172
>pdb|1A28|A Chain A, Hormone-Bound Human Progesterone Receptor Ligand-Binding
Domain
pdb|1A28|B Chain B, Hormone-Bound Human Progesterone Receptor Ligand-Binding
Domain
pdb|2OVH|A Chain A, Progesterone Receptor With Bound Asoprisnil And A Peptide
From The Co-Repressor Smrt
pdb|2OVM|A Chain A, Progesterone Receptor With Bound Asoprisnil And A Peptide
From The Co-Repressor Ncor
pdb|3HQ5|A Chain A, Progesterone Receptor Bound To An Alkylpyrrolidine Ligand.
pdb|3HQ5|B Chain B, Progesterone Receptor Bound To An Alkylpyrrolidine Ligand
Length = 256
Score = 33.1 bits (74), Expect = 0.098, Method: Compositional matrix adjust.
Identities = 27/117 (23%), Positives = 45/117 (38%), Gaps = 1/117 (0%)
Query: 2 AVKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPN 61
VKW+K+LP F L DQ+ S + L+ A + +
Sbjct: 52 VVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQR 111
Query: 62 GKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKS-ETRGLKDSLQVENLQ 117
K S + + + Q F + V EF C+K ++L + GL+ Q E ++
Sbjct: 112 MKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMR 168
>pdb|1E3K|A Chain A, Human Progesteron Receptor Ligand Binding Domain In
Complex With The Ligand Metribolone (R1881)
pdb|1E3K|B Chain B, Human Progesteron Receptor Ligand Binding Domain In
Complex With The Ligand Metribolone (R1881)
pdb|3D90|A Chain A, Crystal Structure Of The Human Progesterone Receptor
Ligand- Binding Domain Bound To Levonorgestrel
pdb|3D90|B Chain B, Crystal Structure Of The Human Progesterone Receptor
Ligand- Binding Domain Bound To Levonorgestrel
Length = 258
Score = 33.1 bits (74), Expect = 0.099, Method: Compositional matrix adjust.
Identities = 27/117 (23%), Positives = 45/117 (38%), Gaps = 1/117 (0%)
Query: 2 AVKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPN 61
VKW+K+LP F L DQ+ S + L+ A + +
Sbjct: 54 VVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQR 113
Query: 62 GKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKS-ETRGLKDSLQVENLQ 117
K S + + + Q F + V EF C+K ++L + GL+ Q E ++
Sbjct: 114 MKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMR 170
>pdb|1SQN|A Chain A, Progesterone Receptor Ligand Binding Domain With Bound
Norethindrone
pdb|1SQN|B Chain B, Progesterone Receptor Ligand Binding Domain With Bound
Norethindrone
Length = 261
Score = 32.7 bits (73), Expect = 0.10, Method: Compositional matrix adjust.
Identities = 27/117 (23%), Positives = 45/117 (38%), Gaps = 1/117 (0%)
Query: 2 AVKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPN 61
VKW+K+LP F L DQ+ S + L+ A + +
Sbjct: 57 VVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQR 116
Query: 62 GKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKS-ETRGLKDSLQVENLQ 117
K S + + + Q F + V EF C+K ++L + GL+ Q E ++
Sbjct: 117 MKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMR 173
>pdb|3G8O|A Chain A, Progesterone Receptor With Bound Pyrrolidine 1
pdb|3G8O|B Chain B, Progesterone Receptor With Bound Pyrrolidine 1
Length = 263
Score = 32.7 bits (73), Expect = 0.10, Method: Compositional matrix adjust.
Identities = 27/117 (23%), Positives = 45/117 (38%), Gaps = 1/117 (0%)
Query: 2 AVKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPN 61
VKW+K+LP F L DQ+ S + L+ A + +
Sbjct: 59 VVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQR 118
Query: 62 GKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKS-ETRGLKDSLQVENLQ 117
K S + + + Q F + V EF C+K ++L + GL+ Q E ++
Sbjct: 119 MKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMR 175
>pdb|3KBA|A Chain A, Progesterone Receptor Bound To Sulfonamide Pyrrolidine
Partial Agonist
pdb|3KBA|B Chain B, Progesterone Receptor Bound To Sulfonamide Pyrrolidine
Partial Agonist
Length = 253
Score = 32.7 bits (73), Expect = 0.10, Method: Compositional matrix adjust.
Identities = 27/117 (23%), Positives = 45/117 (38%), Gaps = 1/117 (0%)
Query: 2 AVKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPN 61
VKW+K+LP F L DQ+ S + L+ A + +
Sbjct: 49 VVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQR 108
Query: 62 GKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKS-ETRGLKDSLQVENLQ 117
K S + + + Q F + V EF C+K ++L + GL+ Q E ++
Sbjct: 109 MKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMR 165
>pdb|1SR7|A Chain A, Progesterone Receptor Hormone Binding Domain With Bound
Mometasone Furoate
pdb|1SR7|B Chain B, Progesterone Receptor Hormone Binding Domain With Bound
Mometasone Furoate
pdb|1ZUC|B Chain B, Progesterone Receptor Ligand Binding Domain In Complex
With The Nonsteroidal Agonist Tanaproget
pdb|1ZUC|A Chain A, Progesterone Receptor Ligand Binding Domain In Complex
With The Nonsteroidal Agonist Tanaproget
Length = 259
Score = 32.7 bits (73), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 27/117 (23%), Positives = 45/117 (38%), Gaps = 1/117 (0%)
Query: 2 AVKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPN 61
VKW+K+LP F L DQ+ S + L+ A + +
Sbjct: 55 VVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQR 114
Query: 62 GKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKS-ETRGLKDSLQVENLQ 117
K S + + + Q F + V EF C+K ++L + GL+ Q E ++
Sbjct: 115 MKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMR 171
>pdb|1EXA|A Chain A, Enantiomer Discrimination Illustrated By Crystal
Structures Of The Human Retinoic Acid Receptor Hrargamma
Ligand Binding Domain: The Complex With The Active
R-Enantiomer Bms270394.
pdb|1EXX|A Chain A, Enantiomer Discrimination Illustrated By Crystal
Structures Of The Human Retinoic Acid Receptor Hrargamma
Ligand Binding Domain: The Complex With The Inactive
S-Enantiomer Bms270395
Length = 246
Score = 32.7 bits (73), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 24/96 (25%), Positives = 42/96 (43%)
Query: 86 VDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQAQVMLAQHVRTHHPAQPARFGRLLLM 145
+D E L A+ L + L++ +V+ LQ+ L + R P+QP F R+L+
Sbjct: 146 MDDTETGLLSAICLICGDRMDLEEPEKVDKLQEPLLEALRLYARRRRPSQPYMFPRMLMK 205
Query: 146 TSQCRNIPSARVQHIFFAKTVANTSMEKLLCDMYKN 181
+ R I + + K M L+ +M +N
Sbjct: 206 ITDLRGISTKGAERAITLKMEIPGPMPPLIREMLEN 241
>pdb|1Z5X|E Chain E, Hemipteran Ecdysone Receptor Ligand-Binding Domain
Complexed With Ponasterone A
Length = 310
Score = 32.0 bits (71), Expect = 0.18, Method: Compositional matrix adjust.
Identities = 24/80 (30%), Positives = 39/80 (48%), Gaps = 2/80 (2%)
Query: 86 VDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQAQVMLAQHVRTHH-PAQPARFGRLLL 144
VD AE+A L A+V+F SE L + +VE +Q+ L +V P F +LL
Sbjct: 214 VDNAEYALLTAIVIF-SERPSLSEGWKVEKIQEIYIEALKAYVENRRKPYATTIFAKLLS 272
Query: 145 MTSQCRNIPSARVQHIFFAK 164
+ ++ R + + + F K
Sbjct: 273 VLTELRTLGNMNSETCFSLK 292
>pdb|3VHV|A Chain A, Mineralocorticoid Receptor Ligand-Binding Domain With
Non-Steroidal Antagonist
Length = 260
Score = 31.2 bits (69), Expect = 0.34, Method: Compositional matrix adjust.
Identities = 12/20 (60%), Positives = 13/20 (65%)
Query: 2 AVKWAKNLPSFAALPFRDQV 21
VKWAK LP F LP DQ+
Sbjct: 56 VVKWAKVLPGFKNLPLEDQI 75
>pdb|3VHU|A Chain A, Mineralocorticoid Receptor Ligand-Binding Domain With
Spironolactone
Length = 294
Score = 31.2 bits (69), Expect = 0.36, Method: Compositional matrix adjust.
Identities = 12/19 (63%), Positives = 13/19 (68%)
Query: 3 VKWAKNLPSFAALPFRDQV 21
VKWAK LP F LP DQ+
Sbjct: 91 VKWAKVLPGFKNLPLEDQI 109
>pdb|2A3I|A Chain A, Structural And Biochemical Mechanisms For The
Specificity Of Hormone Binding And Coactivator Assembly
By Mineralocorticoid Receptor
Length = 253
Score = 31.2 bits (69), Expect = 0.37, Method: Compositional matrix adjust.
Identities = 12/20 (60%), Positives = 13/20 (65%)
Query: 2 AVKWAKNLPSFAALPFRDQV 21
VKWAK LP F LP DQ+
Sbjct: 49 VVKWAKVLPGFKNLPLEDQI 68
>pdb|2AA2|A Chain A, Mineralocorticoid Receptor With Bound Aldosterone
pdb|2AA5|A Chain A, Mineralocorticoid Receptor With Bound Progesterone
pdb|2AA5|B Chain B, Mineralocorticoid Receptor With Bound Progesterone
pdb|2AA7|A Chain A, Mineralocorticoid Receptor With Bound
Deoxycorticosterone
Length = 275
Score = 31.2 bits (69), Expect = 0.37, Method: Compositional matrix adjust.
Identities = 12/19 (63%), Positives = 13/19 (68%)
Query: 3 VKWAKNLPSFAALPFRDQV 21
VKWAK LP F LP DQ+
Sbjct: 72 VKWAKVLPGFKNLPLEDQI 90
>pdb|2AA6|A Chain A, Mineralocorticoid Receptor S810l Mutant With Bound
Progesterone
pdb|2AA6|B Chain B, Mineralocorticoid Receptor S810l Mutant With Bound
Progesterone
pdb|2AAX|A Chain A, Mineralocorticoid Receptor Double Mutant With Bound
Cortisone
pdb|2AAX|B Chain B, Mineralocorticoid Receptor Double Mutant With Bound
Cortisone
pdb|2AB2|A Chain A, Mineralocorticoid Receptor Double Mutant With Bound
Spironolactone
pdb|2AB2|B Chain B, Mineralocorticoid Receptor Double Mutant With Bound
Spironolactone
Length = 275
Score = 31.2 bits (69), Expect = 0.38, Method: Compositional matrix adjust.
Identities = 12/19 (63%), Positives = 13/19 (68%)
Query: 3 VKWAKNLPSFAALPFRDQV 21
VKWAK LP F LP DQ+
Sbjct: 72 VKWAKVLPGFKNLPLEDQI 90
>pdb|2OAX|A Chain A, Crystal Structure Of The S810l Mutant Mineralocorticoid
Receptor Associated With Sc9420
pdb|2OAX|B Chain B, Crystal Structure Of The S810l Mutant Mineralocorticoid
Receptor Associated With Sc9420
pdb|2OAX|C Chain C, Crystal Structure Of The S810l Mutant Mineralocorticoid
Receptor Associated With Sc9420
pdb|2OAX|D Chain D, Crystal Structure Of The S810l Mutant Mineralocorticoid
Receptor Associated With Sc9420
pdb|2OAX|E Chain E, Crystal Structure Of The S810l Mutant Mineralocorticoid
Receptor Associated With Sc9420
pdb|2OAX|F Chain F, Crystal Structure Of The S810l Mutant Mineralocorticoid
Receptor Associated With Sc9420
Length = 256
Score = 31.2 bits (69), Expect = 0.38, Method: Compositional matrix adjust.
Identities = 12/19 (63%), Positives = 13/19 (68%)
Query: 3 VKWAKNLPSFAALPFRDQV 21
VKWAK LP F LP DQ+
Sbjct: 53 VKWAKVLPGFKNLPLEDQI 71
>pdb|1Y9R|A Chain A, Crystal Structure Of The Human Mineralocorticoid
Receptor Ligand-Binding Domain Bound To
Deoxycorticosterone And Harboring The S810l Mutation
Responsible For A Severe Form Of Hypertension
pdb|1Y9R|B Chain B, Crystal Structure Of The Human Mineralocorticoid
Receptor Ligand-Binding Domain Bound To
Deoxycorticosterone And Harboring The S810l Mutation
Responsible For A Severe Form Of Hypertension
pdb|1YA3|A Chain A, Crystal Structure Of The Human Mineralocorticoid
Receptor Ligand-Binding Domain Bound To Progesterone
And Harboring The S810l Mutation Responsible For A
Severe Form Of Hypertension
pdb|1YA3|B Chain B, Crystal Structure Of The Human Mineralocorticoid
Receptor Ligand-Binding Domain Bound To Progesterone
And Harboring The S810l Mutation Responsible For A
Severe Form Of Hypertension
pdb|1YA3|C Chain C, Crystal Structure Of The Human Mineralocorticoid
Receptor Ligand-Binding Domain Bound To Progesterone
And Harboring The S810l Mutation Responsible For A
Severe Form Of Hypertension
Length = 255
Score = 30.8 bits (68), Expect = 0.38, Method: Compositional matrix adjust.
Identities = 12/19 (63%), Positives = 13/19 (68%)
Query: 3 VKWAKNLPSFAALPFRDQV 21
VKWAK LP F LP DQ+
Sbjct: 52 VKWAKVLPGFKNLPLEDQI 70
>pdb|2ABI|A Chain A, Crystal Structure Of The Human Mineralocorticoid
Receptor Ligand-Binding Domain Bound To
Deoxycorticosterone
pdb|2ABI|B Chain B, Crystal Structure Of The Human Mineralocorticoid
Receptor Ligand-Binding Domain Bound To
Deoxycorticosterone
pdb|2ABI|C Chain C, Crystal Structure Of The Human Mineralocorticoid
Receptor Ligand-Binding Domain Bound To
Deoxycorticosterone
Length = 256
Score = 30.8 bits (68), Expect = 0.38, Method: Compositional matrix adjust.
Identities = 12/19 (63%), Positives = 13/19 (68%)
Query: 3 VKWAKNLPSFAALPFRDQV 21
VKWAK LP F LP DQ+
Sbjct: 53 VKWAKVLPGFKNLPLEDQI 71
>pdb|3LTX|A Chain A, Crystal Structure Of The Pacific Oyster Estrogen Receptor
Ligand Binding Domain
pdb|3LTX|B Chain B, Crystal Structure Of The Pacific Oyster Estrogen Receptor
Ligand Binding Domain
pdb|3LTX|C Chain C, Crystal Structure Of The Pacific Oyster Estrogen Receptor
Ligand Binding Domain
pdb|3LTX|D Chain D, Crystal Structure Of The Pacific Oyster Estrogen Receptor
Ligand Binding Domain
Length = 243
Score = 30.4 bits (67), Expect = 0.52, Method: Compositional matrix adjust.
Identities = 35/161 (21%), Positives = 64/161 (39%), Gaps = 27/161 (16%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQ--WSLPLLESSPLFNASEH----V 56
+ WAKN+P + L DQV + I+ W + LL + F + EH +
Sbjct: 53 INWAKNVPGYTDLSLSDQV-------------HLIECCW-MELLLLNCAFRSIEHGGKSL 98
Query: 57 AAVPNGKASQTAADVRVLNGVLQRFRLVG-------VDPAEFACLKAVVLFKSETRGLKD 109
A P+ +++ + + ++ V + E L+A+VL +E R L
Sbjct: 99 AFAPDLVLDRSSWSTVEMTEIFEQVAAVSEQMMQNHLHKDELLLLQAMVLVNAEVRRLAS 158
Query: 110 SLQVENLQDQAQVMLAQHVRTHHPAQPARFGRLLLMTSQCR 150
Q+ N+Q + + +HP +LL+ + R
Sbjct: 159 YNQIFNMQQSLLDAIVDTAQKYHPDNVRHVPAVLLLLTHIR 199
>pdb|1R20|D Chain D, Crystal Structure Of The Ligand-Binding Domains Of The
Heterodimer EcrUSP BOUND TO THE SYNTHETIC AGONIST
BYI06830
pdb|3IXP|D Chain D, Crystal Structure Of The Ecdysone Receptor Bound To
Byi08346
Length = 265
Score = 30.4 bits (67), Expect = 0.62, Method: Compositional matrix adjust.
Identities = 36/163 (22%), Positives = 69/163 (42%), Gaps = 22/163 (13%)
Query: 1 MAVKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVP 60
+ V++AK LP F+ + DQ+ A + +L + ++A+
Sbjct: 82 LIVEFAKGLPGFSKISQSDQI----------TLLKACSSEVMMLRVARRYDAATDSVLFA 131
Query: 61 NGKA-----SQTAADVRVLNGVLQRFRLVG---VDPAEFACLKAVVLFKSETRGLKDSLQ 112
N +A + A V+ +L R + +D +A L A+V+F S+ GL+
Sbjct: 132 NNQAYTRDNYRKAGMAYVIEDLLHFCRCMYSMMMDNVHYALLTAIVIF-SDRPGLEQPSL 190
Query: 113 VENLQDQAQVMLAQHVRTHHPAQPAR---FGRLLLMTSQCRNI 152
VE +Q L ++ + A P FG++L + ++ R +
Sbjct: 191 VEEIQRYYLNTLRVYILNQNSASPRSAVIFGKILGILTEIRTL 233
>pdb|1FCX|A Chain A, Isotype Selectivity Of The Human Retinoic Acid Nuclear
Receptor Hrar: The Complex With The Rargamma-Selective
Retinoid Bms184394
pdb|1FCZ|A Chain A, Isotype Selectivity Of The Human Retinoic Acid Nuclear
Receptor Hrar: The Complex With The Panagonist Retinoid
Bms181156
pdb|1FD0|A Chain A, Isotype Selectivity Of The Human Retinoic Acid Nuclear
Receptor Hrar: The Complex With The Rargamma-Selective
Retinoid Sr11254
Length = 235
Score = 30.0 bits (66), Expect = 0.65, Method: Compositional matrix adjust.
Identities = 23/95 (24%), Positives = 41/95 (43%)
Query: 86 VDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQAQVMLAQHVRTHHPAQPARFGRLLLM 145
+D E L A+ L + L++ +V+ LQ+ L + R P+QP F R+L+
Sbjct: 141 MDDTETGLLSAICLICGDRMDLEEPEKVDKLQEPLLEALRLYARRRRPSQPYMFPRMLMK 200
Query: 146 TSQCRNIPSARVQHIFFAKTVANTSMEKLLCDMYK 180
+ R I + + K M L+ +M +
Sbjct: 201 ITDLRGISTKGAERAITLKMEIPGPMPPLIREMLE 235
>pdb|1FCY|A Chain A, Isotype Selectivity Of The Human Retinoic Acid Nuclear
Receptor Hrar: The Complex With The RarbetaGAMMA-
Selective Retinoid Cd564
Length = 236
Score = 30.0 bits (66), Expect = 0.66, Method: Compositional matrix adjust.
Identities = 23/95 (24%), Positives = 41/95 (43%)
Query: 86 VDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQAQVMLAQHVRTHHPAQPARFGRLLLM 145
+D E L A+ L + L++ +V+ LQ+ L + R P+QP F R+L+
Sbjct: 142 MDDTETGLLSAICLICGDRMDLEEPEKVDKLQEPLLEALRLYARRRRPSQPYMFPRMLMK 201
Query: 146 TSQCRNIPSARVQHIFFAKTVANTSMEKLLCDMYK 180
+ R I + + K M L+ +M +
Sbjct: 202 ITDLRGISTKGAERAITLKMEIPGPMPPLIREMLE 236
>pdb|4FNE|A Chain A, X-Ray Crystal Structure Of The Ancestral 3-Keto Steroid
Receptor - Doc Complex
pdb|4FN9|A Chain A, X-Ray Crystal Structure Of The Ancestral 3-Keto Steroid
Receptor - Progesterone Complex
pdb|4FN9|B Chain B, X-Ray Crystal Structure Of The Ancestral 3-Keto Steroid
Receptor - Progesterone Complex
Length = 254
Score = 30.0 bits (66), Expect = 0.70, Method: Compositional matrix adjust.
Identities = 32/111 (28%), Positives = 47/111 (42%), Gaps = 9/111 (8%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQW-SLPLLESSPLFNASEHVAAVPN 61
VKWAK LP F L DQ+ A+ W S L+ A + + N
Sbjct: 51 VKWAKALPGFRNLHLDDQMTLIQYSWMGLMAF-AMGWRSYKHTNGQMLYFAPD---LIFN 106
Query: 62 GKASQTAADVRVLNG---VLQRFRLVGVDPAEFACLKAVVLFKSETR-GLK 108
+ Q +A + G + Q F + V EF C+KA++L + + GLK
Sbjct: 107 EQRMQQSAMYDLCQGMQQISQEFVRLQVTQEEFLCMKALLLLSTVPKEGLK 157
>pdb|3RY9|A Chain A, Crystal Structure Of The Resurrected Ancestral
Glucocorticoid Receptor 1 In Complex With Doc
pdb|3RY9|B Chain B, Crystal Structure Of The Resurrected Ancestral
Glucocorticoid Receptor 1 In Complex With Doc
Length = 250
Score = 30.0 bits (66), Expect = 0.74, Method: Compositional matrix adjust.
Identities = 33/174 (18%), Positives = 69/174 (39%), Gaps = 8/174 (4%)
Query: 2 AVKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPN 61
AVKWAK LP F L DQ+ + S + L+ A + +
Sbjct: 46 AVKWAKALPGFRNLHLDDQMTLLQYSWMSLMAFSLGWRSYQHTNGNMLYFAPDLIFNEER 105
Query: 62 GKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETR-GLK-----DSLQVEN 115
+ S + ++ + F + V E+ C+K ++L + + GLK D +++
Sbjct: 106 MQQSSMYELCKGMHKISLEFVRLQVSYEEYLCMKVLLLLSTVPKDGLKSQAAFDEIRMSY 165
Query: 116 LQDQAQVMLAQHVRTHHPAQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANT 169
+++ + ++ + + Q RF +L + ++ +Q F+ + T
Sbjct: 166 IKELGKAIVKREGNSSQNWQ--RFYQLTKLLDSMHDLVGGLLQFCFYTFVESKT 217
>pdb|3CLD|A Chain A, Ligand Binding Domain Of The Glucocorticoid Receptor
Complexed With Fluticazone Furoate
pdb|3CLD|B Chain B, Ligand Binding Domain Of The Glucocorticoid Receptor
Complexed With Fluticazone Furoate
pdb|3K23|A Chain A, Glucocorticoid Receptor With Bound D-Prolinamide 11
pdb|3K23|B Chain B, Glucocorticoid Receptor With Bound D-Prolinamide 11
pdb|3K23|C Chain C, Glucocorticoid Receptor With Bound D-Prolinamide 11
pdb|3K22|A Chain A, Glucocorticoid Receptor With Bound Alaninamide 10 With
Tif2 Peptide
pdb|3K22|B Chain B, Glucocorticoid Receptor With Bound Alaninamide 10 With
Tif2 Peptide
Length = 259
Score = 30.0 bits (66), Expect = 0.75, Method: Compositional matrix adjust.
Identities = 35/127 (27%), Positives = 53/127 (41%), Gaps = 15/127 (11%)
Query: 2 AVKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQW------SLPLLESSPLFNASEH 55
AVKWAK +P F L DQ+ A+ W S LL +P +E
Sbjct: 56 AVKWAKAIPGFRNLHLDDQMTLLQYSWMYLMAF-ALGWRSYRQSSANLLCFAPDLIINEQ 114
Query: 56 VAAVPNGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVEN 115
+P G Q + V + L R + V E+ C+K ++L S KD L+ +
Sbjct: 115 RMTLP-GMYDQCKHMLYV-SSELHRLQ---VSYEEYLCMKTLLLLSSVP---KDGLKSQE 166
Query: 116 LQDQAQV 122
L D+ ++
Sbjct: 167 LFDEIRM 173
>pdb|3E7C|A Chain A, Glucocorticoid Receptor Lbd Bound To Gsk866
pdb|3E7C|B Chain B, Glucocorticoid Receptor Lbd Bound To Gsk866
Length = 257
Score = 30.0 bits (66), Expect = 0.76, Method: Compositional matrix adjust.
Identities = 35/127 (27%), Positives = 53/127 (41%), Gaps = 15/127 (11%)
Query: 2 AVKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQW------SLPLLESSPLFNASEH 55
AVKWAK +P F L DQ+ A+ W S LL +P +E
Sbjct: 54 AVKWAKAIPGFRNLHLDDQMTLLQYSWMYLMAF-ALGWRSYRQSSANLLCFAPDLIINEQ 112
Query: 56 VAAVPNGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVEN 115
+P G Q + V + L R + V E+ C+K ++L S KD L+ +
Sbjct: 113 RMTLP-GMYDQCKHMLYV-SSELHRLQ---VSYEEYLCMKTLLLLSSVP---KDGLKSQE 164
Query: 116 LQDQAQV 122
L D+ ++
Sbjct: 165 LFDEIRM 171
>pdb|2Q1H|A Chain A, Ancestral Corticoid Receptor In Complex With Aldosterone
pdb|2Q1V|A Chain A, Ancestral Corticoid Receptor In Complex With Cortisol
Length = 250
Score = 29.6 bits (65), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 32/120 (26%), Positives = 50/120 (41%), Gaps = 27/120 (22%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWS-LPLLESSPLFNASEHVAA--- 58
VKWAK LP F L DQ+ IQ+S + L+ S + + +H
Sbjct: 47 VKWAKALPGFRNLHLDDQM-------------TLIQYSWMSLMAFSLGWRSYKHTNGQML 93
Query: 59 ------VPNGKASQTAADVRVLNG---VLQRFRLVGVDPAEFACLKAVVLFKSETR-GLK 108
+ N + Q +A + G + Q F + V EF C+K ++L + + GLK
Sbjct: 94 YFAPDLIFNEERMQQSAMYDLCQGMRQISQEFVRLQVTYEEFLCMKVLLLLSTVPKDGLK 153
>pdb|1DB1|A Chain A, Crystal Structure Of The Nuclear Receptor For Vitamin D
Complexed To Vitamin D
pdb|1IE8|A Chain A, Crystal Structure Of The Nuclear Receptor For Vitamin D
Ligand Binding Domain Bound To Kh1060
pdb|1IE9|A Chain A, Crystal Structure Of The Nuclear Receptor For Vitamin D
Ligand Binding Domain Bound To Mc1288
pdb|3OGT|A Chain A, Design, Chemical Synthesis, Functional Characterization
And Crystal Structure Of The Sidechain Analogue Of
1,25-Dihydroxyvitamin D3.
pdb|3KPZ|A Chain A, Crystal Structure Of A Novel Vitamin D3 Analogue, Zk203278
Showing Dissociated Profile
pdb|3TKC|A Chain A, Design, Synthesis, Evaluation And Structure Of Vitamin D
Analogues With Furan Side Chains
pdb|4G2I|A Chain A, Structural Basis For The Accommodation Of Bis- And
Tris-Aromatic Derivatives In Vitamin D Nuclear Receptor
Length = 259
Score = 29.6 bits (65), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 29/141 (20%), Positives = 58/141 (41%), Gaps = 20/141 (14%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPNG 62
+ +AK +P F L DQ++ +AI+ + +L S+ F + N
Sbjct: 74 IGFAKMIPGFRDLTSEDQIVLLKS--------SAIE--VIMLRSNESFTMDDMSWTCGNQ 123
Query: 63 KASQTAADVRVLNGVLQ------RFRL----VGVDPAEFACLKAVVLFKSETRGLKDSLQ 112
+DV L+ +F++ + + E L A+ + + G++D+
Sbjct: 124 DYKYRVSDVTKAGHSLELIEPLIKFQVGLKKLNLHEEEHVLLMAICIVSPDRPGVQDAAL 183
Query: 113 VENLQDQAQVMLAQHVRTHHP 133
+E +QD+ L ++R HP
Sbjct: 184 IEAIQDRLSNTLQTYIRCRHP 204
>pdb|1S0Z|A Chain A, Crystal Structure Of The Vdr Lbd Complexed To Seocalcitol.
pdb|1S19|A Chain A, Crystal Structure Of Vdr Ligand Binding Domain Complexed
To Calcipotriol.
pdb|1TXI|A Chain A, Crystal Structure Of The Vdr Ligand Binding Domain
Complexed To Tx522
pdb|2HAM|A Chain A, Crystal Structure Of Vdr Lbd Complexed To 2alpha-Propyl-
Calcitriol
pdb|2HAR|A Chain A, Crystal Structure Of Vdr Lbd In Complex With 2 Alpha-(3-
Hydroxy-1-Propoxy) Calcitriol
pdb|2HAS|A Chain A, Crystal Structure Of Vdr Lbd In Complex With 2alpha-(1-
Propoxy) Calcitriol
pdb|2HB7|A Chain A, Crystal Structure Of Vdr Lbd In Complex With 2alpha(3-
Hydroxy-1-Propyl) Calcitriol
pdb|2HB8|A Chain A, Crystal Structure Of Vdr Lbd In Complex With 2alpha-Methyl
Calcitriol
pdb|3CS4|A Chain A, Structure-Based Design Of A Superagonist Ligand For The
Vitamin D Nuclear Receptor
pdb|3CS6|A Chain A, Structure-Based Design Of A Superagonist Ligand For The
Vitamin D Nuclear Receptor
pdb|3A3Z|X Chain X, Crystal Structure Of The Human Vdr Ligand Binding Domain
Bound To The Synthetic Agonist Compound 2alpha-Methyl-
Amcr277a(C23s)
pdb|3A40|X Chain X, Crystal Structure Of The Human Vdr Ligand Binding Domain
Bound To The Synthetic Agonist Compound 2alpha-Methyl-
Amcr277b(C23r)
pdb|3A78|A Chain A, Crystal Structure Of The Human Vdr Ligand Binding Domain
Bound To The Natural Metabolite
1alpha,25-Dihydroxy-3-Epi-Vitamin D3
pdb|3AUQ|A Chain A, Crystal Structure Of The Human Vitamin D Receptor Ligand
Binding Domain Complexed With Yne-Diene Type Analog Of
Active 14-Epi-2alpha- Methyl-19-Norvitamin D3
pdb|3AUR|A Chain A, Crystal Structure Of The Human Vitamin D Receptor Ligand
Binding Domain Complexed With Yne-Diene Type Analog Of
Active 14-Epi-2beta- Methyl-19-Norvitamin D3
pdb|3AX8|A Chain A, Crystal Structure Of The Human Vitamin D Receptor Ligand
Binding Domain Complexed With
15alpha-Methoxy-1alpha,25-Dihydroxyvitamin D3
Length = 263
Score = 29.3 bits (64), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 29/141 (20%), Positives = 58/141 (41%), Gaps = 20/141 (14%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPNG 62
+ +AK +P F L DQ++ +AI+ + +L S+ F + N
Sbjct: 78 IGFAKMIPGFRDLTSEDQIVLLKS--------SAIE--VIMLRSNESFTMDDMSWTCGNQ 127
Query: 63 KASQTAADVRVLNGVLQ------RFRL----VGVDPAEFACLKAVVLFKSETRGLKDSLQ 112
+DV L+ +F++ + + E L A+ + + G++D+
Sbjct: 128 DYKYRVSDVTKAGHSLELIEPLIKFQVGLKKLNLHEEEHVLLMAICIVSPDRPGVQDAAL 187
Query: 113 VENLQDQAQVMLAQHVRTHHP 133
+E +QD+ L ++R HP
Sbjct: 188 IEAIQDRLSNTLQTYIRCRHP 208
>pdb|2Q3Y|A Chain A, Ancestral Corticiod Receptor In Complex With Doc
Length = 249
Score = 29.3 bits (64), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 32/120 (26%), Positives = 50/120 (41%), Gaps = 27/120 (22%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWS-LPLLESSPLFNASEHVAA--- 58
VKWAK LP F L DQ+ IQ+S + L+ S + + +H
Sbjct: 47 VKWAKALPGFRNLHLDDQM-------------TLIQYSWMSLMAFSLGWRSYKHTNGQML 93
Query: 59 ------VPNGKASQTAADVRVLNG---VLQRFRLVGVDPAEFACLKAVVLFKSETR-GLK 108
+ N + Q +A + G + Q F + V EF C+K ++L + + GLK
Sbjct: 94 YFAPDLIFNEERMQQSAMYDLCQGMRQISQEFVRLQVTYEEFLCMKVLLLLSTVPKDGLK 153
>pdb|3AZ1|A Chain A, Crystal Structure Analysis Of Vitamin D Receptor
pdb|3AZ2|A Chain A, Crystal Structure Analysis Of Vitamin D Receptor
pdb|3AZ3|A Chain A, Crystal Structure Analysis Of Vitamin D Receptor
Length = 253
Score = 29.3 bits (64), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 29/142 (20%), Positives = 58/142 (40%), Gaps = 20/142 (14%)
Query: 2 AVKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPN 61
+ +AK +P F L DQ++ +AI+ + +L S+ F + N
Sbjct: 71 VIGFAKMIPGFRDLTSEDQIVLLKS--------SAIE--VIMLRSNESFTMDDMSWTCGN 120
Query: 62 GKASQTAADVRVLNGVLQ------RFRL----VGVDPAEFACLKAVVLFKSETRGLKDSL 111
+DV L+ +F++ + + E L A+ + + G++D+
Sbjct: 121 QDYKYRVSDVTKAGHSLELIEPLIKFQVGLKKLNLHEEEHVLLMAICIVSPDRPGVQDAA 180
Query: 112 QVENLQDQAQVMLAQHVRTHHP 133
+E +QD+ L ++R HP
Sbjct: 181 LIEAIQDRLSNTLQTYIRCRHP 202
>pdb|3B0T|A Chain A, Human Vdr Ligand Binding Domain In Complex With
Maxacalcitol
Length = 254
Score = 29.3 bits (64), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 29/141 (20%), Positives = 58/141 (41%), Gaps = 20/141 (14%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPNG 62
+ +AK +P F L DQ++ +AI+ + +L S+ F + N
Sbjct: 73 IGFAKMIPGFRDLTSEDQIVLLKS--------SAIE--VIMLRSNESFTMDDMSWTCGNQ 122
Query: 63 KASQTAADVRVLNGVLQ------RFRL----VGVDPAEFACLKAVVLFKSETRGLKDSLQ 112
+DV L+ +F++ + + E L A+ + + G++D+
Sbjct: 123 DYKYRVSDVTKAGHSLELIEPLIKFQVGLKKLNLHEEEHVLLMAICIVSPDRPGVQDAAL 182
Query: 113 VENLQDQAQVMLAQHVRTHHP 133
+E +QD+ L ++R HP
Sbjct: 183 IEAIQDRLSNTLQTYIRCRHP 203
>pdb|3M7R|A Chain A, Crystal Structure Of Vdr H305q Mutant
Length = 253
Score = 29.3 bits (64), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 29/142 (20%), Positives = 58/142 (40%), Gaps = 20/142 (14%)
Query: 2 AVKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPN 61
+ +AK +P F L DQ++ +AI+ + +L S+ F + N
Sbjct: 71 VIGFAKMIPGFRDLTSEDQIVLLKS--------SAIE--VIMLRSNESFTMDDMSWTCGN 120
Query: 62 GKASQTAADVRVLNGVLQ------RFRL----VGVDPAEFACLKAVVLFKSETRGLKDSL 111
+DV L+ +F++ + + E L A+ + + G++D+
Sbjct: 121 QDYKYRVSDVTKAGQSLELIEPLIKFQVGLKKLNLHEEEHVLLMAICIVSPDRPGVQDAA 180
Query: 112 QVENLQDQAQVMLAQHVRTHHP 133
+E +QD+ L ++R HP
Sbjct: 181 LIEAIQDRLSNTLQTYIRCRHP 202
>pdb|3P8X|A Chain A, Synthesis, Structure, And Biological Activity Of Des-Side
Chain Analogues Of 1alpha,25-Dihydroxyvitamin D3 With
Substituents At C-18
Length = 280
Score = 29.3 bits (64), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 29/141 (20%), Positives = 58/141 (41%), Gaps = 20/141 (14%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPNG 62
+ +AK +P F L DQ++ +AI+ + +L S+ F + N
Sbjct: 95 IGFAKMIPGFRDLTSEDQIVLLKS--------SAIE--VIMLRSNESFTMDDMSWTCGNQ 144
Query: 63 KASQTAADVRVLNGVLQ------RFRL----VGVDPAEFACLKAVVLFKSETRGLKDSLQ 112
+DV L+ +F++ + + E L A+ + + G++D+
Sbjct: 145 DYKYRVSDVTKAGHSLELIEPLIKFQVGLKKLNLHEEEHVLLMAICIVSPDRPGVQDAAL 204
Query: 113 VENLQDQAQVMLAQHVRTHHP 133
+E +QD+ L ++R HP
Sbjct: 205 IEAIQDRLSNTLQTYIRCRHP 225
>pdb|2ZFX|A Chain A, Crystal Structure Of The Rat Vitamin D Receptor Ligand
Binding Domain Complexed With Yr301 And A Synthetic
Peptide Containing The Nr2 Box Of Drip 205
pdb|3A2H|A Chain A, Crystal Structure Of The Rat Vitamin D Receptor Ligand
Binding Domain Complexed With Tei-9647 And A Synthetic
Peptide Containing The Nr2 Box Of Drip 205
pdb|3AUN|A Chain A, Crystal Structure Of The Rat Vitamin D Receptor Ligand
Binding Domain Complexed With Yr335 And A Synthetic
Peptide Containing The Nr2 Box Of Drip 205
Length = 265
Score = 29.3 bits (64), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 28/132 (21%), Positives = 54/132 (40%), Gaps = 2/132 (1%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPN- 61
+ +AK +P F L DQ++ + Q S + + S + ++ V +
Sbjct: 80 IGFAKMIPGFRDLTSDDQIVLLKSSAIEVIMLRSNQ-SFTMDDMSWDCGSQDYKYDVTDV 138
Query: 62 GKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQAQ 121
KA T + L + + + E L A+ + + G++D+ VE +QD+
Sbjct: 139 SKAGHTLELIEPLIKFQVGLKKLNLHEEEHVLLMAICIVSPDRPGVQDAKLVEAIQDRLS 198
Query: 122 VMLAQHVRTHHP 133
L ++R HP
Sbjct: 199 NTLQTYIRCRHP 210
>pdb|2XHS|A Chain A, Crystal Structure Of The Ligand Binding Domain Of Fushi
Tarazu Factor 1 Of Drosophila Melanogaster
Length = 245
Score = 29.3 bits (64), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 18/102 (17%), Positives = 39/102 (38%)
Query: 74 LNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQAQVMLAQHVRTHHP 133
N + + + + D ++ C K ++L RG+ + V D Q L + T +P
Sbjct: 134 FNELQNKLQDLKFDXGDYVCXKFLILLNPSVRGIVNRKTVSEGHDNVQAALLDYTLTCYP 193
Query: 134 AQPARFGRLLLMTSQCRNIPSARVQHIFFAKTVANTSMEKLL 175
+ +F L+ + + H++ + + LL
Sbjct: 194 SVNDKFRGLVNILPEIHAXAVRGEDHLYTKHCAGSAPTQTLL 235
>pdb|3A2J|A Chain A, Crystal Structure Of The Human Vitamin D Receptor
(H305fH397F) LIGAND Binding Domain Complexed With
Tei-9647
Length = 263
Score = 29.3 bits (64), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 29/142 (20%), Positives = 58/142 (40%), Gaps = 20/142 (14%)
Query: 2 AVKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPN 61
+ +AK +P F L DQ++ +AI+ + +L S+ F + N
Sbjct: 77 VIGFAKMIPGFRDLTSEDQIVLLKS--------SAIE--VIMLRSNESFTMDDMSWTCGN 126
Query: 62 GKASQTAADVRVLNGVLQ------RFRL----VGVDPAEFACLKAVVLFKSETRGLKDSL 111
+DV L+ +F++ + + E L A+ + + G++D+
Sbjct: 127 QDYKYRVSDVTKAGFSLELIEPLIKFQVGLKKLNLHEEEHVLLMAICIVSPDRPGVQDAA 186
Query: 112 QVENLQDQAQVMLAQHVRTHHP 133
+E +QD+ L ++R HP
Sbjct: 187 LIEAIQDRLSNTLQTYIRCRHP 208
>pdb|3A2I|A Chain A, Crystal Structure Of The Human Vitamin D Receptor (H305f)
Ligand Binding Domain Complexed With Tei-9647
Length = 263
Score = 28.9 bits (63), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 29/141 (20%), Positives = 58/141 (41%), Gaps = 20/141 (14%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPNG 62
+ +AK +P F L DQ++ +AI+ + +L S+ F + N
Sbjct: 78 IGFAKMIPGFRDLTSEDQIVLLKS--------SAIE--VIMLRSNESFTMDDMSWTCGNQ 127
Query: 63 KASQTAADVRVLNGVLQ------RFRL----VGVDPAEFACLKAVVLFKSETRGLKDSLQ 112
+DV L+ +F++ + + E L A+ + + G++D+
Sbjct: 128 DYKYRVSDVTKAGFSLELIEPLIKFQVGLKKLNLHEEEHVLLMAICIVSPDRPGVQDAAL 187
Query: 113 VENLQDQAQVMLAQHVRTHHP 133
+E +QD+ L ++R HP
Sbjct: 188 IEAIQDRLSNTLQTYIRCRHP 208
>pdb|2ZL9|A Chain A, 2-Substituted-16-Ene-22-Thia-1alpha,25-Dihydroxy-26,27-
Dimethyl-19-Norvitamin D3 Analogs: Synthesis, Biological
Evaluation And Crystal Structure
pdb|2ZLA|A Chain A, 2-Substituted-16-Ene-22-Thia-1alpha,25-Dihydroxy-26,27-
Dimethyl-19-Norvitamin D3 Analogs: Synthesis, Biological
Evaluation And Crystal Structure
pdb|2ZLC|A Chain A, 2-Substituted-16-Ene-22-Thia-1alpha,25-Dihydroxy-26,27-
Dimethyl-19-Norvitamin D3 Analogs: Synthesis, Biological
Evaluation And Crystal Structure
pdb|2ZMH|A Chain A, Crystal Structure Of Rat Vitamin D Receptor Bound To
Adamantyl Vitamin D Analogs: Structural Basis For
Vitamin D Receptor Antagonism AndOR PARTIAL AGONISM
pdb|2ZMI|A Chain A, Crystal Structure Of Rat Vitamin D Receptor Bound To
Adamantyl Vitamin D Analogs: Structural Basis For
Vitamin D Receptor Antagonism AndOR PARTIAL AGONISM
pdb|2ZMJ|A Chain A, Crystal Structure Of Rat Vitamin D Receptor Bound To
Adamantyl Vitamin D Analogs: Structural Basis For
Vitamin D Receptor Antagonism AndOR PARTIAL AGONISM
pdb|2ZXM|A Chain A, A New Class Of Vitamin D Receptor Ligands That Induce
Structural Rearrangement Of The Ligand-Binding Pocket
pdb|2ZXN|A Chain A, A New Class Of Vitamin D Receptor Ligands That Induce
Structural Rearrangement Of The Ligand-Binding Pocket
pdb|3AFR|A Chain A, Crystal Structure Of
Vdr-Lbd22S-Butyl-1a,24r-Dihydroxyvitamin D3 Complex
pdb|3VJS|A Chain A, Vitamin D Receptor Complex With A Carborane Compound
pdb|3VJT|A Chain A, Vitamin D Receptor Complex With A Carborane Compound
pdb|3VRT|A Chain A, Vdr Ligand Binding Domain In Complex With
2-Mehylidene-19,25,26,27-
Tetranor-1alpha,24-Dihydroxyvitamind3
pdb|3VRU|A Chain A, Vdr Ligand Binding Domain In Complex With
2-Methylidene-19,24-Dinor- 1alpha,25-Dihydroxy Vitamind3
pdb|3VRV|A Chain A, Vdr Ligand Binding Domain In Complex With
2-Methylidene-26,27-
Dimethyl-19,24-Dinor-1alpha,25-Dihydroxyvitamin D3
pdb|3VRW|A Chain A, Vdr Ligand Binding Domain In Complex With
22s-Butyl-2-Methylidene-26,
27-Dimethyl-19,24-Dinor-1alpha,25-Dihydroxyvitamin D3
Length = 271
Score = 28.9 bits (63), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 28/132 (21%), Positives = 54/132 (40%), Gaps = 2/132 (1%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPN- 61
+ +AK +P F L DQ++ + Q S + + S + ++ V +
Sbjct: 86 IGFAKMIPGFRDLTSDDQIVLLKSSAIEVIMLRSNQ-SFTMDDMSWDCGSQDYKYDVTDV 144
Query: 62 GKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQAQ 121
KA T + L + + + E L A+ + + G++D+ VE +QD+
Sbjct: 145 SKAGHTLELIEPLIKFQVGLKKLNLHEEEHVLLMAICIVSPDRPGVQDAKLVEAIQDRLS 204
Query: 122 VMLAQHVRTHHP 133
L ++R HP
Sbjct: 205 NTLQTYIRCRHP 216
>pdb|1RJK|A Chain A, Crystal Structure Of The Rat Vitamin D Receptor Ligand
Binding Domain Complexed With 2md And A Synthetic
Peptide Containing The Nr2 Box Of Drip 205
pdb|1RK3|A Chain A, Crystal Structure Of The Rat Vitamin D Receptor Ligand
Binding Domain Complexed With 1,25-Dihydroxyvitamin D3
And A Synthetic Peptide Containing The Nr2 Box Of Drip
205
pdb|1RKG|A Chain A, Crystal Structure Of The Rat Vitamin D Receptor Ligand
Binding Domain Complexed With 2mbisp And A Synthetic
Peptide Containing The Nr2 Box Of Drip 205
pdb|1RKH|A Chain A, Crystal Structure Of The Rat Vitamin D Receptor Ligand
Binding Domain Complexed With 2am20r And A Synthetic
Peptide Containing The Nr2 Box Of Drip 205
pdb|2O4J|A Chain A, Crystal Structure Of Rat Vitamin D Receptor Ligand Binding
Domain Complexed With Vitiii 17-20z And The Nr2 Box Of
Drip 205
pdb|2O4R|A Chain A, Crystal Structure Of Rat Vitamin D Receptor Ligand Binding
Domain Complexed With Vitiii 17-20e And The Nr2 Box Of
Drip 205
Length = 292
Score = 28.9 bits (63), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 28/132 (21%), Positives = 54/132 (40%), Gaps = 2/132 (1%)
Query: 3 VKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQWSLPLLESSPLFNASEHVAAVPN- 61
+ +AK +P F L DQ++ + Q S + + S + ++ V +
Sbjct: 76 IGFAKMIPGFRDLTSDDQIVLLKSSAIEVIMLRSNQ-SFTMDDMSWDCGSQDYKYDVTDV 134
Query: 62 GKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVENLQDQAQ 121
KA T + L + + + E L A+ + + G++D+ VE +QD+
Sbjct: 135 SKAGHTLELIEPLIKFQVGLKKLNLHEEEHVLLMAICIVSPDRPGVQDAKLVEAIQDRLS 194
Query: 122 VMLAQHVRTHHP 133
L ++R HP
Sbjct: 195 NTLQTYIRCRHP 206
>pdb|1NHZ|A Chain A, Crystal Structure Of The Antagonist Form Of Glucocorticoid
Receptor
pdb|1P93|A Chain A, Crystal Structure Of The Agonist Form Of Glucocorticoid
Receptor
pdb|1P93|B Chain B, Crystal Structure Of The Agonist Form Of Glucocorticoid
Receptor
pdb|1P93|C Chain C, Crystal Structure Of The Agonist Form Of Glucocorticoid
Receptor
pdb|1P93|D Chain D, Crystal Structure Of The Agonist Form Of Glucocorticoid
Receptor
Length = 280
Score = 28.5 bits (62), Expect = 2.0, Method: Compositional matrix adjust.
Identities = 32/127 (25%), Positives = 52/127 (40%), Gaps = 15/127 (11%)
Query: 2 AVKWAKNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQW------SLPLLESSPLFNASEH 55
AVKWAK +P F L DQ+ A+ W S LL +P +E
Sbjct: 77 AVKWAKAIPGFRNLHLDDQMTLLQYSWMSLMAF-ALGWRSYRQSSANLLCFAPDLIINEQ 135
Query: 56 VAAVPNGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSETRGLKDSLQVEN 115
+P+ + ++ L R + V E+ C+K ++L S KD L+ +
Sbjct: 136 RMTLPD--MYDQCKHMLYVSSELHRLQ---VSYEEYLCMKTLLLLSSVP---KDGLKSQE 187
Query: 116 LQDQAQV 122
L D+ ++
Sbjct: 188 LFDEIRM 194
>pdb|2WJP|A Chain A, Crystal Structure Of Murd Ligase In Complex With D-Glu
Containing Rhodanine Inhibitor
pdb|2X5O|A Chain A, Discovery Of Novel 5-Benzylidenerhodanine- And
5-Benzylidene- Thiazolidine-2,4-Dione Inhibitors Of Murd
Ligase
pdb|2XPC|A Chain A, Second-Generation Sulfonamide Inhibitors Of Murd: Activity
Optimisation With Conformationally Rigid Analogues Of D-
Glutamic Acid
Length = 439
Score = 27.7 bits (60), Expect = 3.5, Method: Compositional matrix adjust.
Identities = 26/108 (24%), Positives = 43/108 (39%), Gaps = 19/108 (17%)
Query: 7 KNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQW----------SLPLLESSPLFNASEHV 56
K L +F LP R +V+ N ++W S + + + H+
Sbjct: 291 KALTTFTGLPHRFEVVLEH---------NGVRWINDSKATNVGSTEAALNGLHVDGTLHL 341
Query: 57 AAVPNGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSET 104
+GK++ + R LNG R G D A+ A L+ V ++ET
Sbjct: 342 LLGGDGKSADFSPLARYLNGDNVRLYCFGRDGAQLAALRPEVAEQTET 389
>pdb|2JFF|A Chain A, Crystal Structure Of Murd Ligase In Complex With D-Glu
Containing Sulfonamide Inhibitor
pdb|2JFG|A Chain A, Crystal Structure Of Murd Ligase In Complex With Uma And
Adp
pdb|2JFH|A Chain A, Crystal Structure Of Murd Ligase In Complex With L-Glu
Containing Sulfonamide Inhibitor
pdb|2UUO|A Chain A, Crystal Structure Of Murd Ligase In Complex With D-Glu
Containing Sulfonamide Inhibitor
pdb|2UUP|A Chain A, Crystal Structure Of Murd Ligase In Complex With D-Glu
Containing Sulfonamide Inhibitor
pdb|2VTD|A Chain A, Crystal Structure Of Murd Ligase In Complex With D-Glu
Containing Sulfonamide Inhibitor
pdb|2VTE|A Chain A, Crystal Structure Of Murd Ligase In Complex With D-Glu
Containing Sulfonamide Inhibitor
pdb|2Y68|A Chain A, Structure-Based Design Of A New Series Of D-Glutamic Acid-
Based Inhibitors Of Bacterial Murd Ligase
pdb|2Y66|A Chain A, New 5-Benzylidenethiazolidine-4-One Inhibitors Of
Bacterial Murd Ligase: Design, Synthesis, Crystal
Structures, And Biological Evaluation
pdb|2Y67|A Chain A, New 5-Benzylidenethiazolidine-4-One Inhibitors Of
Bacterial Murd Ligase: Design, Synthesis, Crystal
Structures, And Biological Evaluation
pdb|2Y1O|A Chain A, Dual-target Inhibitor Of Murd And Mure Ligases: Design,
Synthesis And Binding Mode Studies
Length = 445
Score = 27.7 bits (60), Expect = 3.7, Method: Compositional matrix adjust.
Identities = 26/108 (24%), Positives = 43/108 (39%), Gaps = 19/108 (17%)
Query: 7 KNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQW----------SLPLLESSPLFNASEHV 56
K L +F LP R +V+ N ++W S + + + H+
Sbjct: 292 KALTTFTGLPHRFEVVLEH---------NGVRWINDSKATNVGSTEAALNGLHVDGTLHL 342
Query: 57 AAVPNGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSET 104
+GK++ + R LNG R G D A+ A L+ V ++ET
Sbjct: 343 LLGGDGKSADFSPLARYLNGDNVRLYCFGRDGAQLAALRPEVAEQTET 390
>pdb|2UAG|A Chain A, Udp-N-Acetylmuramoyl-L-Alanine:d-Glutamate Ligase
pdb|3UAG|A Chain A, Udp-N-Acetylmuramoyl-L-Alanine:d-Glutamate Ligase
pdb|4UAG|A Chain A, Udp-N-Acetylmuramoyl-L-Alanine:d-Glutamate Ligase
pdb|1UAG|A Chain A, Udp-N-Acetylmuramoyl-L-Alanine:d-Glutamate Ligase
Length = 437
Score = 27.7 bits (60), Expect = 3.9, Method: Compositional matrix adjust.
Identities = 26/108 (24%), Positives = 43/108 (39%), Gaps = 19/108 (17%)
Query: 7 KNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQW----------SLPLLESSPLFNASEHV 56
K L +F LP R +V+ N ++W S + + + H+
Sbjct: 291 KALTTFTGLPHRFEVVLEH---------NGVRWINDSKATNVGSTEAALNGLHVDGTLHL 341
Query: 57 AAVPNGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSET 104
+GK++ + R LNG R G D A+ A L+ V ++ET
Sbjct: 342 LLGGDGKSADFSPLARYLNGDNVRLYCFGRDGAQLAALRPEVAEQTET 389
>pdb|1E0D|A Chain A, Udp-N-Acetylmuramoyl-L-Alanine:d-Glutamate Ligase
pdb|1EEH|A Chain A, Udp-N-Acetylmuramoyl-L-Alanine:d-Glutamate Ligase
Length = 437
Score = 27.7 bits (60), Expect = 4.0, Method: Compositional matrix adjust.
Identities = 26/108 (24%), Positives = 43/108 (39%), Gaps = 19/108 (17%)
Query: 7 KNLPSFAALPFRDQVIXXXXXXXXXXXXNAIQW----------SLPLLESSPLFNASEHV 56
K L +F LP R +V+ N ++W S + + + H+
Sbjct: 291 KALTTFTGLPHRFEVVLEH---------NGVRWINDSKATNVGSTEAALNGLHVDGTLHL 341
Query: 57 AAVPNGKASQTAADVRVLNGVLQRFRLVGVDPAEFACLKAVVLFKSET 104
+GK++ + R LNG R G D A+ A L+ V ++ET
Sbjct: 342 LLGGDGKSADFSPLARYLNGDNVRLYCFGRDGAQLAALRPEVAEQTET 389
>pdb|4E2J|A Chain A, X-Ray Crystal Structure Of The Ancestral Glucocorticoid
Receptor 2 Ligand Binding Domain In Complex With
Mometasone Furoate And Tif-2 Coactivator Fragment
pdb|4E2J|B Chain B, X-Ray Crystal Structure Of The Ancestral Glucocorticoid
Receptor 2 Ligand Binding Domain In Complex With
Mometasone Furoate And Tif-2 Coactivator Fragment
Length = 250
Score = 27.3 bits (59), Expect = 4.2, Method: Compositional matrix adjust.
Identities = 12/20 (60%), Positives = 13/20 (65%)
Query: 2 AVKWAKNLPSFAALPFRDQV 21
AVKWAK LP F L DQ+
Sbjct: 48 AVKWAKALPGFRNLHLDDQM 67
>pdb|3GN8|A Chain A, X-Ray Crystal Structure Of Ancgr2 In Complex With
Dexamethasone
pdb|3GN8|B Chain B, X-Ray Crystal Structure Of Ancgr2 In Complex With
Dexamethasone
Length = 249
Score = 27.3 bits (59), Expect = 4.3, Method: Compositional matrix adjust.
Identities = 12/20 (60%), Positives = 13/20 (65%)
Query: 2 AVKWAKNLPSFAALPFRDQV 21
AVKWAK LP F L DQ+
Sbjct: 46 AVKWAKALPGFRNLHLDDQM 65
>pdb|1XNX|A Chain A, Crystal Structure Of Constitutive Androstane Receptor
pdb|1XNX|B Chain B, Crystal Structure Of Constitutive Androstane Receptor
Length = 256
Score = 26.9 bits (58), Expect = 6.5, Method: Compositional matrix adjust.
Identities = 15/68 (22%), Positives = 34/68 (50%), Gaps = 2/68 (2%)
Query: 90 EFACLKAVVLFKSETRGLKDSLQVENLQDQAQVMLAQHVRTHHPAQPARF--GRLLLMTS 147
E+ + A LF + G+ +++ LQ++ ++L H+ +RF +L+ + +
Sbjct: 166 EYVLMAATALFSPDRPGVTQREEIDQLQEEMALILNNHIMEQQSRLQSRFLYAKLMGLLA 225
Query: 148 QCRNIPSA 155
R+I +A
Sbjct: 226 DLRSINNA 233
>pdb|1XLS|E Chain E, Crystal Structure Of The Mouse CarRXR LBD HETERODIMER
Bound To Tcpobop And 9cra And A Tif2 Peptide Containg
The Third Lxxll Motifs
pdb|1XLS|F Chain F, Crystal Structure Of The Mouse CarRXR LBD HETERODIMER
Bound To Tcpobop And 9cra And A Tif2 Peptide Containg
The Third Lxxll Motifs
pdb|1XLS|G Chain G, Crystal Structure Of The Mouse CarRXR LBD HETERODIMER
Bound To Tcpobop And 9cra And A Tif2 Peptide Containg
The Third Lxxll Motifs
pdb|1XLS|H Chain H, Crystal Structure Of The Mouse CarRXR LBD HETERODIMER
Bound To Tcpobop And 9cra And A Tif2 Peptide Containg
The Third Lxxll Motifs
Length = 242
Score = 26.9 bits (58), Expect = 6.7, Method: Compositional matrix adjust.
Identities = 15/68 (22%), Positives = 34/68 (50%), Gaps = 2/68 (2%)
Query: 90 EFACLKAVVLFKSETRGLKDSLQVENLQDQAQVMLAQHVRTHHPAQPARF--GRLLLMTS 147
E+ + A LF + G+ +++ LQ++ ++L H+ +RF +L+ + +
Sbjct: 152 EYVLMAATALFSPDRPGVTQREEIDQLQEEMALILNNHIMEQQSRLQSRFLYAKLMGLLA 211
Query: 148 QCRNIPSA 155
R+I +A
Sbjct: 212 DLRSINNA 219
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.323 0.132 0.388
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 4,445,365
Number of Sequences: 62578
Number of extensions: 138437
Number of successful extensions: 947
Number of sequences better than 100.0: 295
Number of HSP's better than 100.0 without gapping: 218
Number of HSP's successfully gapped in prelim test: 77
Number of HSP's that attempted gapping in prelim test: 475
Number of HSP's gapped (non-prelim): 369
length of query: 181
length of database: 14,973,337
effective HSP length: 93
effective length of query: 88
effective length of database: 9,153,583
effective search space: 805515304
effective search space used: 805515304
T: 11
A: 40
X1: 16 ( 7.4 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 40 (21.5 bits)
S2: 48 (23.1 bits)